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Objetives of the thesis 
 
Chiral amines occur as structural elements in many biologically active natural and unnatural 
products. In addition, they find applications as chiral auxiliaries, catalysts, and resolving agents. 
Consequently, the asymmetric hydrogenation of imines has received much attention as a direct, 
atom-economical route to optically active amines. The Pfaltz group has developed chiral iridium 
catalysts enabling the reduction of imines, bearing at least one aryl substituent, in excellent 
enantioselectivities (up to 96% ee). However, purely aliphatic imines gave only low conversions 
and enantioselectivities. Therefore, the development of an efficient protocol for the hydrogenation 
of purely aliphatic imines remained of great interest. 
 
The goal of this doctoral thesis was to continue the studies initiated by F. Barrios to gain a better 
understanding of the reaction course in imine hydrogenation as well as to develop an efficient 
protocol for the iridium-catalysed asymmetric hydrogenation of aliphatic imines. 
 
In the first chapter, the aim was to identify and further investigate the active catalyst in solution. By 
using an achiral iridium complex (with an achiral ligand) and a chiral imine additive, the 
preparation of a chiral catalyst under reaction conditions would demonstrate that cyclometalation of 
the imine additive by the iridium complex generated a more reactive and selective catalyst prior to 
commencing the catalytic cycle of hydrogenation. 
 
The goal of second chapter was to prepare a chiral imine ligand, which would be used as an 
additional ligand for the generation of the chiral catalyst in solution. Three different ligand scaffolds 
were designed with different steric and electronic properties.  
 
The aim of the third project was to optimize the synthetic protocol for asymmetric hydrogenation of 
purely aliphatic imines. An extended catalyst and additive screening as well as optimisation of the 
reaction conditions would result in a highly selective hydrogenation methodology for these 
substrates. 
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Chirality 
 
The left and the right human hand, converse twisting snake houses or corkstrew stairs appear to be similar to 
the general audience. But when attempting to superimpose such objects, they cannot be brought into 
congruence. They are called chiral, an expression that stems from the greek word “χέιρ” (cheir) = hand. The 
same principle applies in chemistry. Molecules which look the same but are mirror images of each other are 
called enantiomers (greek: “ενάντιος” (enantios) = opposite). Enantiomers exhibit the same physical 
properties except their optical rotation which is of opposite orientation. Furthermore, they operate in 
different ways in a chiral environment, such as the human body and thus exhibit different physiological 
properties. Many examples of enantiomers with different physiological properties are known and some are 
shown in Figure 1. An every-day example is the monoterpene carvone (1) found in many essential oils. 
While the (S)-enantiomer smells like caraway, the (R)-enantiomer tastes like spearmint. Another example is 
aspargine (2), a common amino acid. Whereas the (S)-enantiomer tastes bitter, the (R)-enantiomer is tastes 
sweet.[1] More dramatic examples can be found in medicine. The first incident that emphazised the 
importance of enantiomerically pure drugs was Contergan (Thalidomid) (3), where the (R)-enantiomer acts 
as a sedative but the (S)-enantiomer is highly teratogenic.   
 
Figure 1: Enantiomers of commonly encountered every-day chemicals 
 
These examples highlight the need for selective preparation of drugs. Therefore chemists have a strong and 
long-standing interest in the stereoselective synthesis of drugs. Several methods can be used to obtain 
enantiomerically pure material. Four different approaches have been developed to date:  
First of all, application of enantiomerically pure substances isolated from natural resources, which are 
summarized as the “chiral pool”. Examples include amino acids, monosaccharides, terpenes or alkaloids;  
Secondly, resolution (racemate separation), which is achieved by addition of an enantiomerically enriched 
material to afford crystallisation of diastereomerically pure salts or applying separation techniques such as 
chromatography with chiral stationary phase to afford enantiomer separation. This method can only deliver a 
maximum of 50% yield.  
Thirdly, to overcome the loss of 50% of the material, variations of resolution such as dynamic kinetic 
resolution, where interconversion of the racemic starting materials is faster than subsequent separation by 
derivatisation of the material, have been developed. Such procedures are also called DYKAT (dynamic 
kinetic asymmetric transformation);  
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Fourthly, enzymatic or microbiological transformations; these are highly selective and efficient processes but 
often display limited substrate scope. A famous example is the lipase Candida antarctica which has been 
applied in numerous industrial processes;[2] 
Ultimately, asymmetric synthesis and catalysis; while a reagent based approach has been the main focus in 
the early days of investigating stereoselective synthesis, in the last three to four decades the use of chiral 
catalysts has emerged as a very powerful tool for the preparation of enantiomerically pure building blocks.[3] 
 
Asymmetric Synthesis and Catalysis 
 
Asymmetric catalysis can often out-compete other approaches by a number of factors. Artificial catalysts 
offer a large substrate scope and can also be used in organic solvents in contrary to enzymatic or 
microbiological catalytic processes. In asymmetric synthesis, auxiliaries need to be removed and disposed of 
and therefore often require elaborate or cumbersome purification processes. Furthermore, the generation of 
large amounts of waste displays a major drawback. On the other hand, artificial catalysts can circumvent 
these issues both in economic as well as ecological terms. As an example, asymmetric hydrogenation offers a 
number of highly desirable advantages. Perfect atom economy, in that all the atoms the molecules applied in 
the reaction (hydrogen gas and substrate) are incorporated in the product. Usually, high conversions and high 
selectivities are obtained with low catalyst loadings, while reactions are conducted under mild conditions, 
thus offering a large functional group tolerance. 
The importance of asymmetric hydrogenation had been rewarded, together with asymmetric oxidation of 
organic molecules, with the Nobel prize in chemistry in 2001 given to Knowles, Noyori and Sharpless.1 
Famous examples of industrial asymmetric hydrogenation processes include L-DOPA (7) which has been 
produced on a one ton scale per year (Scheme 1).[4],[5]  
 
Scheme 1: Industrial rhodium-catalysed asymmetric hydrogenation of enamine 4 in the L-DOPA process 
 
Vitamin E (11) (Scheme 2)[6] and Metolachlor (15) (Scheme 3)[7] are produced on much larger scale (300 to 
>10’000 tons per year) and highlight the importance of asymmetric hydrogenation for the chemical industry. 
                                                          
1 http://www.nobelprize.org/nobel_prizes/chemistry/laureates/2001/press.html 
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Scheme 2: Industrial ruthenium-catalysed asymmetric hydrogenation of allylic alcohol 8 by BASF 
 
 
Scheme 3: Industrial iridium-cataysed asymmetric hydrogenation of imine 12 by Syngenta 
 
Large scale test reactions have also been conducted in the pharmaceutical industry, such as on levofloxacin[8] 
(19) (Scheme 4)  or dextrometorphan[9] (Scheme 5).  
 
Scheme 4: Industrial iridium-catalysed asymmetric hydrogenation of imine 16 by Daichi Pharmaceuticals 
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Scheme 5: Industrial iridium-catalysed asymmetric hydrogenation of imine 20 by Lonza 
 
 
Chiral amines 
 
Chiral amines are ubiquitous in nature. They are found in many natural products as well as in synthetic 
targets, both drug candidates and agrochemical agents. A selection is given in Figure 2 and Figure 3. Chiral 
amines can be prepared by plethora of synthetic methods. Before the development of stereoselective 
synthesis, the only method to isolate enantiomerically pure amines was by recrystallisation with enantiopure 
carboxylic acids such as tartaric acid or malic acid. A representative example for an industrial synthesis 
evolving from resolution to asymmetric synthesis is given in the case of Tamsulosin (27).[10],[11]  
 
Figure 2: Pharmaceuticals, drug candidates and agrochemicals containing chiral amines 
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Figure 3: Pharmaceuticals, drug candidates and agrochemicals containing chiral amines 
 
Over the years three main synthetic approaches for the preparation of chiral amines have evolved (Scheme 
6). (1) Formation of a carbon-carbon bond by nucleophilic addition of an organometallic reagent to an 
aldimine or ketimine. (2) Reduction of prochiral imines with a chiral catalyst and a hydrogen source. (3) 
carbon-nitrogen bond formation by carbene insertion into a N-H bond.  
 
Scheme 6: Synthetic procedures to prepare chiral amines 
 
Enantioselective hydrogenation of imines represents the most efficient method out of the three to prepare 
enantiomerically enriched chiral amines (except for the preparation of quaternary stereogenic centres alpha 
to an amine). Nevertheless, imine hydrogenation bears a number of challenges: 
 
• C=N double bonds are intrinsically not very reactive and require a Lewis acid to promote 
nucleophilic attack. 
• C=N double bonds are sensitive to hydrolysis, especially under Lewis acidic conditions. 
• They exist as anti/syn isomers, as aminals in the presence of amines and as hemiaminals in the 
presence of alcohols. Imines with an alkyl substituent at the iminoyl carbon can also undergo imine-
enamine tautomerisation. Such species interconvert under the reaction conditons. 
• The reactivity of a C=N double bond is highly dependent on the nitrogen substituent and thus 
sometimes limits the substrate scope. 
• The product amines are strong ligands and thus may poison and deactivate the catalyst. 
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The C=N double bond – isomerisation and other phenomena 
 
Many difficulties with reducing imine double bonds are associated with their existence as E/Z isomers, 
imine/enamine tautomerism as well as E/Z interconversion in solution.  
McCarthy and co-workers have investigated the uncatalysed syn-anti interconversion of N-aryl and N-alkyl 
imines (Scheme 7).[12] For aldimines, energy barriers between 14-20 kcal mol-1 were determined for 
uncatalysed isomerisation in solution (CCl4). The low barriers were explained by the “lateral shift 
mechanism”, also described as in-plane inversion. This isomerisation mechanism involves a linear transition 
state, where the nitrogen is adopting an sp-configuration. All the π-bonds in the aromatic system remain 
intact and the unshared electron pair is occupying the p-orbital of the nitrogen in the transition state. 
 
Scheme 7: “Lateral shift mechanism“ in the E/Z isomerisation of imines 
 
Kessler and co-workers have studied the influence of substituents at the N-aryl ring in the thermal 
isomerisation of chinonaniles 32 (Scheme 8).[13] By determining the coalescence temperature of the proton in 
capital letter by NMR studies, a clear trend towards facilitated isomerisation by electron-poor chinonaniles 
was observed ( 
Table 1). However, the substituent in para-position (e.g. methoxy) facilitates a rotational mechanism by 
electron pair migration to a phenoxide zwitterionic structure. 
 
Scheme 8: Thermic isomerisation of chinonaniles 32 
 
Table 1: Coalescence temperatures of different chinonaniles 32 with electron-withdrawing and –donating substituents 
Coalescence T [°C] 152 146 144 144 140 134 125 125 96 90 68 
R OMe tBu N(Me)2 F H SMe Br I CO2Et C(=O)Me NO2 
 
Clark and Parker reported on a thermodynamic study of imine-enamine tautomerisation in different solvents 
(Scheme 9).[14] A clear trend of polar solvents favouring enamine 34 and 35 formation was observed. 
However, only poor solvent dependence on the cis-/trans-isomerisation of the enamine tautomers 34 and 35 
was observed. This suggested that isomerisation would predominantly proceed via the imine tautomer 33. 
Studies were conducted in d6-DMSO, where imine-enamine tautomerisation is clearly favoured over E/Z 
interconversion. 
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Scheme 9: Enamine interconversion of 34 and 35 via 33 
 
Jennings and Boyd investigated thermal interconversion on a series of N-alkyl ketimines by 1H-NMR 
coalescence experiments in apolar solution (biphenyl, m.p. 69 °C) (Scheme 10).[15] The ∆G values observed 
were insensitive to the nature of the iminoyl carbon substituents (e.g. aryl, alkyl or hydrogen). They 
concluded that thermal E/Z interconversion occurred by a mechanism close to pure nitrogen inversion. For 
an N-aryl substituent, the energy of the dipolar (or diradical) transition state to result in rotation around the 
C=N double bond, would be considerably lowered. This interconversion mechanism was called out-of-plane 
rotation.  
 
Scheme 10: Imine interconversion processes of nitrogen inversion (CAlkyl) and out-of-plane rotation (CAryl) 
 
Furthermore, a strong solvent dependence on the interconversion mechanism was observed. While E/Z 
interconversion of 36 in diphenyl solution was fast at 200 °C, imine-enamine tautomerisation was slow. 
However, when 36 was dissolved in trichlorobenzene, E/Z interconversion was observed already at 140 °C 
by coalescence. Additionally the imine and enamine signals collapsed at 200 °C consistent with rapid imine-
enamine tautomerisation. A more illustrative example is the rapid imine-enamine tautomerisation of 37 in 
deuterated methanol. Imine 37 can be crystallized in pure Z isomeric form. Once dissolved, the C-methyl 
protons rapidly show concomitant deuterium incorporation. This example demonstrated the dominance of 
imine/enamine tautomerism over E/Z isomerisation in methanol.  
 
Figure 4: Imines 36 and 37 
 
Fischer and Albrecht investigated E/Z imine-enamine equilibria of several N-aryl propiophenone-derived 
imines 38 by NMR spectroscopy with regards to N-aryl substituent effects (Scheme 11,  
Table 2).[16] Only substituents in the meta-position of the N-aryl ring displayed a clear Hammet dependence. 
Substituents in the para-position of the N-aryl ring result in additional stabilizing and destabilizing effects 
which could not be correlated or described with Hammet coefficients. 
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Scheme 11: Imine-enamine tautomerism of 38 to 39 
 
Table 2: Percentage of enamine 39 observed by 1H-NMR with different substituents at the N-Aryl ring on 38 
R1 % enamine 
4-NMe2 0 
4-OPh 2.2 
4-OMe 1.6 
4-Me 3.0 
4-F 2.4 
4-Br 5.3 
4-Cl 5.7 
4-CN 27.5 
4-NO2 38.9 
3-Me 4.0 
3-OMe 4.1 
3-F 7.4 
3-Br 7.0 
3-NO2 10.7 
H 3.9 
 
The studies on E/Z ketimine isomers by Jennings and Boyd were extended to investigations of the 
equilibrium distribution of acyclic N-alkyl imines 40 to 45 (Figure 5).[17] Steric factors were investigated by 
increasing the size of the CAlkyl-substituent and it appeared that the larger the CAlkyl-substituent, the E-isomer 
became more destabilized due to steric repulsion. This also concluded that the steric bulk exhibited by a 
phenyl group lies in the range of a n-propyl and iso-propyl group. 
 
Figure 5: Investigation of imine-enamine ratio with regards to the CAlkyl-substituent at the iminoyl carbon in 40 to 45 
 
On the other hand, electronic effects appeared to overrule steric repulsion. Three examples of increasing 
steric bulk around the N-alkyl substituent in 46 to 48 did not change the ratio of E/Z isomers significantly 
(Figure 6). The ratio of E/Z isomers did not change significantly over a large solvent range either: CDCl3, 
CCl4, C6D6, C6H3Cl3, CD3CN, (CD3)2CO and tBuOH. 
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Figure 6: Unaffected E/Z ratio of imines 46 to 48 with increasing size of the N-substituent 
 
Steric repulsion between ortho-substituents of imine 49 resulted in formation of the of the Z isomer. While 
steric clash could be prevented by a rotation of the phenyl substitent out of the plane of delocalization, also a 
destabilizing repulsive interaction between the nitrogen lone pair and the aromatic π-electrons was discussed 
(Scheme 12). 
 
Scheme 12: Favoured formation of the Z isomer in 49 due to electronic repulsion of the aryl ring  
and the nitrogen atom lone pair 
 
James and co-workers investigated the rate of isomerisation of 50 in benzene/MeOH 1:1 at ambient 
temperature (Figure 7).[18] Isomerisation rates of Z=>E of 155 h-1 and E=>Z of 11 h-1 were determined by 
EXSY NMR experiments. These values have been obtained with large mixing times of 1.8 seconds. Thus, 
they need to be considered with care, since accurate numbers can only be obtained with much shorter mixing 
times. They also investigated the asymmetric hydrogenation of imine 50. The TOF of their catalyst was 
determined to be between 14 to 66 h-1. Since the E/Z isomer ratio and the rate of isomerisation did not affect 
the ee, it was concluded that the rate of the reaction entirely depended on the diffusion of hydrogen into the 
solution and not isomerisation. Isomerisation processes catalysed or promoted by the transition metal have 
not been discussed but may well be considered in such an example. 
 
Figure 7: Imine 50 
 
Kocovsky and co-workers have analysed a number of N-aryl imines with aromatic, heteroaromatic and alkyl 
substituents at both carbons adjacent to iminoyl funtionality (Figure 8). The main configuration of the imine 
double bond was observed to be E with E/Z ratios between 10:1 and 7:1. This only holds true as long as one 
substituent is large (e.g. aryl) and one is small (e.g. methyl) as in 51. Mixtures are observed when both 
substituents are sterically demanding, especially in the case of an aryl and a large alkyl substituent as in 52. 
Enamines have been observed predominantly in substrates bearing electron withdrawing substituents such 
CH2COOEt as in 53. They postulated the enamine form to be more stable due to a stabilizing hydrogen-
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bonding between the N-H proton and the electron-withdrawing group. Equilibration of imines was observed 
in CDCl3 solution in the case of β-enamino nitriles as 54. Also, traces of Brønsted acids were shown to 
facilitate isomerisation.  
 
Figure 8: Predominant imine or enamine tautomer of 51 to 54 observed in solution, 
 depending on the substrate structure and substituent 
 
Facilitated isomerisation by Brønsted acids is particularly interesting since iridium hydride species have been 
demonstrated to be Brønsted acidic. Therefore, E/Z ratio of N-aryl imines in solution can possibly be ignored 
due to rapid interconversion in case where E/Z isomerisation is faster than hydrogenation, e.g. catalysed by 
metal coordination or Brønsted acidic hydrides. 
 
 
Asymmetric Imine Hydrogenation 
 
The first approach for the preparation of enantiomerically enriched chiral amines was reported by Kagan and 
co-workers. They developed a hydrosilylation reaction catalysed by rhodium catalyst 56 with ligand 57 and 
subsequent hydrolysis to afford the chiral amines 58 and 60 (Scheme 13).[19] Rhodium-catalysed 
hydrosilylation had been developed independently by Ojima and co-workers[20] using Wilkinson’s catalyst 
and Ph2SiH2.2  
 
 
Scheme 13: Asymmetric rhodium-catalysed imine hydrosilylation of 55 and 59 
 
This newly developed protocol for imine hydrosilylation also paved the way for the development of 
enantioselective hydrogenation of imines. While homogeneous hydrogenation of imines had already been 
reported by McQuillin and co-workers employing a rhodium catalyst [(Py)3RhCl3] and sodium borohydride 
in the presence of hydrogen gas,[21] Scorrano and co-workers reported the first example of an asymmetric 
hydrogenation of an imine (Scheme 14).[22] They generated a rhodium catalyst 61 very similar to the one 
Kagan used in the hydrosilylation of imines. 
  
                                                          
2 Kagan and co-workers were not aware of this discovery when submitting their work. 
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Scheme 14: Asymmetric rhodium-catalysed imine hydrogenation of 55 using 61 
 
During the next decade, with the development of new chiral phopshorus ligands such as 63, higher 
enantioselectivities were achieved. Furthermore, a temperature dependence was noted. Conducting reactions 
at lower temperature provided higher enantioselectivities while maintaining reactivity. A selected example is 
given in Scheme 15.[23],[24] 
 
Scheme 15: Improved ee in the asymmetric rhodium-catalysed hydrogenation of imine 55 at lower temperature 
 
By the time of the late 1980’s, asymmetric hydrogenation had been established on C=C, C=O and C=N 
double bonds with rhodium and ruthenium catalysts. Industrial asymmetric hydrogenations were dominated 
by rhodium and ruthenium catalysts due to their high efficiencies and extensive studies in the literature. This 
drastically changed in 1990 when an industrial team of researchers led by Blaser and co-workers reported on 
the first enantioselective hydrogenation of imines using iridium complexes generated from 64 and chiral 
phosphorus ligands such as 63. Efforts were devoted to structural analogues 65 and 66 of the potent 
herbicide Metolachlor (Scheme 16).[25] Further studies led to the currently applied protocol using Xyliphos 
ligands (Scheme 3). 
Aryl
N
R
HN
O
PPh2Ph2P
1.1 mol%
I2 (4 mol%), H2 [20 bar]
benzene/MeOH 1:1, 0 °C, 16 h
98%
84% ee HN
Ph
HN
Ph
HN
Ph
99%
52% ee
99%
16% ee
99%
22% ee
64 63
65 66
67 60
[Ir(COD)Cl]2
1 mol%
 
Scheme 16: First example of iridium-catalysed asymmetric imine hydrogenation 
 
Shortly after the discovery of Blaser, Osborn and co-workers reported similar results on the asymmetric 
hydrogenation of imines by iridium(III) hydride complexes such as 69 or 70. Very low catalyst loadings up 
to 0.1 mol% showed highly efficient asymmetric reduction of imine 68 (Scheme 17) and 59 (Scheme 18) 
albeit with low to moderate enantioselectivities. The catalyst was optimized for each substrate. The role of 
iodine was demonstrated to be of critical importance. The complexes were prepared by refluxing 
[Ir(I)(P’P)(COD)]BF4 in the presence of LiI. The oxidation was postulated to occur due to the presence of 
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water by an unknown mechanism.[26] Such an oxidation thus probably also occurs in situ in the system 
reported by Blaser.3,[27]  
 
Scheme 17: Asymmetric hydrogenation of imine 68 by iridium(III) hydride iodo-bridged trimer 69 
 
 
Scheme 18: Asymmetric hydrogenation of imine 70 by iridium(III) hydride iodo-bridged trimer 70 
 
In 1992, Buchwald and co-workers developed a titanocene complex 72 and employed it in asymmetric 
hydrogenation of imines. While excellent enantioselectivites were obtained for cyclic amines such as 73,  
moderate to high enantioselectivities were observed with acyclic imines such as 55 (Scheme 19). Very high 
hydrogen gas pressure, elevated reaction temperature, long reaction times and an impractical preparation of 
the catalyst from complex 71 with n-butyl lithium represented major drawbacks of this methodology. 
Furthermore, the E/Z ratio of the imine could be well correlated to the enantiomeric excess observed for each 
substrate and therefore limited the possibilities towards optimisation.[28] 
 
Scheme 19: Titanocene 72 catalysed asymmetric hydrogenation of imine 55 
 
                                                          
3 details are given in the mechanistic section 
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In 1996, Noyori and co-workers showed high ee’s in the asymmetric transfer hydrogenation of imines 
employing a ruthenium-diamine complex 74 and 75. While excellent enantioselectivities and very fast 
reactions were obtained for cyclic substrates such as tetrahydroquinoline 75 (Scheme 21), moderate to good 
enantioselectivities with very long reaction times were observed for acyclic imine 55 (Scheme 20).[29] 
 
 
Scheme 20: Asymmetric hydrogenation of imine 55 by ruthenium catalyst 74 
 
Scheme 21: Asymmetric hydrogenation of tetrahydroquinoline 75 by ruthenium catalyst 76 
 
In 1997, Pfaltz and co-workers[30] developed iridium catalyst 78 with a phosphine-oxazoline ligand and used 
it in the asymmetric hydrogenation of imines (Scheme 22). The isopropyl substituent on the oxazoline was 
demonstrated to be optimal for imine hydrogenation. Full conversion with moderate to high 
enantioselectivities was observed for a number of substrates. A remarkable concentration effect was 
observed in the case of imine 59: decreasing the substrate and catalyst concentration improved the 
enantioselectivity of the hydrogenation significantly. Such high enantioselectivites marked a significant 
improvement of iridium catalysts in asymmetric imine hydrogenation. 
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Scheme 22: Asymmetric hydrogenation of imine 59 with iridium-PHOX catalyst 78 
 
A careful study of the different substituents at the imine was conducted (Scheme 23).  
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Scheme 23: Substrate scope evaluated in asymmetric hydrogenation of imines catalysed by iridium-PHOX complexes 
 
While acetophenone N-benzyl derived imines like 79 showed high reactivity and selectivity irrespective of 
their substituents, increasing the steric bulk at the acetophenone ring as in 80 decreased the ee while 
maintaining reactivity. Aryl-alkyl imines with different N-substituents 81 provided the corresponding amines 
in high yields and varying enantioselectivities. The steric bulk and electronic effect of the N-substituent 
appeared to influence both reactivity and selectivity. Quite drastically, both ee and conversion were low in 
the case of dialkyl-derived N-benzyl and N-phenyl imines 82 to 85. Electronically activated imines such as 
oximes, oxime ethers, hydrazones and imines derived from trifluoromethylphenyl ketone showed no 
reactivity. Cyclic imines were reduced with moderate enantioselectivities. No correlation between the E/Z 
ratio of the imine and the enantioselectivity was observed. Furthermore, higher enantioselectivity was 
obtained with interconverting acyclic E/Z imines compared to cyclic imines with fixed geometry. Additives 
such as iodide, phthalimide and amines were evaluated. While iodide resulted in significantly lower 
enantioselectivity and opposed optical rotation of the product amine, sodium acetate or 1,2-diaminoethane 
completely inhibited the reaction. 
The discovery by Pfaltz and co-workers marked the beginning of a plethora of chiral iridium complexes 
employed as catalysts for asymmetric imine hydrogenation. A summary of the progress over the last 15 years 
is given on the following pages.  
A detailed reinvestigation of modified phosphine-oxazoline complexes developed in the Pfaltz laboratory 
depicted highly effective and selective catalysts for asymmetric imine hydrogenation.[31] Iridium complexes 
with a SimplePHOX ligand as 87 showed enhanced reactivity and selectivity when comparing to previously 
employed PHOX catalyst 86. Reaction temperatures could be lowered to -20 °C maintaining reactivity with 
the SimplePHOX catalysts (Scheme 24). While hydrogen pressure did not influence the outcome of the 
reaction, lowering the catalyst loading to 0.1 mol% resulted in reduced conversion. It stated in the paper, that 
“imines derived from dialkylketones gave only low conversion and enantioselectivity, whereas cyclic imines 
with a C=N bond in a five or six-membered ring showed no reactivity.“ No further details on such 
experiments were provided. 
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Scheme 24: Asymmetric hydrogenation of imine 59 with complexes 86 or 87 
 
Zhang and co-workers reported on highly selective imine hydrogenation employing iridium-ferrocene-
binaphane ligand 88.[32] While high to excellent enantioselectivities were observed in the case of 89 and 60, 
dialkyl imines showed significantly reduced reactivity and selectivity as seen for amines 90, 91 and 92 
(Scheme 25). Many additives such as phthalimide, TBAI or benzylamine did not give any improvement. 
Iodine on the other hand depicted opposite effects. In one example, the ee could be improved to 94% but 
with a similar substrate, it eroded from 99% to 69%. The cause was not further investigated. An iridium(III)-
species was postulated to be the active catalyst during hydrogenation, and the catalyst was suggested to 
maintain its oxidation state under reaction conditions.4 
                                                          
4 in relation to the findings by Spindler and Osborn 
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Scheme 25: Asymmetric hydrogenation of N-Aryl imines using 64 and 885  
The same system has also been applied to NH imines in 2009.[33] The hydrochloric salts of NH imines were 
directly subjected to hydrogenation conditions. While excellent results were obtained with acetophenone-
derived imines, only two dialkyl imines displayed high conversion with reduced enantioselectivity (Scheme 
26). Preliminary mechanistic information was obtained with deuterium hydrogenation and deuterium 
incorporation was only observed at the α-position of the amine to about 60%. 
 
 
Scheme 26: Asymmetric hydrogenation of NH imines using 64 and 88 
 
In 2004, Andersson and co-workers introduced new Ir(P’N) complexes such as 96, analogous to the 
phosphineoxazolines by Pfaltz, for asymmetric imine hydrogenation.[34] Only acetophenone-derived N-aryl 
imines were tested, giving results similar to Pfaltz’ phosphineoxazoline catalysts. In 2006, Andersson and 
co-workers reported on a more detailed study of imine hydrogenation using their previously introduced 
iridium(P´N) catalysts.[35] While imine 59 afforded amine 60 in full conversion and high ee, dialkyl derived 
imines gave the corresponding amines as 97 in low yield. Amine 98 was not obtained (Scheme 27), neither 
were cyclic amines. 
 
                                                          
5 The authors did not determine absolute configuration, no supporting information is available. 
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Scheme 27: Asymmetric hydrogenation of imines using 96 
 
Bolm and co-workers introduced chiral sulfoxime ligands such as 100 for enantioselective imine 
hydrogenation.[36] Iodine was required to oxidize the catalyst since the absence of iodine resulted in no 
catalytic activity. Only acetophenone-derived N-aryl imines were evaluated. Within 4 to 12 hours, full 
conversion was achieved with high enantioselectivity in the case of imine 99 (Scheme 28). 
 
Scheme 28: Asymmetric imine hydrogenation with iridium-sulfoxime catalyts generated from 64 and 100 
 
Imamoto and co-workers reported on highly active iridium catalysts such as 102 for enantioselective imine 
hydrogenation. Different acetophenone-derived N-aryl amines such as 103 were prepared with up to 99% 
enantioselectivity (Scheme 29). Only the complex with a BArF counterion showed catalytic activity. The 
only example of a dialkyl amine 98 did not show any conversion.[37] 
 
Scheme 29: Asymmetric hydrogenation of imines using 102 
 
Zhou and co-workers introduced highly elaborate spiro phosphinooxazoline iridium complexes such as 104 
as catalysts for asymmetric imine hydrogenation.[38] Only acetophenone-derived N-aryl imines were 
evaluated providing the corresponding amines 60 or 105 in full conversion and high enantioselectivities 
(Scheme 30). As shown, electron-withdrawing substituents at the N-aryl ring in amine 105 resulted in 
slightly increased enantioselectivity. 
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Scheme 30: Asymmetric hydrogenation of imines using 104 
 
The origin of enantioselectivity was explained in 
a cartoon model (Figure 9). The space around the 
metal centre was divided into quadrants. In the 
upper right the steric repulsion of the ligand 
backbone structure was postulated to hinder the 
substrate placing any bulky substituent into that 
quadrant. On the other hand, the lower left 
quadrant is experiencing less steric bulk by only 
one of the phosphorus substituents. This might 
allow the second least sterically demanding 
methyl group of the substrate being placed in that quadrant. Ultimately, the upper left as well as the lower 
right were believed to be the least sterically demanding. Therefore, the two large phenyl substituents of the 
substrate could be placed in these quadrants. According to this model, hydrogen would be added to the 
substrate from its Si face to furnish the (R)-amine, the same enantiomer that is also observed in the catalytic 
reaction.  
Knochel introduced ferrocenyl P’N iridium complex 106 as a catalyst for asymmetric imine hydrogenation. 
Only acetophenone-derived N-aryl imines were evaluated.[39] Increasing the steric bulk at the N-aryl ring 
improved the enantioselectivity significantly as demonstrated on amine 107 (Scheme 31). 
 
Scheme 31: Asymmetric hydrogenation of imines using 106 
 
In 2009, Feringa and co-workers reported on monodentate phosphoramidite ligands like 108 employed in 
iridium catalysed asymmetric imine hydrogenation.[40] Similar to the findings by Knochel, increasing the 
steric bulk at the N-aryl substituent resulted in significantly improved enantioselectivity (Scheme 32).  
A clear trend towards increased reactivity with less coordinating counterions was observed. While BArF and 
Figure 9: Cartoon model of complex 104 attempting to 
explain its enantioinduction 
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PF6 provided the corresponding amines at atmospheric hydrogen pressure, 50 bar hydrogen gas pressure was 
required when using the chloride precursor. The only dialkyl N-phenyl imine evaluated gave poor 
enantioselectivity as seen with amine 83.  
 
Scheme 32: Asymmetric imine hydrogenation with iridium-phosphoramidite catalyts generated from 108 and 109 
 
In 2008, Xiao and co-workers reported on chiral counterion-aided asymmetric imine hydrogenation. Iridium 
diamine complexes such as 112 were tested in combination with chiral phosphoric Brønsted acids such as 
113.[41]  
 
 
Scheme 33: Asymmetric imine hydrogenation with complex 112-113 
While no conversion was observed when using the iridium(III) complex 112 alone, addition of phosphoric 
acid 113 resulted in high conversion with up to 97% ee (Scheme 33). The protonated complex, generated by 
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protonation of the neutral complex with the phosphoric acid furnished a significantly more reactive catalyst. 
Addition of yet another equivalent of phosphoric acid 113 with regards to the catalyst resulted in high 
conversion while maintaining the excellent enantioselectivity. Acetophenone-derived, as well as dialkyl N-
aryl imines, were hydrogenated with high conversion and excellent enantioselectivities. However, the 
enormous molecular weight of the catalyst, its elaborate synthesis and incomplete conversion represent 
major disadvantages of this methodology. 
The same catalyst was also evaluated in reductive amination of 117 and 118.[42] While no imine condensation 
and isolation is required prior to reduction, chemoselectivity issues arise due to competitive ketone reduction 
(Scheme 34). Similar enantioselectivities to the one’s in imine hydrogenation are obtained. Again, excellent 
results with acetophenone-derived, as well as dialkyl N-aryl imines, have been obtained. Despite being 
conceptually interesting, 5 mol% catalyst loading with such a large catalyst remains intolerable compared to 
state-of-the-art methodology. Furthermore, higher yields are obtained over two steps when reactions are 
carried out separately. 
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Scheme 34: Asymmetric reductive amination using complex 112-113 
 
A very interesting catalyst structure was reported also by Xiao and co-workers.[43] While investigating 
Ir(Cp*)Cl dimer complexes as catalysts for reductive amination of 121 and 118, formation of a 
cyclometalated complex 122 was observed. These complexes proved to be highly versatile and effective 
catalysts for reductive amination employing an azeotropic mixture of formic acid and triethylamine (Scheme 
35). No example of an enantioselective reaction was reported. Complexes with electron-withdrawing 
substituents displayed higher reactivity. 
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Scheme 35: Reductive amination with iridacycles such as 122 
 
Asymmetric hydrogenation of imines has also been achieved with iron catalysts. Beller and co-workers 
reported on a iron(II)-PNNP catalyst prepared in situ from 124 and 125 for asymmetric imine transfer 
hydrogenation.[44] While N-phenyl and N-tosyl imines gave no conversion, N-phosphinyl imines such as 123 
gave excellent results (Scheme 36). A catalytic amount of base is required for high enantioselectivity. Side 
reactions such as aldol condensations as well as hydrolysis are observed. Especially substrates with large 
sterically demanding substituents decomposed prior to reduction. With dialkyl imines lower conversions 
with poor enantioselectivities were obtained. 
 
Scheme 36: Asymmetric hydrogenation of N-phosphinyl imines as 123 with an Fe-catalyst 
 
Beller and co-workers also reported on asymmetric imine hydrogenation using a combination of an achiral 
organometallic catalyst with a chiral organic Brønsted acid.[45] With iron(III)-complex 129 and chiral 
phosphoric acid 113, high enantioselectivities were obtained with both acetophenone-derived and dialkyl 
imines (Scheme 37). Side reactions such as aldol condensations and hydrolysis could be minimized when 
conducting reactions under anhydrous conditions.  
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Scheme 37: Asymmetric hydrogenation of imines using an iron(III) complex 129  
in combination with chiral phosphoric acid 113 
 
 
Other catalytic protocols for the preparation of chiral amines 
 
Apart from metal-catalysed asymmetric hydrogenation, a number of catalytic methods for the preparation of 
chiral amines have been developed. Hydrosilylation has been extensively studied since its discovery by 
Kagan in 1973. A very versatile organocatalyst 133 (Sigamide) has emerged which is able to convert a 
plethora of imines with both aromatic and aliphatic groups at the prochiral carbon (Scheme 38). The nitrogen 
is generally protected with para-methoxy-phenyl to ease preparation of primary amines by oxidative 
deprotection.[46] 
 
Scheme 38: Organocatalytic hydrosilylation employing Sigamide 
 
Similar to hydrosilylation, asymmetric reduction employing chiral oxazaborolidine 135 and using borane as 
the hydrogen source was developed by Itsuno and co-workers (Scheme 39).[47] 
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Scheme 39: Asymmetric reduction with chiral oxazaborolidine 135 
 
Mukaiyama and co-workers reported a chiral cobalt catalyst 138 using boronate 139 as a hydrogen source for 
the asymmetric reduction of imine 137 (Scheme 40).[48]  
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Scheme 40: Asymmetric reduction with cobalt catalyst 138 
 
Organocatalytic asymmetric imine reduction has been independently discovered by Rueping and List in 
2005. Both reported asymmetric reductions using a chiral phopshoric acid and Hantzsch ester 140 as the 
hydrogen source (Scheme 41). The work of Rueping only reported on acetophenone-derived N-aryl imines 
with moderate to high enantioselectivities.[49] On the other hand, List and co-workers reported one dialkyl 
imine with high enantioselectivity of 90%.[50] Long reaction times and stoichiometric waste products 
represent two main disadvantages of such organocatalysed imine reduction over metal-catalysed imine 
hydrogenation. 
 
Scheme 41: Asymmetric organocatalytic reduction of imines with chiral phosphoric acids and 140 
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Other hydrogen sources for organocatalysed imine reduction are benzothiazolines. An efficient synthetic 
method has been developed by Akiyama (Scheme 42).[51] Interestingly, the hydride source bears a stereogenic 
carbon. The influence thereof has not been investigated yet. 
 
Scheme 42: Asymmetric organocatalytic reduction of imines with 113 and 141 
 
The concept of organocatalytic imine reduction employing stochiometric hydrogen sources has also been 
merged with alkyne hydroamination.[52] In a primary step of the catalytic cycle, a gold complex 144 affords 
the corresponding enamine which is – after imine/enamine tautomerisation - reduced in situ to afford the 
desired chiral amine 60 (Scheme 43). While nitrogen substituents are limited to aniline derivatives (142), 
both aromatic and aliphatic substituents at the alkyne (143) were used. Generally, high enantioselectivities 
are obtained, albeit with the drawback of very long reaction times and incomplete conversions. If the 
reaction sequence was conducted in a stepwise manner, similar results as in the overall reaction were 
obtained.  
 
Scheme 43: One-pot hydroamination and imine reduction 
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Mechanistic studies of iridium-catalysed imine hydrogenations 
 
Togni and co-workers have postulated a general mechanistic picture for the catalytic cycle of imine 
hydrogenation (Scheme 44).[53] The initial step of the catalytic cycle is the formation of an iridium hydride 
complex. The imine 146 can then coordinate onto (148). Subsequent hydride transfer generates an iridium 
amide complex 149. Heterolytic hydrogen cleavage and amide protonation regenerates the iridium hydride 
complex 150 and frees the product amine 147.  
 
Scheme 44: General catalytic cycle for imine hydrogenation postulated by Togni 
 
Oxidative addition of hydrogen to metal complexes has been postulated as the primary step in iridium 
catalysed hydrogenation reactions. Indeed, Crabtree and Morris identified iridium hydride complexes 152, 
154, 155 and 156 when subjecting iridium complexes 151 or 153 to an atmosphere of hydrogen at low 
temperature (Scheme 45).[54],[55] 
Scheme 45: Preparation of several iridium hydride complexes by Crabtree and Morris 
 
Landis and co-workers conducted a detailed study on oxidative addition of hydrogen onto iridium 
diphosphine complex 157. Similar to Crabtree’s findings, heterolytic cleavage occurred at -80 °C under 
kinetic control, but at temperatures around -45 °C dihydride complexes underwent isomerisation reactions to 
form the thermodynamic products 158 and 159 (Scheme 46).[56] Isotope studies with deuterium gas revealed 
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scrambling through COD-allyl species even at very low temperatures. Such scrambling processes did not 
involve reductive elimination of hydrogen and formation of iridium(I) complexes. 
 
 
Scheme 46: Oxidative addition and subsequent isomerisation of iridium hydride complex 157 to 158 and 159 
 
Similar results have also been observed by Pfaltz and co-workers when investigating oxidative addition of 
hydrogen with iridium phosphineoxazoline complex 86 (Scheme 47). The observed dihydride intermediates 
160, 161 and 162 were postulated to be present during the early stage of the catalytic cycle in 
enantioselective hydrogenation. In a combined experimental and computational study the corresponding 
isomers were characterised.[57] 
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Scheme 47: Observation of dihydride complexes 160, 161 and 162 upon subjection of 86 to hydrogen at low temperature 
 
The observation of only one (out of four possible) diastereomers with cyclooctadiene 
in the coordination sphere of the iridium centre is in accordance with the findings by 
Crabtree. He demonstrated that iridium complexes of the type 
((PR3)(Py)Ir(COD))PF6 form hydride complex 154 (Scheme 45) where one hydride 
is situated trans to the nitrogen.[58] Furthermore, the steric repulsion of the 
cyclohexyl rings at the phosphorus direct the position of the cyclooctadiene. With 
regard to the dihydride disolvent complexes, different ratios of isomers were 
obtained. As observed by Landis, the reaction is occurring under kinetic control. 
Similar to the cyclooctadiene complex 154, coordination of the hydride to a weak 
trans-donor such as nitrogen or a solvent molecule is favoured. In order to explain 
the driving force of oxidative addition at such low temperatures, a study of the 
binding strength to iridium centres can be considered.[59] The binding strength of 
several ligands has been investigated on a 14-electron iridium(III) d6-complex 163 
(Figure 10). The complex can be generated by counterion abstraction using NaBArF. The “naked” 14-
electron complex 163 was then tested in competitive binding. In this study the order of bonding strength was 
determined to be H2 > CH2Cl2 > agostic C-H. 
 
 
Figure 10: 
Agostic C-H—Ir  
interaction in 163 
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The behaviour of iridium complexes with cyclooctadiene as a ligand has also been studied with 
cyclometalated complex 164 by van Koten and co-workers.[60] The isomerisation of such iridium complexes 
with cyclooctadiene within the coordination sphere was studied with cyclometalated benzylic amines 
(Scheme 48). This amine bore a substituent in the meta position. Thus isomerisation of the cyclooctadiene 
ligand would be observed by the formation of a new complex 171 where the substituent changed from Rortho 
to Rpara. Once the substituent was in the para-position, no fluxional behaviour between -80 and +105 °C 
could be observed by NMR. In deuterium labelling studies, no exchange with the solvent (benzene or 
toluene) was observed. First order kinetics indicated that an intra- rather than an intermolecular process is 
operating. Deuterium incorporation was observed at one of the N-methyl groups. The conversion of the 
cyclometalated complex can therefore be explained by the mechanism via 165 to 170 outlined below 
involving reversible C-H activation of both a sp2 (165<->169) and a sp3-hybridized carbon centre (164<-
>165 and 170<->171). 
 
Scheme 48: Isomerisation of iridacycle 164 to 171 by reversible sp2- and sp3-C-H activation 
 
The last step of the catalytic cycle is postulated to be the reductive elimination of an iridium-coordinated 
amide. Simultaneous heterolytic cleavage of hydrogen gas regenerates the hydride and dissociates the amide 
by protonation. Rettig and co-workers demonstrated that iridium-amide complexes such as 172 cleave 
hydrogen heterolytically (Scheme 49).[61] Interestingly, an opposite syn orientation between the NH proton 
and the halide was observed in 173. It was explained by intramolecular hydrogen bonding between the NH 
and the halide. The controlling factor of the observed stereochemistry is thus the hydrogen bonding. This 
interaction is also stabilising the otherwise unstable metal hydrides, as no loss of hydrogen was observed 
even when complex 173 was heated to 80 °C in vacuo. On the other hand, heating 173 to 80 °C under an 
atmosphere of hydrogen generated dihydride complex 174 along with methane elimination.  
 
Scheme 49: Preparation of complex 173 mimicing reductive elimination in imine hydrogenation 
 
Even more surprising is the oxidative addition of hydrogen to olefin-coordinated iridium amide complex 
175. At atmospheric hydrogen pressure in the presence of excess methylene dihalide, e.g. dichloromethane, 
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formation of halide complex 176 is observed (Scheme 50). The transformation was postulated to proceed via 
a mer-amine-trihydride IrH3[P'NH'P] intermediate. 
 
 
Scheme 50: Activation of CH2Cl2 under hydrogenation conditions by iridium-amide complex 175 to afford 176 
 
For all steps in the catalytic cycle that occur between heterolytic hydrogen cleavage and reduced amide 
dissociation, no exact experimentally derived picture exists to date. Several groups have conducted detailed 
investigations of iridium catalysed imine hydrogenation.  
Spindler and co-workers detected benficial effects with iodine as the counterion (Scheme 16).[25] Addition of 
iodine resulted in increased reaction rates as well as higher enantioselectivities. Iodine was suggested to 
serve as the oxidant for the iridium(I) complex 64 to form the active iridium(III) catalyst. Detailed 
mechanistic investigations by Togni and co-workers later strengthened this hypothesis (explanation given 
later in this chapter). Furthermore, when investigating a range of N-aryl imines, the equilibrium of the syn- 
and anti-isomers, as well as imine-enamine tautomerisation, were demonstrated to proceed faster than 
hydrogenation by H/D exchange experiments in d4-MeOD. This concluded that the anti/syn ratio was not 
selectivity-determining in this case. 
Deuterium labelling experiments were conducted by Osborn and co-workers[27] on the very same substrate 
68-CD3 as investigated by Spindler (Scheme 51). More than 95% Incorporation of hydrogen across the C=N 
double bond was observed, which ruled out hydrogenation of the enamine tautomer. Kinetic experiments 
indicated a rate dependece of 0.5 on the catalyst loading. This suggested that the dimer 69 is in equilibrium 
with a small quantity of monomer and another monomer-imine complex. Those species were considered to 
be the active catalysts in the catalytic cycle. Furthermore, deuterium labelling experiments indicated no 
observable isotope effect. This was attributed to the fact that only small quantities of monomeric catalyst are 
active during catalysis.  
 
Scheme 51: Deuterium labelling experiments on imine 68-CD3 by Osborn 
 
Similar results were observed by James and co-workers investigating related rhodium-catalysed imine 
hydrogenation by high-pressure NMR experiments.[18] With this specific setup, several aspects of the 
reaction were investigated. The starting imine was observed predominantly as the E isomer with an E/Z ratio 
of 14:1. The isomerisation rates for both isomers at 25 °C were determined to be 155 h-1 for Z->E and 11 h-1 
for E->Z. As the TOF of the catalyst were determined to be between 14-66 h-1, no conclusions regarding the 
hydrogenation selectivity with regards to the E/Z isomerisation could be drawn. Diffusion of hydrogen gas 
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into the solution was observed to be rate-determining since a zero-order kinetic behaviour was detected. In 
order to exclude the possibilty of the enamine being the reduced substrate, deuterium labelling experiments 
were conducted (Scheme 52). While concomitant deuterium incorporation at the methyl group in d4-MeOD 
was observed due to imine-enamine tautomerism, no deuterium-hydrogen scrambling was observed in imine 
55-CD3. 
 
Scheme 52: Deuterium labelling experiments on 55-CD3 by James 
 
Buchwald and Willoughby detected a strong dependence on the E/Z ratio of the imines and the observed 
enantiomeric excess of the product amine 84 (Scheme 53).[62],[63] While cyclic substrates gave the 
corresponding amines in very high ee’s, acyclic imines such as 178 were reduced with ee’s between 58% and 
86%. The E/Z ratio of the imine 178 did not remain constant over the course of the reaction. It rose from 11:1 
up to 30:1 in favour of the E isomer when conducting the reaction at 65 °C. With higher temperature (75 °C) 
it only rose to 18:1. Two conclusions were drawn from this observation. Primarily, the Z-isomer is more 
reactive and secondly, E/Z isomerisation is slower than hydrogenation at high pressure. Probably E/Z 
isomerisation is unaffected by the presence of the chiral catalyst. The enantiomeric excess of the product 
amine 84 can thus be correlated to E/Z ratio of the imine in solution (11:1 = 91.7:8.3 = 83% ee). 
Furthermore, a strong dependence on hydrogen pressure and ee was observed. It was explained by a slow 
hydrogenation, constant E/Z-isomerisation and thus overall lower enantioselectivity in the catalytic reaction. 
If the reaction was conducted stochiometrically, 83% ee was observed. 
 
 
Scheme 53: Correlation of E/Z isomer ratio and ee in imine hydrogenation by 72 
 
Imine hydrolysis of coordinated substrates has been observed in rhodium-catalysed imine hydrogenation as a 
side reaction and possible origin of catalyst poisoning.[64] Even when preparing reactions under inert 
atmosphere, low residual amounts of water resulted in the formation of a rhodium(I) complex 184 with two 
inequivalent NH2 protons. This complex could be isolated and characterized by X-Ray crystallography 
(Scheme 54). 
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Scheme 54: Observation and identification of complex 184 bearing inequivalent amine protons 
 
Togni and co-workers conducted a detailed study on iridium Xyliphos complexes used in the asymmetric 
hydrogenation of metolachlor.[65] Several intermediates were isolated in the course of the investigation 
(Scheme 55). When 64 and ligand 187 were mixed, clear formation of [Ir(P’P)(COD)]Cl complex 13 ensued. 
Counterion exchange with tetrafluoroborate afforded 188. Interestingly, attempted counterion exchange with 
iodide furnished a neutral square pyramidal iridium(I) complex 189. Treatment with tetrafluoroboric acid 
afforded iodo-hydride complex 190 which isomerised to 191. 
 
Scheme 55: Iridium complexes obtained from complex 13 in attempted counterion exchange 
 
Upon addition of iodine it formed an iodo-bridged iridium(III) dimer 192 by oxidation of 189 (Scheme 56). 
Complex 192 was demonstrated to be the most active catalyst out of all structures 188 to 192 with similar 
values to the in situ generated catalyst. Halide-free complex 188 showed the poorest activity while 
complexes 190 and 191 depicted similar activity compared to 192. It was concluded that under 
hydrogenation conditions a species such as 190 or 191 is present and closely related to the active catalyst. It 
also explained the crucial role of iodine as an additive. In order to generate the active catalyst, iodine aids 
oxidation of the iridium(I) precursor 64 via dissociation or hydrogenation of the cyclooctadiene ligand to 
form the iridium(III) dimer 192. 
Chapter 1 – Introduction 
 
41 
 
Scheme 56: Preparation of iodo-bridged trimer 192  
 
Several iridium(III) complexes were studied as catalyst-substrate adducts on the Metolachlor-related model 
substrate 68 (Scheme 57). Four different imine dihydride adducts 193 were observed with N,O-coordination. 
The C=N double bond was always situated trans to a phosphorus atom of the ligand in η1-coordination. This 
configuration is consistent with the relative trans influence of the H, N, O and P donors. The iminoyl carbon 
is more electrophilic (if trans to the less basic phosphane), the hydride is more nucleophilic (if trans to the 
more basic phosphane). Chemical exchange between 193a and 193c is observed on the NMR time scale. 
Such an exchange is consistent with a mechanism of dissociation of the ether-tethered oxygen (which is 
observed always trans to a hydride) and occupation of this vacant position by one of the phosphorus atoms 
of the ligand. 
 
Scheme 57: Identification of several imine adduct complexes 193 
 
The mechanistic studies by Togni were extended with kinetic investigations. Analogous amine complexes 
such as 194 were observed at low temperature by NMR experiments (Scheme 58).[53] These complexes were 
unstable in CH2Cl2 solution and the amine was readily displaced by the imine 68 to afford 197. If no imine 
was added, η6-coordination of the aryl ring of the amine was observed at room temperature (195). This led to 
the conclusion that the imine is a much better ligand than the amine, as well as imine coordination is 
favoured over η6-amine coordination. This is consistent with the industrial process where hydrogenation 
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proceeds rapidly to completion despite a very high concentration of product amine at the end of the reaction. 
Reversible C-H activation (β-hydride elimination) of the amine complex in THF was observed over the 
course of 12 hours at room temperature via 196.[60]  
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Scheme 58: Iridium amine adduct complexes 194, 195 and 196 
 
Shvo´s diruthenium bridging hydride complex 198 is an efficient catalyst for aldehyde, ketone and imine 
transfer hydrogenation (Scheme 59).[66],[67],[68] Detailed mechanistic studies have been conducted with 
aldehydes and the two mononuclear ruthenium complexes 199 and 200 have been postulated to be in 
equilibrium with the dimer. The hydroxy-cyclopentadienyl ruthenium hydride 199 was proposed to be the 
active catalyst. Shvo’s catalyst was used for experiments to understand the mechanism of Noyori-type half-
sandwich complexes with ruthenium or iridium as the metal centre. 
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Scheme 59: Shvo´s diruthenium bridging hydride complex 198 and its monomers 199 and 200 
 
Two possible mechanisms for C=N double bond reduction have been postulated: An inner-sphere 
mechanism (Scheme 60),[69] where the nitrogen atom of the imine coordinates onto the metal centre, and an 
outer-sphere mechanism (Scheme 61),[70] where a proton and a hydride are transferred in a concerted fashion 
onto the imine without coordination to the metal centre.  
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Scheme 60: Inner-sphere mechanism of an imine hydrogenation by Shvo’s catalyst 199 
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Scheme 61: Outer-sphere mechanism of an imine hydrogenation by Shvo’s catalyst 199 
 
Casey and co-workers trapped a Ru-amine complex when mixing 199 with imine 204 (Scheme 62). They 
predominantly observed the trapped amine 206 derived from the imine nitrogen which supported a concerted 
outer-sphere mechanism.[70] 
  
Scheme 62: Trapping of imine 204 by Shvo’s catalyst 199 indicating an outer-sphere mechanism 
 
A computational study by Lledos and co-workers supported such an outer-sphere mechanism quite clearly by 
the calculated energy profiles when compared to a possible inner-sphere mechanism.[71] 
Oro and co-workers investigated complex (Ir(C6H6)(PiPr3)(H)2)BF4 208 as a model catalyst for homogeneous 
imine hydrogenation.[72] Starting from arene half-sandwich complex 208 (Scheme 63), ligand displacement 
by excess nitrile solvent readily occurred. Both complexes 208 and 211 are active catalysts for imine 
hydrogenation but complex 208 was shown to be much more reactive than 211. 
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Scheme 63: Identification of iridacycles 212 and 213 in the course of investigating  
homogeneous imine hydrogenation catalysed by 208 or 211 
 
The poor performance of 211 was explained by NMR spectroscopic studies which revealed cyclometalation 
of the imine 209 to give 212. The aniline complex 213 was observed due to imine hydrolysis if water was not 
strictly excluded. Furthermore, adding up to 5 equivalents of aniline did not disturb or influence the activity 
of catalyst 211, 212 or 213 in imine hydrogenation. 
The observation of a cyclometalated imine was also reported by James and co-workers as a common 
activation phenomena encountered in iridium catalysed imine hydrogenation.[73] In order to gain a better 
understanding and ease cyclometalation, Oro and co-workers investigated diphenyl NH imine 214 which 
clearly depicted a stronger tendency towards cyclometalation than imine 209 (Scheme 64). Both precursors 
208 and 211 formed the same complex 215, which did not display any catalytic activity for imine 
hydrogenation. Multiple substrate cyclometalation was therefore suggested as a pathway for catalyst 
deactivation. 
 
Scheme 64: Preparation of double iridacycle 215 
 
Cyclometalation was shown to be favoured in strongly coordinating solvents such as acetone or methanol 
(Scheme 65). However, under hydrogenation conditions, such cyclometalated structures are disfavoured and 
formation of the η5-coordinated complexes like 210 was observed. Complex 210 was recognized to also be 
the sole catalyst resting state when 208 is used in other solvents such as 1,2-dichloroethane or THF. In 
kinetic experiments a first-order dependence on catalyst, imine and hydrogen concentration was observed. 
This result was deemed unhelpful since it is compatible with various sequences of elementary reactions. 
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Addition of aniline prior to commencing the catalysis significantly shortened induction periods. This 
undermined that η5-coordination, as in the formation of 210, was of critical importance. 
 
Scheme 65: Rearrangement of iridacycles as 216 or 217 under hydrogen atmosphere in acetone or methanol 
 
When attempting to inactivate complexes 212, 216 or 217 by addition of tetraphenyl borate6,[74] formation of 
218 and >90% recovered imine 209 were detected (Scheme 66). The rearrangement of complexes such as 
212 to 210 proceeds thus at a slower rate than deactivation by BPh4 coordination. Furthermore, it was 
concluded that solvent-coordinated cyclometalated imine complexes 212, 216 or 217 do not act as 
hydrogenation catalysts since they rather rearrange to complexes like 210 prior to catalysis. 
 
Scheme 66: Generation of η6-arene complex 218 from hydride-disolvent complexes 212, 216 and 217 
 
The η5-coordinated dihydride complex 210 readily reacted with imine 209 to form the cyclometalated 
complexes 212, 216 or 217 via the corresponding dihydride tri-solvent complex 216 (S = Acetone or MeOH,  
Scheme 67). This observation was not made in less coordinating solvents such as THF or CH2Cl2 where 
complex 210 remained unchanged. The latter two examples of 218 and 220 demonstrated cyclometalation to 
be reversible by rearrangement of the catalyst in solution. Therefore η5-coordinated 210 and cyclometalated 
complexes 212, 216 or 217 were believed to be in equilibrium under hydrogenation conditions.  
                                                          
6 to form stable neutral dihydride complexes 
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Scheme 67: Reversibility of iridacycle formation in complexes 212, 216 and 217 
Furthermore, mixtures of complex 210 and imine 209 formed dimeric cyclometalated complex 221 (Scheme 
68). When heated to 50°C for prolonged time, complex 222 is formed. The substitution of hydrides to 
chlorides is commonly observed for iridium(III) hydride complexes in chlorinated solvents as reported by 
Oro and co-workers.[75] These dimeric complexes 221 and 222 did not show any catalytic activity in imine 
hydrogenation and the formation of 222 during catalysis is unlikely due to the requirement of extensive 
heating periods of the reaction mixture in the presence of excess imine. 
 
Scheme 68: Formation of hydrido-chloro dimer iridacycle complexes 221 and 222 
 
Concomitant hydrogen-deuterium exchange was observed when complex 210 was dissolved in CD2Cl2 and 
subjected to a deuterium atmosphere at room temperature for one hour (Scheme 69). 
 
Scheme 69: Concomitant incorporation of deuterium into complex 210 under D2 atmosphere 
 
NH-ND exchange was observed in d4-MeOD (Scheme 70). 
 
Scheme 70: Proton-Deuterium exchange in deuterated methanol 
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In conclusion, a mechanism which strongly depended on hydrogen bonding was postulated: Reduction of the 
C=N double bond takes place in an ionic outer-sphere mechanism of a catalyst formed in situ with direct 
involvement of the product amine (Scheme 71). The product amine is deprotonating the dihydride complex 
223 to facilitate oxidative addition of hydrogen gas giving 224. The coordinative versatility of a benzene ring 
to undergo either η6- (223) or η4-coordination (224 and 225) renders this process feasible. Amine to imine 
exchange was calculated to be the most endothermic process in the catalytic cycle. 
 
Scheme 71: Postulated catalytic cycle by Oro for imine hydrogenation of 209 employing 208 
 
Sanchez-Delgado and co-workers have investigated the kinetics of [Ir(PBn3)(Py)COD]PF6 complex 226, an 
analogous complex to the Crabtree catalyst.[76] The P’N complex showed higher activity than the 
corresponding P’P complex (Scheme 72). 
 
Scheme 72: Hydrogenation of imine 227 by Crabtree analogous complex 226 
 
At low temperature, the unstable dihydride di-solvent complex 229 was formed (Scheme 73). When the 
dihydride complex 229 was subjected to imine substrate, fast displacement of the solvent molecules with 
formation of two new species 230 and 231 was observed. The greater the excess of imine added, 231 was 
favoured. It was therefore suggested, that a mono-coordinated 230 and a di-coordinated imine-iridium 
complex 231 exist in solution. The rate determining step of the reaction was determined to be the 
dissociation of the reduced amine in 232 and re-coordination of a hydrogen molecule to the iridium centre to 
afford 230. The major species in solution was determined to be the THF-dihydride 230, which had also been 
observed by NMR spectroscopy. Therefore, the rate law was determined to be of third order and dependent 
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on Ir, imine and hydrogen. The solubilty of hydrogen in THF was pointed out to be temperature-independent 
and the activation energy was determined to be around 16 kcal/mol for this transformation. 
 
Scheme 73: Proposed catalytic cycle by Sanchez-Delgado for imine hydrogenation of 227 by 226 
 
In a theoretical study on asymmetric imine hydrogenation with iridium phosphineoxazoline complexes, 
calculations on nine different possible mechanisms were calculated by Hopmann and Bayer.[77]  
 
Scheme 74: Postulated catalytic cycle by Hopmann and Bayer, numbers indicating  
energy differences between computed energies of structures 
 
All calculations were started from dihydride imine complex 233. Relatively high overall energy barriers of 
43.5 to 57.5 kcal mol-1 were computed for mechanisms involving coordination of the substrate to the iridium 
centre. Therefore, several outer-sphere mechanisms, involving a dissociated imine, were computed. Overall 
energy barriers between 32.8 to 17.7 kcal mol-1 clearly indicated that such a mechanism is favoured. The 
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calculated mechanism with the lowest overall barrier is depicted in Scheme 74. While η2-coordination was 
unfavoured, a stepwise protonation affording 236 – hydride transfer via 237 – sequence proved more viable. 
Ultimately, rearrangment of the hydride ligands and introduction of an additional labile ligand (H2 or 
CH2Cl2) lowered the overall barrier significantly.  The results indicated that the iridium centre adopts an 
iridium(III) oxidation state throughout the catalytic cycle. However, a dihydride intermediate 233 is in 
equilibrium with the dihydride-dihydrogen complex 234 species via dihydrogen coordination.  
The calculated mechanism is partially similar to the one calculated and experimentally observed with 
dinuclear iridium complexes by Oro and co-workers.[78] In both examples, a stepwise protonation and a 
concerted dihydrogen coordination - hydride transfer sequence from an iridium(III) hydride complex to a 
free imine has been postulated. This suggested an outer-sphere mechanism. Nevertheless, the Brønsted acidic 
nature of iridium complexes might also result in protonation of the imine prior to hydrogenation.  This has 
not been considered in the computational study. 
 
Cyclometalation in imine hydrogenation 
 
Cyclometalation of imine and azo-compounds onto an iridium centre was first reported by Stufkens and co-
workers investigating insertion of labile iridium(I) complex 240 into sp2-hybridized C-H bonds (Figure 
11).[79] 
 
Figure 11: First reported cyclometalation of different imines and diazocompounds 209 and 242-248 
 
The iridium hydride complexes such as 241 were characterised by their specific IR frequency of the iridium-
hydride bond in the range of 2000 to 2200 cm-1. No exchange of the hydride to a deuteride was observed 
when the complexes were dissolved in deuterated solvents such as chloroform or benzene. The frequency of 
the C=N double bond is lowered upon complexation which corresponds to a slight elongation of the bond. 
The chemical NMR shifts of the hydrides indicate its position to be trans to the ligand with a low trans 
influence. In structurally comparable [Pd(PR3)2(Imine)Cl] complexes only η1-imine σ(N)-coordination was 
observed.[80] 
The role of metal basicity was discussed comparing C-H activation abilities of palladium(II), iridium(I) and 
rhodium(I) complexes. It was concluded that the attack of C-H bonds of azo- and imine-ligands by Rh(I) and 
Ir(I) is strongly dependent on: a) the electronic (basic) properties of the metal atom; b) the type of C-H bond 
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with the preference of reactivity aromatic > olefinic > aliphatic. Cyclometalations are more feasible with 
electron-rich metal centres. This was demonstrated using basic tri-alkyl phosphines compared to electron-
poor tri-aryl phosphines. On the other hand, with electron-accepting ligand such as CO, only σ-N-η1-
coordinated complexes were observed with Rh(I). These results led to the conclusion, that cyclometalation 
proceeds via prior η1-imine coordination, followed by intramolecular addition of the C-H bond to the metal 
centre.  
The reactivity of cyclometalated complexes such as 250 has been studied by treatment with halogens, silver 
perchlorate, nitriles and carbon monoxide (Scheme 75). The iridacylces were shown to be stable under a 
number of reaction conditions. While ligand exchange reactions proceeded with halogens giving 252 and 
253, the cationic complexes had to be generated prior to exchange with carbon monoxide (251) or nitriles 
(252). The neutral iridacycle 250 did not show any reactivity with a number of reagents such as acidic HCl, 
electrophilic carbon monoxide, basic phosphine or hydrogen. 
 
Scheme 75: Reactivity studies of iridacycle 250 
 
James and co-workers have studied imine hydrogenation with different metals (Rh, Ru and Ir) in great detail. 
In attempts to isolate intermediates in the course of rhodium-catalysed imine hydrogenation, an iridacycle 
256 was observed (Scheme 76).[73] In 256, a somewhat longer Ir-O bond distance was observed by X-Ray 
crystallography, which was attributed to the strong trans-influence of the ortho-C-ligand. The high-field 
NMR shift of the hydride (-16.35 ppm) is explained by the small trans-influence of the imine-N-ligand. 
Coordination of the imine-nitrogen in η1-fashion in 255 results in reductive elimination of hydrogen gas from 
155, which has been observed and evidenced by 1H-NMR experiments. The metal centre is rendered basic 
and nucleophilic by two phosphine ligands. Hydrogen evolution formally results in reduction of Ir(III) to 
Ir(I) and re-oxidation to Ir(III) by cyclometalation.  
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Hydrolysis was only observed in methanol. It was suggested that competitive coordination between acetone 
and water is in favour of acetone. Since pre-coordination of water is necessary for imine hydrolysis, it is not 
observed in acetone. Imine hydrolysis under hydrogenation conditions has also been observed with a 
rhodiumI complex (Scheme 54).[64] 
 
Scheme 76: Formation of iridacycle 256 under hydrogenation conditions 
 
When the cyclometalated complex was subjected to hydrogenation conditions, precipitation of catalytically 
inactive neutral dihydride complex was observed (Scheme 77).  
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Scheme 77: Preparation of neutral dihydride complex 259 
 
Cyclometalation of Ir(III) dihydro-bis-solvent complexes was studied in further detail (Figure 12).[81] 
Stochiometric addition of imines to di-hydride complexes 155 or 257 (Scheme 76) readily ensued in 
iridacycle formation of 260, 261 and 262 apart from N-perfluorophenyl which remained unaffected over the 
course of several hours. Surprisingly chelation via the phenol group in 261 was not observed but C-H 
activation instead. This is in contrast to Cu(II), Ru(II) and V(IV) complexes which all preferentially form 
N,O chelated complexes. All three complexes did not show any catalytic activity under hydrogenation 
conditions. 
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Figure 12: Iridacycles 260, 261 and 262 
 
In order to understand the general lack of reactivity of such complexes under hydrogenation conditions, 
James and co-workers generated Ir(III) cyclometalated imine complexes in situ (Scheme 78).[82] In all cases 
precipitation of neutral di-hydride complexes and concomitant generation of HPF6 was observed. 
 
Scheme 78: Preparation of neutral dihydride iridacycles 259 and 263-266 
 
The supernatant of such reaction mixtures contained only imine and no trace of amine by GC analysis. The 
neutral di-hydride complexes are insoluble in MeOH,  but soluble in CH2Cl2. No catalytic activity was 
observed under hydrogenation conditions in CH2Cl2 either. The formation of di-hydride complexes such as 
270 by heterolytic cleavage of dihydrogen has also been observed by Crabtree (Scheme 79).[83] 
 
Scheme 79: Generation of  cationic dihydride complex 270 by Crabtree 
 
In order to understand the mechanism of cyclometalation, James and co-workers conducted deuterium 
experiments on 257-D4. Interestingly, even under exclusion of hydrogen gas and protic hydrogen sources, the 
di-hydride complex was observed. Not even trace amounts of the deuterated complex were observed by 1H-
NMR (Scheme 80). 
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Scheme 80: Generation of 264 from deuterated 257-D4 under deuterium gas 
 
The catalytic inactivity of the neutral dihydro complexes such as 264 was explained by their non-polar 
character. Ir- and Rh-cationic species are essential for effective imine hydrogenation. This can be explained 
by the fact that “Rh(III) cyclometalated complexes undergo reversible reductive elimination of the 
cyclometalated imine to furnish the Rh(I) complexes, which can then undergo the required oxidative addition 
of H2”. 
However, out of all substrates studied in imine hydrogenation and substrate cyclometalation, a completely 
contrasting behaviour was observed with imine 209 (Scheme 81).[81] While the analogous Rh(III) complex 
179 (Scheme 54) was deactivated by the amine product (η4-coordination of the aniline) the iridium complex 
151 afforded amine 219 via 257 and 272 quantitatively with 2 mol% catalyst at atmospheric hydrogen 
pressure within 1 hour. 
 
Scheme 81: Catalytic imine hydrogenation with iridacycle 258 as an out-of-cycle reservoir complex 
 
Cyclometalation of imine 209 was explained to be less favoured due to the electron-poor C=N double bond, 
as well as the steric bulk exhibited by the close proximity of the N-aryl ring. Indeed, the stoichiometric 
reaction of the dihydro-bis-solvent complex 257 and imine 209 revealed only partial formation of the 
cyclometalated species 273 in MeOD solution. Furthermore, when excess imine was added and the argon 
atmosphere was replaced by a hydrogen atmosphere, the signals of the cyclometalated complex disappeared 
and the dihydrido-bis-solvent 257 complex was regenerated. This clearly demonstrated the reversibility of 
Chapter 1 – Introduction 
54 
the cyclometalation reaction under catalytic conditions. Thus, hydrogenation occurred via hydrogen transfer 
in the di-hydrido-η1-imine intermediate 272. 
A more general picture of the reactivity of cyclometalation was reported by Martinez.[84] In a series of 
cyclopalladation reactions, selective formation of the endometallacycle was observed. Similar results were 
observed by Barloy when imines were subjected to [Ir(Cp*)(Cl2)]2 complexes affording cationic iridacycles 
(Figure 13).[85] Barloy and coworkers noted another striking difference in diastereomer formation. Acyclic 
imines, contrary to cyclic ones, were unable to control the configuration at the metal so that a 1:1 mixture of 
274 and 275 was obtained. Furthermore, epimerisation of the CH(Me)(Ph) phenyl ring was observed in 
EXSY NMR experiments as well as chemical exchange between both diastereomeric metal complexes. This 
demonstrated the many degrees of freedom cyclometalated acyclic ligands experience with Cp* ligands. 
 
 
Figure 13: Iridacycles 274, 275 and 276 
 
Cyclometalation of [Ir(Cp*)(Cl)2]2 (279) with benzaldimines 277 and 278 has been studied by Jones and co-
workers with regards to regioselectivity (substrates with meta-substituents), kinetics (substrates with para-
substituents) and mechanism (electrophilic C-H activation).[86] Since cyclometalation reactions are about 10 
times faster with 277 than with 278, an electrophilic C-H activation mechanism was postulated (Scheme 82). 
In kinetic studies, a primary isotope effect was investigated with a fully deuterated benzaldimine. Since a 
KIE larger than 5 was detected, the consistency with an electrophilic C-H activation mechanism was 
strengthened. 
 
 
Scheme 82: Preparation of iridacycles 280 and 281 
 
Regioselectivity was found to be extremely sensitive to steric effects. With 283, 285 and 286 only the first 
regioisomers 289, 291 and 292 was isolated (Scheme 83). With 282, 284 or 287 a mixture of both 
regioisomers 288/294, 290/295 and 293/296 was observed. Fluorine (290/295) is an exception forming 
preferentially 295 due to the „ortho effect“. 
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Scheme 83: Generation of diastereomeric mixtures of iridacycles depending on the substituent 
 
Steric effects also play an important role in the cyclometalation of meta-substituted aldimine 297. 
Regioisomer 298 is strongly favoured compared to 299 (Scheme 84). 
 
Scheme 84: Regioselective cyclometalation of imine 297 favouring iridacycle 298 
 
Cyclometalation was demonstrated to be reversible under acidic conditions. Addition of trifluoroacetic acid 
to 288 (294) in MeOH afforded equilibrium of both complexes within 2 hours (Scheme 85). This result is 
similar to those observed in acid-promoted rearrangements of palladacycles. 
 
Scheme 85: Reversible cyclometalation of 288 in acidic methanol solution 
 
 
Additive effects in imine hydrogenation 
 
Tani and co-workers identified protic amines such as 301 as additives giving higher conversions in the 
asymmetric hydrogenation of imine 55 using iridium BINAP complexes generated from 64 and 300 (Scheme 
86).[87] While a chiral amine additive did not influence the enantioselectivity of the catalyst in a positive or 
negative manner, both aromatic and aliphatic amines afforded higher enantioselectivities. The reaction was 
stopped at 60% conversion and the E/Z ratio of the acyclic imine 55 was similar to the beginning (92:8).  
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Scheme 86: Asymmetric hydrogenation of imine 55 using amine 301 as additive 
 
Zhu and Zhang investigated iridium-catalysed imine hydrogenation of 2,3,3-trimethylindolenine (302) 
(Scheme 87).[88] While chiral amines or iodide sources resulted in low to no conversion, addition of 
phtalimide (304) resulted in full conversion and high enantioselectivity. Apolar solvents such as toluene or 
dichloromethane gave very high enantioselectivities whereas polar solvents such as DMF or MeOH gave 
very low enantioselectivities. The beneficial effect was primarily rationalized based on findings by 
Colquhoun.[89] He reported on imidato ligands which acted as pseudo-halogen ligands in terms of their σ-
acceptor and π-donor properties. However, N-methylated phthalimide gave similar results and potassium 
phthalimide gave very low enantiomeric excess. Therefore, the direct influence of an Ir-N bond was 
questioned. Nevertheless, coordination via one oxygen atom is possible. Indeed, 1,3-indanedione forms a 
keto-enol species in solution and the presence of it as an additive increased the enantioselectivity of the 
hydrogenation. However, the improvement was not found with other imine substrates. Furthermore, addition 
of Brønsted acids gave better conversion but similar enantioselectivity. 
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Scheme 87: Asymmetric hydrogenation of imine 302 using phtalimide (304) as additive 
  
 
 
 
 
 
Chapter 2 – A Summary of Previous Results 
by F. Barrios-Landeros 
 
The project of this doctoral thesis was based on results of Dr. Fabiola Barrios-Landeros. She conducted 
post-doctoral studies in the research group of Prof. Andreas Pfaltz from April 2007 to December 2008. 
Within that time, I worked along her as a project student for eight weeks. The results from the internship are 
included in this chapter of previous results. 
This chapter is based on the progress report of Dr. Fabiola Barrios-Landeros of April 2008 and the leaving 
presentation of December 2008. The text has been modified but the main structure has been used. I, York 
Schramm, hereby clearly claim that this chapter is not out of my intellectual effort. It solely is added to aid 
the reader understand how the project developed. 
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Dihydride Iridium Intermediates 
 
In the introduction chapter an overview of previous studies on oxidative hydrogen addition to iridium 
complexes was given. Among these studies, Mazet and co-workers had reported on dihydride species being 
formed under catalytic conditions (Scheme 88).[57] The iridium complex [Ir(COD)(PHOX)]BArF 86 was 
activated under atmospheric hydrogen pressure at low temperatures. Primarily, the dihydride species 160 
with the cyclooctadiene still coordinated was observed. Prolongued exposure to hydrogen resulted in 
hydrogenation of the cyclooctadiene and formation of two dihydride disolvent complexes 161 and 162. The 
exact geometrical identity of the different dihydride complexes was studied by Mazet (studied by 1H nOe and 
31P NMR experiments) at only about 30% conversion of complex 86.  
F. Barrios subjected the reaction mixture to hydrogen gas until complex 86 was no longer detected and 
observed 160 as well as all isomers of the dihydride complexes 161, 162, 306 and 307.  
 
 
Scheme 88: Activation of complex 86 to afford dihydride complexes 160, 161, 162, 306 and 307 
 
Overall a different ratio of the octahedral complex isomers was observed compared to the studies by Mazet. 
161 and 162 are the major species and 306 and 307 the minor ones. Both complexes 161 and 162 are 
electronically favored due to the trans influences of their corresponding ligands. One hydride ligand is 
coordinated trans to the nitrogen and a solvent molecule trans to phosphorus of the phosphine oxazoline 
ligand. The second hydride ligand is coordinated trans to a second solvent molecule, exhibiting its 
characteristic high field NMR shift. The 1H- (Spectrum 1) and 31P{1H}-NMR spectra (Spectrum 2) of these 
complexes were recorded at −73 °C to avoid signal overlapping. 
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Spectrum 1: 1H-NMR spectra of dihydride species 161, 162, 306 and 307 observed in solution at -73 °C in THF-d8 
 
 
Spectrum 2: 31P{1H}-NMR spectra of dihydride species 161, 162, 306 and 307 observed in solution at -73 °C in THF-d8 
 
Since many studies on asymmetric (imine) hydrogenation, both experimental and computational one’s, 
suggested involvement of iridium hydride species during the catalytic cycle at some stage,7 the activated 
species for the hydrogenation of imines could be formed from the corresponding dihydride species 161, 162, 
306 and 307.  
Therefore, the activation of complex 86 was monitored by NMR and the subsequent reaction with imine 59 
afforded a species that contained a single hydride signal (Scheme 89). Upon complete activation of complex 
86 to dihydride complexes 161, 162, 306 and 307 in THF, addition of imine 59 at 0 °C resulted in formation 
of a hydride-imine complex 308. The signals in the 1H-NMR spectra of the COD-bound complex 160 
remained unchanged, whereas the signals of the COD-free dihydride unsaturated complexes 161, 162, 306 
and 307 disappeared and a new monohydride species appeared. The postulated structure of the 
cyclometalated imine complex 308 was supported by ESI-MS analysis. Imine 59 was not reduced under 
these conditions as only imine 59 (and not the amine 60) was detected by GC-MS analysis of the reaction 
mixture. Complex 308 was also prepared by directly mixing 86 and 59 at 0 °C. 
 
                                                          
7 See chapter 1 
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Scheme 89: Preparation of complex 308 
 
If the same reaction was performed in dichloromethane, a different species displaying a single 1H-NMR 
hydride and one 31P{1H}-NMR signal was obtained (Scheme 90). However, imine 59 was hydrogenated 
under these conditions and amine 60 was observed by 1H-NMR spectroscopy and detected by GC-MS 
analysis. ESI-MS measurements confirmed the corresponding cyclometalated amine complex 309. Complex 
309 was also prepared from 86 and racemic 60 (2 equivalents) under identical reaction conditions. 
 
 
Scheme 90: Preparation of complex 309 
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Characterization of cyclometalated intermediates 
 
In order to verify cyclometalation had occurred at the ortho-position of the imine, complex 86 and imine 310 
were reacted to form complex 311 (Scheme 91). Clear formation of a single hydride species with one 31P-
NMR signal was observed.  
 
Scheme 91: Preparation of iridacycle 311 with p-F-imine 310 
 
Since the intermediate is formed in situ in the presence of 2 to 3 equivalents of imine 310, it was impossible 
to analyze the aromatic region in the 1H-NMR. Therefore 13C NMR analysis was used to identify C3 from all 
other aromatic carbon signals. Both the chemical shift and heteronuclear coupling of C3 were expected to 
change significantly upon binding to the iridium metal. The expected C3 carbon could be observed at 128.5 
ppm as a doublet of doublets of doublets (J = 31.7, 5.4 and 2.8 Hz, Spectrum 3). The splitting of the signal 
arises from the heteronuclear coupling of the carbon atom to phosphorus, fluorine and the hydride. Two-
dimensional HMBC analysis clearly depicted this signal to be C3 and therefore evidenced the ortho-
cyclometalation of the imine. 
 
Spectrum 3: 13C{1H}-NMR in THF-d8 at -33 °C of iridacycle 311 
 
Complexes 161, 162, 306 and 307 were mixed with imine 59 at -73 °C to evaluate the propensity of the 
cyclometalation (Spectrum 4 and Scheme 92). Within 5 minutes of addition, two new hydride signals were 
observed.  
 
Scheme 92: Addition of imine 59 to dihydride complexes 161, 162, 306 and 307 at -73 °C 
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Spectrum 4: 1H-NMR spectra following the formation of iridacycle 308 from -73 °C to 22 °C 
 
The two signals corresponding to the dihydride complexes 161 and 162 disappeared almost completely while 
two new signals of iridacycle 308 and 308’ appeared (Scheme 93).  
 
Scheme 93: Interconversion of configurational isomers of 308 and 308’ 
 
For comparison, allowing the dihydride complexes 161, 162, 306 and 307 warm up to room temperature for 
only 3 minutes resulted in decomposition. The two newly formed hydride complexes were assigned as 
interconverting configurational isomers, one being the thermodynamically and one the kinetically favoured 
product. Upon warming the complex mixture from -73 °C to -33 °C and then to room temperature (22 °C), 
one hydride species was transformed into the other (Spectrum 4). Judging from the similar chemical shifts as 
well as the coupling constants, the hydride is expected to be cis to the phosphorus. As it is a very strong 
trans-donor (strong σ-donor), it is expected to be situated trans to a weak donor (a π-acceptor). Thus, it 
should be opposite of either nitrogen. With the restriction of the hydride being cis to the phosphorus and 
trans to a nitrogen atom, an isomerisation pathway involving a trigonal planar intermediate can be 
postulated. Interconversion via dissociation of a THF molecule would become more feasible with increased 
22 °C  
t = 180 min 
-33 °C  
t = 160 min 
-73 °C  
t = 90 min 
-73 °C 
t = 45 min 
-73 °C 
t = 5 min 
-73 °C 
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-73 °C 
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temperature to afford the thermodynamically favoured isomer 308. This experiment clearly demonstrated 
that imine cyclometalation onto dihydride complexes 161 and 162 occurs within minutes even at −73 °C. 
This high reactivity of the imine with dihydride complexes suggests that the same process takes place under 
catalytic conditions at room temperature. While reduction of imine 59 is not observed in THF, experiments 
aiming at isolating complex 308 could not be performed in CH2Cl2 since imine 59 is directly reduced and 
hence complex 309 formed.  
 
Attempts to crystallize the iridacycle 308 prepared from complex 86 with BArF as a counterion were 
unsuccessful. On the other hand, starting from the corresponding PF6 complex 312, single crystals of 313 
were obtained (Scheme 94) and the structure was determined by X-ray crystallography (Figure 14). 
 
 
Scheme 94: Preparation of complex 313 furnishing X-Ray quality crystals 
 
The cyclometalated nature of the iridium(III)-complex was confirmed. The complex is octahedral with a 
PHOX ligand, a cyclometalated imine 59, one molecule of THF and a hydride in the coordination sphere 
(Figure 14).  
 
Figure 14: Crystal structure of complex 313 
 
The exact position of the hydride could not be determined by X-ray diffraction but the free coordination site 
can be well recognized. The hydride ligand is cis to the phosphorus atom which is consistent with the 
heteronuclear coupling constant of  JP-H ≈ 20 Hz. Selected bond lengths and angles are depicted in Table 3. 
Six out of the eight angles formed around the metal are between 85 and 98 degrees consistent with the 
octahedral environment around the metal. The atoms in the cyclometal plane have distorted angles of 77.0 
and 103.5 due to the 5-membered ring constraint. 
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Table 3: Selected bond lengths and angles of complex 313 
 
Atoms Bond lenghts (Å) Atoms Angles (deg) 
Ir1 O2 2.12 P1 Ir1 O2 (THF) 98.2 
Ir1 C25 2.06 P1 Ir1 C25  173.4 
Ir1 N2 (Imine) 2.20 P1 Ir1 N2 (Imine) 103.5 
Ir1 P1  2.32 P1 Ir1 N1 (PHOX) 85.4 
Ir1 N1 (PHOX) 2.04 N1 (PHOX) Ir1 O2 175.8 
  N1 (PHOX) Ir1 C25  88.1 
  N1 (PHOX) Ir1 N2 (Imine) 89.7 
  N2 (Imine) Ir1 O2 91.6 
  N2 (Imine) Ir1 C25 77.0 
  O2 Ir1 C25 88.4 
 
In order to better understand the stability of the iridacycle under hydrogenation conditions, iridacycle 308 
was subjected to imine 314 under hydrogenation conditions and aliquot analysis by ESI-MS was performed 
every 15 minutes. 
 
Scheme 95: Exchange of cyclometalated imine 59 in complex 308 for imine 314 
 
Spectrum 5 shows an aliquot of the reaction mixture at the beginning. No signal corresponding to iridacycle 
315 was observed in earlier aliquots. At the end of the reaction, a small signal corresponding to iridacycle 
315 can be observed (Spectrum 6). With regards to the reactivity of iridacycle 308, exchange can be 
neglected. The appearance of the mass signals might originate from decomposition processes of 308 
undergoing cyclometalation with imine 314. 
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Spectrum 5: ESI-MS spectra of 308 at the beginning of 
the reaction 
 
Spectrum 6: ESI-MS spectra of 308 (and 315) at the end 
of the reaction 
 
On the other hand, if amine 316 was cyclometalated to generate iridacycle 317 (Scheme 96 and Spectrum 7), 
addition of imine 59 under hydrogenation conditions resulted in complete exchange of the amine to the imine 
affording complex 308 was observed (Spectrum 8). 
 
PhHN
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5986
CH2Cl2, H2 [1 bar]
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Scheme 96: Exchange of amine 316 by imine 59 on iridacycle 317 
 
 
Spectrum 7: ESI-MS spectra of 317 at the beginning of 
the reaction 
 
 
Spectrum 8: ESI-MS spectra of 308 at the end of the 
reaction 
 
Under deuteration conditions, a gradual increase of the mass intensities can be observed (Scheme 97 and 
Spectrum 10). This suggests that under deuteration conditions, multiple isomerisation and scrambling 
processes are occurring at the cyclometalated complex 308. 
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Scheme 97: Concomitant incorporation of deuterium into iridacycle 308 
 
 
Spectrum 9: Initial ESI-MS spectra of iridacycle 308 
 
Spectrum 10: ESI-MS spectra after prolongued exposure 
of iridacycle 308 to deuteration conditions 
 
In order to identify the resting state of the iridium complex under reaction conditions, 15N-labelling was used 
to determine whether the cyclometalated substrate was reduced or not, judged by the chemical shift in the 
15N-NMR spectrum. Furthermore, imine cyclometalation was believed to be irreversible whereas amine 
cyclometalation was expected to be reversible. The corresponding iridacycles 308 (Scheme 98) and 309 
(Scheme 99) were mixed with 15N-labelled imine 59 or amine 60 and allowed to exchange overnight. With 
308, no scrambling of imine was observed by 15N-NMR spectroscopy.  
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Scheme 98: Exchange of imine 59 investigated with labelled 15N-59 
 
On the other hand, subjecting complex 309 (Figure 15 and Spectrum 11) to 15N-amine 60, exchange to a 
thermodynamic equilibrium of 309 and 15N-309 could be detected by 1H-NMR spectroscopy due to the 
specific coupling of the hydride (Scheme 99, Spectrum 12 and Spectrum 13). 
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Spectrum 11: 1H-NMR of 309 (14N: 
doublet) 
 
Spectrum 12: 1H-NMR of 15N-309  
(14N: doublet & 15N: dd) 
 
Spectrum 13: 1H{31P}-NMR of 15N-309 
(14N: singlet & 15N:doublet) 
 
 
Figure 15: Complex 309 
 
Scheme 99: Interconversion of complexes 309 and 15N-309 
 
 
Cyclometalated complexes as catalysts 
 
Both NMR spectroscopic and ESI-MS analysis indicated that the cyclometalated complexes were stable in 
solution. To elucidate whether they are intermediates in the catalytic cycle or iridacycle formation is only a 
side reaction under reaction conditions, their role in the course of the reaction was investigated.  
 
A previous study in our lab demonstrated that dialkyl imines were hydrogenated in low conversion and low 
enantiomeric excesses.[30],[31] Possibly due to prevention of ortho-metalation, the active catalyst cannot be 
formed. Therefore, reductions of imines with different substitution patterns at the ortho position of the 
aromatic ring were conducted to evaluate the difference in reactivity and enantioselectivity (Table 4). At 
atmospheric hydrogen pressure imine 59 (Entry 1) is hydrogenated in full conversion and 88% ee. Reactivity 
is lowered with a methyl- or fluoro-substituent at the ortho-position in imines 318, 319 and 320 (Entries 2, 4 
and 5). At higher pressure, imine 318 is reduced with 70% conversion (Entry 3), but imine 320 only in 11% 
conversion (Entry 6). Imines 310, 314, 322, 323 and 324 (Entries 9 to 13) were tested to evaluate electronic 
effects at the aromatic ring. All substrates were fully reduced and 81% ee (electron-rich or –neutral) to 88% 
ee (electron-poor) was observed.  
 
Substrates hindering or preventing ortho-C-H activation either by destabilizing a planar Aryl-(C=N) 
orientation (318), heteroatom substitution (319), absence of a sp2-aromatic C-H bond in the ortho-position 
(320) or a methylene group (321) did not react under 1 bar hydrogen over the course of four hours. This 
suggests that ortho-metalation of the substrate is required to form an active catalyst. However, increased 
pressure did furnish the corresponding amines, which suggests that under forcing conditions alternative 
reaction pathways are possible. 
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Table 4: Hydrogenation of imines 59, 310, 314 and 318-324 
 
Entry Imine p [bar] Conv. [%]a ee [%]b 
1 59 (R = Ph) 1 >99 88 
2 
318 (R = 2-Me-Ph) 
1 0 - 
3 50 70 67 
4 319 (R = 2-F-Ph) 1 95 - 
5 
320 (R = 2,6-di-F-Ph) 
1 0 - 
6 50 11 - 
7 
321 (R = Bn) 
1 0 - 
8 50 >99 n.d.c 
9 314 (R = 4-Me-Ph) 1 >99 81 
10 322 (R = 4-OMe-Ph) 1 >99 81 
11 310 (R = 4-F-Ph) 1 >99 86 
12 323 (R = 4-Cl-Ph) 1 >99 86 
13 324 (R = 4-CF3-Ph) 1 >99 88 
a) Determined by GC analysis; b) determined by HPLC on a chiral stationary phase; c) n.d. = not determined. 
 
To test whether the ortho-metalated iridacycle was an active catalyst or the active catalyst was formed 
thereof, 86 was activated in the presence of 59 in THF to afford 308, redissolved in CH2Cl2 and directly 
injected as a catalyst into the reaction mixture (Scheme 100).  
 
 
Scheme 100: Asymmetric hydrogenation of imine 59 using iridacycle 308 formed in situ 
 
In the hydrogenation of imine 59, full conversion with only 26% ee were obtained. Attempts to isolate and 
crystallize 308 remained unsuccessful. However, a yellow solid was obtained after elution on silica gel. The 
isolated complex displayed no BArF signals in the 1H- and 19F-NMR. It still had one hydride 1H-NMR signal 
and one 31P{1H}-NMR signal. The exact nature of complex 325 was not elucidated and the counterion was 
tentatively assigned as a chloride (Scheme 101).  
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Scheme 101: Preparation and isolation of complex 325 
 
The catalytic activity of the isolated cyclometalated iridium complex 325 was tested. With 2 mol% of 325 no 
conversion of imine 59 was observed under hydrogenation conditions. This lack of reactivity can be 
attributed to the counterion. If the counterion was a chloride, it could as well serve as a ligand within the 
coordination sphere of the iridium centre and thus prevent coordination of an imine or hydrogen molecule. 
Therefore abstraction of the chloride with NaBArF should result in a free coordination site to render the 
complex an active catalyst. Indeed, if 325 was mixed with an equimolar amount of NaBArF and tested in 
catalysis, imine reduction proceeded in 80% conversion and 87% ee (Scheme 102). Under similar reaction 
conditions virtually identical enantiomeric excess and similar but lower conversion of 80% were observed 
when using 86 as the catalyst (>99%, 87% ee). This experiment clearly demonstrated that 325 generated an 
active catalyst upon addition of NaBArF. Both complex 86 with imine 59 as well as iridacycle 325 formed 
the same catalytically active species under hydrogenation conditions.  
 
 
Scheme 102: Asymmetric hydrogenation of imine 59 using iridacycle 325 as a catalyst 
 
 
Catalytic Deuteration 
 
In the course of attempting to prepare the cyclometalated amine complex with a deuteride, the 1H-NMR 
spectrum of the amine after the reaction revealed incorporation of deuterium at the ortho-position of the 
aromatic ring (Spectrum 14). The same result was obtained when amine 60 was subjected to deuteration 
conditions (Scheme 103). This demonstrated the lability and reversibility of amine cyclometalation.  
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Scheme 103: Reversible cyclometalation of amine 7 and resulting deuterium incorporation at the ortho-position A 
 
Spectrum 14: Aromatic region of the 1H NMR spectra of deuterated amine 60.  
Signal A has an integral of only 0.5 instead of 2 
 
While both the imine and amine substrate were shown to cyclometalate, it remained unclear whether 
deuterium incorporation would take place before or after the substrate had been reduced. In order to assess 
the extent of deuterium incorporation before reduction of the imine substrate, it was subjected to deuteration 
conditions in THF (Scheme 104). While hydrogenation of imine takes place at room temperature in CH2Cl2, 
the reaction in coordinating solvents like THF is slow. To inhibit reduction of the C=N double bond and 
solely study reversible cyclometalation of the imine under catalytic deuteration conditions, the imine was 
reduced with D2 in THF at low temperature. 
  
 
Scheme 104: Incorporation of deuterium in the imine 59 and amine 60 
 
At 0 °C the imine was recovered and had no deuterium incorporation at any position. While formation of the 
cyclometalated complex was demonstrated under these conditions, this suggested that upon generation of 
iridacycle 308, addition of D2 and elimination of C–D does not take place under these conditions. 
Furthermore, after cyclometalation, the resulting iridium catalyst is stable and no reversible cyclometalation 
of the imine occurs. At 23 °C 35% conversion to the amine 60 was observed after four hours. The imine and 
amine recovered were analyzed by 1H- and 2D-NMR spectroscopy and deuterium incorporation was only 
observed at the ortho-position of the amine. If the reduction of the imine occurs, it possibly also involves 
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formation of an aromatic C-D bond when the product amine is released. In other words, the imine is bound to 
the metal center via the ortho-carbon and this bond is broken after the C=N double bond has been reduced. 
Therefore a cyclometalated species is involved in the catalytic cycle at some stage. 
 
From a simplified mechanistic perspective, one would expect hydrogen to add across the C=N double bond. 
While incorporation of deuterium into the ortho-position of the acetophenone ring can be explained by 
reversible cyclometalation, deuterium should also be incorporated at the α-position and the nitrogen atom of 
the product amine (Scheme 105).  
 
 
Scheme 105: Catalytic deuteration of imine 59 
 
In one experiment (batch 1), incorporation of deuterium at the α-position and at the methyl group was 
observed (Scheme 106) whereas a second experiment (batch 2) showed deuterium at the ortho-position as 
well. No deuterium label was detected at the nitrogen since the acidic N-deuterium was exchanged for a 
proton during workup. Incorporation of deuterium at the methyl group can occur by imine/enamine 
tautomerism. Moreover, deuterium incorporation in the α-position did only occur to a partial extent. Within 
the two batches of the identical reaction setup, significant differences in overall deuterium incorporation 
were observed. To test whether the proton or deuterium scrambling originated from adventitious water or the 
solvent, all solvents were degassed and distilled over CaH2. The results were not significantly different 
between the reactions with crown cap solvent and dried solvents and neither when comparing reactions in 
CD2Cl2 instead of CH2Cl2. Therefore, the possible role of solvent or adventitious water as the source of 
scrambling was discarded. 
 
 
Scheme 106: Catalytic deuteration of unlabelled imine 59 with deuterium gas 
 
To elucidate the origin of the protons in the α-position in the deuteration with D2, differently 2D-labeled 
imines of 59 were prepared via condensation of d5- or d7-aniline and CD3-, C6D5- or d8-acetophenone 
(Scheme 107). However, incomplete labelling of the methyl group was observed due to residual water in 
KOtBu during preparation of 59-d3 and 59-d13. Therefore, deuterium labelling was enriched via 
imine/enamine tautomerism with d4-methanol. 
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Scheme 107: Differently labelled imine substrates of 59 
 
59-d3 displayed high incorporation of hydrogen or deuterium along the C=N double bond with respect to the 
gas employed. While in the 1st batch significant incorporation of hydrogen at the methyl position was 
observed, only low 1H-incorporation at the methyl-position was observed in the 2nd batch. Overall, these 
observations were in accordance with a mechanism of deuterium being added across the C=N double bond. 
Minor isomerisation processes as well as reversible post-hydrogenative deuterium incorporation at the ortho-
position have occurred (Scheme 108).  
 
Scheme 108: Catalytic hydrogenation and deuteration of imine 59-d3 
 
Imine 59-d10 displayed inconsistent results. While complete hydrogen incorporation at the α-position was 
retained with hydrogen gas, the origin as well as the inconsistency between the two batches when using 
deuterium could not be explained. Furthermore, inconsistent incorporation of deuterium at the methyl 
position within the two batches was observed (Scheme 109). 
 
 
Scheme 109: Catalytic hydrogenation and deuteration of imine 59-d10 
 
The picture became even more complicated with 59-d13. Incorporation of hydrogen at three positions under 
deuterium conditions with a fully deuterated substrate questioned the experimental setup (Scheme 110). 
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Scheme 110: Catalytic hydrogenation and deuteration of imine 59-d13 
 
One possible explanation for incorporation of hydrogen at the α-carbon under deuteration conditions is the 
formation of an Ir–H bond by cyclometalation of the imine. This hydride would be transferred to the α-
carbon of the imine substrate. If the hydrogen from the methyl group ends up at the α-carbon, a 
tautomerization process via imine/enamine interconversion occurs during catalysis which in turn can result in 
exchange between the methyl protons and the Ir-hydrides due to their acidity.  
 
The deuterium labelling experiments gave rise to the speculation that an imine/enamine tautomerisation 
under hydrogenation conditions could be part of the catalytic cycle (Scheme 111). Such an imine/enamine 
tautomerisation could be catalysed by Brønsted acidic hydrides or the reduced amines. 
 
 
Scheme 111: Possible imine-enamine tautomerisation of imine 59 upon cyclometalation before undergoing hydrogenation 
 
Therefore, substrates preventing imine/enamine tautomerism such as 326 and 327 were tested to assess 
whether or not the methyl group was the source of protons that incorporate at the α-carbon during 
deuteration. If the substrate does not undergo reduction when tautomerization is prevented, an alternate 
mechanism could be proposed, i.e. reduction of the C=C bond in the enamine tautomer.  
Imine 326 was not reduced at 1 bar or even at 50 bar of H2 pressure (Table 5). This result could be due to the 
change in electronic properties of the substrate or because tautomerization in this substrate is prevented. 
Imine 326 with a tert-butyl group could not be hydrogenated at 1 or 50 bar pressure. The experiment was not 
suitable to rule out an enamine mechanism. It was not possible to assess if the lack of reactivity is due to the 
increased steric hindrance or because the substrate cannot undergo tautomerization. 
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Table 5: Reduction of imines 326 and 327 
 
 
 
Entry Imine p [bar] Conv. [%]a ee [%]b 
1 326 (R = CF3) 
1 0 - 
50 <1 - 
2 327 (R =tBu) 
1 0 - 
50 0 - 
a) Determined by GC analysis; b) determined by HPLC on a chiral stationary phase. 
 
 
React-IR Studies 
 
The catalytic hydrogenation of imine 59 was monitored by in situ infrared spectroscopy. The reactions were 
setup in a three neck flask with a H2 inlet adaptor, pressure gauge and IR probe. The reaction was performed 
on a 0.5 mmol scale of imine 59 in 4 mL of CH2Cl2 with 2% catalyst and different hydrogen pressures. The 
substrate solution under H2 atmosphere was equilibrated and the catalyst was added by syringe. The change 
in the concentration of imine and amine were monitored acquiring a spectrum every 2 min.  
Initial experiments displayed a linear behavior, suggesting a zero order dependence of the reaction on the 
concentration of substrate. Alternatively the limited solubility of hydrogen gas could explain the observed 
linear behaviour. Therefore reaction conditions, under which hydrogenation is slower than hydrogen gas 
diffusion into the solution were investigated. While conducting the reaction at −78 °C failed due to 
insolubility of the imine, hydrogen pressure could only be varied between 1 and 2 bar. Lowering the catalyst 
loading from 3 mol% to 1 mol% depicted an exponential decay of the imine as well as an exponential growth 
of the amine concentration when monitored by React-IR. The different behaviour is depicted in Figure 17 
comparing three different catalyst loadings. 
 
 
Figure 16: General setup of monitoring the reaction by 
ReactIR 
 
Figure 17: Profile of amine formation at different catalyst loadings. 
 
 
Sufficiently different rates were observed with hydrogen gas pressure between 1.2 and 1.8 bar. A linear trend 
was observed, but rates were too low to determine the reaction order since the reaction could only be 
followed at low pressures. 
     
  
0
0.02
0.04
0.06
0.08
0.1
0.12
0.14
0 2000 4000 6000 8000 10000 12000 14000
time (s)
[a
m
ine
]
1%
2%
3%
Chapter 2 – A Summary of Previous Results by F. Barrios-Landeros 
76 
Asymmetric Hydrogenation of Dialkyl Imines 
 
Since cyclometalation was demonstrated to be a key element in the catalytic cycle, the low reactivity of 
aliphatic imines such as 328, 329, 330 and 331 could be explained by their inability to form the active 
catalyst for imine hydrogenation. Speculatively, iridacycle 308 formed under hydrogenation conditions could 
be a superior catalyst compared to 86. Indeed, addition of 59 to generate complex 308 in situ resulted in 
higher conversion both at atmospheric as well as 50 bar hydrogen pressure (entries 5 vs. 6; 7 vs. 8; 9 vs. 10). 
Entries 11 and 12 also show a change in the enantioselectivity. No experiments have been conducted with 
the isolated complex 308. 
 
Table 6: Asymmetric hydrogenation of dialkyl imines 328 to 331 
 
CH2Cl2, H2 [bar], 23 °C, 4 h R
HN
Ph
R
N
Ph 2 mol%
P N
O
Ph
Ph
BArF
Ir
86
+
Ph
N
Ph
59
5 mol%
 
Entry Imine Additive H2 [bar] Conv. [%]a ee [%]b 
1 
 
- 1 0 - 
2 2 1 0 - 
3 
 
- 1 n.d.c 69 
4 2 1 n.d.c 71 
5 
 
- 1 0 - 
6 2 1 10 - 
7 - 50 25 - 
8 2 50 >99 60 
9 N Ph
331  
- 1 0 - 
10 2 1 70 - 
11 - 50 >99 31 
12 2 50 >99 23 
a) Determined by GC analysis; b) determined by HPLC on a chiral stationary phase; c) n.d. = not determined. 
 
Chemoselective hydrogenation was observed when attempting to hydrogenate trisubstituted olefin 332 in the 
presence of imine 59. While hydrogenation of 332 readily occurs within two hours at atmospheric hydrogen 
pressure, complete inhibition of olefin reduction was observed upon addition of imine 59 (Scheme 112). 
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Scheme 112: Inhibition of olefin hydrogenation by catalyst 86 in the presence of imine 59 
 
Complete reduction of imine 59 to amine 60 was observed in stoichiometric presence of olefin 332 (Scheme 
113). Similar to the 2nd experiment in Scheme 112, iridacycle 308 was formed in situ and appeared to be 
favoured over formation of other iridium complexes under hydrogenation conditions as well as olefin 
reduction. Addition of 60 resulted in generation of an iridium species which was not able to hydrogenate 
olefin 332 either.  
 
 
Scheme 113: Hydrogenation of olefin 332 inhibited both by imine 59 and amine 60 
 
 
Summary / Conclusions 
 
C-H activation is not a side reaction that occurs under catalytic hydrogenation conditions. The formation of a 
cyclometalated complex seems to occur prior to hydrogenation. This is supported by the irreversibility of the 
cyclometalation of the imine. The cyclometalated complex represents a catalytically active species under 
hydrogenation conditions. The cyclometalated amine can be formed in CH2Cl2 under hydrogenation 
conditions.  
 
The cyclometalated complex is therefore believed to be a key intermediate in the course of the reaction, 
possibly resembling the active complex to a very close extent. This is disclosed by the inability of the 
cyclometalated complex to undergo exchange of the coordinated imine. 
 
Furthermore, activation of the Ir-PHOX complex 86 with H2 was shown to result in complete conversion to 
unsaturated dihydride intermediates which are stable at low temperature in THF (1H- and 31P{1H}-NMR). 
These dihydride complexes are very reactive and cyclometalate imines at –78 °C within a few minutes. The 
identity of the cyclometalated complex was established by ESI-MS analysis, NMR studies and a X-Ray 
crystal structure of the related PF6 complex 313. 
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The cyclometalated complex 325 was used as a precatalyst and turned into an active species that catalysed 
imine hydrogenation upon addition of an equimolar amount of NaBArF. Similar conversion and virtually 
identical ee of the product amine 60 were observed compared to the reaction performed with complex 86. 
 
Addition of a catalytic amount of imine 59 to complex 86 resulted in the generation of iridacycle 325 in situ. 
It also improved the conversion of aliphatic imine 328 to 331. Furthermore, it altered the enantiomeric 
excess in one example. It also inhibited the reduction of trisubstituted olefin 332. 
  
 
 
 
 
 
Chapter 3 – Mechanistic Investigations 
 
  
Imines as possible in situ additives for improved aliphatic imine hydrogenation 
 
F. Barrios had demonstrated that using iridium PHOX complex 86 in combination with imine 59 afforded 
higher yields in the asymmetric hydrogenation of aliphatic imines. This was explained by the in situ 
formation of iridacycle 325 which was postulated to be the active catalyst in solution (Figure 18).  
 
 
Figure 18: Complexes 86 and 325 and imine 59 
 
To verify these previous findings, hydrogenations with the combinations of complex 86 with imine 59 as 
well as iridacycle 325 with NaBArF were tested as shown in Table 7. Since virtually identical enantiomeric 
excesses as well as similar conversion were obtained, it indicated that a common intermediate must be 
present in both reaction setups. The omittance of either NaBArF when using 325 or imine 59 when using 86 
resulted in significantly reduced conversions. Furthermore, different enantiomeric excesses were obtained. 
This confirmed the hypothesis that only a cationic iridacycle derived from neutral iridacycle 325 is an 
efficient catalyst for hydrogenation of aliphatic imines 329 to 331. 
 
Table 7: Asymmetric hydrogenation of N-Phenyl aliphatic imines with either iridacycle 325 or generation of 325 in situ 
 
Entry Catalyst Imine Conv. [%]a) ee [%]b) 
1 86 and 59 329 (R = Cy) 13 71 (R) 
2 86 and 59 330 (R = iPr) 8 60 (R) 
3 86 and 59 331 (R = n-Bu) 10 20 (-) 
4 325 and NaBArF 329 (R = Cy) 20 71 (R) 
5 325 and NaBArF 330 (R = iPr) 11 60 (R) 
6 325 and NaBArF 331 (R = n-Bu) 10 21 (-) 
a) Determined by GC analysis. b) determined by HPLC analysis on a chiral stationary phase. 
 
The stability of the in situ formed iridacycle was demonstrated in cross-over experiments when reducing 
imine 322 with iridacycle 325 (Scheme 114). By GC analysis, neither imine 59 nor amine 60 could be 
detected even in trace amounts in the course of the reaction. These results are consistent with the hypothesis 
that cyclometalation is irreversible and the imine remains bound to iridium throughout the catalytic reaction. 
The enantiomeric excess of 333 remained constant throughout the reaction as verified by aliquot HPLC 
analysis. 
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Scheme 114: Asymmetric hydrogenation of imine 322 with iridacycle 325 without observation of imine 59 or amine 60 
 
To verify that the product amine would not affect any enantiodiscrimination, control experiments using 
enantiopure amine 60 as an additive in the hydrogenation of imine 334 were conducted (Scheme 115). While 
full conversion was observed when adding imine 598, racemic amine 335 was obtained in low conversion 
with enantiopure amine 60. 
 
 
Scheme 115: Investigation of the influence of chiral amine 60 on aliphatic imine 334 
 
The same results were observed with achiral complex 336 and enantiopure amine 60 (Scheme 116). 
Therefore, it was concluded that the chiral amine 60 produced in the hydrogenation of 59 (and thus present in 
solution) does not cyclometalate onto the iridium centre in the presence of imine and form an active catalyst. 
Reversible cyclometalation of amine 60 has been observed, however with a strong favour of the amine being 
replaced by an imine.9  
                                                          
8 See chapter 5 
9 See chapter 2 
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Scheme 116: Investigation of the influence of enantiopure amine 60 with achiral catalyst 336 
 
F. Barrios had conducted comparison experiments between complex 86 and iridacycle 325 on the 
hydrogenation of imine 59. The discrepancy between the conversions of 99% and 80% when comparing 
complex 86 and 325 with NaBArF could not be explained (Scheme 117). However, no detailed kinetic 
investigations have been conducted. 
 
Scheme 117: Comparison of complexes 86 and 325 for the asymmetric hydrogenation of imine 59 
 
To test whether residual chloride in solution would coordinate to the metal centre and thus reduce its 
reactivity, lithium chloride was added to the hydrogenation (Scheme 118). The amount of LiCl was varied 
from 0, 20, 364 up to 100 mol% and aliquots were collected during the reaction. In all cases the reaction 
proceeded with similar rate irrespective of the amount of LiCl added. This could be explained by limited 
solubility of LiCl in CH2Cl2. A more pronounced effect could possibly be observed with a soluble chloride 
source, such as tetrabutyl ammonium chloride, but this experiment has not been conducted. 
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Scheme 118: Testing the possible effect of residual chloride in solution 
 
In order to exclude aniline, a byproduct resulting from hydrolysis, affecting the conversion of the 
hydrogenation, varying amounts of aniline from 0, 5, 10 up to 20 mol% were added to the reaction to test for 
competitive coordination to the catalyst (Scheme 119). In all reactions, full conversion with identical ee of 
40% was observed. Therefore, the presence of aniline in the reaction mixture had no influence on either the 
reactivity or selectivity of the iridacycle catalyst 337. 
 
 
Scheme 119: Testing the possible effect of aniline in solution 
 
Since the active catalyst was generated in situ from complex 86 and imine 59 in the studies presented above, 
an approach for a general ligand screening was targeted. Therefore, the catalyst was generated in situ from 
[Ir(COD)2]BArF (109), PHOX ligand 338 and imine 59 and tested in the asymmetric hydrogenation of imine 
329 (Scheme 120). Both conversion and enantioselectivity were identical to a reaction employing complex 
86 and imine 59. 
 
Scheme 120: Comparison of generating iridacycle 325 in situ from either 109 and 338, or 86 
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Unfortunately, when applying imine 34010, identical conversion but significantly lower ee were obtained 
compared to using 86 with 340 (Scheme 121). Possibly the larger steric bulk from imine 340 did affect 
iridacycle formation under these conditions. No further optimisation studies were conducted. 
 
 
Scheme 121: Comparison of generating iridacycle 337 in situ from either 109 and 338, or 86 with bulky imine 340 
 
 
Cyclometalation of different imines 
 
The mechanistic investigations of F. Barrios concluded that cyclometalated Ir(III) complexes such as 308 
represent catalytically active structures in solution for the hydrogenation of imines (Scheme 122). Since 
dissociation of the imine 59 was not observed in the course of the reaction by ESI-MS experiments, the 
catalyst was assumed to be stable and bear imine 59 cyclometalated throughout the reaction at the iridium 
centre. This would indicate that the cyclometalated imine 59 is also involved in the enantiodiscriminating 
step.  
 
Scheme 122: Activation of complex 86 to iridacycle 308 by cyclometalation of imine 59 
 
This is highlighted in Scheme 123 where the aliphatic imine is approaching the iridacycle. Upon 
coordination to the metal centre in structure 341, the hydride is transferred to the prochiral iminoyl carbon 
atom, and the electrons from the C=N double bond coordinate the amide to the iridium centre to provide the 
amide complex 342. The oxidation state of iridium is not changed overall and the vacant coordination site is 
occupied by a solvent molecule. 
 
                                                          
10 See chapter 5 
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Scheme 123: Hydride transfer to aliphatic imine on iridacycle 308 
 
In order to verify the participation of the imine in the enantiodiscriminating step, an iridacycle such as 344 
with an achiral PHOX ligand and a chiral imine such as 343 should generate a chiral catalyst for asymmetric 
imine hydrogenation. If the imine remains cyclometalated during the catalytic reaction, asymmetric 
induction on imine 59 from the chiral imine 343 should be observed in the enantioenriched amine product 60 
(Scheme 124).  
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Scheme 124: Asymmetric hydrogenation with iridacycle 344 bearing a chiral imine 
 
To investigate this, chiral imine 346 was prepared by condensation of acetophenone (117) and 1-
naphtylethylamine (345) (Scheme 125). The corresponding chiral imines had been shown to induce high 
diastereoselectivity, e.g. in asymmetric addition of alkyl lithium reagents[90] or asymmetric addition to 
aldehydes.[91]  
 
Scheme 125: Preparation of chiral imine 346 
 
Prior to cyclometalation, they were tested in hydrogenation. No amine product 347 was observed (Scheme 
126). Nevertheless, the reaction mixture underwent a colour change from red to yellow. This is accounted by 
the activation of the iridium PHOX complex undergoing cyclooctadiene hydrogenation, thus generating di-
hydride intermediates (Scheme 122). 
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Scheme 126: Hydrogenation of imine 346 using 336 
 
When the catalyst was changed from 336 to a complex with a sterically more demanding ligand such as 348 
or 312 and hydrogenations were conducted at higher pressure, full conversion to the amine was observed 
(Scheme 127). 
 
Scheme 127: Hydrogenation of imine 346 using 12, 348 and 312 at elevated hydrogen pressure 
 
Only complexes 348 and 312 with substituents in the oxazoline ring showed high conversion. Therefore, 
cyclometalation was conducted with these complexes. Two observations were made: Instead of one single 
hydride 1H-NMR and one 31P-NMR signal more than 5 hydride signals were observed. Additionally, the 
expected colour change from red to yellow, caused by iridium oxidation, was not observed to a sufficient 
extent. The reaction mixtures remained red or dark orange. This indicated that either activation of the 
complex 312 or cyclometalation of 346 did not occur. 
 
 
Scheme 128: Attempted iridacycle generation from 312 and 346 
 
Analysis of the reaction mixture showed that activation of the complex 312 had occurred but no iridacycle 
formation ensued. Instead, formation of the trinuclear complex 350 was observed (Scheme 129). This 
Chapter 3 – Mechanistic Investigations 
87 
160 160
structure had earlier been identified as a degradation product of complex 349 and was shown to be 
catalytically inactive.[92] 
 
 
Scheme 129: Deactivation product 350 observed in attempted cyclometalation of 346 to 312 
 
Therefore, the reaction was conducted in a step-wise manner with the sterically less-demanding complex 
336. Activation with hydrogen gas depicted the expected hydride signals for the different iridium species in 
solution at low temperature, cyclooctadiene-bound complex 160 and di-hydride disolvent complexes 306 and 
307 (Scheme 130 and Spectrum 15). The origin of the broad signals was not investigated further and these 
signals were not assigned. 
 
Scheme 130: Activation of complex 336 to dihydride species 160, 306 and 307 
 
Spectrum 15: Hydride region in 1H-NMR in the activation of 12 
 
Upon addition of imine 346, two new peaks were observed which were assigned to configurational isomers 
of the newly formed iridacycle. While clear spectra could be obtained at -13 °C (Spectrum 16), warming the 
sample to room temperature resulted in the formation of other species and a plethora of hydride signals was 
observed (Spectrum 17). 
306 & 307 
306 & 307 
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Spectrum 16: Hydride region in 1H-NMR in the activation of 336 upon addition of imine 346 
 
Spectrum 17: Hydride region as in Spectrum 16 upon warming to room temperature 
 
To facilitate cyclometalation, the size of the cyclometalating imine was reduced. Preparation of aldimine 352 
proceeded with 87% yield. The corresponding ketimine 353 was prepared in 29% yield (Scheme 131). 
 
 
Scheme 131: Preparation of chiral imines 352 and 353 
 
Aldimine 352 was subjected to cyclometalation with iridium PHOX complex 336 (Scheme 132). The crude 
reaction mixture displayed two overlapped hydride signals and two 31P-NMR signals along with smaller ones 
(Spectrum 18 and Spectrum 19). These were assigned to the configurational isomers of complexes 354 and 
355.  
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Scheme 132: Generation of configurational isomers 354 and 355 
 
Spectrum 18: Hydride region in the 1H-NMR of complex mixture of 354 and 355 
 
Spectrum 19: 31P{1H}-NMR of complex mixture of 354 and 355 
 
The crude reaction mixture of complexes 354 and 355 was subjected to flash chromatography and a new 
single hydride signal (Spectrum 20) as well as one single 31P-NMR signal (Spectrum 21) was observed for 
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complex 356 (Scheme 133). The counterion was tentatively assigned as a chloride but could not be 
conclusively identified. MALDI-MS analysis showed two main mass signals at m/z 729 and 765. The 
molecular mass of complex 356 is expected at 768. While the isotopic pattern of the MALDI-MS analysis 
supported the postulated structure of [356-3u]+ or [356-39u]+, the exact masses corresponding to the species 
[356-H]+ (m/z 767) or [356-Cl]+ (m/z 733) could not be observed. 2D-NMR experiments showed NOE 
contacts between the hydride and the ortho-protons of the iridacycle, the ortho-protons of one phenyl 
substituent at the phosphorus atom as well as one weak NOE contact to a proton of the oxazoline. No NOE 
contacts to the stereogenic centre of the imine were detected. This led to the postulated structure 356 (Figure 
19). 
 
 
Scheme 133: Generation of chloride iridacycle 356 by elution on silica gel 
 
 
Spectrum 20: 1H-NMR of 356 
 
Spectrum 21: 31P{1H}-NMR of 356 
 
 
Figure 19: Observed NOE contacts 
in 356 
 
Due to loss of the BArF counterion during the work-up procedure, the reaction was attempted with 
complexes 357 or 358 and the crude was eluted on silica gel. More than one hydride 1H-NMR and many 31P-
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NMR signals were observed (Figure 20). Therefore, complexes 357 and 358 were no longer evaluated in 
cyclometalations. 
 
 
Figure 20: Iridium PHOX complexes 357 and 358 
 
Cyclometalation was also carried out with ketimine 353. After elution on silica gel, two hydride signals and 
two 31P-NMR signals were observed (Spectrum 22). These were assigned to configurational isomers of 
complex 359 ( Scheme 134). 
 Scheme 134: Preparation of iridacycle 359 
 
Spectrum 22: 1H-NMR of both configurational isomers of 359 
 
2D-NMR analysis of 359 is shown in Figure 21. Overlapping signals did not allow for accurate identification 
of all protons. Furthermore, NOE experiments showed three contacts which could not be assigned to specific 
protons due to very similar chemical shifts. MALDI-MS analysis showed one mass signal at m/z 744. 
Complex 359 has a molecular weight of 782 g mol-1. FAB-MS analysis showed one mass signal at m/z 745. 
ESI-MS also showed one mass signal at m/z 747. This signal would correspond to [359-Cl]+. No mass signal 
of [359-H]+ was found. The isotope distribution fitted well with the postulated structures of 359. Only soft 
ionisation techniques such as ESI-MS allowed for the identification of the correct structure from solution. 
 
Cyclometalation was also attempted with complex 348 (Scheme 127). More than five hydride 1H-NMR 
signals were observed as well as formation of the trinuclear complex deactivation product similar to 350 
(Scheme 129). Therefore, complex 348 was no longer considered in cyclometalation reactions. 
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Figure 21: Chemical shifts for both configurational isomers of iridacycle 359 
 
In order to study the behaviour of complex 359 in solution, it was mixed with an equimolar amount of 
NaBArF in CD2Cl2. A rearrangement was observed and only one species 360 ensued. NMR analysis 
(Spectrum 23 and Spectrum 24) depicted the presence of a single isomer by one 1H-NMR hydride and one 
31P-NMR signal in solution. When using AgPF6 instead of NaBArF as the chloride abstraction reagent, >4 
hydride 1H-NMR and 31P-NMR signals were observed. 
 
Scheme 135: Generation of 360 from 359 upon addition of NaBArF in CD2Cl2 
 
Spectrum 23: 1H-NMR of 360 
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Spectrum 24: 31P{1H}-NMR of 360 
 
Formation of one single species 360 in solution from configurational isomers of 359 showed that, upon 
addition of NaBArF, chloride abstraction and rearrangement of the complex occurred. The observed species 
360 was believed to resemble the active catalyst structure in solution. This also demonstrated that the 
formation of configurational isomers in the preparative cyclometalation is irrelevant for the observed 
structure in solution. Upon chloride abstraction, a rearrangement of all configurational isomers to a single 
species is observed. Therefore, all complexes, isolated as mixtures of configurational isomers, where used as 
precursors in hydrogenation reactions. 
 
To test the catalytic activity of species such as 360, hydrogenation of imine 59 was carried out (Table 8): 
While no conversion was observed at atmospheric hydrogen pressure, increasing the pressure to 2.5 bar 
afforded partial conversion. Full conversion was observed at further elevated hydrogen pressure (6 bar).  
 
Table 8:  Asymmetric hydrogenation of imine 59 using iridacycles 356 and 359 as catalysts 
 
Entry Catalyst [mol %] NaBArF [mol %] p [bar] Conv. [%]a) ee [%]b) 
1 (S)-(Δ)-356 [2 mol%] 5 2.5 87 4 (S) 
2 (S)-(Δ)-356 [10 mol%] 10 2.5 >99 4 (S) 
3 (S)-(Δ)-359 [2 mol%] 5 2.5 40 6 (R) 
4 (S)-(Δ)-359 [10 mol%] 10 2.5 >99 8 (R) 
1 (S)-(Δ)-356 [2 mol%] 5 6 94 3 (S) 
2 (S)-(Δ)-356 [10 mol%] 10 6 >99 4 (S) 
3 (S)-(Δ)-359 [2 mol%] 5 6 >99 6 (R) 
4 (S)-(Δ)-359 [10 mol%] 10 6 >99 8 (R) 
a) Determined by GC analysis. b) determined by HPLC analysis on a chiral stationary phase. 
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Consistent enantiomeric excesses were observed both at 2.5 and 6 bar hydrogen pressure. In order to induce 
higher enantioselectivity, the size of the substituent in the benzylic position was changed to an ethyl group. 
Preparation of imines 362 and 363 is shown in Scheme 136. 
 
Scheme 136: Preparation of chiral imines 362 and 363 
 
Cyclometalation of imine 362 delivered complex 364 as a single isomer (Scheme 137). 2D-NMR analysis 
showed three key NOE contacts between the hydride and several protons. Furthermore, the nitrogen 
substituent of the imine is either freely rotating or the phenyl ring is rotated towards the oxazoline ligands 
since strong NOE contacts between the aldimine proton and the ethyl group of the chiral imine are observed 
(Figure 22). 
 
 
Scheme 137: Preparation of iridacycle 364 
 
 
Figure 22: NOE contacts observed in complex 364 
 
Cyclometalation of imine 363 afforded complex 365. One dominant 1H-NMR hydride signal and one 31P-
NMR signal were observed along with some minor impurities. Upon mixing with NaBArF, a single species 
366 was observed by 1H-NMR (Spectrum 25). 2D analysis depicted three NOE contacts which could be 
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assigned (Figure 23). The phenyl ring of the nitrogen substituent experiences hindered rotation which is 
observed by EXSY signals. Therefore, complete assignment of species 366 is hampered by transferred NOE 
contacts which cannot be definitively assigned.  
 
 
Scheme 138: Generation of complex 366 in CD2Cl2 
 
 
Spectrum 25: 1H-NMR of 366 
 
 
Figure 23: Observed NOE contacts in 366 
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With the new complexes 364 and 365 in hand hydrogenations were reinvestigated (Table 9). In order to 
obtain higher ee’s, hydrogenations were conducted at lower temperature. Contrary to the results in Table 8 
the (R)-amine 60 was observed with complex 356 and the (S)-amine 60 with complex 359. Complexes 364 
and 365 gave lower ee’s at low temperature (Entries 5 and 6) and comparable ones to 356 and 359 (Entries 7 
and 8) at ambient temperature. The reason for the observation of opposed enantioselectivity in the 
hydrogenation with complex 356 (Entries 1 and 2) and 359 (Entries 3 and 4) could not be rationalised. 
 
Table 9: Asymmetric hydrogenation of imine 59 using iridacycles 356, 359, 363 and 365 as catalysts 
 
Entry Catalyst [mol %] p [bar] T [°C] t [h] Conv. [%]a) ee [%]b) 
1 (S)-(Δ)-356 6 -20 14 >99 6 (R) 
2 (S)-(Δ)-356 6 -20 14 >99 5 (R) 
3 (S)-(Δ)-359 1 23 4 20 6 (S) 
4 (S)-(Δ)-359 5 23 4 >99 4 (S) 
5 (R)-(Λ)-364 6 -20 14 >99 4 (R) 
6 (R)-(Λ)-364 6 -20 14 >99 2 (R) 
7 (R)-(Λ)-365 1 23 4 5 6 (R) 
8 (R)-(Λ)-365 5 23 4 40 4 (R) 
a) Determined by GC analysis. b) determined by HPLC analysis on a chiral stationary phase. 
 
To confirm the enantioinduction of complex 359, both enantiomers of imine 353 were prepared. They were 
subsequently cyclometalated onto complex 336 and the obtained iridacycles 359 used as catalysts in crude 
form after elution on silica gel. Reproducible enantioselectivities between 4 to 6% were observed (Table 10). 
This clearly demonstrated the participation of the cyclometalated chiral imine in the enantiodiscriminating 
step of the hydrogenation. 
Table 10: Asymmetric hydrogenation of imine 59 using iridacycles (S)-359 and (R)-359 
 
Entry Catalyst p [bar] Conv. [%]a) ee [%]b) 
1 (S)-(Δ)-359 1 16 4 (S) 
2 (S)-(Δ)-359 5 54 6 (S) 
3 (R)-(Λ)-359 1 18 4 (R) 
4 (R)-(Λ)-359 5 44 6 (R) 
a) Determined by GC analysis. b) determined by HPLC analysis on a chiral stationary phase. 
 
In order to obtain higher enantioselectivities in the hydrogenation, other cyclometalating ligands were tested 
in the following.  
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Other ligands for cyclometalation 
 
Apart from the chiral imine ligands already presented, structurally similar ligands with a C=N double bond 
were tested in cyclometalation and the corresponding iridacycles tested in hydrogenations. All complexes 
were isolated by elution chromatography and used as catalysts without further purification. Oxazolines 367, 
368 and 369 were evaluated since oxazolines in general have been demonstrated to effect high 
stereoselectivity in a number of transformations. Furthermore, oxazoline 369 would form a six-membered 
iridacycle.11 Imine 370 was believed to facilitate cyclometalation due to eased rotation of the nitrogen 
substituent compared to imine 346. Imines 371 and 372 were evaluated to investigate the possibility of 
exocyclic iridacycle formation.12 The 2,6-dimethyl benzaldehyde moiety was used to force cyclometalation 
to occur in an endocyclic fashion. 
 
 
Scheme 139: Preparation of iridacycles 373-378 
 
Scheme 140: Ligands 367-372 
 
The yellow precipitate of crude complex 373 showed four 1H-NMR hydride resonances and four 31P-NMR 
signals as well as a strong BArF signal in the 19F-NMR. The crude complex 374 did not show any hydride 
signal. More than four yellow spots were observed in TLC and a BArF signal was observed by 19F-NMR 
indicating incomplete counterion metathesis or impurities present in the isolated iridacycle 374. Complex 
375 could not be obtained. Instead an iridium tri-hydride trinuclear complex such as 350 was isolated (Figure 
24).  
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Figure 24: Iridacycles 373, 374 and 375 
                                                          
11 Six-membered iridacycles are commonly observed in alkene-isomerisation chemistry  
12 exocyclic with regards to the C=N double bond not being part of the ring/metallacycle.  
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Quite differently, iridacycle formation of 376 proceeded smoothly furnishing a crude complex with two 
hydride 1H-NMR resonances and one 31P-NMR signal. No 19F-NMR signal was detected. Complex 377 was 
readily formed. Three weak hydride 1H-NMR signals, but no 31P-NMR, as well as no 19F-NMR signal was 
observed. Complex 378 could not be obtained as no crystalline material was isolated (Figure 25). 
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Figure 25: Iridacycles 376, 377 and 378 
 
Table 11 summarizes the results. Apart from complex 373 (Entries 1 and 2), low conversions were observed. 
Additionally, the low enantioselectivities render it hard to draw any conclusions. When comparing imine to 
oxazoline ligands with regards to the stability of the formed iridacycles, only complex 376 gives consistent 
enantioselectivities both at atmospheric as well as at elevated hydrogen pressure (Entries 4 and 5). Virtually 
racemic product is obtained with complex 373 at 5 bar hydrogen pressure (Entry 2). Complex 374 and 377 
also depicted an enantioselectivity of maximum 2% at atmospheric hydrogen pressure (Entry 3 and 6). This 
might originate from exchange of the cyclometalating ligand to the achiral imine forming a catalyst which 
leads to formation of racemic amine. 
Table 11: Asymmetric hydrogenation of imine 59 using iridacycles 373, 374, 376 and 377 
 
Entry Catalyst p [bar] Conv. [%]a) ee [%]b) 
1 373 1 21 6 (R) 
2 373 5 99 2 (R) 
3 374 1 15 2 (R) 
4 376 1 2 9 (S) 
5 376 5 16 9 (S) 
6 377 1 8 2 (S) 
a) Determined by GC analysis. b) determined by HPLC analysis on a chiral stationary phase. 
 
Imine 370 was also reacted with [Ir(Cp*)Cl2]2 (279) to afford the half-sandwich Cp*-complex (R)-379 
(Scheme 141).  
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Scheme 141: Preparation of complex (R)-379 
 
The crystal structure of (R)-379 is shown in Figure 26 and Figure 27. 
 
Figure 26: Front view of (R)-379 
 
Figure 27: Side view of (R)-379 
 
On the other hand, the combination of a chiral ligand and an achiral imine provided high enantioselectivities 
of 87% ee.13 In an attempt to increase the ee, the introduction of a sterically demanding group in the 
cyclometalating imine was pursued (Scheme 142). Imine 383 was prepared from α-tetralone (380). Silyl enol 
ether formation employing mesityl magnesium bromide as a mild base afforded 381 in 82% yield.[93] 
Subsequent titanium(IV)-mediated C-alkylation delivered the tetralone 382 in 34% yield.[94] Ultimately 
condensation with aniline afforded imine 383 in 29% yield. 
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Scheme 142: Synthesis of imine 383 
                                                          
13 See chapter 2 
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Cyclometalation was performed with 1 eq. of complex 86 and 2 eq. of imine 383 to selectively afford the 
matched pair of the two possible diastereomers of complex 384 (Scheme 143). The isolated complex 384 
showed two hydride 1H-NMR resonances. Upon addition of NaBArF one hydride signal remained. 
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Scheme 143: Iridacycle preparation of 384 
 
Complex 384 was tested as a catalyst for imine hydrogenation. Compared to using complex 86 without an 
additive, both significantly lower conversion and lower enantioselectivity were observed (Scheme 144).  
 
 
Scheme 144: Asymmetric hydrogenation of imine 59 with iridacycle 384 
 
When the experiment was conducted in a stepwise fashion, similar conversion and even lower 
enantioselectivity were observed (Scheme 145). 
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Scheme 145: Stepwise procedure of iridacycle generation from 86 and 383 and subsequent hydrogenation of imine 59 
 
In order to obtain a better understanding in the role of the cyclometalated imine, two different model imines 
80 and 322 were selected (Figure 28) and the corresponding iridacycles prepared. It was desired to influence 
the ee in the hydrogenation by the cyclometalated imine. In the hydrogenation of aryl-alkyl N-phenyl imines, 
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imine 80 displayed the highest enantioselectivity of 90% ee using complex 86 while imine 322 gave the 
lowest enantioselectivity of 78% ee with complex 86. 
 
Figure 28: Imines 391 and 322 
 
Table 12 displays the enantioselectivities obtained for imines 59, 391 and 73 (Entries 1, 4 and 7). Both 
iridacycles, with imine 80 or 322, afforded amine 60 with slightly lower enantioselectivity compared to in 
situ generated 325 (Entry 1 vs. 2 and 3). On the other hand, imine 80 was reduced with high 
enantioselectivity regardless of the iridacycle catalyst used (Entries 4 to 6). Additionally, imine 322 was 
reduced with lower enantioselectivity by all iridacycles (Entries 7 to 9). Apparently the structure of the imine 
being hydrogenated does have a strong influence on the enantioselectivity of the catalyst. 
 
Table 12: Asymmetric hydrogenation of imines 59, 80 and 322 using iridacycles derived from imines 80 and 322 
 
Entry Catalyst Imine Conv. [%]a) ee [%]b) 
1 86 59 (R = Ph) >99 87 (R) 
2 [Ir(PHOX)(80)(H)(Cl)] 59 (R = Ph) >99 81 (R) 
3 [Ir(PHOX)(322)(H)(Cl)] 59 (R = Ph) >99 82 (R) 
4 86 80 (R = 2-Naph) >99 90 (-) 
5 [Ir(PHOX)(80)(H)(Cl)] 80 (R = 2-Naph) >99 90 (-) 
6 [Ir(PHOX)(322)(H)(Cl)] 80 (R = 2-Naph) >99 90 (-) 
7 86 322 (R = 4-MeO-Ph) >99 78 (-) 
8 [Ir(PHOX)(80)(H)(Cl)] 322 (R = 4-MeO-Ph) >99 82 (-) 
9 [Ir(PHOX)(322)(H)(Cl)] 322 (R = 4-MeO-Ph) 85 78 (-) 
a) Determined by GC analysis. b) determined by HPLC analysis on a chiral stationary phase. 
 
Cyclometalation of aliphatic C-H bonds was also evaluated. C(sp3)-H activation and metalation with iridium 
has been observed in iridium-catalysed allylic substitution.[95] Therefore, imine 329 was subjected to 
cyclometalation reaction conditions (Scheme 146). A strongly yellow coloured band was observed during 
elution chromatography. However, it did not show a hydride 1H-NMR resonance. Instead three weak signals 
were detected between -20 and -30 ppm. Furthermore no 31P-NMR signal could be observed with sufficient 
intensity. Therefore, it was concluded that other products than the desired iridacycle 385 had been formed. 
 
Chapter 3 – Mechanistic Investigations 
102 
 
Scheme 146: Attempted preparation of iridacycle 385 with an Ir-C(sp3) bond 
 
To test the C-H activation of a C(sp2)-hybridized carbon centre other than aryl, imine 386 was subjected to 
cyclometalation conditions (Scheme 147). In the 1H-NMR spectrum of the crude complex 387 one hydride 
signal was observed. However, the integrals of the aromatic region did not match the expected numbers. Five 
protons too few were counted. The structure was tentatively assigned as the cyclometalated benzylidene 
acetone complex 387 (Figure 29). Further studies to characterize the complex are required. Nevertheless, 
cyclometalation of an olefinic C(sp2)-hybridized C-H bond was observed.  
 
Scheme 147: Preparation of iridacycle 387 via olefinic C-H bond activation 
 
 
Figure 29: NMR shifts and key NOE contacts in complex 387 
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Improving iridacycle synthesis by counterion metathesis 
 
The previously conducted preparation of the iridacycles featured an elution chromatography to exchange the 
BArF counterion to a chloride. Significant variations in isolated yields were observed. Therefore, a 
counterion metathesis was investigated (Scheme 148). Complex 86 and imine 59 were thus activated to 
afford 308 in the presence of hydrogen. Subsequently, different chloride salts were added to afford iridacycle 
325.  
Scheme 148: Preparation of iridacycle 325 involving counterion metathesis 
 
Lithium chloride, ammonium chloride and sodium chloride all furnished the same product as usually 
obtained after elution of the crude iridacycle by flash chromatography.14 The procedure was further 
optimised by switching the solvent to ethyl acetate and adding silical gel to facilitate the counterion 
metathesis. With this protocol in hand, a number of iridacycles were prepared in yields of 55-60% (Scheme 
149). 
 
 
Scheme 149: Preparation of iridacycles 325, 337, 389 and 390 via counterion metathesis 
 
Iridacycles 325, 337 and 390-391 where isolated as yellow amorphous solids. NMR analysis showed one to 
three hydride 1H-NMR resonances and the corresponding 31P-NMR signals. NOE analysis depicted several 
key contacts which facilitated determination of the structure in solution. Complex 325 (Figure 30) was 
observed as one single isomer in solution (Spectrum 26 and Spectrum 27).  
 
                                                          
14 With lithium iodide a distinct colour change of the reaction mixture was observed. The 1H-NMR displayed a differnt hydride resonance. 
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Figure 30: NMR shifts and key NOE contacts in iridacycle 325 
 
Since no NOE contacts were found between the hydride and the cyclometalated imine, they were assigned as 
trans to each other. The phenyl rings at the phosphorus atom could be fully assigned and each phenyl ring 
depicted three resonances which indicates free rotation. Furthermore one NOE contact between the hydride 
and the ortho-protons of one P-phenyl ring was observed. Thus, they were assigned cis to each other. The N-
phenyl ring of the cyclometalated imine displayed chemical exchange but no NOE contacts to either the 
oxazoline moiety or any P-phenyl substituent. 
 
Spectrum 26: 1H-NMR of 325 
 
Spectrum 27: 31P{1H}-NMR of 325 
 
Iridacycle 337 displayed virtually identical features as 325. Again one single isomer was observed in 
solution (Spectrum 28 and Spectrum 29). Key NOE contacts are given in Figure 31 which confirmed the 
postulated structure. An additional NOE contact with the ortho-proton of the cyclometalated phenyl ring was 
also observed. 
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Figure 31: NMR shifts and key NOE contacts in iridacycle 337 
Spectrum 28: 1H-NMR of 337 
 
Spectrum 29: 31P{1H}-NMR of 337 
A different picture was observed upon cyclometalation of the more bulky imine 340. The N-Aryl substituent 
resulted in the formation of three configurational isomers of complex 389 (Spectrum 30 and Spectrum 31). 
Contrary to complexes 325 and 337, NOE contacts between the hydride and the aryl ring of the 
cyclometalated imine were observed. This isomer was assigned as shown in Figure 32 on the left side. The 
cyclometalated imine and the hydride are cis to each other. Additionally, the P-phenyl ring experiences 
hindered rotation which is depicted in the EXSY signals of the ortho-protons. This is also observed in the 
other configurational isomer shown on the right side in Figure 32. Probably also due to this fluxional 
behaviour, no NOE contact between the hydride and the P-phenyl ring was observed. 
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Figure 32: NMR shifts and key NOE contacts of two configurational isomers of iridacycle 389 
 
Spectrum 30: 1H-NMR of 389 
 
Spectrum 31: 31P{1H}-NMR of 389 
 
Complex 390 displayed similar structural features compared to 389. Two configurational isomers were 
observed in solution (Spectrum 32 and Spectrum 33). No fluxional behaviour of the P-phenyl ring was 
observed. The NOE contacts are given in Figure 33. 
 
 
Figure 33: NMR shifts and key NOE contacts of two configurational isomers of iridacycle 390 
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Spectrum 32: 1H-NMR of 390 
 
Spectrum 33: 31P{1H}-NMR of 390 
 
Numerous attempts to crystallize complexes 325, 337, 389 and 390 failed. Instead, only oily residual solids 
were obtained when crystallisation was attempted from chlorinated solvents to apolar solvents (e.g. alkanes 
or ethers). All iridacycles could be obtained as solids by trituration with n-pentane. In the course of 
investigating other ligand structures as potential catalysts for imine hydrogenation, crystal formation of 
complex 391 was observed after leaving the oily residue on the bench for a few weeks. NMR analysis of 
complex 391 displayed one isomer in solution (Spectrum 34 and Spectrum 35). NMR shifts and key NOE 
contacts are given in Figure 34. 
 
Figure 34: NMR shifts and key NOE contacts in iridacycle 391 
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Spectrum 34: 1H-NMR of 391 
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Spectrum 35: 31P{1H}-NMR of 391 
 
The unit cell obtained from complex 391 contained twelve complexes and is shown in Figure 35, Figure 36 
and Figure 37. Schematically, it consisted of layers with four complexes with central mirror point symmetry. 
These layers are twisted in a helical structure. Between those layers dichloromethane molecules can be 
observed. It depicts well the problematic nature of such crystalline materials. Instead of forming tightly 
packed solids, these structures are isolated as layers of monomers which results in the formation of oily 
sticky material. 
 
Figure 35: Bottom four 
complexes in unit cell of 
iridacycle 391 superimposed 
 
 
 
 
 
 
  Figure 36: Center four complexes 
in unit cell of iridacycle 391 
superimposed 
 
 
 
 
 
 
 
 
Figure 37: Top four complexes in 
unit cell of iridacycle 391 
superimposed 
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The quality of the obtained crystals was poor and therefore several restrictions were introduced to solve the 
structure.15 When superimposing the three layers and again superimposing these four crystal structures the 
structure displayed in Figure 38 is obtained. The crystal structure supported the previously postulated 
structures by NOE NMR experiments. No discussion on bond length or angles is given due to the 
preliminary character of the structure and the poor data quality. Nevertheless, the same octahedral geometry 
was observed in all complexes of the unit cell and can thus be confirmed. 
All complexes displayed are iridacycles with a hydride-chloride cis-relationship. This has not been observed 
in the literature yet with P’N-ligands but only with NHC-ligands. Otherwise, a hydride and a chloride are 
usually observed trans to each other.[96] 
 
Figure 38: Preliminary crystal structure of iridacycle 391 
 
  
                                                          
15 Comment from the crystallographer Dr. Markus Neuburger: „Apart from the fact that diffraction stopped to be observable at 
quite low Theta values it also seems that they were multiply twinned. The triclinic unit cell did not permit transformation to higher 
symmetry, even if the structure vaguely suggested the presence of a 31 axes as a symmetry element. Attempts to use alternative 
methods to determine the unit cell, for instance the program “cell_now”, always confirmed the strange unit cell with two axes a and 
b of approximately the same dimension and the angle γ of about 120 degrees, but angles α and β far away from 90 degrees which 
makes transformation to a higher symmetry impossible. The Z value of the structure is 12. The data quality did not permit to locate 
all atoms, and like that the refinement finished at some intermediate state. Nevertheless the structure seems to demonstrate that 
all 12 complex molecules have the same configuration. While all peripheral groups are fuzzy the coordination sphere seems to be 
determined well enough to identify the compound and confirm its main geometrical features.“ 
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Chiral ligands as cyclometalating reagents 
 
With imine 353 applied as a chiral cyclometalating ligand for imine hydrogenation, selectivities not higher 
than 6% ee were achieved (Table 8). Therefore, a new ligand scaffold was designed. It should resemble the 
structure of the chiral imines 353 but be more rigid. A connection as shown in red in 353 (Figure 39) was 
desired. Therefore, an isoquinoline structure with a chiral benzylic position was chosen. The steric hindrance 
of the chiral imine ligand was increased by the introduction of an isopropyl group at the stereogenic center. 
The two geminal methyl groups in 392 were incorporated to avoid oxidation and subsequent aromatisation of 
the isoquinoline. 
 
Figure 39: Desired dashed connection in imine 353 leading to isoquinoline ligand 392 
 
The synthesis of ligand 392 is outlined in chapter 4. Cyclometalation of both enantiomers of ligand 392 
proceeded smoothly and afforded an amorphous yellow solid of complex 393 ( Scheme 150). The absolute 
configuration of ligand 392 was not determined. One hydride was observed in solution as shown in Spectrum 
36.  
 
Scheme 150: Preparation of iridacycle 393 
 
Spectrum 36: 1H-NMR of 393 
 
Both enantiomers of complexs 393 were tested as catalysts in asymmetric hydrogenation of imine 59. Both 
the absolute configuration of ligand 392, as well as the optical rotation of complexes 393, was not 
determined. The optical orientation in brackets refers to the optical rotation of ligand 392. At 1 bar pressure 
the enantiodiscriminating role of the cyclometalated ligand was clearly observed (Scheme 151). Similar 
conversions with opposite but identical enantioselectivity were obtained. 
 
Chapter 3 – Mechanistic Investigations 
111 
 
Scheme 151: Asymmetric hydrogenation of imine 59 employing iridacycle 393 
 
When the reaction was conducted at 5 bar hydrogen pressure, full conversion of the imine was observed. 
Unfortunately racemic amine was obtained. This is probably due to catalyst decomposition and 
cyclometalation of imine 59, thus rendering the catalyst achiral producing racemic amine. With these low 
conversions and enantioselectivites as well as the postulated decomposition of the complex at elevated 
pressure the ligand structure was no longer investigated.16  
 
In order to obtain higher ee values for amine 60 using iridacycle complexes with a chiral imine ligand and an 
achiral PHOX ligand as catalysts, efforts were devoted to other ligand structures. Two important aspects 
were maintained. The stereogenic centre is situated in the α-position to the imine nitrogen and the C=N 
double bond is incorporated into a ring structure to maintain a rigid ligand scaffold. As it was unclear to what 
extent electronic properties of the ligand would influence the reactivity of the catalyst, Therefore, two 
structurally analogous ligands 394 and 395 were prepared (Figure 40). 
 
N
*
O
N
*
N
*
392 394395  
Figure 40: Structurally similar (to 392) ligands 394 and 395 
 
The tetrahydropyridine 394 features the same imine C=N double bond as 392 while reducing the sterical 
demand of the ligand itself. The benzoxazine 395 resembles the isoquinoline 392 structurally but the 
heterocycle alters the electronic properties of the ligand significantly and thus might strongly influence the 
reactivity of the catalyst. The synthesis of tetrahydropyridine 394 is outlined in chapter 4. Cyclometalation 
afforded iridacycle 396 as a yellow amorphous solid after trituration with n-pentane (Scheme 152). 
  
                                                          
16 The analogous tert-butyl variant of ligand 392 precursor was not subjected to enantiomer separation by semi-preparative HPLC. 
Chapter 3 – Mechanistic Investigations 
112 
 
Scheme 152: Preparation of iridacycle 396 
 
Similar 1H- and 31P-NMR signals (Spectrum 37 and Spectrum 38) were observed for complexes 396 derived 
from both enantiomers of 394. However, the hydride signal was of very low intensity and integrals did not 
match with other protons in the aliphatic or aromatic region. From the NMR data no conclusions could be 
drawn.  
 
Spectrum 37: 1H-NMR of 396 
 
Spectrum 38: 31P{1H}-NMR of 396 
 
Both enantiomers of complex 396 were tested as catalysts for asymmetric hydrogenation of imine 59 
(Scheme 153). The absolute configuration in brackets refers to tetrahydropyridine 394. In both cases racemic 
amine was obtained.  
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Scheme 153: Asymmetric hydrogenation of imine 59 with iridacycle 396 
 
The generation of racemic amine could occur for a number of reasons. Most likely, the desired iridacycle 396 
has not been formed as the NMR data indicated. Instead, an unidentified iridium complex was applied as the 
catalyst, or coordination of ligand 394 to the metal centre is labile and thus 394 is readily replaced by 59. 
Another possibility is that ligand 394 is too small to induce any enantiodiscrimination in imine 
hydrogenation when cyclometalated onto iridium.  
In order to obtain an idea of the chiral environment around the metal centre, ligand 394 was attempted to 
cyclometalate onto [Ir(Cp*)Cl]2 279. Such Cp*-complexes have been reported on a large variety of imine 
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ligands which would facilitate comparison with other ligand structures.17 Therefore, 279 and (S)-394 were 
mixed to prepare complex 397 (Scheme 154). While NMR analysis showed the formation of a single isomer, 
crystallisation remained unsuccessful. Instead, a homogeneous solution of a saturated CHCl3/n-pentane 
solution was observed in all attempts. To enforce crystallisation, the cationic hexafluorophosphate complex 
398 was prepared. Unfortunately, only black precipitate had formed during the crystallisation period. NMR 
analysis indicated decomposition and generation of impurities. All other crystallisation attempts failed. 
 
 
Scheme 154: Preparation of complexes 397 and 398 
 
Since tetrahydropyridine ligand 394 did not afford the desired iridacycle catalysts which afforded higher ee‘s 
in asymmetric imine hydrogenation, efforts were devoted to benzoxazines such as 395 (Figure 41). 
Syntheses of benzoxazine ligands 395, 399 and 400 are outlined in chapter 4. With these three benzoxazine 
ligands it was intended to obtain a better idea of the influence of the substituent at the stereogenic centre in 
the benzylic position with regards to enantioinduction. 
 
 
Figure 41: Benzoxazine ligands 395, 399 and 400 
 
All six enantiomers were prepared and the corresponding iridacycles 401 to 403 formed (Scheme 155). All 
iridacycles were obtained as single configurational isomers in solution.  
 
                                                          
17 See chapter 1 
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Scheme 155: Preparation of iridacycles 401-403 
 
Iridacycles 401 to 403 (Figure 42) were tested as catalysts for asymmetric hydrogenation of imine 59 (Table 
13). 18 
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Figure 42: Benzoxazine iridacycles 401-403 
 
Table 13: Asymmetric hydrogenation of imine 59 with iridacycle 401 to 403 
2 mol% HN
*
Ph
Ph
CH2Cl2, H2 [1 bar], 23 °C, 4 h
N
Ph
Ph
59
401, 402 or 403 NaBArF
2 mol%
60  
Entry Catalyst p [bar] Conv. [%]a) ee [%]b) 
1 (+)-401 1 63 15 (S) 
2 (S)-(Δ)-402 1 31 23 (R) 
3 (S)- (Δ)-402 5 97 14 (R) 
4 (R)-(Λ)-402 1 20 23 (S) 
5 (R)-(Λ)-402 5 >99 14 (S) 
6 (S)-(Δ)-403 1 15 17 (R) 
7 (S)-(Δ)-403 5 94 2 (R) 
8 (R)-(Λ)-403 1 20 16 (S) 
9 (R)-(Λ)-403 5 95 5 (S) 
a) Determined by GC analysis. b) determined by HPLC analysis on a chiral stationary phase. 
 
Several interesting observations were made. The enantioselectivity could be increased when replacing the 
methyl-substituent in 401 (Entry 1) with a sterically more demanding isopropyl group as in 402 (Entry 2). 
Consistent enantioselectivities were obtained for both enantiomers of 402 as seen in entries 2-5. However, 
upon increasing the hydrogen pressure to 5 bar a lower ee of 14% was obtained (Entries 3 and 5). And the 
                                                          
18 The absolute configuration of benzoxazine 399 was not determined. The optical rotation in brackets in Table 13 (Entry 1) refers 
to the benzoxazine 399 and not to the iridacycle 401. 
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sterically even more demanding iridacycle 403 afforded a lower ee than 402. Conducting the reaction at 5 
bar hydrogen pressure afforded almost racemic product (Entries 7 and 9). 
 
In order to gain more insight into the catalyst performance of complexes 402 and 403 during the reaction, 
samples were taken at regular intervals and the ee and conversion determined by GC and HPLC analysis. 
The conversion and enantiomeric excess are displayed in Figure 43. 
 
 
Figure 43: Development of ee and conversion over the course of the hydrogenation of imine 59 with 402 and 403 
 
From the first aliquot of the hydrogenation using 403 as a catalyst, a high ee of 44% was detected for both 
enantiomers. But as the reaction proceeded the enantiomeric excess eroded and flattened to a level of about 
12%. This also explained the observed ee of 17% which corresponds well to the ee between 3 to 4 hours 
reaction time in the hydrogenation in Table 13.  
On the other hand, complex 402 showed a constant ee throughout the reaction, within experimental error. 
Additionally, a lower conversion and reaction rate was observed within the same reaction time. This allows 
for two significant conclusions: The tert-butyl ligand in 403 readily becomes replaced by an achiral ligand 
which results in a more active achiral catalyst producing racemic amine. This explains the erosion of 
enantioselectivity. Benzoxazine complexes 402 and 403 are catalytically less active than the iridacycles 
derived from imines such as 353 or 59. 
The instabilty of the tert-butyl benzoxazine complex 403 was also investigated in the hydrogenation of 
acyclic aliphatic imine 329 (Scheme 156). Imine 329 cannot undergo cyclometalation to form the 
corresponding iridacycle. Due to rapid decomposition of complex 403 very low conversions of amine 97 
were obtained. 
 
 
Scheme 156: Asymmetric hydrogenation of imine 329 with iridacycle 403 
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In the context of comparing the different imine ligands and their chiral environment upon iridacycle 
formation, benzoxazine (S)-395 was reacted with [Ir(Cp*)Cl2]2 (279) to afford complex (S)-404 (Scheme 
157). The crystal structure is shown in Figure 44 and Figure 45. 
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Scheme 157: Preparation of iridium complex (S)-404 
Figure 44: Front view of (S)-404 Figure 45: Top view of (S)-404 
 
Since complex 402 afforded moderate ee’s for the asymmetric hydrogenation of imine 59, benzoxazine 395 
was tested as a chiral additive in combination with PHOX catalyst 86 (Scheme 158). Both enantiomers of 
395 were cyclometalated onto 86 to identify the match/mismatch case. For comparison, iridacycle 325 is also 
listed (Table 14). 
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Scheme 158: Preparation of diastereomeric complexes 405 and 406  
 
Table 14: Asymmetric hydrogenation of imines 325, 329, 330 and 331 using diastereomeric benzoxazine iridacycles  
405 and 406  
 
Entry Catalyst Imine Conv. [%]a) ee [%]b) 
1 405 329 (R = Cy) 1 - 
2 405 330 (R = iPr) 2 - 
3 405 331 (R = n-Pr) 1 - 
4 405 59 (R = Ph) 20 20 (R) 
5 406 329 (R = Cy) 4 60 (-) 
6 406 330 (R = iPr) 11 54 (-) 
7 406 331 (R = n-Pr) 19 10 (-) 
8 406 59 (R = Ph) >99 81 (R) 
9 325 329 (R = Cy) 13 71 (-) 
10 325 330 (R = iPr) 8 60 (-) 
11 325 331 (R = n-Pr) 10 20 (-) 
12 325 59 (R = Ph) 80 87 (R) 
a) Determined by GC analysis. b) determined by HPLC analysis on a chiral stationary phase. 
 
Complex 406 was identified as the match case and complex 405 as the mismatch case due to the observed 
reactivity. Nevertheless iridacycle 325 delivers superior results. Therefore, the benzoxazines such as 395 
were no longer considered as additional ligands for further reaction condition optimisation. 
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Effects of chiral Binol-phosphoric acids on imine hydrogenation 
 
The highest ee‘s in the asymmetric hydrogenation of aliphatic imines to date have been reported by Xiao and 
co-workers.[41] They applied a chiral diamine-Cp* half-sandwich iridium complex with an elaborate chiral 
Brönsted acid. While the ligand alone did provide the amine in high selectivity with low conversion, addition 
of a chiral phosphoric acid resulted in high conversion while maintaining the enantioselectivity. The 
phosphoric acid was postulated to differentiate the prochiral faces of the imine as well as activate the imine 
by protonation. High selectivities were obtained due to the application of the matched pair of catalyst and 
iminium activating acid. Chiral phosphoric acids have also been reported to provide enantiomerically 
enriched amines with high ee in asymmetric reductions.[97] 
In order to evaluate the potential of chiral phosphoric acids in iridium PHOX catalysed asymmetric imine 
hydrogenation, two representative chiral phosphoric Brönsted acids 407 and 408 were prepared according to 
literature procedures (Figure 46). The synthesis is outlined in chapter 4. The chiral phosphoric acids were 
tested both in combination with chiral complexes 86 and 87 as well as achiral complex 336 (Table 15). 
 
 
Figure 46: Chiral phosphoric acids 407 and 408 
 
The addition of a catalytic amount of phosphoric acid 407 in combination with chiral catalyst 86 afforded 
amine 60 in only 11% conversion and 82% ee. While the ee is slighty lower than using 86 alone, the poor 
conversion was surprising. If the reaction was carried out at 50 bar hydrogen pressure, 93% conversion and 
78% ee were observed. To test the chiral induction potential of the phosphoric acids 407 and 408 alone they 
were used along with complex 336. Very poor conversion and low enantioselectivity were observed. At 
atmospheric hydrogen pressure only one to two turnover numbers (TON) were achieved.19[98] This is in 
strong contrast to using complex 86 without 407 or 408 resulted in full conversion within 2 hours at 1 bar. 
  
                                                          
19 Complex 336 was demonstrated to be less active compared to 86 or 348 
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Table 15: Asymmetric hydrogenation of imine 59 employing combinations of iridium complexes 86, 87 or 336 with 407 or 408 
 
Entry Catalyst Acid Solvent p [bar] Conv. [%]a ee [%]b 
1 336 (R)-408 CH2Cl2 1 2 9 (R) 
2 336 (R)-407 CH2Cl2 1 2 5 (R) 
3 336 (R)-408 CH2Cl2 50 49 2 
4 336 (R)-407 CH2Cl2 50 52 2 
5 86 (R)-407 CH2Cl2 1 11 82 (R) 
6 86 (R)-408 Toluene 1 10 70 (R) 
7 86 (R)-408 Toluene 50 93 78 (R) 
8 86 (R)-407 CH2Cl2 1 7-11 82 (R) 
9 86 (R)-407 CH2Cl2 50 92 78 (R) 
10 87 (R)-408 CH2Cl2 1 3 - 
11 87 (R)-408 CH2Cl2 50 88 87 (R) 
12 87 (R)-407 CH2Cl2 1 1 - 
13 87 (R)-407 CH2Cl2 50 86 88 (R) 
14 87 (R)-407 Toluene 1 3-6 - 
15 87 (R)-407 Toluene 50 71-88 80 (R) 
a) Determined by GC analysis. b) determined by HPLC analysis on a chiral stationary phase. 
 
The results did not fit any obvious trend. In order to better understand the role of the phosphoric acid, 
different catalyst loadings were examined (Table 16). Increased quantities of phosphoric acid resulted in 
lower conversion as well as hydrolysis of imine 59 in CH2Cl2 (Entries 1 to 12). In toluene, hydrolysis 
appears to be less pronounced. Furthermore, with high loadings of phosphoric acid, no effect on the 
enantioselectivity was observed and hydrolysis remained dominant. Apparently, chiral phosphoric acids 
alone did not exhibit significant enantiodiscrimination when being used along with an achiral catalyst such as 
86. In combination with an iridium PHOX catalyst hydrolysis was favoured over hydrogenation even at high 
pressure. The difference between the 407 and 408 with regards to enantioselectivity can be neglected. 
Therefore, the effect of chiral phosphoric acids was no longer investigated. 
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Table 16: Asymmetric hydrogenation of imine 59 employing combinations of iridium complexes 336 with 407 or 408 
 
Entry Acid Acid [mol %] Solvent p [bar] t [h] Conv. [%]a Amine [%] ee [%]b 
1 407 1 CH2Cl2 50 2 36 n.d. rac. 
2 407 2 CH2Cl2 50 2 15 n.d. rac. 
3 407 5 CH2Cl2 50 2 7 n.d. rac. 
4 407 10 CH2Cl2 50 2 5 n.d. 6 
5 408 1 CH2Cl2 50 12 >99 97 rac. 
6 408 2 CH2Cl2 50 12 98 89 rac. 
7 408 5 CH2Cl2 50 12 73 54 rac. 
8 408 10 CH2Cl2 50 12 67 49 rac. 
9 407 1 CH2Cl2 50 12 74 62 rac. 
10 407 2 CH2Cl2 50 12 62 36 rac. 
11 407 5 CH2Cl2 50 12 37 1 n.d. 
12 407 10 CH2Cl2 50 12 53 1 n.d. 
13 408 1 toluene 50 12 >99 93 rac. 
14 408 2 toluene 50 12 59 37 3 
15 408 5 toluene 50 12 48 20 7 
16 408 10 toluene 50 12 43 13 10 
17 407 1 toluene 50 12 >99 52 rac. 
18 407 2 toluene 50 12 67 38 12 
19 407 5 toluene 50 12 82 30 20 
20 407 10 toluene 50 12 >99 20 20 
21 408 10 toluene 100 24 52 18 12 
22 408 20 toluene 100 24 55 15 18 
23 408 30 toluene 100 24 69 16 18 
24 408 40 toluene 100 24 82 17 n.d. 
25 407 10 toluene 100 24 50 16 rac. 
26 407 20 toluene 100 24 62 13 rac. 
27 407 30 toluene 100 24 74 12 rac. 
28 407 40 toluene 100 24 75 12 rac. 
a) Determined by GC analysis. b) determined by HPLC analysis on a chiral stationary phase. 
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Deuterium labelling studies 
 
F. Barrios had investigated imine hydrogenation by deuterium labelling experiments to better understand the 
hydride transfer process in the catalytic cycle. As one would expect introduction along the C=N double bond, 
incorporation of deuterium in the α-position should be observed to a very high extent. A deuterium 
incorporated at the nitrogen atom would be exchanged during workup. However, the observed deuterium 
incorporation at the methyl position was contradictory to a simple H2 addition across the C=N double bond.20 
Since inconsistent numbers were obtained by F. Barrios, deuteration experiments were repeated using 
different iridacycle catalysts (Table 17). Imine 322 was chosen to additionally study the stability of the 
iridacycle catalysts. GC analysis would depict even trace amounts of imine 59 or amine 60. 
 
Table 17: Asymmetric hydrogenation of imine 322 with iridacycles 325, 391 and 403 
 
Entry Catalyst ortho [% D] α [% D] Methyl [% D] Conv. [%]a) 
1 325 0 41 13 >99 
2 325 0 48 17 >99 
3 391 10 55 0 >99 
4 391 25 55 0 >99 
5 391 25 58 0 >99 
6 391 50 50 0 >99 
7 403 5 35 17 >99 
8 403 9 41 20 >99 
9 403 12 43 22 >99 
10 403 20 48 24 >99 
a) Determined by GC analysis. 
 
Quite large discrepancies were observed over the course of four setups. Whereas 325 did not show any 
incorporation at the ortho-position (Entries 1 and 2), the analogue 391 did not show any incorporation at the 
methyl position (Entries 3 to 6). With 391, substitution of imine 59 by (most likely) imine 322 was observed 
by detection of 59 and 60 in GC analysis after the reaction. No aliquot analysis during the reaction was 
conducted. Whether such a replacement had happened during the reaction or after full conversion of imine 
322 was not clear. However the large amount of deuterium-incorporation in the ortho-position is supportive 
                                                          
20 See chapter 2 
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of rapid reversible amine cyclometalation indicating such a substitution after the reaction. No reversible 
cyclometalation was observed with 325. The lack of deuterium incorporation at the ortho-position with 325 
was in contrast to previously obtained results by F. Barrios. Complex 403 was demonstrated to decompose 
under hydrogenation conditions. Therefore, these results are not interpreted. 
 
The low extent of deuterium incorporated at the α–position in the hydrogenation with deuterium was 
somewhat contradictory. Where else would a deuterium atom be incorporated? Where would a proton under 
deuteration conditions originate from? An issue in experiments with 59-CD3 labelled and 59-d13 labelled 
imine were trace amounts of residual KOtBu used in the preparation of these deuterated imines.21 
Hydrogenations of these substrates gave brownish coloured reaction mixtures. Residual KOtBu possibly 
biased the outcome of these reactions. On the other hand, no such phenomena were observed with 59-d10.  
 
All experiments by F. Barrios were re-examined. Instead of iridium complex 86, iridacylce 325 was used as 
the catalyst in combination with an equimolar amount of NaBArF. Primarily, deuterium labelled derivatives 
of imine 59 (59-CD3, 59-d10 and 59-d13) were subjected to hydrogen gas (Scheme 159). 
 
 
Scheme 159: Re-examination of deuterium labelling experiments previously conducted by F. Barrios 
 
In all three cases, no deuterium incorporation at the α–position was observed. This is consistent with 
dihydrogen being added across the C=N double bond. Moreover, 59-CD3 as well as 59-d13 displayed about 
50% residual deuterium incorporation (by 1H-NMR). This might originate from imine-enamine tautomerism 
prior to catalytic reduction. The incorporation of deuterium in the ortho-position in 59-CD3 demonstrates that 
the deuterium is transferred from the methyl position to the ortho-postion to a small extent. While 44% of 
deuterium was removed from the methyl group, only 5% could be found in the molecule. Apparently the rest 
was removed from the molecule to an unknown destination. 
 
When evaluating the corresponding hydrogenation with D2, conclusions are diffuclt to draw (Scheme 160). 
In the case of 59-CD3, deuterium incorporation at the α-position occurred to a large extent of 80%. However, 
only 80% residual deuterium incorporation at the methyl position was observed. On the other hand, 
                                                          
21 Labelled imines were isolated by Kugelrohr distillation. 
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deuteration of 59-d10 afforded 50% deuterium incorporation at the α-position and 20% at the methyl position. 
Obviously, the protons from the methyl group were partially transferred to the α-position. Another possibility 
is the presence of the enamine tautomer in the catalytic cycle. The final experiment with 59-d13 raised some 
significant questions: How can one observe hydrogen incorporation when conducting hydrogenation with D2 
on a fully deuterated substrate? The origin of hydrogen in such a setup could not be explained. The glass 
surface of the reaction vial might be possible origin of protons. Such a situation has been observed in studies 
of trifluoroborate coupling reagents.[99] However this was not investigated in detail and remains speculative. 
 
 
Scheme 160: Deuterium labelling experiments with partially labelled variations of imine 59 
 
In order to gain further insight into the role of the iridacycle catalyst in such labelling experiments, a labelled 
derivative of 325 was prepared (Scheme 161). NMR analysis revealed hydrogen incorporation of about 30% 
in the hydride ligand. Furthermore, about 30% deuterium incorporation was observed at the methyl position 
of the cyclometalated imine 59-d10 (Spectrum 39 and Spectrum 40). Other sources of hydrogen can be 
excluded since the reaction was set up under inert conditions and 99.99% Deuterium gas quality was used. 
 
 
Scheme 161: Preparation of iridacycle 325 bearing a deuterium-labelled imine ligand 
Chapter 3 – Mechanistic Investigations 
124 
Spectrum 39: 1H-NMR of labelled 325 
 
Spectrum 40: 31P{1H}-NMR of labelled 325 
 
This experiment demonstrated that already during cyclometalation an exchange between the protons of the 
methyl group and the hydride is occurring. In order to observe such an exchange process also in the course of 
a hydrogenation, imine 59 (Scheme 162) was analysed by collection of aliquots. 
 
 
Scheme 162: Deuteration of imine 59 with 86 for aliquot analysis 
 
Spectrum 41 displays the incorporation of deuterium over time. While the deuterium-incorporation at the 
methyl position (green) and the α-position (blue) remains constant, the erosion of hydrogen content in the 
ortho-position can be depicted (red). Unfortunately this experiment did not deliver the desired information 
about possible exchange between the methyl-protons and the hydride, since the amine was demonstrated to 
remain unaffected in the presence of the catalyst. 
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Spectrum 41: 1H-NMR traces of the hydrogenation shown in Scheme 162;  
methyl group (green), ortho-Aryl (red), α-position (blue) 
 
On the other hand, the reaction with H2 and 59-d10 (Scheme 163) revealed several important features. While 
progressive incorporation of hydrogen at the ortho-position (red) can be explained by reversible 
cyclometalation of the product amine, incorporation of hydrogen remained constant at both the α- (blue) and 
the methyl position (green) (Spectrum 42). 
 
 
Scheme 163: Hydrogenation of imine 59-d10 with 86 for aliquot analysis 
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Spectrum 42: 1H-NMR traces of the hydrogenation shown in Scheme 163;  
methyl group (green), ortho-Aryl (red), α-position (blue) 
 
When taking a closer look at the orange frame, partially Me-labelled 59-d10 can be observed. The amount of 
Me-labelled 59-d10 was about 13% and remained constant in the aliquots taken after 10, 20 and 30 minutes. 
Imine was no longer detected after 60 minutes. Therefore, incorporation of deuterium is occurring prior to 
catalysis and possibly involves the transfer of the deuteride from the ortho-position to the methyl position of 
the substrate. However, in the chosen setup of Scheme 163 it does not affect the overall label incorporation 
significantly.  
 
These experiments demonstrate that addition of hydrogen occurs along the C=N double bond. Minor 
isomerisation processes prior to hydrogenation strongly affect the extent of incorporation and thus bias 
results in a way that interpretation becomes very difficult.  
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Stochiometric Hydride Transfer studies 
 
In previous experiments it was demonstrated that addition of NaBArF is necessary to generate the active 
catalyst in solution from iridacycle 325. In order to gain an understanding of the structure in solution, 
chloride abstraction was studied in NMR experiments. Therefore, iridacycle 325 and NaBArF were dissolved 
in CD2Cl2 to generate 308 (Scheme 164). 
 
 
Scheme 164: Generation of complex 308 in solution 
 
Spectrum 43: 1H-NMR of 308 
 
Spectrum 44: 31P{1H}-NMR of 308 
 
Spectrum 43 and Spectrum 44 depict two configurational isomers of 308 in solution. CH2Cl2 is known to 
coordinate to iridium centres but in a weak fashion.22 Therefore, isomers of the iridium complex in solution 
                                                          
22 See chapter 1 (introduction) 
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as well as interconverting species can be present. No EXSY signals could be observed with mixing times up 
to 750 ms. Judging from the chemical shifts of the hydrides, in one case the hydride is situated trans to a 
weak donor such as the nitrogen of the oxazoline or the imine. In the other case, the high field resonance 
indicates its orientation trans to an empty coordination site. 
 
A different picture is obtained when chloride abstraction is conducted in THF (Scheme 165). One single 
configurational isomer of 308 is observed in solution (Spectrum 45 and Spectrum 46) which depicts similar 
NOE contacts to the previously characterised complex by F. Barrios. The N-phenyl ring is experiencing 
hindered rotation as observed by EXSY signals. 
 
Scheme 165: Generation of complex 308 in solution, key NOE contacts depicted on the right 
 
Spectrum 45: 1H-NMR of 308 
 
Spectrum 46: 31P{1H}-NMR of 308 
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While chloride abstraction afforded two configurational isomers of 308 in CH2Cl2 and one isomer in THF, 
the catalytic reaction is only observed in CH2Cl2 at room temperature. This would allow the study of the 
hydride transfer of “naked“ complex 308 in the presence of imine 59. 
 
Iridacycle 325, NaBArF and 59-15N were added to a Young’s NMR tube and dissolved in CD2Cl2. Iridacycle 
325 shows one 1H-NMR hydride doublet signal at -18.2 ppm and one 31P-NMR singal at 2.63 ppm. Upon 
dissolution in CD2Cl2, those signals are no longer observed. After 30 minutes, four hydride signals can be 
observed, all of them doublets (Spectrum 47). Thus the coupling constant between the 1H-hydride and the 
15N of the imine is too small to be observed. On the other hand, the 31P{1H}-NMR depicts doublets of 
doublets which are indicative of the coupling to both the hydride and the imine nitrogen atom (Spectrum 48). 
The signals in the blue frame are of specific interest. Since the 31P{1H}-NMR depicts doublets of doublets 
and the signal is only observed for a limited amount of time, it was assigned to complex 409 (Scheme 166). 
 
 
Scheme 166: Generation of complex 409 observed for a limited time period in CD2Cl2 
 
 
Spectrum 47: 1H-NMR of 409 (blue) and 410 (red) 
 
 
Spectrum 48: 31P{1H}-NMR of 409 (blue) and 410 (red) 
 
Over the course of 26 hours, only one 1H-NMR hydride signal and one 31P{1H}-NMR resonance remained 
(red frame). The structure of this new complex 410 was unclear. When taking a closer look at the 1H-NMR 
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spectrum, a distinctive coupling pattern of two new signals at around 5 ppm was observed (orange frame, 
Spectrum 49). A doublet of doublets of doublets (ddd) was observed. It was reduced to a set of doublets of 
doublets with in the 1H{31P}-NMR decoupling experiment (Spectrum 50). 
 
Spectrum 49: 1H-NMR of 410 
 
 
Spectrum 50: Detailed section from 4.7 to 5.3 ppm in the 1H-NMR of 410 
 
The large coupling constant of 70 Hz indicated a 1JN,H coupling. Therefore, the new complex was assigned to 
an aniline bound species 410 with two inequivalent NH2 protons (Scheme 167). In a different setup, the 
existence of the coordinated aniline could be further confirmed by a 1H-15N HMBC correlation experiment.23 
No residual water signal was detected. Two new signals were observed at 3.22 and 1.52 ppm. These were 
assigned to the methyl group resonances of the product amine 60 and acetophenone (117). Thus, no more 
labelled imine 59-15N was observed in solution since it was completely hydrolysed. Imine hydrolysis by a 
rhodium diphosphine complex in imine hydrogenation had been reported by James and co-workers.[64] Thus, 
the NMR sample was worked up and subsequent GC analysis depicted aniline, acetophenone (117) and 
amine 60.  
 
                                                          
23 Whereas free aniline is expected to have a chemical shift of -330 ppm, the coordinated aniline showed a high-field shift of more 
than 100 ppm to a resonance of -230 ppm. The signal at -325 ppm corresponds to residual imine 59-15N, where the ortho-protons 
of the aniline ring as well as the methyl group show correlation signals to the labelled nitrogen atom. 
1H-NMR 
1H{31P}-NMR 
4 Hz 3JH,P 
11 Hz 2JH,H 
70 Hz 1JH,N 
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Scheme 167: Hydrolysis of imine 59-15N in hydride transfer studies 
 
HPLC analysis showed that amine 60 was obtained predominantly as the (R)-enantiomer with an ee of 67%. 
The (R)-enantiomer is also obtained in the catalytic reaction. Additionally, hydrolysed 15N-aniline is 
observed as the main component. The mass spectra recorded from GC-MS analysis indicate a m/z ratio of the 
amine (14N:197 and 15N:198) of three to one. Therefore, both 60-14N and some 60-15N labelled amine are 
detected. This amine could originate from the added imine as well as from the cyclometalated imine. 
Therefore, decomposition processes of the catalyst have to be taken into account.  
Since stochiometric amounts of imine were added to the mixtures and only very small portions of amine 
were detected, concomitant hydrolysis must occur during reduction of the imine. In attempts to reproduce 
generation of complex 410, amine 60 was not observed in every batch. When working under strict exclusion 
of water, species 409 could be observed for 24 hours before decomposition processes occurred. Therefore, 
the reduction of imine 59 to amine 60 is not the dominant process observed in a stochiometric reaction.  
 
The role of imine-enamine tautomerism in the hydrogenation of imines 
 
F. Barrios had raised the concern that imines which cannot undergo imine-enamine tautomerism cannot be 
hydrogenated, indicating that not the imine but the enamine is the actual species being reduced. Deuterium 
labelling experiments supported this hypothesis by deuterium incorporation at the methyl group of imine 59. 
Furthermore, substrates preventing imine-enamine tautomerism, such as 326 or 327 could not be reduced 
even at 50 bar hydrogen pressure (Figure 47). 
 
 
Figure 47: Imine-enamine tautomerism upon cyclometalation and imine 326 and 327 preventing enamine formation 
 
In a re-evaluation, imines 326 and 327 were subjected to hydrogenation conditions in combination with 
imine 59 to afford iridacycle catalyst 325 in situ (Table 18). When comparing entries 1 to 2 as well as 3 to 4, 
conversion of the imine was achieved in the presence of 59. This demonstrated that hydrogenation occurs 
along the C=N double bond. No conversion in the absence of imine 59 could be explained by the difficult 
formation of the iridacycle with imines 326 and 327. Iridacycle formation was shown to involve the methyl 
group as deuterium incorporation was detected in partially deuterated iridacycle 325 in Scheme 161.  
 
When investigating a series of imine 411 to 413 able to undergo imine-enamine tautomerism, conversion 
was observed at elevated hydrogen pressure in all cases (Entries 6, 8, 10). Similarly, imine 414 afforded the 
corresponding amine in low yield at atmospheric hydrogen pressure, whereupon imine-enamine tautomerism 
would result in dearomatization of one aryl substituent. Imine 320 could only be hydrogenated upon addition 
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of imine 59 (Entry 14). This demonstrates that addition of imine 59 extended the substrate scope to di-ortho-
substituted imines which cannot form the corresponding iridacycle themselves.  
 
Table 18: Hydrogenation of imines undergoing/preventing imine-enamine tautomerism 
 
Entry Imine 59 p [bar] Conv. [%]a) 
1 326 - 50 0 
2 326 2 mol% 50 10 
3 327 - 50 0 
4 327 2 mol% 50 30 
5 411 - 1 8-13 
6 411 - 50 28-35 
7 412 - 1 0 
8 412 - 50 >99 
9 413 - 1 25 
10 413 - 50 >99 
11 414 - 1 27 
12 414 - 50 >99 
13 320 - 50 0 
14 320 2 mol% 50 >99 
a) Determined by GC analysis. 
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Synthesis of isoquinoline ligand 
 
The retrosynthetic analysis of the isoquinoline ligand 414 is outlined in Scheme 168. 414 would be obtained 
from intramolecular imine condensation of 415 which in turn would be obtained by Mitsunobu substitution 
of an alcohol of 416 to an amine. Alcohol 416 would be obtained after deprotection of 417 which was 
intended to be prepared by a Pd-catalysed α-arylation of isobutyrophenone (418) and enantiopure aryl 
bromide 419. 
 
 
Scheme 168: Retrosynthetic analysis of isoquinoline ligand 414. 
 
Scheme 169 depicts a short literature research which provided established Buchwald-Hartwig coupling 
reaction conditions both for 418[100] and 419.[101],[102]  
 
 
Scheme 169: α-Arylation of protected alcohol 419 and isobutyrophenone (418). 
 
Protection of benzylic alcohol 424 with chlorosilane 425 proceeded smoothly in full conversion to afford the 
protected racemic alcohol 419 (Scheme 170). 
 
 
Scheme 170: Preparation of protected aryl bromide 419. 
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Subsequently, aryl bromide 419 was subjected to Buchwald-Hartwig α-arylation (Table 19).[101],[103] 
 
Table 19: α-Arylation of protected benzylic alcohol 419 and ketones 117, 418 and 426. 
 
Entry Ketone Catalyst Ligand Base yield 
1 418 Pd(OAc)2 (10 mol%) P(
tBu)3•HBF4 (25 mol%) NaO
tBu (1.5 eq.) 0% 
2 418 Pd(OAc)2 (10 mol%) rac-BINAP (12.5 mol%) KO
tBu (3.0 eq.) 0% 
3 418 Pd2(dba)3 (10 mol%) D
tBuPF (12.5 mol%) KOtBu (3.0 eq.) 0% 
4 426 Pd2(dba)3 (5 mol%) rac-BINAP (6 mol%) NaO
tBu (1.3 eq.) 0% 
5 117 Pd2(dba)3 (5 mol%) rac-BINAP (6 mol%) NaO
tBu (1.3 eq.) 0% 
 
Surprisingly, no conversion was observed even when employing sterically less demanding ketones such as 
426 or 117. Partial decomposition of aryl halide 419 was observed. Therefore, the aryl bromide was replaced 
by 2-bromobenzonitrile (429) and attempted to couple with acetophenone (117). Again, no conversion was 
observed (Scheme 171). 
 
 
Scheme 171: α-Arylation of aryl bromide 429 and acetophenone (117). 
 
Only decomposition of the aryl bromide was observed. Literature search revealed that ortho-substituted aryl 
halides such as 431 undergo α-arylation in 1,4-dioxane to afford 432 (Scheme 172).[104] 
 
 
 
Scheme 172: α-Arylation of 2-bromoiodobenzene (431) and propiophenone (426). 
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Therefore, both propiophenone (426) and isobutyrophenone (418) were subjected to α-arylation with 2-
bromoiodobenzene (431). Furthermore, aryl bromide 419 was also evaluated as a coupling partner (Table 
20). 
  
Table 20: α-Arylation of protected benzylic alcohol 419 and aryl halide 431 with ketones 418 and 426. 
 
Entry Aryl halide Ketone Catalyst Ligand base T [°C] t [h] yield 
1 431 426 
Pd2(dba)3 
(0.5 mol%) 
P(tBu)3•HBF4 
(2.5 mol%) 
NaOtBu 
(1.3 eq.) 
60 °C 9 h 0% 
2 431 426 
Pd2(dba)3 
(0.5 mol%) 
P(tBu)3•HBF4 
(2.5 mol%) 
NaOtBu 
(1.3 eq.) 
80 °C 14 h 70% 
3 431 418 
Pd2(dba)3 
(5 mol%) 
P(tBu)3•HBF4 
(12 mol%) 
NaOtBu 
(1.5 eq.) 
80 °C 12 h 0%a 
4 431 418 
Pd(dba)2 
(7.5 mol%) 
DtBuPF 
(9 mol%) 
KHMDS 
(1.5 eq.) 
85 °C 18 h 0% a 
5 419 426 
Pd(dba)2 
(5 mol%) 
DtBuPF 
(6 mol%) 
NaOtBu 
(1.6 eq.) 
80 °C 12 h 44% 
6 419 426 
Pd(dba)2 
(5 mol%) 
DtBuPF 
(6 mol%) 
NaOtBu 
(1.6 eq.) 
90 °C 24 h 85% 
7 419 418 
Pd(dba)2 
(5 mol%) 
DtBuPF 
(6 mol%) 
NaOtBu 
(1.6 eq.) 
80 °C 12 h 10% 
8 419 418 
Pd(dba)2 
(5 mol%) 
DtBuPF 
(6 mol%) 
NaOtBu 
(1.6 eq.) 
100 °C 24 h 28% 
9 419 418 
Pd(dba)2 
(5 mol%) 
DtBuPF 
(6 mol%) 
NaOtBu 
(1.6 eq.) 
100 °C 24 h 0%b 
10 419 418 
Pd(dba)2 
(10 mol%) 
P(tBu)3•HBF4 
(12 mol%) 
NaOtBu 
(1.6 eq.) 
100 °C 48 h 43% 
[a] no conversion and partial aryl halide decomposition. [b] in toluene 
 
While ketone 426 afforded the arylated product in 70% yield at slightly higher temperatures (Entry 2), 
ketone 418 displayed no conversion (Entries 3 and 4). Satisfyingly, when reacting propiophenone (426) with 
sterically demanding aryl bromide 419, the desired arylated product 428 was obtained in 85% yield when 
conducting the reaction at 90 °C for 24 hours (Entry 6). Under these conditions, reactivity was also observed 
for isobutyrophenone (418) in combination with 419 (Entries 7 and 8). Prolonged reaction times (48 h) and 
further increase of reaction temperature to 100 °C afforded the desired arylated product 427 in 43% yield 
(Entry 10).  
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Deprotection of 427 afforded the undesired hemiacetal 435 via intermediate alcohol 434 in full conversion 
(Scheme 173). 
  
 
Scheme 173: Deprotection of 427 affording hemi-acetal 435. 
 
The hemi acetal 435 was subjected to acidic workup but the free alcohol 434 could not be observed by NMR. 
Since hemiacetals are known to be in equilibrium with the corresponding ketone, 435 was subjected to a 
number of reaction conditions to either afford the Mitsunobu product[105] or the mesylated acetal as depicted 
in Scheme 174. However, in all attempts no conversion was observed. Therefore this synthetic route was no 
longer followed. 
 
 
Scheme 174: Attempted derivatisation of hemi-acetal 435. 
 
While isobutyrophenone (418) and 2-bromoiodobenzene (431) showed no reaction, propiophenone (426) and 
431 afforded the desired arylated product 432 in high yield (Table 20). Thus methylation of the α-carbon to 
obtain 433 was investigated (Table 21).  
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Table 21: Methylation of 432. 
 
Entry Base Solvent T [°C] t [h] T [°C] t [h] yield 
1 LDA THF -78 °C 30 min 
-78 °C 
23 °C 
60 min 
overnight 
0% 
2 LDA THF -78 °C 30 min 
-78 °C 
23 °C 
30 min 
overnight 
0% 
3 NaH THF 
-78 °C 
0 °C 
35 min 
30 min 
-78 °C 
23 °C 
45 min 
2 h 
0% 
4 LiHMDS THF 
-78 °C 
0 °C 
15 min 
10 min 
-78 °C 
23 °C 
40 min 
overnight 
3% 
5 LiHMDS THF 
-78 °C 
23 °C 
60 min 
10 min 
-78 °C 
23 °C 
-78 °C 
overnight 
0% 
6 KHMDS toluene 
-78 °C 
23 °C 
45 min 
20 min 
-78 °C 
60 min 
H2O quench  
0% 
7 KHMDS toluene 
-78 °C 
23 °C 
60 min 
10 min 
-78 °C 
23 °C 
-78 °C 
overnight 
0% 
8 
KOtBu,  
18-crown-6 
THF 23 °C 15 min 23 °C 15 min 
12%  
(48% O-alkylated; 
22% rec. sm) 
 
While methylation with strong bases failed at lower temperatures (Entries 1-7), KOtBu and 18-crown-6 ether 
in THF afforded the desired ketone 433 at room temperature in 12% yield (Entry 8).[106] By alternating the 
order of addition and lowering the reaction temperature to 0 °C, methylation of ketone 432 proceeded in 91% 
conversion providing the desired ketone 433 in 19% yield along with 72% O-methylated 436 displayed in 
Scheme 175. The reaction was not investigated in the absence of 18-crown-6 ether. The presence of crown-
ether might be responsible for the high excess of O-alkylation. 
 
 
Scheme 175: Methylation of 432. 
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In order to obtain the C-alkylated product 433 selectively, enamine formation of 432 with pyrrolidine was 
attempted but enamine 437 could not be obtained (Scheme 176). 
 
 
Scheme 176: Attempted enamine formation of 432 to afford 437. 
 
Due to the poor selectivity of the alkylation, recovery of 432 was investigated. Scheme 177 displays the 
results: While boron tribromide afforded a 7:3 ratio of 432 and 437, trimethylsilyl iodide provided ketone 
432 alone in 89% yield.[107],[108]  
 
 
Scheme 177: Regeneration of ketone 432 by demethylation. 
 
With 433 in hand, lithium-halogen exchange and subsequent addition of an electrophile was investigated. As 
the electrophile N-(4-methoxyphenyl)ethanimine 439 was chosen. Deprotection of the PMP-group of 440 
under oxidative acidic conditions[109] would form 415 which should directly undergo intramolecular imine 
condensation to afford the desired isoquinoline ligand 414 as shown in Scheme 178.  
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Scheme 178: Revised synthetic route involving lithiation of 438, subsequent electrophilic attack  
of 439 and PMP-deprotection to afford 414. 
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However, when 433 was lithiated and freshly prepared 439 added, a different product 444 was isolated. 
Condensation of acetaldehyde and para-anisidine did afford the α,β-unsaturated crotonaldehyde-derived 
aldimine 443 and not 439. Furthermore, the lithiated species 438 is prone to intramolecular attack to the 
ketone and rearranged into species 442 with a benzylic anion, in equilibrium with the tertiary lithium 
alkoxide 441. 441 underwent Michael addition and subsequent cyclisation to afford 444 as a single 
diastereomer. Scheme 179 outlines the potential side reaction.  
 
 
Scheme 179: Potential side reaction upon lithiation and electrophile addition to 433. 
 
The reaction of aryl bromide 433 with n-BuLi and other electrophiles such as isopropylaldehyde or 
acetaldehyde gave a mixture of products. Therefore lithiation of 433 was no longer investigated.  
 
In order to introduce an amino group, α-arylation of aryl bromides 445 and 446 was investigated (Scheme 
180). Upon coupling of 445 isobutyrophenone (418), hydrogenation with Pd/C would afford 415. With aryl 
bromide 446, coupling to 418 and subsequent hydrolysis would allow for reductive amination of the ketone 
to give 415. When aryl halide 445 was α-arylated with isobutyrophenone (418) a complex product mixture 
was obtained. Aryl halide 446 decomposed under the reaction conditions. The desired products were not 
observed by GC-MS analysis and could not be isolated by flash chromatography. 
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Scheme 180: Preparation of aryl bromides 445 and 446. 
 
Additionally, aryl bromides 447 and 448 were prepared (Scheme 181).[110] Both 447 and 448 did not afford 
the desired coupling products, but decomposition of the aryl bromides occurred. 
 
 
Scheme 181: Preparation of aryl bromides 447 and 448. 
 
Since coupling of aryl halides 445, 446, 447 and 448 was not successful; efforts were devoted towards 
protection of the keto functionality in order to re-investigate bromine-lithium exchange. Primarily, acetal- 
and thioacetal formation were investigated (Table 22). No acetal or thioacetal formation was observed. 
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Table 22: Efforts towards acetal protection of ketone 433. 
 
Entry Alcohol Reagent Catalyst Solvent Temp. time yield 
1[111]  (MeO)3CH ZrCl4•(THF)2 CH2Cl2 23 °C 18 h 0% 
2  4Å MS p-TsOH toluene 115 °C 12 h 0% 
3[112]  (MeO)3CH (nBu)3NBr3 CH2Cl2 23 °C 24 h 0% 
4[113] MeOH (MeO)3CH CF3SO3H MeNO2 115 °C 6 h 0% 
5[113] 
 
(MeO)3CH CF3SO3H MeNO2 115 °C 6 h 0% 
6  4Å MS p-TsOH toluene 115 °C 12 h 0% 
7[114]  Silica gel p-TsOH CH2Cl2 55 °C 24 h 0% 
 
Therefore, protection by methylenation was attempted (Table 23). The desired 1,1,-disubstituted terminal 
olefin 449 or 450 would be converted to the ketone at a later stage in the synthesis by ozonolysis. While 
attempts with titanium-mediated carbene generation from dichloromethane were unsuccessful (Entries 1 and 
2)[115], the Tebbe reagent provided the desired olefin 449 in up to 39% yield (Entry 6). Exclusion of light 
significantly enhanced the life-time of the Tebbe reagent in solution.[116],[117],[118],[119] 
 
Table 23: Methylenation of 427 and 433. 
 
Entry Substrate Reagent Solvent T [°C] t [h] yield 
1 427 Mg, TiCl4, CH2Cl2 THF 0 °C to 23 °C 1 h 0% 
2 433 Mg, TiCl4, CH2Cl2 THF 0 °C to 23 °C 1 h 0% 
3 433 (Cp)2Ti(Me)2 toluene 75 °C 24 h 0% 
4 433 (Cp)2Ti(Me)2, exlusion of light toluene 75 °C 24 h 0% 
5 433 (Cp)2Ti(Me)2, exlusion of light toluene 85 °C 72 h 16% 
6 433 (Cp)2Ti(Me)2, exlusion of light 
toluene/THF 
1:1 
70 °C 48 h 39% 
Reactions were very sluggish and the olefin products difficult to purify due to their high lipophilic character. 
Therefore, subsequent one-pot deprotection of the olefin to the free secondary alcohol 451 was conducted. 
Isolated yields lower than 50% were achieved (Scheme 182). 451 was subjected to Mitsunobu reaction 
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conditions[120],[121],[122] to afford the N-Boc-protected amine. Instead the elimination product 452 was formed 
exclusively.  
 
 
Scheme 182: Deprotection and attempted Mitsunobu reaction on 449. 
 
Robin Wehlauch observed formation of 454 by α-arylation of 418 and 453 during his internship. Under 
optimized conditions, 454 was obtained in 67% yield as shown in Scheme 183.  
 
 
Scheme 183: α-arylation of isobutyrophenone (418) and 2-bromostyrene (453). 
 
Subsequent ozonolysis followed by treatment with triphenylphosphine afforded the keto-aldehyde 455 
(Scheme 184). Under optimized reaction conditions, 455 was obtained in 89% yield.[123]  
 
 
 
Scheme 184: Ozonolysis of 454. 
 
Keto-Aldehyde 455 was condensed with para-anisidine to afford 456. On the other hand, condensation with 
BocNH2 to obtain 457 failed. N-PMP aldimine formation of 456 proceeded smoothly in >95% conversion 
determined by NMR (Scheme 185). The PMP protection group was chosen since it can be oxidized and 
cleaved under acidic conditions. Furthermore, the aldimine offered the possibility of introducing a variety of 
substituents by nucleophilic addition.  
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Scheme 185: Condensation of 455 with amines. 
 
Hence, aldimine 456 was generated in situ and dried in vacuo. The corresponding nucleophile was added to 
afford the desired protected secondary amine. Scheme 186 gives an overview of attempted nucleophilic 
additions. Addition of alkyl Grignard and alkyl lithium reagents showed different reactivity. With methyl 
lithium, the hemi-aminal 458 was obtained in 30% yield. This observation is similar to hemi-acetal 435 
obtained from 427 (Scheme 173). It appears that the methyl group is small enough to facilitate nucleophilic 
attack of the generated amide or alkoxide. Contrary to methyl lithium, methyl magnesium bromide gave a 
complex product mixture. On the other hand, isopropyl magnesium chloride afforded the corresponding 
secondary amine 459 under mild reaction conditions in 53% yield. A similar reactivity was observed with 
tert-butyl magnesium chloride delivering amine 460 in 25% yield. The same reaction with tert-butyl lithium 
did not give any product probably due to the high basicity of the lithium reagent. 
 
 
Scheme 186: Addition of alkyl Grignard and lithium reagents to 456. 
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Different reagents with moderate oxidizing strength to deprotect 459 were tested. The free amine generated 
in situ directly underwent intramolecular imine condensation to afford the isoquinoline ligand 392 (Scheme 
187). 
  
 
Scheme 187: Oxidative deprotection of 459 and subsequent intramolecular imine condensation.24 
 
In order to obtain enantiomerically pure isoquinoline ligand 392, separation of 459 by semipreparative HPLC 
on a chiral stationary phase was performed. However, when converting enantiopure 459 to 392 partial 
racemisation was observed with CAN (Scheme 188). Therefore separation of enantiomers was performed 
with isoquinoline 392. Reactions with enantiopure 459 gave higher yields of 392 even though the racemate 
of 459 was purified by flash chromatography. The contaminant in the racemic material could not be 
identified by NMR or GC analysis. 
 
 
Scheme 188: Oxidative deprotection of enantiomerically enriched 459 giving 392 with erosion of enantiomeric excess. 
 
  
                                                          
24 CAN = Cerium Ammonium Nitrate; TCCA = Trichloroisocyanuric acid 
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Synthesis of tetrahydropyridine ligand 
 
The retrosynthetic analysis of ligand 394 is depicted in Scheme 189. 394 would be obtained from 
intramolecular imine condensation of 462 which in turn would be generated from 463. Diastereoselective 
reduction of 464 and subsequent re-oxidation of to the ketone would afford 463. 464 would be obtained from 
Michael addition of N-sulfinimine 465 and Michael acceptor 466. 
 
 
Scheme 189: Retrosynthetic analysis of ligand 394. 
 
The synthetic route is based on the synthesis of 1,3,5-substituted piperidines like 472 reported by Ellman and 
co-coworkers (Scheme 190).[124] The application of enantiopure N-sulfinamides 468 to generate N-
sulfinimines like 465 as chiral auxiliaries afforded the corresponding Michael addition products 470 in 
excellent diastereoselectivities. While Ellman and co-workers reduced the imine directly in-situ, no efforts to 
isolate such structures have been reported. 
 
 
Scheme 190: Preparation of 1,3,5-substituted piperidines such as 472 by Ellman and co-workers. 
 
With enantiopure sulfinimine 465 the direct preparation of each enantiomer of the desired ligand could be 
envisioned. A similar route as the one by Ellman was followed to afford the corresponding 
tetrahydropyridines. Preparation of the N-sulfinyl imines 465 and 474 proceeded with moderate to high 
yields as shown in Scheme 191. 
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Scheme 191: Preparation of N-sulfinyl imines 465 and 474. 
 
The subsequent addition of the lithium enamide of 465 to phenyl vinyl ketone 466 presented several 
challenges. While isolated yields of up to 54% were obtained for Michael adduct 464 (Scheme 192), the 
product could not be isolated in pure form by flash chromatography. Co-elution of unreacted starting 
material and side products was observed. Repetitive flash chromatography still resulted in co-elution of 
product and side products due to similar Rf values. 
 
 
Scheme 192: Michael addition of lithium enolate of 465 to 466 affording 464. 
 
In order to elucidate possible impurities in phenyl vinyl ketone 466, the synthesis thereof was varied 
(Scheme 193).[125],[126] Furthermore, 466 was purified by flash chromatography as well as distillation. No 
difference in reactivity was observed with regards to the isolation protocol or purity of 466. In all cases, low 
to moderate yields were obtained with a maximum of 54%. Therefore, the poor reactivity was accounted to 
the substrate 466 itself. Ellman and co-workers did not apply phenyl vinyl ketone in their substrate scope, 
therefore the results could not be compared. All substrates employed by Ellmann featured trans- or cis-
disubstituted double bonds. 
 
 
 
Scheme 193: Preparation of phenyl vinyl ketone 466. 
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The crude Michael adduct 464 was reduced with L-Selectride. Ellmann and co-workers had reported 
diastereoselectivities higher than 97:3 for all substrates employed for reactions performed at -40 °C. With 
464, yields of up to 44% were obtained, even up to 5 equivalents of L-Selectride (Scheme 194). Reactions at 
-40 °C provided the amine 477 with a dr of 83:17. Lowering the reaction temperature to -50 °C improved the 
diastereoselectivity to 97:3 while maintaining the reactivity. Subsequent re-oxidation of the benzylic alcohol 
477 to the ketone 463 with Dess-Martin periodane proceeded in 75% yield and allowed for an accurate 
determination of diastereomeric excess by 1H-NMR. Diastereomers were also separated by semipreparative 
HPLC on a chiral stationary phase in case of mixtures with a dr lower than 97:3. 
 
 
Scheme 194: Diastereoselective reduction of imine 464 and subsequent re-oxidation to ketone 463. 
  
Deprotection of the sulfinyl amine (S)-463 or (R)-463 and subsequent intramolecular condensation delivered 
the corresponding tetrahydropyridines (S)-392 and (R)-392 as shown in Scheme 195. Basic workup followed 
by dichloromethane extraction was used to remove any polar side products.  
 
 
Scheme 195: Imine condensation with (S)-463 and (R)-463. 
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Synthesis of benzoxazine ligand 
 
The retrosynthetic analysis of benzoxazine ligand 395 is outlined in Scheme 196. 395 would be generated by 
benzoxazine condensation from amide 478. 478 would be obtained by benzoylation of amine 479 which in 
turn would be prepared from 2-methoxybenzoic acid (480). 
 
 
Scheme 196: Retrosynthetic analysis of benzoxazine ligand 395. 
 
The synthetic route is based on the preparation of (phosphinophenyl)benzoxazine ligands developed by P. 
Kündig and co-workers as shown in Scheme 197.[127],[128],[129] Acyl chloride formation of 481 from 2-
methoxybenzoic acid (480) was followed by nucleophilic addition of isopropyl zinc iodide to afford 482. 
Subsequent reductive amination provided benzylic amine 479, which was separated to its enantiomers by 
recrystallization with mandelic acid. After benzoylation of (R)-479 to amide (R)-484, deprotection of the 
methoxy group to obtain (R)-485 was conducted with AlBr3 to prevent racemization. Benzoxazine formation 
of (R)-486 was followed by an ipso-substitution to obtain the (phosphinophenyl)benzoxazine ligand (R)-487.  
 
 
Scheme 197: Synthesis of ligand 487. 
 
Since no phosphine introduction was intended, amide formation with benzoyl chloride followed by 
benzoxazine formation would provide the desired ligands. In order to vary the alkyl substituent in the 
benzylic position, a modular synthesis was conducted. Nucleophilic addition of Grignard reagents to nitriles 
(Scheme 198) and subsequent one-pot Birch reduction afforded the benzylic amines 479 and 489.[130] This 
also significantly reduced the number of steps compared to P. Kündig’s synthetic route. 
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Scheme 198: Intended preparation of 479 and 489. 
 
Demethoxylation was observed for 489, which was obtained as a 1:4.5 mixture along with 490 (Scheme 
199). Electron-transfer-induced reductive demethylation of methyl ethers has been observed for a number of 
alkali metals in anhydrous solvents as well as for reactions under Birch conditions.[131],[132]  
 
 
Scheme 199: Preparation of 489 and observation of 490. 
 
On the other hand, nucleophilic addition of isopropyl magnesium chloride to 488 and subsequent Birch 
reduction afforded the desired benzylic amine 479 in 86% yield (Scheme 200). 
 
 
Scheme 200: Preparation of 479. 
 
Introduction of a tert-butyl group was conducted via the synthetic route reported by P. Kündig and co-
workers as depicted in Scheme 201. Condensation of 491 and benzylamine afforded imine 492 in 88% yield. 
Subsequent addition of tert-butyl lithium required solvent exchange from pentane to THF and slow addition 
of 492 to afford N-benzylamine 493 in 77% yield. Deprotection of the amine 493 by Pd/C and hydrogen gas 
delivered benzylic amine 494 in 89% yield. 
 
 
Scheme 201: Preparation of 494. 
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While P. Kündig and co-workers separated enantiomers at that stage, yields of enantiomerically enriched 
amines were very low in the case of 479. Furthermore, 489 and 490 were isolated as a mixture. Therefore 
489 was transformed to 490 with boron tribromide in 96% yield and treated with benzoyl chloride to afford 
the benzamide 495 in 85% yield (Scheme 202). Enantiomers of 495 were separated by semipreparative 
HPLC on a chiral stationary phase. 
 
 
Scheme 202: Amide formation of 495 and separation of enantiomers by SemiPrep HPLC. 
 
In a similar fashion, 479 was deprotected using boron tribromide to afford 496 in 80% yield as shown in 
Scheme 203. Subsequent addition of benzoyl chloride gave benzamide 497 in essentially quantitative yield. 
Enantiomers were separated by semipreparative HPLC on a chiral stationary phase.  
 
 
Scheme 203: Deprotection of 489, amide formation and separation of enantiomers to afford (R)-497. 
 
Enantiomers of 494 were separated by recrystallisation with enantiopure mandelic acid 498 to afford the 
diastereomerically enriched mandelic acid salts. The free amine (R)-494 was demethylated using boron 
tribromide to afford (R)-499 in 90% yield. Addition of benzoyl chloride then furnished benzamide (R)-500 in 
essentially quantitative yield (Scheme 204). 
 
 
Scheme 204: Preaparation of (R)-500. 
 
With the benzamides 495, 497 and 500 in hand, cyclisation employing phosphorus oxychloride was 
investigated. Depending on the alkyl substituent, quite different yields were observed. Whereas cyclisation 
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of the methyl-substituted benzamide 495 with POCl3 to deliver 399 gave poor yields of only up to 6% yield, 
cyclisation with triflic anhydride failed. Moderate yields up to 42% were obtained with 497 affording 398 
and up to 29% in the case 500 giving benzoxazine 400. 
 
 
Scheme 205: Cyclisation of benzamides 495, 497 and 500. 
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Preparation of chiral BINOL-based phosphoric acids 
 
The synthesis of BINOL-derived chiral phosphoric acids is well documented in the literature. Therefore, 
literature procedures for the preparation of 408 and 407 were performed (Figure 48). 
 
 
Figure 48: Chiral phosphoric acids 407 and 408. 
 
At the outset, (R)-BINOL 501 was methylated using methyl iodide and potassium carbonate to afford (R)-
502 in 98% yield. Subsequent deprotonation at the ortho-position and halogen quenching provided (R)-503 
in 71% yield (Scheme 206). Attempts to introduce boron by addition of triethyl boronate instead of iodine 
failed. (R)-503 is used as a general building block for preparation of BINOL-based ligands and acids. 
 
 
Scheme 206: Preparation of building block (R)-503. 
 
(R)-503 was arylated by Kumada coupling with mesityl magnesium bromide (504) using nickel catalyst 505 
to afford (R)-506 (Scheme 207). Deprotection of the methyl ether (R)-506 was demonstrated to result in 
higher yields when conducted in a one-pot fashion.[133] Hence, (R)-506 was directly subjected to boron 
tribromide to afford (R)-507 in 52% yield over two steps. 
 
 
Scheme 207: Synthesis of BINOL (R)-507. 
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In a similar fashion, (R)-503 was reacted with zinc bromide 508. 508 was freshly prepared from 1,3,5-
triisopropylbromobenzene and zinc bromide, and reacted with (R)-503 in a Negishi coupling using Fu’s 
palladium-catalyst 509 to afford (R)-510 (Scheme 208). One-pot demethylation with boron tribromide 
afforded (R)-511 in 50% yield over two steps.[134]  
 
 
Scheme 208: Synthesis of BINOL (R)-511. 
 
Ultimately, preparation of the phosphoric acid was performed in a three-step one-pot procedure (Scheme 
209). Phosphorylation with phosphorus oxychloride, subsequent hydrolysis of the phosphine chloride and 
acidification followed by recrystallisation in aqueous hydrogen chloride furnished the chiral phosphoric 
acids (R)-407 in 55% and (R)-408 in 25% yield.[135] 
 
 
Scheme 209: Preparation of chiral phosphoric acids (R)-407 and (R)-408. 
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Asymmetric Hydrogenation of acyclic aliphatic imines 
 
In the previous chapter the in situ formation of iridacycle catalysts for the hydrogenation of aliphatic imines 
has been demonstrated. In order to render the gained knowledge into a synthetically useful methodology, 
optimisation studies were conducted. In a primary attempt, the cyclometalating imine was varied. Different 
substituents at the acetophenone-derived aryl ring as well as at the N-aryl ring were introduced. In situ 
cyclometalation and iridacycle formation prior to catalysis would form the active catalyst. 
The structurally related PHOX and SimplePHOX catalysts were demonstrated to afford the highest 
enantioselectivities in imine hydrogenation of acetophenone-derived N-aryl imines.[31] They were evaluated 
as catalysts. The influence on both enantioselectivity and reactivity of a large variety of imines as additives 
was tested. Cyclohexyl methyl N-phenyl imine 329 was chosen as the test substrate. Full conversion and 
73% enantiomeric excess were obtained with PHOX catalyst 86 in the presence of imine 59. Using 
SimplePHOX catalyst 87, 74% enantiomeric excess was observed along with full conversion (Scheme 210). 
HN
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Scheme 210: Asymmetric hydrogenation of cyclohexyl methyl N-phenyl imine 329 with  
iridium catalysts 86 or 512 and imine additive 59 
 
The first variation of the catalytic system was the introduction of a sterically more demanding acetophenone-
derived aryl ring.  
Scheme 211: Asymmetric hydrogenation of imines 329, 330 and 331 with iridium catalysts 86 or 87 and imine additive 512 
 
3,5-Dimethylacetophenone-derived imine 512 was used as an additive (Scheme 211). When applying PHOX 
catalyst 86, full conversion with low, inverted enantioselectivity of 4% was observed. On the other hand, 
very low conversions were obtained when using SimplePHOX catalyst 87. In order to exclude substrate 
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incompatibility, imines 330 and 331 were also tested. When comparing catalysts 86 and 87, imines 329, 330 
and 331 were significantly less reactive with the combination of 87 and 512. This was somewhat surprising 
since catalyst 87 and imine 59 afforded amine 97 in full conversion and 74% enantiomeric excess, virtually 
identical to the results obtained with PHOX catalyst 86 (Scheme 210). While the electronic properties of the 
PHOX and the SimplePHOX ligands are quite different with regards to the phosporus moiety, it rather 
seemed that the two additional methyl group at the acetophenone-derived aryl ring exhibit too large steric 
bulk and thus prevent iridacycle formation. 
 
In order to test this hypothesis, the corresponding iridacycles were prepared. Iridacycle preparation of 514 
and 515 provided yellow solids displaying one hydride 1H- and one 31P-NMR signal (Scheme 212). 
 
 
Scheme 212: Preparation of iridacycles 514 and 515 
 
Table 24 displays the results of testing them as catalysts in the hydrogenation of different aliphatic imines. 
Reactions were performed at lower pressure to obtain a clear picture of the reactivity or possible 
decomposition processes. At higher hydrogen pressure, other mechanisms might be operating and thus 514 
and 515 show a similar reactivity. In situ iridacycle formation can not be verified at high pressure. Only 
imine 59 (entries 3, 11 and 12) was reduced with moderate to high yields, albeit still with lower 
enantioselectivity compared to using 86 or 87 alone. 
 
Table 24: Asymmetric hydrogenation of imines 59, 329, 330 and 331 with iridacycles 514 and 515 
 
Entry Catalyst Imine p [bar] 
Conv. 
[%]a) 
ee [%]b) 
1 
 
329 1 0 - 
2 7 15 - 
3 59 1 4 - 
4 7 60 58 (R) 
5 330 1 0 - 
6 7 8 - 
7 331 1 3 - 
8 7 20 - 
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9 
 
329 1 0 - 
10 7 2 - 
11 59 1 25 86 (R) 
12 7 98 86 (R) 
13 330 1 0 - 
14 7 0 - 
15 331 1 6 - 
16 7 12 - 
a) Determined by GC analysis. b) determined by HPLC analysis on a chiral stationary phase. 
 
These results indicated that the steric repulsion of the acetophenone-derived aryl ring is too large and thus 
hydrogenation only takes place at high pressure. Despite these disappointing preliminary results, other imine 
substrates with larger substituents were prepared. The synthesis of the 3,5-di-isopropyl imine 522 was 
conducted as shown in Scheme 213. 2,6-diisopropylaniline 516 was brominated to 4-bromo-2,6-
diisopropylaniline 517 with tetra-n-butyl ammonium perbromide in 91% isolated yield. Sandmeyer de-
azonation (Meerwein reduction) with hypophosphorous acid provided 3,5-di-isopropylbromobenzene 518 in 
56% yield. Subsequent Vilsmeier-Haack-type formylation with n-butyl lithium and dimethylformamide 
furnished the corresponing aldehyde 519 in 66% yield. Nucleophilic addition of methyl magnesium bromide 
gave the benzylic alcohol 520 in 85% yield. Oxidation of the benzylic alcohol 520 to the desired ketone 521 
with Dess-Martin-Periodane performed smoothly in 95% yield. Ultimately, condensation of ketone 521 with 
aniline (142) in refluxing toluene provided imine 522 as a yellow oil in 45% yield. 
 
 
Scheme 213: Synthesis of imine 522 
 
Identical to the conducted synthetic route delivering 522, 3,5-di-tert-butylbenzaldehyde 523 was reacted with 
methyl magnesium bromide to provide the benzylic alcohol 524 in 96% yield (Scheme 214). Subsequent 
oxidation with Dess-Martin Periodane to the ketone 525 in 96% and condensation with aniline (142) to the 
imine 526 in 56% yield proceeded as expected. 
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Scheme 214: Preparation of imine 526 
 
The influence of imines 522 and 526 as additives was subsequently tested in the hydrogenation of aliphatic 
imines (Table 25). They were only tested with the PHOX catalyst 86, since the SimplePHOX analogue 87 
had already shown very poor conversions in combination with the sterically less demanding imines 330 and 
331 in test reactions (Scheme 211). 
 
Table 25: Asymmetric hydrogenation of imines 329, 330 and 331 using 86 and 522 or 526 
 
Entry Imine Additive Imine Conv. [%]a) ee [%]b) 
1 
522 
329 45 26 (S) 
2 330 29 4 (R) 
3 331 23 rac. 
4 
526 
329 10 20 (R) 
5 330 13 5 (R) 
6 331 13 4 
a) Determined by GC analysis. b) determined by HPLC analysis on a chiral stationary phase. 
 
With both imines 522 and 526 lower conversions than with imine 512 were obtained. Again, the 
enantioselectivity was inverted in the case of the 522 but not with 526. The overall low yields compared to 
the results obtained using imines 59 and 512 strenghtened the concern that such imines exert too much steric 
bulk. The poor conversion could be explained by the inability of iridacycle formation with imine 522 or 526. 
Indeed, when attempting to prepare the corresponding iridacycle of imine 526 no iridacycle could be 
isolated.  
On the contrary, the corresponding iridacycle 527 of imine 522 was obtained as a single species displaying 
one hydride 1H- and one 31P-NMR signal. When using iridacycle 527 as a catalyst, full conversion was 
observed (Table 26). The enantioselectivity was increased from 26% to 42% of the (S)-enantiomer for imine 
329. The same enantiomer was also obtained when the iridacycle catalyst was formed in situ. Inversion of 
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enantioselectivity was observed as well in the case of the imine 330. This had not been the case when the 
catalyst was formed in situ. 
 
Table 26: Asymmetric hydrogenation of imines 329, 330 and 331 using iridacycle 527 
 
Entry Catalyst Substrate Conv. [%]a) ee [%]b) 
1 
 
329 >99 42 (S) 
2 330 >99 10 (S) 
3 331 >99 rac. 
a) Determined by GC analysis. b) determined by HPLC analysis on a chiral stationary phase. 
 
The origin of inverted enantioselectivty of the catalyst was unclear. The two isopropyl groups of imine 522 
might result in a change of the overall catalyst conformation. The high impact on enantiodiscrimination with 
such imine additives is displayed in the inversion of enantioselectivity with imines 512 and 522. However, 
when attempting to further increase the steric bulk of the additive only poor yields are observed and 
iridacycle formation does not occur in the case of imine 526. This is possibly due to steric repulsion of the 
additive imine to the ligand.  
Since increasing the steric bulk of the acetophenone aryl ring did not afford higher selectivities, electronic 
effects of the imine additive were studied. Therefore, the substituent in the para-position of the acetophenone 
aryl ring was varied (Table 27). All enantioselectivites obtained have to be compared to the ee of 73% for the 
(R)-isomer obtained in full conversion with acetophenone-derived N-phenyl imine 59 (Entry 1). 3,5-Alkyl di-
substituted imines 512, 522 and 526 gave lower conversions and lower (opposite) enantioselectivities 
(Entries 2, 3 and 4). With regards to substituents in the para-position of the acetophenone-derived aryl ring, 
electron‒rich or electron‒neutral imines 528, 314 and 322 (Entries 5, 6 and 7) as well as electron‒poor 
imines 323 and 310 (Entries 8 and 9) furnished amine 97 in full conversion in enantiomeric excesses of 56-
66%. Only strongly electron‒withdrawing imines such as 324, 529, 530 and 531 (Entries 10 to 13) lowered 
both conversion and enantioselectivity. Overall no improvement in terms of enantioselectivity was observed.  
A trend of decreased reactivity and selectivity can be drawn from the table disfavouring imine additives with 
strongly electron-withdrawing substituents. Similar to substituents in the para-position of the acetophenone-
derived aryl ring, electron‒poor imines reduce the reactivity and selectivity of the formed iridacycle catalyst. 
Whereas alkyl-substituents in the meta-position seem to significantly influence the enantiodiscrimination of 
the catalyst by their steric bulk, imines such as 530 and 531 could as well explain the poor conversion due to 
their electron-withdrawing substituents. Especially NO2-substituted imines 529-531 showed lower 
conversion and poor enantioselectivity.  
Moreover, virtually no difference between a methyl- and a fluoro-substituent in the ortho-position in terms 
of selectivity is observed (Entries 13 and 14). Especially with 319, a strong effect on the 
enantiodiscrimination would be expected due to the electronic difference to imine 59. However, the obtained 
reactivity and selectivity are virtually identical to imine 59. 
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Table 27: Asymmetric hydrogenation of 329 with 86 forming iridacycles with electronically varied imines 
 
Entry Imine Additive Conv. [%]a) ee [%]b) 
1 59 (Ar = Ph) >99 73 (R) 
2 512 (Ar = 3,5-di-Me-Ph) >99 4 (S) 
3 522 (Ar = 3,5-di-iPr-Ph) 45 26 (S) 
4 526 (Ar = 3,5-di-tBu-Ph) 10 20 (R) 
5 528 (Ar = 4-tBu-Ph) >99 64 (R) 
6 314 (Ar = 4-Me-Ph) >99 63 (R) 
7 322 (Ar = 4-OMe-Ph) >99 67 (R) 
8 323 (Ar = 4-Cl-Ph) >99 56 (R) 
9 310 (Ar = 4-F-Ph) >99 66 (R) 
10 324 (Ar = 4-CF3-Ph) 95 50 (R) 
11 529 (Ar = 4-NO2-Ph) 40 45 (R) 
12 530 (Ar = 3,5-di-NO2-Ph) 15 15 (R) 
13 531 (Ar = 3-NO2-Ph) 75-99c) 48 (R) 
14 319 (Ar = 2-F-Ph) 90-95c) 70 (R) 
15 318 (Ar = 2-Me-Ph) >99 69 (R) 
a) Determined by GC analysis;  
b) determined by HPLC analysis on a chiral stationary phase;  
c) range observed over three reactions. 
 
In further optimisation attempts, the N-aryl-ring was varied as can be seen in Table 28. Primarily, 
electronically different substituents in the para-position were evaluated. A similar trend to previous results 
with electronically different imine additives was observed. Electron‒withdrawing substituents as with imine 
532 (Entry 2) lower both reactivity and enantioselectivity. Electron-neutral substitution, e.g. with a methoxy 
substituent from para (99) to meta (533) and ortho (534) (Entries 1, 3 and 4) substitution did not alter 
reactivity or enantioselectivity significantly. Neither did a large halogen atom in ortho-position (Entry 5) as 
in 535. On the other hand, introduction of an alkyl substituent in the ortho-position as with the imine 536 
(Entry 6) did increase the enantioselectivity while maintaining reactivity. A sterically more demanding 
isopropyl substituent of imine 537 (Entry 7) further increased the enantioselectivity. Ultimately, application 
of acetophenone N-2,6-dimethylphenyl imine 340 (Entry 8) gave the highest enantioselectivity of 85%. 
Overall, substitution at the N-aryl ring did increase enantioselectivity with sterically demanding alkyl groups. 
Attempts to prepare sterically more demanding imines such as N-2,6-diisopropyl or N-2,6-dimethoxy failed. 
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Table 28: Asymmetric hydrogenation of 329 using 86 and electronically and sterically varied imines 99, 340 and 532-537 
 
Entry Imine Additive Conv. [%]a) ee [%]b) 
1 99 (Ar = 4-OMe-Ph) >99 69 (R) 
2 532 (Ar = 4-CF3-Ph) 60 59 (R) 
3 533 (Ar = 3-OMe-Ph) >99 68 (R) 
4 534 (Ar = 2-OMe-Ph) >99 71 (R) 
5 535 (Ar = 2-Br-Ph)c) >99 68 (R) 
6 536 (Ar = 2-Me-Ph) >99 78 (R) 
7 537 (Ar = 2-iPr-Ph) >99 81 (R) 
8 340 (Ar = 2,6-di-Me-Ph) >99 85 (R) 
a) Determined by GC analysis;  
b) determined by HPLC analysis on a chiral stationary phase;  
c) p-tolyl acetophenone-derived moiety. 
 
For comparison, complex 87 was also evaluated as a catalyst in this application (Table 29). While 
substituents at the acetophenone-derived aryl ring as 322, 529 and 531 (Entries 2, 3 and 4) gave similar 
reactivities and slightly increased enantioselectivities compared to complex 86, the sterically more 
demanding imines 512, 536, 537 and 340 (Entries 5 to 8) gave lower to no turnovers. This is possibly due to 
steric repulsion and thus prevented iridacycle formation with complex 87. While complex 87 and imine 536 
provide amine 97 in the same enantioselectivity as complex 86 and imine 340, several aspects disfavour this 
combination. Preparation of the SimplePHOX complex 87 requires more synthetic steps than the PHOX 
complex 86. Additionally, imine 536 is isolated as an oil and prone to hydrolysis when handled in air. On the 
contrary, imine 340 is isolated as a solid relatively stable and inert to decomposition processes when handled 
in air. 
 
Table 29: Asymmetric Hydrogenation of 329 using 87 and different imine additives. 
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Entry Imine Additive Conv. [%]a) ee [%]b) 
1 59 (R = H; Rˈ = H) >99 74 (R) 
2 322 (R = 4-OMe; Rˈ = H) >99 73 (R) 
3 529 (R = 4-NO2; Rˈ = H) >99 58 (R) 
4 531 (R = 3-NO2; Rˈ = H) >99 55 (R) 
5 512 (R = 3,5-di-Me; Rˈ = H) 3 - 
6 536 (R = H; Rˈ = 2-Me) 60 85 (R) 
7 537 (R = H; Rˈ = 2-iPr) 40 70 (R) 
8 340 (R = H; Rˈ = 2,6-di-Me) 0 - 
a) Determined by GC analysis; b) determined by HPLC analysis on a chiral stationary phase. 
 
The next goal was to optimize reaction conditions with regard to reaction temperature. To better compare the 
results obtained, imine 59 and 340 were used as additives. Both complexes 86 and 87 were tested as catalysts 
systematically (Table 30). Optimal conditions were found when the reaction was carried out at -5 °C. Full 
conversion to amine 97 with high enantioselectivity of 92% was achieved with catalyst 86 and imine 340 
(Entry 4). The same enantioselectivity could also be reached with the combination of catalyst 87 and imine 
536 albeit with incomplete conversion (Entry 6). Complex 87 and imine 59 provide amine 97 at temperatures 
as low as -20 °C, but enantioselectivities no higher than 87% were obtained (Entry 10). On the other hand, 
the iridacycle generated from PHOX catalyst 86 show low (with 340, Entry 9) to no (with 59, Entry 8) 
catalytic activity at -20 °C. 
 
Table 30: Optimization of reaction parameters for asymmetric hydrogenation of imine 329 
 
Entry Catalyst Imine Additive T [°C] t [h] Conv. [%]a) ee [%]b) 
1 86 - 23 4 27 36 (R) 
2 87 - 23 4 3 - 
3 86 59 -5 12 >99 73 (R) 
4 86 340 -5 12 >99 92 (R) 
5 87 59 -5 12 >99 85 (R) 
6 87 536 -5 12 77 92 (R) 
7 87 340 -5 12 0 - 
8 86 59 -20 4 2 - 
9 86 340 -20 4 35 90 (R) 
10 87 59 -20 4 >99 87 (R) 
11 87 340 -20 4 0 - 
a) Determined by GC analysis; b) determined by HPLC analysis on a chiral stationary phase. 
 
Table 31 summarizes all the optimisation experiments. While initially no conversion was observed in the 
absence of imine 59 even at elevated pressure (Entry 2), the conversion was drastically improved upon the 
addition of imine 59 (Entry 3) and full conversion was observed when conducting the reaction at higher 
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pressure (Entry 4). Furthermore, optimisation of the imine additive structure leading to sterically demanding 
N-aryl imine additive 340 improved the enantioselectivity of the reaction (Entry 5). Ultimately, conducting 
the reaction at low temperature further improved the enantioselectivity while maintaining the reactivity 
(Entry 6). The reaction conditions are exceptionally mild.  
 
Table 31: Summary of optimization efforts towards the asymmetric hydrogenation of imine 329 
 
Entry Imine Additive p [bar] T [°C] t [h] Conv. [%]a) ee [%]b) 
1 - 1 23 4 5 69 (R) 
2 - 50 23 4 27 35 (R) 
3 59 1 23 4 50 69 (R) 
4 59 50 23 4 >99 73 (R) 
5 340 50 23 4 >99 85 (R) 
6 340 50 -5 18 >99 92 (R) 
a) Determined by GC analysis; b) determined by HPLC analysis on a chiral stationary phase. 
 
While PHOX complex 86 and SimplePHOX complex 87 have been demonstrated to be the most selective 
catalysts for acetophenone-derived N-aryl imine[31] no such evaluation has been conducted for aliphatic 
imines. Therefore many complexes available within the Pfaltz group were tested on a substrate with two 
alkyl chains, n-hexyl methyl N-phenyl imine 334 (Table 32). Such a substrate has a different scaffold 
compared to acetophenone-derived N-aryl imines or imine 59. It was intended to obtain a better picture of 
the general ability of the ligands to differentiate between to alkyl groups which exert akin steric bulk. 25 
 
As can be seen from Table 32, the initially used PHOX and SimplePHOX catalysts displayed the highest 
enantioselectivites (Entries 1 to 5). In many cases the combination of the iridium catalyst and imine 340 
resulted in poor yields and enantioselectivities, especially when the hydrogenation was conducted at lower 
reaction temperatures. An explanation might be the inability of the correspong iridacycle formation or the 
fact that the resultant iridacycle is not reactive. The preparative cyclometalation of all possible combinations 
has not been studied. Some ligands (e.g. L5 and L6) did already show low conversion and selectivity with 
acetophenone-derived N-aryl imines[31] and thus some ligands might inherently be less active towards imine 
hydrogenation. 
 
The best ligand found for imine 334 turned out to be the tBu-PHOX ligand L1 (Entries 1 to 3). Only ligand 
L18 also provided an enantioselectivity above 20% (Entry 30). Since the synthesis of such a ligand is more 
elaborate than L1, complex [Ir(L1)(COD)]BArF 388 in combination with imine 340 was selected as the most 
potent combination forming the active iridacycle catalyst in situ for imine hydrogenation of acyclic 
substrates. 
 
                                                          
25 Imine 334 was freshly prepared and stored as a stock solution. All screening reactions were conducted with the same stock 
solution. Reactions were setup while being purged with argon. Over the course of a few days, the stock solution of imine 334 did 
turn yellow while being stored under argon atmosphere in the freezer. The poor yields are due to competitive hydrolysis which 
occurred to a large extent at lower reaction temperatures. On re-examination by freshly preparing imine 334 via distillation under 
inert atmosphere and setting up all hydrogenation in the glove box, no competitive hydrolysis was observed. 
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Table 32: Screening of iridium catalysts for asymmetric hydrogenation of imine 334 
 
Entry L (Ligand) 
Imine 
Additive 
T [°C] t [h] Conv. [%]a) ee [%]b) 
1 
L1 
R2 = 
tBu 
R1 = Ph 
 
59 23 4 >99 24 (R) 
2 340 23 4 84 47 (R) 
3 340 -5 18 21 53 (R) 
4 
L2 
R2 = 
iPr 
R1 = Ph 
59 23 4 >99 18 (R) 
5 340 23 4 >99 36 (R) 
6 340 -5 18 60 44 (R) 
7 
L3 
R2 = 
tBu 
R1 = Cy 
59 23 4 >99 18 (R) 
8 340 23 4 79 7 (R) 
9 
L4 
R2 = 
iPr 
R1 = Cy 
59 23 4 >99 14 (R) 
10 340 23 4 84 4 (R) 
11 L5 R = o-Tol 
 
59 23 4 97 7 (R) 
12 L6 R = Cy 59 23 4 >99 8 (R) 
13 L7 R2 = 
tBu, R1 = o-Tol 
 
59 23 4 39 - 
14 
L8 R2 = 
tBu, R1 = Ph 
59 23 4 51 - 
15 59 23 4 >99 14 (R) 
16 
L9 R2 = 
iPr, R1 = Ph 
340 23 4 80 8 (S) 
17 340 -5 18 3 5 (S) 
18 L10 R2 = 
tBu, R1 = Cy 59 23 4 13 - 
19 
L11 R2 = 
iPr, R1 = Cy 
59 23 4 95 10 (R) 
20 340 23 4 28 - 
21 L12 R2 = 
tBu, R1 = 
tBu 59 23 4 33 - 
22 L13 R2 = 
iPr, R1 = 
tBu 59 23 4 43 - 
23 L14 R2 = 
tBu, R1 = o-Tol 
 
59 23 4 >99 3 (R) 
24 
L15 R2 = 
iPr, R1 = Ph 
59 23 4 >99 13 (R) 
25 340 23 4 51 - 
26 340 -5 18 12 16 (R) 
27 L16 R2 = 
tBu, R1 = 
tBu 59 23 4 31 rac. 
28 L17 R2 = 
tBu, R1 = Cy 59 23 4 97 11 (R) 
29 
L18 R2 = 
iPr, R1 = Cy 
59 23 4 >99 21 (R) 
30 340 -5 18 1 33 (R) 
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31 
L19 
 
59 23 4 >99 18 (R) 
32 340 23 4 27 - 
33 340 -5 18 3 8 (R) 
34 
L20 R2 = 
tBu, R1 = o-Tol 
 
59 23 4 >99 17 (R) 
35 340 -5 18 4 8 (R) 
36 
L21 R2 = 
tBu, R1 = Ph 
59 23 4 >99 11 (R) 
37 340 23 4 14 4 (R) 
38 
L22 R2 = 
iPr, R1 = Ph 
59 23 4 >99 10 (R) 
39 340 23 4 80 12 (R) 
40 340 -5 18 9 7 (R) 
41 L23 n = 1, R = tBu 
 
59 23 4 >99 2 (R) 
42 L24 n = 1, R = Ph 59 23 4 >99 5 (R) 
43 L26 n = 2, R = o-Tol 59 23 4 >99 3 (R) 
44 L27 n = 2, R =  tBu 59 23 4 >99 2 (R) 
45 L25 n = 1 
 
59 23 4 30 - 
46 L28 n = 2 59 23 4 >99 12 (R) 
47 L29 R = Cy 
 
59 23 4 >99 3 (R) 
48 L30 R = Ph 59 23 4 >99 15 (R) 
a) Determined by GC analysis; b) determined by HPLC on a chiral stationary phase. 
 
Subsequently this combination of complex 388 and imine 340 was tested under optimised reaction 
conditions on imine 329 (Scheme 215). Surprisingly, significantly lower yield and different 
enantioselectivity were obtained. The enantioselectivity was in the same range as when the reaction was 
carried out in the absence of an additive imine. Without the additive, higher conversion was observed. 
Therefore, formation of the iridacycle might have occurred but imine 329 exhibits too much steric bulk to 
undergo hydrogenation by the in situ formed iridacycle catalyst. This would also explain the poor yield. 
 
 
Scheme 215: Asymmetric hydrogenation of imine 329 employing combination of complex 388 and additive 340 
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The next substrate evaluated was cyclopentyl methyl N-phenyl imine 538 (Table 33). At room temperature, 
full conversion with moderate enantioselectivities between 42% and 52% were obtained. Importantly, the 
substrate itself proved to be particularly air- and moisture-sensitive and thus could only be handled in the 
glove box. When hydrogenations were conducted at lower temperature, poor conversion along with 
hydrolysis of imine 538 to a large extent was observed. Residual water from the imine additive, the catalyst 
or even the hydrogen gas applied represent possible origins. Nevertheless, the substrate is less robust than 
other di-alkyl acyclic imines. This can be observed when storing imine 538 under an argon atmosphere in the 
fridge. Decomposition to a brown material is observed within 12 hours.  
The best results were obtained using the combination of either complex 86 and imine 340 or complex 87 and 
imine 59. With catalyst 388 and imine 59, no conversion was observed at all. Similar to imine 329 the 
cyclopentyl ring might result in too much steric repulsion between the formed iridacycle catalyst and the 
imine substrate 538. 
 
Table 33: Asymmetric Hydrogenation of imine 538 
 
Entry Catalyst Imine Additive T [°C] t [h] Conv. [%]a) ee [%]b) 
1 86 - 23 4 2 - 
2 87 - 23 4 0 - 
3 86 59 23 12 >99 50 (-) 
4 86 340 23 12 >99 52 (-) 
5 87 59 23 12 >99 42 (-) 
6 87 340 23 12 0 - 
7 86 59 -5 12 6 56 (-) 
8 87 59 -5 12 28 63 (-) 
9 86 340 -5 18 8 63 (-) 
10 388 340 -5 18 0 - 
a) Determined by GC analysis; b) determined by HPLC analysis on a chiral stationary phase. 
 
Imine 331 represents a challenging substrate as it contains two short alkyl chains (Table 34). Surprisingly, 
full conversion to amine 67 was observed in the absence of an imine additive such as 59. A possible 
explanation might be formation of a different catalyst with this particular substrate or a different mechanism 
operating. The different enantioselectivity observed (Entry 1) in the absence of imine 59 depicts the 
discrepancy. The best results were obtained with identical reaction conditions used for imine 334 giving 
similar enantioselectivity (Entry 9). 
 
Table 34: Asymmetric Hydrogenation of imine 331 
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Entry Catalyst Imine Additive T [°C] p [bar] t [h] Conv. [%]a) ee [%]b) 
1 86 - 23 50 4 >99 30 (-) 
2 86 59 23 1 4 16 21 (-) 
3 86 59 23 50 4 >99 23 (-) 
4 87 59 23 50 12 >99 19 (-) 
5 86 340 23 50 4 >99 35 (-) 
6 86 59 -5 50 12 >99 31 (-) 
7 388 59 -5 50 12 >99 20 (-) 
8 86 340 -5 50 12 >99 40 (-) 
9 388 340 -5 50 12 >99 52 (-) 
10 87 59 -5 50 12 >99 25 (-) 
11 87 340 -5 50 12 5 - 
a) Determined by GC analysis; b) determined by HPLC analysis on a chiral stationary phase. 
 
 
Table 35 depicts the results of sec-butyl methyl N-phenyl imine 540 with an additional methyl group in the 
alkyl side chain. The best enantioselectivity of 80% was obtained using 388 with imine 340 (Entry 11).  
 
Table 35: Asymmetric Hydrogenation of imine 540 
 
Entry Catalyst Imine Additive T [°C] p [bar] t [h] Conv. [%]a) ee [%]b) 
1 86 - 23 1 4 1 - 
2 86 59 23 1 4 13 42 (-) 
3 86 - 23 50 4 30 41 (-) 
4 86 59 23 50 12 >99 41 (-) 
5 86 340 23 50 12 >99 62 (-) 
6 87 59 23 50 12 >99 43 (-) 
7 87 340 23 50 12 22 37 (-) 
8 86 59 -5 50 12 >99 50 (-) 
10 86 340 -5 50 12 >99 70 (-) 
11 388 340 -5 50 12 >99 80 (-) 
12 87 59 -5 50 12 >99 51 (-) 
13 87 340 -5 50 12 0 - 
a) Determined by GC analysis; b) determined by HPLC analysis on a chiral stationary phase. 
 
Yet another substrate tested was isopropyl methyl N-phenyl imine 330 shown in Table 36 
 
Table 36. Whereas full conversion could be observed when the reaction was conducted at room temperature, 
lowering the reaction temperature to -5° already resulted in decreased conversion. Imine 330 is not 
particularly sensitive to hydrolysis. Longer reaction times than 12 hours have not been studied. Best results 
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were obtained using the combination of PHOX complex 86 and imine 340. Yields varied over the range of 
33-43% in the reaction conducted within the time-frame of 12 hours on an average of four runs. 
 
Table 36: Asymmetric Hydrogenation of imine 330 
 
Entry Catalyst Imine Additive T [°C] t [h] Conv. [%]a) ee [%]b) 
1 86 - 23 4 8 19 (R) 
2 86 59 23 4 >99 59 (R) 
3 87 59 23 4 52 57 (R) 
4 86 59 -5 12 30 66 (R) 
5 87 59 -5 12 96 75 (R) 
6 86 340 -5 12 33-43c) 84 (R) 
7 388 340 -5 12 3 - 
a) Determined by GC analysis; b) determined by HPLC analysis on a chiral stationary phase; c) 4 runs were performed. 
 
A particularly challenging substrate is the tert-butyl methyl N-phenyl imine 541 (Table 37). Indeed the large 
steric bulk exerted by the substrate is displayed in the poor conversions over all hydrogenations conducted. 
Whereas moderate yields of 30% with 38% ee are obtained at room temperature (Entry 3) , the energy barrier 
seems to be too high to afford any reaction at -5 °C (Entries 5 to 7). Furthermore, similar to imines 329 and 
538, no conversion is observed using complex 388 in combination with imine 340. 
 
Table 37: Asymmetric Hydrogenation of imine 541 
 
Entry Catalyst Imine Additive T [°C] p [bar] t [h] Conv. [%]a) ee [%]b) 
1 86 59 23 1 4 3 - 
2 86 - 23 50 4 6 4 (R) 
3 86 59 23 50 4 30 38 (R) 
4 87 59 23 50 12 20 8 (R) 
5 86 59 -5 50 18 8 46 (R) 
6 86 340 -5 50 18 4 35 (R) 
7 388 340 -5 50 18 0 - 
a) Determined by GC analysis; b) determined by HPLC analysis on a chiral stationary phase. 
 
As reported in chapter 2, the iridacycle catalyst formed under hydrogenation conditions was demonstrated to 
be a selective reduction catalyst for C=N imine double bonds leaving olefins untouched. To apply this 
hypothesis to a more challenging substrate, 6-Methyl-5-hepten-2-one N-phenyl imine 542 was tested in 
hydrogenation (Table 38). 
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Table 38: Asymmetric Hydrogenation of imine 542 
 
Entry Catalyst Imine Additive T [°C] t [h] Conv. [%]a 59 vs. 60 a) ee [%]b) 
1 86 340 23 4 >99 74.4 : 17.3 ~20-40 
2 388 340 23 4 >99 58.1 : 33.8 ~20-40 
3 388 340 -5 18 >99 90.4 : 2.8 56 (-) 
a) Determined by GC analysis; b) determined by HPLC analysis on a chiral stationary phase. 
 
The mono-hydrogenated 543 and the di-hydrogenated product 544 could not be separated by flash 
chromatography. The product mixtures were directly subjected to HPLC analysis. Enantiomers of 543 and 
544 overlayed in the HPLC chromatogram. Ee‘s between 20 to 40% (estimated) were observed. Therefore, 
reaction conditions optimisation was conducted by lowering the reaction temperature to -5 °C. Satisfyingly, 
virtually selective imine hydrogenation was observed with an enatioselectivity of 56%. This is in the range of 
substrates tested with two alkyl chains such as imines 334 and 331.  
Another example for competitive olefin and imine reduction is the reaction of (2E,3E)-N,4-diphenylbut-3-en-
2-imine 545 (Scheme 216). While cyclometalation was expected to occur prior to olefin hydrogenation based 
on the results of F. Barrios, a mixture of products was obtained in the hydrogenation at atmospheric 
hydrogen pressure. The findings of F. Barrios cannot be applied with this particular substrate due to 
conjugation of the C=N double bond, the olefin and the aromatic ring. 
 
 
Scheme 216: Hydrogenation of α,β-unsaturated imine 545 
 
A clear preference for olefin reduction towards 548 can be observed. Whether this originates from steric or 
electronic reasons cannot be explained. The hydrogenation itself appears to be disfavoured since about 26% 
of hydrolysed imine are detected in the form of the α,β-unsaturated ketone 546. In contrast, if the reaction is 
carried out at elevated hydrogen pressure (50 bar), complete conversion to the saturated amine 549 without 
hydrolysis is observed (Scheme 217). For this particular imine 545, olefin hydrogenation occurs prior to 
imine hydrogenation. Nevertheless, cyclometalation of the imine substrate is possible. However, the exact 
nature of the iridacycle could not be determined by NMR spectroscopy (see iridacycle chapter). 
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Scheme 217: Hydrogenation of α,β-unsaturated imine 545 at elevated hydrogen pressure 
 
Amine 82 belongs to the structure family of methamphetamines. Such substances are of particular interest in 
psychopharmacological applications. No enantioselective hydrogenation of this structure class has been 
reported yet (Jan 2013). Imine 550 is particularly sensitive to moisture and requires strict handling under 
inert atmosphere. Table 39 summarizes the results. The highest enantioselectivity was observed when the 
reaction was carried out at -5 °C with complex 388 and imine 340. If the hydrogenation was carried out at 
room temperature using 388, a plethora of side products was obtained. Only at lower temperature selective 
hydrogenation could be achieved. 
 
Table 39: Asymmetric Hydrogenation of imine 550 
 
Entry Catalyst Imine Additive T [°C] t [h] Conv. [%]a) ee [%]b) 
1 86 59 23 4 >99 22 (+) 
2 86 59 -5 12 97 26 (+) 
3 86 340 23 4 >99 34 (+) 
4 86 340 -5 12 >99 62 (+) 
5 388 59 23 4 >99 18 (+) 
6 388 59 -5 12 >99 29 (+) 
7 388 340 23 4 <5c) - 
8 388 340 -5 18 94 72 (+) 
a) Determined by GC analysis;  
b) determined by HPLC analysis on a chiral stationary phase;  
c) large amount of side products observed 
 
Scheme 218 summarizes the best results for all acyclic aliphatic N-phenyl imines. Imine substrates with two 
alkyl chains such as 334, 331, 540, 542 and 550 are fully converted to the corresponding amines under 
optimised reaction conditions. An improvement in reactivity and enantioselectivity was obtained in all cases 
when comparing to the reaction of the iridium catalyst without additive. When attempting to hydrogenate 
substrates with sterically more demanding substituents, only imine 329 is fully reduced while other imines 
such as 538, 330 and 541 experience only partial conversion. This can be explained by the steric repulsion of 
the imine substituent and the catalyst. In such a case, hydrolysis becomes favoured and substrates 
particularly prone to side reactions decompose under hydrogenation reaction conditions. 
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Scheme 218: Summary of asymmetric hydrogenation of aliphatic N-phenyl imines 
 
To investigate whether the N-phenyl substituent was essential, acyclic all-aliphatic imines were prepared. 
The corresponding N-methyl and N-adamantyl substrates could not be prepared. In contrary to the N-phenyl 
derivatives, all-aliphatic imines are particularly air- and moisture-sensitive. Strict exclusion – except for the 
N-benzyl derivative – of water and air was necessary. Therefore, hydrogenations had to be set up in a glove 
box. Otherwise complete hydrolysis of the substrate was observed under hydrogenation reaction conditions.  
The first example is cyclohexyl methyl N-benzyl imine 551. N-benzyl imines have been intensively 
investigated by many research groups. High enantioselectivities with full conversion are generally 
obtained.[136]  In the same tenor, full conversion was observed using catalyst 86 and imine 59 as shown in 
Table 40. However, reducing the reaction temperature or modifying the imine to a more bulky structure did 
result in reduced reactivity of the catalyst. Furthermore, hydrolysis of the imine is observed to a large extent. 
While slightly higher enantioselectivity of 48% was obtained using imine 340, the reduced reactivity and 
thus resulting hydrolysis limit the choice of catalyst and imine for this specific substrate. 
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Table 40: Asymmetric Hydrogenation of imine 551 
 
Entry Catalyst Imine Additive T [°C] t [h] Conv. [%]a) Hydrolysis [%] ee [%]b) 
1 86 59 23 4 >99 - 44 (R) 
2 86 59 -5 18 98 58 39 (R) 
3 86 340 23 4 >99 48 36 (R) 
4 86 340 -5 18 >99 83 48 (R) 
5 388 59 23 4 >99 - 18 (R) 
6 388 59 -5 18 >99 - 31 (R) 
7 388 340 23 4 >99 56 16 (R) 
8 388 340 -5 18 96 64 39 (R) 
a) Determined by GC analysis;  
b) determined after derivatisation to the 1-naphtoylamide by HPLC analysis on a chiral stationary phase. 
 
The next example is cyclohexyl methyl N-n-butyl imine 552. This substrate prooved to be particularly 
sensitive to moisture. Similar to the results obtained with imine 551, only the combination of catalyst 86 and 
imine 59 gave the corresponding amine 553 in full conversion (Table 41). A low enantioselectivty of 33% 
was observed. This is significantly lower than the corresponding N-phenyl substrate. Nevertheless, the low 
steric bulk and flexibility of the N-alkyl chain can explain the low enantioselectivity observed. 
 
Table 41: Asymmetric Hydrogenation of imine 552 
 
Entry Catalyst Imine Additive Conv. [%]a) ee [%]b) 
1 86 59 >99 33 (R) 
2 86 340 38 23 (R) 
3 388 59 63 rac. 
4 388 340 43 26 (R) 
a) Determined by GC analysis; b) determined by GC analysis on a chiral stationary phase. 
 
The steric bulk of the N-substituent was then increased by investigating cyclohexyl methyl N-isopropyl 
imine 554 (Table 42). Indeed, the first catalytic hydrogenation furnished the corresponding amine 55 in full 
conversion and good enantioselectivity of 72% (Entry 1). Unfortunately, all attempts to improve the 
enantioselectivity were unsucessful. Similar trends as with imines 551 and 552 were observed. 
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Table 42: Asymmetric Hydrogenation of imine 554 
 
Entry Catalyst Imine Additive Conv. [%]a) ee [%]b) 
1 86 59 >99 72 (R) 
2 86 340 39 68 (R) 
3 388 59 96 44 (R) 
4 388 340 32 34 (R) 
a) Determined by GC analysis;  
b) determined after derivatisation to the acetamide by GC analysis on a chiral stationary phase; 
 
Ultimately, to further investigate effect of the steric bulk exhibited by the nitrogen substituent, cyclohexyl 
methyl N-cyclohexyl imine 556 was subjected to hydrogenation. Full conversion to amine 557 in good 
enantioselectivity of 77% was observed (Entry 1, Table 43). This is in a similar range to the comparable N-
phenyl analogue imine 329 which is reduced with 73% enantiomeric excess (Scheme 210). 
 
Table 43: Asymmetric Hydrogenation of imine 556 
 
Entry Catalyst Imine Additive Conv. [%]a ee [%]b 
1 86 59 >99 77 (R) 
2 86 340 0 - 
3 388 59 96 51 (R) 
4 388 340 13 - 
a) Determined by GC analysis;  
b) determined after derivatisation to the 1-naphtamide by HPLC analysis on a chiral stationary phase. 
 
Scheme 219 summarizes results for acyclic aliphatic N-alkyl imines. In all reactions, the (R)-enantiomer was 
observed as the major product. In case of the N-isopropyl amine 555 or N-cyclohexyl amines 557 similar 
enantioselectivities to N-phenyl amine 97 were obtained. This suggests, that the nitrogen substituent plays a 
crucial role for the selectivity of the hydrogenation reaction. In this context, the lower enantioselectivities of 
amine 84 and 553 can be explained by the flexibility of the nitrogen substituent.  
N-alkyl substituents lower the reactivity of the C=N imine double bond towards hydrogenation so that side 
reactions such as hydrolysis are observed. Nevertheless, the reactivity can be fine-tuned by the appropiate 
choice of the catalyst and the imine additive. 
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Scheme 219: Summary of asymmetric hydrogenation of aliphatic N-alkyl imines 
 
 
Asymmetric Hydrogenation of cyclic aliphatic imines 
 
Cyclic amines frequently appear in natural products and biologically important molecules, e.g. 
tetrahydroquinolines or more complex alkaloids such as nicotine, levofloxacine or morphine. To extend the 
application of the methodology developed, cyclic imines with aliphatic and aromatic substituents were 
evaluated. Preparation of cyclic aliphatic imines such as 560 was prepared from piperidin-2-one 558 and is 
shown in Scheme 220. After N-silylation with trimethylchlorosilane to afford 559 in 95% yield, subsequent 
treatment with methyl lithium afforded the desired cyclic imine 560 in low yield (20%). Attempts to 
introduce other substituents with the corresponding alkyl lithium reagent failed.  
 
 
Scheme 220: Preparation of cyclic imine 560 
 
Therefore 558 was N-Boc protected to afford 561 in 71% yield. Nucleophilic attack of phenyl magnesium 
bromide furnished the desired acyclic NH-Boc precursor 562 in 45% yield. Deprotection and intramolecular 
imine condensation gave 563 in quantitative yield (Scheme 221). 
 
Chapter 5 – Synthetic Investigations 
179 
 
Scheme 221: Preparation of cyclic imine 563 
 
In an analogous fashion as shown in Scheme 222, 561 was treated with n-butyl magnesium chloride to afford 
564 in 33% yield. Deprotection and imine condensation afforded 565 in quantitative yield.  
 
 
Scheme 222: Preparation of cyclic imine 565 
 
Purification of 6-membered cyclic imines 560, 563 and 565 was performed via Kugelrohr distillation. Imines 
560 and 565 proved to be particularly sensitive to air and moisture. Literature study revealed that such 
aliphatic cyclic substrates have been studied in transition-metal catalysed imine hydrogenation only by 
Buchwald.[136] On the other hand, quinolines as well as 2-aryl cyclic imines were frequently studied.[136] 
When imines 560 and 565 were stored under argon in the freezer, slow brownish colorisation was observed 
over the course of a few days. The corresponding NMR spectra indicated small amounts of unidentified side 
products. Therefore, cyclic imines were subjected to hydrogenation experiments in 90-95% purity.  
In addition to the 6-membered cyclic imines 560, 563 and 565 the four 5-membered cyclic imines 566, 567, 
568 and 56926 were also tested in hydrogenation reactions (Scheme 223). Similar to the 5-membered cyclic 
imines, substrates 567, 568 and 569 proved to be highly senstitve to moisture and air. Imine 566 was freshly 
distilled prior to hydrogenation experiments. Neither the imine nor the corresponding amine eluted on a short 
silica plug during work-up. Therefore derivatisation to the N-acetamide or N-trifluoroacetamide was 
required. Reaction mixture analysis was performed with the corresponding amide and enamide.   
 
                                                          
26 kindly provided by V. Köhler, Research group of Prof. T. Ward 
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Scheme 223: Cyclic imines evaluated with in situ formed iridacycles as catalysts. 
 
Initial hydrogenation experiments were conducted on imine 567 given in Table 44. At room temperature, 
employing similar reaction conditions as with acyclic aliphatic imines, no conversion was observed. In a 
related iridium-(f)-binaphane catalysed hydrogenation of cyclic imines, only a solvent mixture of 
dichloromethane and ethyl acetate at 50 °C displayed sufficient reactivity.[137] Conducting hydrogenations 
under these conditions afforded the corresponding amine 570 in somewhat higher but still low conversions 
(Entries 8-11). Conversions were calculated from observed enamide and amide peaks of GC analysis. No 
isolation by flash chromatography was performed. When attempting to reproduce these results, no 
conversion of imine 567 was observed. The reason thereof could not be determined. Due to varying 
conversions and low enantiomeric excesses, no further optimisation studies were conducted. 
 
Table 44: Asymmetric hydrogenation of cyclic imine 567 
 
Entry Catalyst Additive Solvent p [bar] T [°C] t [h] Conv. [%]a) ee [%]b) 
1 86 59 CH2Cl2 50 23 24 0 - 
2 86 59 CH2Cl2 50 50 24 1 - 
3 86 340 CH2Cl2 100 23 24 0 - 
4 388 59 CH2Cl2 100 23 24 0 - 
5 388 340 CH2Cl2 100 23 24 0 - 
6 86 59 Cl2HCCHCl2 50 50 24 2 - 
7 86 59 EtOAc 50 50 24 2 - 
8 86 59 EtOAc/CH2Cl2 (2:1) 100 50 24 0-11 12 
9 86 340 EtOAc/CH2Cl2 (2:1) 100 50 24 0-20 12 
10 388 59 EtOAc/CH2Cl2 (2:1) 100 50 24 0-12 18 
11 388 340 EtOAc/CH2Cl2 (2:1) 100 50 24 0-3 5 
a) Determined after derivatisation to the N-trifluoroacetamide by GC analysis;  
b) determined after derivatisation to the N-trifluoroacetamide by GC analysis on a chiral stationary phase. 
 
Next, imine 560 was evaluated. No conversion was observed when conducting the reaction in 
dichloromethane in the presence or absence of imine 59 (Table 45, Entries 1 and 2). The reactivity drastically 
changed upon employing the solvent mixture of CH2Cl2/EtOAc in the presence or absence of imine 59 
(Entries 3 and 4).  
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Table 45: Asymmetric hydrogenation of cyclic imine 560 
 
Entry Catalyst Additive Solvent p [bar] T [°C] t [h] Conv. [%]a) ee [%]b) 
1 86 - CH2Cl2 50 50 24 0 - 
2 86 59 CH2Cl2 50 50 24 0 - 
3 86 - EtOAc/CH2Cl2 (2:1) 100 50 24 0 - 
4 86 59 EtOAc/CH2Cl2 (2:1) 100 50 24 >99 0-3 (R) 
5 86 340 EtOAc/CH2Cl2 (2:1) 100 50 24 >99 rac. 
6 388 59 EtOAc/CH2Cl2 (2:1) 100 50 24 >99 rac. 
7 388 340 EtOAc/CH2Cl2 (2:1) 100 50 24 >99 rac. 
8 86 I2 EtOAc/CH2Cl2 (2:1) 100 50 24 13 24 (R) 
9 86 59 + I2 EtOAc/CH2Cl2 (2:1) 100 50 24 5 26 (R) 
a) Determined after derivatisation to the N-acetamide by GC analysis;  
b) determined after derivatisation to the N-acetamide by GC analysis on a chiral stationary phase. 
 
While virtually racemic amine was observed, the desired reactivity could be observed employing the 
combination complex 86 and imine 59. Optimisation attempts with complex 388 or imine 340 still furnished 
racemic amine (Entry 5 to 7). Surprisingly, iodine addition resulted in formation of a less reactive but more 
selective catalyst compared to the combination 86 and 59 (Entries 8 and 9). Reduced reactivity upon iodine 
addition has been observed on iridium-PHOX catalysed hydrogenation of imines.[30] 
 
Imine 560 demonstrated the desired reactivity upon addition of 2 mol% imine 59 as an additive. However, 
with other substrates, quite different reactivties were observed as can be seen in Table 46. While imines 565, 
566 and 568, even under forcing conditions of 100 bar hydrogen pressure, showed no conversion, phenyl-
substituted imines 563 and 569 gave very surprising results.  
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Table 46: Asymmetric hydrogenation of cyclic imine 563, 565, 566, 568 and 569 
 
Entry Imine Catalyst Additive Solvent p [bar] Conv. [%]a) ee [%]b) 
1 
565 
n = 2 
R = n-Bu 
86 - CH2Cl2 50 0 - 
2 86 59 CH2Cl2 50 0 - 
3 86 - EtOAc/CH2Cl2 (2:1) 50 0 - 
4 86 59 EtOAc/CH2Cl2 (2:1) 50 0 - 
5 
566 
 
n = 1 
R = Me 
86 - CH2Cl2 50 0 - 
6 86 59 CH2Cl2 50 0 - 
7 86 - EtOAc/CH2Cl2 (2:1) 50 0 - 
8 86 59 EtOAc/CH2Cl2 (2:1) 100 2 - 
9 86 340 EtOAc/CH2Cl2 (2:1) 100 0 - 
10 388 59 EtOAc/CH2Cl2 (2:1) 100 0 - 
11 388 340 EtOAc/CH2Cl2 (2:1) 100 0 - 
12 
568  
n = 1 
R = Bn 
86 - CH2Cl2 100 0 - 
13 86 59 CH2Cl2 100 0 - 
14 86 - EtOAc/CH2Cl2 (2:1) 100 0 - 
15 86 59 EtOAc/CH2Cl2 (2:1) 100 0 - 
16 
563  
n = 2 
R = Ph 
86 - CH2Cl2 50 >99 80 
17 86 59 CH2Cl2 50 >99 80 
18 86 - EtOAc/CH2Cl2 (2:1) 50 98 51 
19 86 59 EtOAc/CH2Cl2 (2:1) 50 95 48 
20 
569  
n = 1 
R = Ph 
86 - CH2Cl2 50 90 74 
21 86 59 CH2Cl2 50 85 74 
22 86 - EtOAc/CH2Cl2 (2:1) 50 81 38 
23 86 59 EtOAc/CH2Cl2 (2:1) 50 55 37 
a) Determined after derivatisation to the N-acetamide by GC analysis;  
b) determined after derivatisation to the N-acetamide by GC analysis on a chiral stationary phase; 
 
Already in dichloromethane high conversion of 90% along with reasonable enantioselectivity of 74% was 
observed for the 5-membered cyclic imine 569 (Entry 20). Moreover, no additional imine was required for 
achieving high conversions (Entries 20 vs. 21). This suggests that either imine 569 itself forms the 
corresponding iridacycle catalyst (due to less steric bulk compared to 59 or 340) or hydrogenation proceeds 
via a different mechanism. Interestingly, the solvent mixture of CH2Cl2 and EtOAc resulted in lower 
conversions than CH2Cl2 alone (entries 16-17 vs. 18-19). 
In a similar fashion to 569, the analogous 6-membered imine 563 is fully reduced in dichloromethane both in 
the absence or presence of imine 59. Again, formation of the iridacycle catalyst with imine 563 might occur 
or hydrogenation proceed via a different mechanism. A good enantioselectivity of 80% was observed. 
Furthermore, higher conversions compared to imine 569 were obtained. This can be an evidence for 
iridacycle formation with the cyclic imine 563. An iridacycle with imine 563 benefits from a favourable 
overall geometry with regards to the iridacycle angle (C-Ir-N) and the iridium-nitrogen atom distance 
compared an iridacycle formed with 569 and results in a more stable and more reactive iridacycle. 
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Scheme 224 summarizes results for cyclic aliphatic imines. In the series of N-phenyl, N-alkyl and cyclic 
aliphatic imines, these substrates exhibit the lowest reactivity. While no conversion was observed for imines 
565, 566, 567 and 568, the methodology employing an iridium(I) precatalyst and an acetophenone N-aryl 
imine was sucessfully applied on imine 560 although only racemic amine could be obtained. Furthermore, 
imines 563 and 569 were fully reduced with good enantioselectivities. With 563 and 569 no imine additive is 
required, most likely due to the ability of the substrate to form the corresponding iridacycle catalyst with the 
iridium(I) complex under reaction conditions. 
 
 
Scheme 224: Summary of asymmetric hydrogenation of cyclic aliphatic imines 
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Working Techniques, solvents and reagents 
 
The synthesis of air- and moisture sensitive compounds were carried out in oven- or flame-dried glassware 
under an athmosphere of argon employing standard Schlenk techniques or under nitrogen athmosphere in a 
glove box (MBraun Labmaster 130).  
Flash and elution chromatography was performed on Merck Silica gel 60 (particle size 40-64 µm). Solvents 
were of technical grade. 
Solvents employed in chemical transformations were obtained from a solvent purification system (PureSolv, 
Innovative Technology Inc.) or from septum sealed bottles over molecular sieves (Sigma-Aldrich, crown-
cap). THF was distilled over potassium/benzophenone prior to use and 1,4-dioxane was distilled over CaH2 
prior to application. 
Deuterated solvents were purchased from Cambridge Isotope Laboratories or Arma. CD2Cl2 was stored over 
molecular sieves under an athmosphere of argon. 
Commercially available reagents were purchased from various suppliers and used without further 
purification. 
  
Analytical Methods 
 
Thin layer chromatography (TLC): TLC plates were obtained from Machrey-Nagel (Polygram 
SIL/UV254, 0.2 mm silica with fluorescence indicator). UV light (254 nm) or stain solutions (KMnO4, 
Ce(SO4)2, Ninhydrine) were used to visualize the respective compounds. 
  
Melting point (m.p.): Melting points were determined on a Büchi 535 and Büchi 545 (Gademann group) 
apparatus. The values are not corrected. 
 
NMR spectroscopy: NMR spectea were recorded on a Bruker Avance 400 (400 MHz) and Avance 500 (500 
MHz) NMR spectrometer. The chemical shifts (δ) are indicated in parts per million (ppm). The chemical 
shift values have been corrected to internal standard signals of deuterated solvents : 7.26 (1H) and 77.16 (13C) 
for CDCl3 ; 5.32 (1H) and 53.84 (13C) for CD2Cl2 ; 3.58 (1H) and 67.21 (13C) for THF ; 2.50 (1H) and 39.52 
(13C) for DMSO. 31P-NMR spectra are corrected to 85% phopsphoric acid (δ = 0.0 ppm). 19F-NMR spectra 
are corrected to CFCl3 (δ = 0.0 ppm). Calibration has been performed with external standards. 1D-routine 
13C- and 31P-NMR spectra are recorded 1H-decoupled. 2D-routine correlation experiments (COSY, NOESY, 
HMQC, HMBC) were run without accurate pulse determination. Advanced two-dimensional correlation 
experiments (EXSY, 1H-31P HMBC) were carried out with prior 1H-90° pulse determination. Multiplets are 
assigned as s (singlet), d (doublet), t (triplet) and q (quartet). All higher coupling patterns are indicated as m 
(multiplet). Broad peaks are assigned as br (broad). 
 
Infrared spectroscopy (IR): Infrared spectra were collected on a Shimadzu FTIR-8400S spectrometer. The 
compounds were measured as pure substance via Specac ATR attachment. When, the solid samples were 
measured as potassium bromide discs, the spectra were collected on a Perkin Elmer 1600 series FTIR 
spectrometer. The absorption bands are given in wave numbers (ν [cm−1]). The peak intensity is described 
by: s (strong), m (medium), w (weak). 
 
Mass spectroscopy (MS): Mass Spectra were recorded by H. Nadig (Uni Basel) and Mass Spectrometry 
Service Facility (LOC, ETH Zurich). Electron impact ionixzation (EI) was measured on a VG70-250 
spectrometer. Fast atom bombardement (FAB) was measured on a MAR 312 spectrometer. 3-nitrobenzyl 
alcohol was used as matrix in FAB. Electron spray ionization (ESI) was measured by C. Ebner, F. Bächle 
and P. Isenegger (Uni Basel) on an open source Finnigan MAT LCQ and on a Varian 1200L triple Quad 
MS/MS. The signals are given in mass to charge ratio (m/z). The fragments and intensities are given in 
brackets. All values are rounded tot he nearest number. 
 
High Resolution Mass Spectrometry (HRMS): High resolution mass spectra were recorded by Mass 
Spectrometry Service Facility (LOC, ETH Zurich) on a Bruker Daltonics maXis (UHR-TOF) and Bruker 
solariX 94 ESI/MALDI-FT-ICR spectrometer and by H. Nadig (University of Basel) on a bruker maXis 4G 
QTOF-ESI Spectrometer. 
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Elemental analysis (EA): Elemental analyses were performed by W. Kirsch (Uni Basel), S. Mittelheisser 
(Uni Basel) and M. Schneider (ETHZ) in the microlaboratory on a Leco CHN-900 (Kirsch, Schneider) as 
well as a Vario Micro Cube by Elementar.  
 
Optical rotations: Optical Rotations were measured on a Perkin Elmer Polarimeter 341 in a cuvette ( ø = 1 
dm) at 20 °C and 589 nm (sodium lamp). The concentration c is given in g/100 mL. The values are the 
average of three consecutive measurements and uncorrected. 
 
High Performance Liquid Chromatography (HPLC): HPLC analyses were performed on Shimadzu 
systems with SLC-10A/SIL-20AHT system controller, CTO-10AC/AS column oven, LC10-AD/20-AD 
pump system, DGU-14A/20AD3 degasser and SPD-M10A/M20A diode array- or UV/VIS detector. Chiral 
columns Chiracel AD-H, AS-H, OB-H, OD-H, OJ or OJ-H (4.6 x 250 mm) from Daicel Chemical Industries 
were used. Semipreparative separations were on a Shimadzu system with SIL-10ADvp autosampler, LC-
10ATvp pump system, CTO-10ACvp column oven, SPD-10Avp diode array detector and FRC-10Avp 
fraction collector) Daicel Chiracel AD or OD (2 x 25 cm) columns were used. 
 
Gas Chromatography (GC): Gas chromatograms were recorded on Carlo Erba HRGC Mega2 Series 800 
(HRGS Mega2), on CarboErga GC8000Top and on Shimadzu GC-2010 plus instruments, Separations on 
achiral phases were performed on a Restek Rtx-1701 (30 m x 0.25 mm x 0.25 µmol) or a Macherey-Nagel 
Optima 5-Amin (0.25 mm x 0.25 µm x 30 m) column. Separations of enantiomers were achieved on a 
Chiraldex γ-cyclodextrin TFA G-TA (30 m x 0.25 mm x 0.12 µm) or a Brechbühler β-cyclodextrin 
DEtTButSil (SE54), (0.25 mm x 0.25 µm x 25 m) column. 
 
Gas Chromatography / Mass Spectroscopy (GC-MS): GC-MS analysis was performed on open-source 
5890 Series II (GC-columns : Macherey-Nagel OPTIMA1 Me2Si, 25 m x 0.2 mm, 0.35 um, 20 psi, split ca. 
20 :1, carrier gas : 1 mL/min helium, 5971 series mass selective detector (EI) ; Macherey-Nagel Optima5 5% 
PhMeSi, 25 m 0.2 mm, 0.35 um, 20 psi, split ca 20:1, carrier gas : 1 mL/min helium, 5970A series mass 
selective detector (EI)) and Shimadzu GC 2010 plus with GCMS-QP2010 SE mass detectors. The signals are 
given in mass-to-charge ratios (m/z) and often with the relative intensity in brackets. 
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Imines 
 
General Method: 
A 25mL oven-dried two-neck round-bottom flask equipped with a stirrer, reflux condenser and a stopper was 
evacuated and purged with Argon gas three times. Freshly activated 4Å mol sieves were added under an 
argon counterflow. The stopper was replaced with a septum and ketone, aniline and solvent were added. A 
spatula tip of p-toluenesulfonic acid was added. The septum was replaced by a stopper and the solution was 
heated to reflux for 24 to 48 hours. After cooling to room temperature under argon the solution was filtered 
through a paper filter and rinsed with toluene. The solvent was removed under reduced pressure and the 
product was purified by Kugelrohr distillation. 
 
Compounds 59[30], 534[138], 533[139], 99[30] had been prepared previously in our laboratories. 
 
 
N-(1-(4-methoxyphenyl)ethylidene)aniline (322)[140] 
 
By general method 4-methoxyacetophenone (2.7 g, 18 mmol, 1.0 eq.) and 
aniline (2 g, 21.9 mmol, 1.21 eq.) were dissolved in dry benzene (7.5 mL). 
Purification by Kugelrohr distillation (110-180 °C at 0.07 mbar) afforded 
3.4 g (15.1 mmol, 83%) of 322 as a yellow solid. 
 
C15H15NO (MW = 225.29 g/mol): 
m.p.: 91-92 °C (Lit. 92-94°C); 1H-NMR (500 MHz, CDCl3): 7.85 (d, J = 8.6 Hz, 2H, CHArCArC=N), 7.25 (t, 
J = 7.7 Hz, 2H, CHArCHArCAr-N), 6.98 (t, J = 7.4 Hz, 1H, CHArCHArCHArCAr-N), 6.86 (d, J = 8.6 Hz, 2H, 
CHArCArOMe), 6.70 (d, J = 7.7 Hz, 2H, CHArCAr-N), 3.77 (s, 3H, OCH3), 2.11 (s, 3H, CH3C=N); 13C{1H}-
NMR (126 MHz, CDCl3) δ 164.65 (C=N), 161.62 (CArOMe), 151.99 (CAr-N), 132.30 (CArC=N), 129.02 
(CHArCHArCAr-N), 128.94 (CHArCArC=N), 123.12 (CHArCHArCHArCAr-N), 119.71 (CHArCAr-N), 113.70 
(CHArCArOMe), 55.51 (OCH3), 17.30 (CH3C=N). 
 
 
N-(1-cyclohexylethylidene)aniline (329)[141] 
 
By general method cyclohexyl methyl ketone (1.83 g, 14.53 mmol, 1.0 eq.) and 
aniline (1.49 g, 15.98 mmol, 1.1 eq.) were dissolved in dry toluene (10 mL). 
Purification by Kugelrohr distillation (130 °C at 0.15 mbar) afforded 1.30 g (6.44 
mmol, 44%) of 329 as a colourless oil. 
 
C14H19N (MW = 201.31 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 7.32 – 7.22 (m, 2H), 7.05 – 6.98 (m, 1H), 6.71 – 6.63 (m, 2H), 2.30 (tt, J = 
11.5, 3.2 Hz, 1H), 1.93 (dd, J = 6.7, 5.5 Hz, 2H), 1.89 – 1.80 (m, 2H), 1.74 – 1.70 (m, 3H), 1.49 – 1.16 (m, 
6H); 13C{1H}-NMR (101 MHz, CDCl3) δ 175.75, 151.94, 128.96, 122.91, 119.52, 49.53, 30.39, 26.30, 
26.28, 17.81; GC (Machary-Nagel Optima-5-Amin (0.50 µm x 0.25 µm x 30 m), 60 kPa H2, 100 °C/2 min, 
10 °C/min, 250 °C/7 min): tR = 18.5 min; HRMS: calculated: 201.1512; found: 201.1512. 
 
 
N-(1-(o-tolyl)ethylidene)aniline (318)[142] 
 
By general method acetophenone (2.29 g, 17 mmol, 1.0 eq.) and aniline (2 g, 22 
mmol, 1.3 eq.) were dissolved in dry benzene (20 mL). Purification by Kugelrohr 
distillation (100-160 °C at 0.1 mbar) afforded 2.74 g (13.1 mmol, 77%) of 318 as 
a yellow oil. 
 
C15H15N (MW = 209.29 g/mol): 
Major: 1H-NMR (500 MHz, CDCl3) δ 7.419 (m, 1H, CHArCArC=N), 7.392 (m, 2H, CHArCHArCAr-N), 7.297 
(m, 1H, CHArCHArCArCH3), 7.280 (m, 1H, CHArCArCH3), 7.278 (m, 1H, CHArCHArCArC=N), 7.127 (m, 1H, 
CHArCHArCHArCAr-N), 6.876 (m, 2H, CHArCAr-N), 2.543 (s, 3H, CArCH3), 2.18 (s, 3H CH3C=N);  
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13C{1H}-NMR (126 MHz, CDCl3) δ 170.036 (C=N), 151.291 (CAr-N), 141.571 (CArC=N), 135.04 (CArCH3), 
131.111 (CHArCArCH3), 129.103 (CHArCHArCAr-N), 128.683 (CHArCHArCArCH3), 127.183 (CHArCArC=N), 
125.849 (CHArCHArCArC=N), 123.459 (CHArCHArCHArCAr-N), 119.303 (CHArCAr-N), 21.23 (CH3C=N), 
20.51 (CArCH3). 
Minor: 1H-NMR (500 MHz, CDCl3) δ 7.122 (m, 1H, CHArCHArCArCH3), 7.115 (m, 1H, CHArCHArCArC=N), 
7.107 (m, 2H, CHArCHArCAr-N), 7.052 (m, 1H, CHArCArC=N), 7.036 (m, 1H, CHArCArCH3), 6.906 (m, 1H, 
CHArCHArCHArCAr-N), 6.687 (m, 2H, CHArCAr-N), 2.493 (s, 3H CH3C=N), 2.133 (s, 3H, CArCH3); 13C{1H}-
NMR (126 MHz, CDCl3) δ 171.106 (C=N), 150.290 (CAr-N), 139.050 (CArC=N), 133.01 (CArCH3), 130.208 
(CHArCArCH3), 128.251 (CHArCHArCAr-N), 128.162 (CHArCHArCArCH3), 127.069 (CHArCArC=N), 125.379 
(CHArCHArCArC=N), 123.498 (CHArCHArCHArCAr-N), 120.841 (CHArCAr-N), 29.32 (CH3C=N), 21.33 
(CArCH3); GC-MS: (Optima-5-Amine, 100.2/10.270/10): tR = 14.6 min, m/z = 209 ([M]+), 194 ([M-CH3]+), 
118 (([M-NPh]+). 
 
 
N-(1-(2-fluorophenyl)ethylidene)aniline (319) 
 
By general method 2-fluoroacetophenone (2.5 g, 18.1 mmol, 1.0 eq.) and aniline 
(2 g, 22 mmol, 1.2 eq.) were dissolved in dry benzene (20 mL). Purification by 
Kugelrohr distillation (110-160 °C at 0.1 mbar) afforded 3.08 g (14.5 mmol, 80%) 
of 319 as a yellow oil. 
 
C14H12FN (MW = 213.25 g/mol): 
E/Z mixture 7:1, signals overlapping, only major isomer characterised: 1H-NMR (500 MHz, CDCl3) δ 7.85 
(td, J = 7.7, 1.9 Hz, 1H, CHArCArC=N), 7.41 (dddd, 1H, J = 8.2, 7.1, 5.1, 1.8 Hz, CHArCHArCArF), 7.37 (t, J 
= 7.7 Hz, 2H, CHArCHArCAr-N), 7.22 (t, J = 7.5 Hz, 1H, CHArCHArCHArCArC-N), 7.15 (m, 1H, CHArCAr-F), 
7.12 (m, 1H, CHArCHArCArC=N), 6.83 (d, J = 7.7 Hz, 2H, CHArCAr-N), 2.25 (d, J = 3.5 Hz, 3H, CH3C=N); 
13C{1H}-NMR (126 MHz, CDCl3): 165.37 (C=N), 161.22 (d, J = 250.6 Hz, CAr-F), 150.85 (CAr-N), 131.70 
(d, J = 8.6 Hz, CHArCHArCArF), 130.18 (d, J = 3.5 Hz, CHArCArC=N), 129.15 (CHArCHArCAr-N) , 124.42 
(CHArCHArCHArCArC-N), 123.69 (CHArCHArCArC=N), 119.43 (CHArCAr-N), 116.37 (d, J = 22.9 Hz, 
CHArCAr-F), 20.80 (d, J = 6.8 Hz, CH3C=N); 19F NMR (376 MHz, CDCl3) δ -113.34 (major), -113.43 
(minor); IR (neat, ATR) ν/cm-1 = 3060 (w), 3031 (w), 2997 (w), 1634 (s), 1610 (m), 1593 (s), 1576 (m), 
1485 (s), 1450 (m), 1368 (m), 1293 (m), 1211 (s), 1169 (w), 1113 (m), 1072 (m). 801 (m), 759 (s), 716 (m), 
696 (s); MS (EI, 70 eV): 213.1 (55.7%), 198.1 (100%), 118.1 (8.1%); EA: calc. C, 78.85; H, 5.67; N, 6.57, 
found C, 78.68; H, 5.86; N, 6.47 
 
 
N-(1-(3-nitrophenyl)ethylidene)aniline (531) 
 
By general method 3-nitroacetophenone (0.5 g, 3 mmol, 1.0 eq.) and 
aniline (0.33 g, 3.6 mmol, 1.2 eq.) were dissolved in dry toluene (10 mL). 
Purification by Kugelrohr distillation (170 °C at 0.1 mbar) afforded 0.357 
g (1.49 mmol, 49%) of 531 as a yellow solid. 
 
C14H12N2O2 (MW = 240.26 g/mol): 
m.p.: 96 °C; 1H-NMR (400 MHz, CDCl3) δ 8.89 – 8.70 (m, 1H, CHArCArNO2), 8.44 – 8.22 (m, 2H, 
CHArCArNO2&CHArCArC=N), 7.64 (t, J = 8.0 Hz, 1H, CHArCHArCArC=N), 7.38 (t, J = 7.8 Hz, 2H, 
CHArCHArCAr-N), 7.13 (t, J = 7.4 Hz, 1H, CHArCHArCHArCAr-N), 6.80 (d, J = 7.3 Hz, 2H, CHArCAr-N), 2.30 
(s, 3H, CH3C=N); 13C{1H}-NMR (101 MHz, CDCl3) δ 163.33 (C=N), 150.91 (CAr-N), 141.21 (CArC=N), 
133.10 (CHArCArC=N), 129.51 (CArC=NCHArCArNO2), 129.24 (CHArCHArCAr-N), 125.12 
(CHArCHArCHArCAr-N), 124.01 (CHArCArNO2), 122.38 (CHArCHArCArC=N), 119.31 (CHArCAr-N), 17.50 
(CH3C=N); IR (neat, ATR) ν/cm-1 = 3114 (w), 3099 (w), 3076 (w), 3070 (w), 3017 (w), 1623 (m), 1593 (m), 
1576 (m), 1521 (s), 1483 (s), 1473 (s), 1432 (m), 1368 (m), 1345 (s), 1317 (m), 1286 (m), 1258 (m), 1213 
(m), 1170 (w), 1111 (m), 1060 (m), 1024 (w), 900 (m), 818 (m), 744 (s), 735 (s), 693 (s); MS (EI, 70 eV): 
240.1 (84.2%), 225.1 (100%), 179.1 (42.5%); HRMS: calculated: 240.0894; found: 240.0900; EA: calc. C, 
69.99; H, 5.03; N, 11.66; found: C, 69.81; H, 5.14; N, 11.56 
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N-(1-(3,5-dinitrophenyl)ethylidene)aniline (530) 
 
By general method 3,5-dinitroacetophenone (0.5 g, 2.38 mmol, 1.0 eq.) 
and aniline (0.26 g, 2.85 mmol, 1.2 eq.) were dissolved in dry toluene (10 
mL). Purification by recrystallisation from ethanol afforded 0.291 g (1.02 
mmol, 43%) of 530 as an orange solid.  
 
C14H11N3O4 (MW = 285.25 g/mol): 
m.p.: 132-133 °C; 1H-NMR (400 MHz, CDCl3) δ 9.19 – 9.08 (m, 3H, CHArNO2), 7.48 – 7.34 (m, 2H, 
CHArCHArCAr-N), 7.22 – 7.13 (m, 1H, CHArCHArCHArCAr-N), 6.82 (dd, J = 8.3, 1.0 Hz, 2H, CHArCAr-N), 2.38 
(s, 3H, CH3C=N); 13C{1H}-NMR (101 MHz, CDCl3) δ 161.25 (C=N), 150.01 (CAr-N), 148.83 (CAr-NO2), 
143.01 (CArC=N), 129.37 (CHArCHArCAr-N), 127.24 (CHArCArC=N), 124.68 (CHArCHArCHArCAr-N), 120.02 
(CAr-NO2CHArCAr-NO2), 119.22 (CHArCAr-N), 17.48 (CH3C=N); IR (neat, ATR) ν/cm-1 = 3117 (w), 3101 (w), 
3059 (w), 3050 (w), 1646 (m), 1625 (m), 1590 (m), 1535 (s), 1481 (w) 1461 (w), 1438 (w), 1367 (m), 1345 
(s), 1334 (s), 1285 (m), 1237 (w), 1209 (m), 1169 (w), 1144 (m), 1100 (w), 1073 (m), 910 (m), 903 (m), 810 
(m), 795 (m), 753 (s), 728 (s), 654 (s); MS (EI, 70 eV): 285.1 (100%), 270.1 (82.8%), 224.1 (18.1%), 178.1 
(24.1%); HRMS: calculated: 285.0744; found: 285.0740; EA: calc. C, 58.95; H, 3.89; N, 14.73; found: C, 
58.93; H, 3.99; N, 14.64 
 
 
N-(1-(3,5-dimethylphenyl)ethylidene)aniline (512) 
 
By general method 3,5-dimethylacetophenone (0.3 g, 2 mmol, 1.0 eq.) and 
aniline (0.2 g, 2.2 mmol, 1.1 eq.) were dissolved in dry toluene (7.5 mL). 
Purification by Kugelrohr distillation (137 °C at 0.08 mbar) afforded 0.165 g 
(0.74 mmol, 37%) of 512 as an off-yellow solid. 
 
C16H17N (MW = 223.31 g/mol): 
b.p.: 137 °C at 0.08 mbar; m.p.: 44 °C; 1H-NMR (400 MHz, CDCl3) δ 7.58 (s, 2H, CHArCArC=N)), 7.40 – 
7.29 (m, 2H, CHArCHArCAr-N), 7.11 (s, 1H, CArCH3CHArCArCH3), 7.10 – 7.05 (m, 1H, CHArCHArCHArCAr-
N), 6.79 (dt, J = 8.3, 1.6 Hz, 2H, CHArCAr-N), 2.38 (s, 6H, CArCH3), 2.21 (s, 3H, CH3C=N); 13C{1H}-NMR 
(101 MHz, CDCl3) δ 166.10 (C=N), 151.95 (C-N), 139.68 (CArC=N), 138.05 (CArCH3), 132.25 
(CArCH3CHArCArCH3), 129.07 (CHArCHArCAr-N), 125.14 (CHArCArC=N), 123.27 (CHArCHArCHArCAr-N), 
119.54 (CHArCAr-N), 21.49 (CArCH3), 17.70 (CH3C=N); IR (neat, ATR) ν/cm-1 = 3027 (w), 3010 (w), 2959 
(w), 2917 (w), 1628 (s), 1600 (m), 1590 (s), 1576 (m), 1480 (m), 1447 (m), 1438 (m), 1376 (w), 1363 (m), 
1321 (m), 1272 (w), 1208 (s), 1167 (m), 1155 (m), 1071 (m), 1026 (m), 906 (m), 852 (s), 800 (s), 761 (s), 
694 (s); MS (EI, 70 eV): 223.1 (43.9%), 208.1 (100%); GC-MS: (Rtx-5MS, 100.2/10.270/10): tR = 19.1 
min, m/z = 223 ([M]+); EA: calc. C, 86.06; H, 7.67; N, 6.27, found C, 86.19; H, 7.65; N, 6.28 
 
 
N-(1-(3,5-diisopropylphenyl)ethylidene)aniline (522) 
 
By general method 521 (0.5 g, 2.45 mmol, 1.0 eq.) and aniline (0.29 g, 3.18 
mmol, 1.3 eq.) were dissolved in dry toluene (10 mL). Purification by 
Kugelrohr distillation (160 °C at 0.08 mbar) afforded 0.310 g (1.11 mmol, 
45%) of 522 as a yellow oil. 
 
C20H25N (MW = 279.42 g/mol): 
E/Z mixture 8:1, signals overlapping; Major: 1H-NMR (500 MHz, CDCl3) δ: 7.65 (d, J = 4.0 Hz, 2H, 
CHArCArC=N), 7.35 (t, J = 7.7 Hz, 2H, CHArCHArCAr-N), 7.20 (s, 1H, CArCH(CH3)2CHArCArCH(CH3)2), 7.08 
(t, J = 7.4 Hz, 1H, CHArCHArCHArCAr-N), 6.80 (d, J = 7.7 Hz, 2H, CHArCAr-N), 2.97 (hept, J = 6.9 Hz, 2H, 
CH(CH3)2), 2.23 (d, J = 7.0 Hz, 3H, CH3C=N), 1.30 (d, J = 7.1 Hz, 12H, CH(CH3)2); 13C{1H}-NMR (125 
MHz, CDCl3) δ:166.23 (C=N), 152.10 (CAr-N), 149.18 (CArCH(CH3)2), 139.68 (CArC=N), 129.07 
(CHArCHArCAr-N), 127.05 (CHArCHArCHArCAr-N), 123.19 (CArCH(CH3)2CHArCArCH(CH3)2), 123.07 
(CArCH(CH3)2CHArCArC=N), 119.54 (CHArCAr-N), 34.48 (CH(CH3)2), 24.23 (CH(CH3)2), 17.84 (CH3C=N); 
IR (neat, ATR) ν/cm-1 = 3058 (w), 2960 (s), 2927 (m), 2869 (m), 1634 (s), 1595 (s), 1485 (m), 1465 (m), 
1440 (w), 1364 (m), 1255 (w), 1209 (s), 875 (w), 802 (w), 759 (w), 699 (m); MS (EI, 70 eV): 279.2 
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(40.79%), 264.2 (100%), 248.1 (9.7%); HRMS: calculated: 279.1982; found: 279.1983; EA: calc. C, 85.97; 
H, 9.02; N, 5.01; found: C, 85.71; H, 8.91; N, 5.01. 
 
 
N-(1-(3,5-di-tert-butylphenyl)ethylidene)aniline (526) 
 
By general method 525 (0.5 g, 2.15 mmol, 1.0 eq.) and aniline (0.25 g, 2.8 
mmol, 1.3 eq.) were dissolved in dry toluene (10 mL). Purification by 
Kugelrohr distillation (170 °C at 0.1 mbar) afforded 0.368 g (1.2 mmol, 
56%) of 526 as a yellow-white solid. 
 
C22H29N (MW = 307.47 g/mol): 
m.p.: 86-90 °C; 1H-NMR (500 MHz, CDCl3) δ:7.84 (s, 2H, CHArCArC=N)), 7.58 (s, 1H, 
CArC(CH3)3CHArCArC(CH3)3), 7.36 (t, J = 7.7 Hz, 2H, CHArCHArCAr-N), 7.09 (t, J = 7.5 Hz, 1H, 
CHArCHArCHArCAr-N), 6.82 (d, J = 7.7 Hz, 2H, CHArCAr-N), 1.40 (s, 18H, C(CH3)3); 13C{1H}-NMR (125 
MHz, CDCl3) δ: 166.42 (C=N), 152.23 (CAr-N), 150.93 (CArC(CH3)3), 139.13 (CArC=N), 129.07 
(CHArCHArCAr-N), 124.88 (CArC(CH3)3CHArCArC(CH3)3), 123.12 (CHArCHArCHArCAr-N), 121.54 
(CHArCArC=N), 119.52 (CHArCAr-N), 35.14 (C(CH3)3), 31.63 (C(CH3)3), 17.92 (CH3C=N); IR (neat, ATR) 
ν/cm-1 = 3061 (w), 2961 (m), 2934 (w), 2905 (w), 2865 (w), 1685 (w), 1636 (m), 1590 (m), 1477 (m), 1447 
(m), 1393 (w), 1362 (m), 1323 (m), 1247 (m), 1212 (s), 1168 (m), 1068 (m), 1024 (m), 903 (m), 879 (m), 
798 (m), 755 (s), 701 (s); MS (EI, 70 eV): 307.2 (52.7%), 292.2 (100%), 276.2 (12.6%); HRMS: calculated: 
307.2295; found: 307.2294; EA: calc. C, 85.94; H, 9.51; N, 4.56; found: C, 85.93; H, 9.49; N, 4.44. 
 
 
N-(1-(4-(tert-butyl)phenyl)ethylidene)aniline (528) 
 
By general method 4-tert-butyl acetophenone (0.48 g, 2.72 mmol, 1.0 eq.) 
and aniline (0.35 g, 3.93 mmol, 1.44 eq.) were dissolved in dry toluene (10 
mL). Purification by Kugelrohr distillation (125 °C at 0.08 mbar) afforded 
0.28 g (1.11 mmol, 41%) of 528 as yellow-white solid. 
 
C18H21N (MW = 251.37 g/mol): 
b.p.: 125 °C at 0.08 mbar; m.p.: 63-64 °C; 1H-NMR (400 MHz, CDCl3) δ 7.93 (d, J = 8.5 Hz, 2H, 
CHArCArC=N), 7.48 (d, J = 8.5 Hz, 2H, CHArCArC(CH3)3), 7.35 (t, J = 7.8 Hz, 2H, CHArCHArCAr-N), 7.08 (t, 
J = 7.4 Hz, 1H, CHArCHArCHArCAr-N), 6.79 (t, J = 7.4 Hz, 2H, CHArCAr-N), 2.22 (s, 3H, CH3C=N), 1.36 (s, 
9H, C(CH3)3);  
13C{1H}-NMR (101 MHz, CDCl3) δ 165.31 (C=N), 154.01 (CArC(CH3)3), 152.01 (CAr-N), 136.88 (CArC=N), 
129.06 (CHArCHArCAr-N), 127.12 (CHArCArC=N), 125.44 (CHArCArC(CH3)3), 123.21 (CHArCHArCHArCAr-N), 
119.58 (CHArCAr-N), 34.97 (C(CH3)3), 31.38 (C(CH3)3), 17.40 (CH3C=N); IR (neat, ATR) ν/cm-1 = 3053 
(w), 2971 (w), 2952 (m), 2902 (w), 2864 (w), 1623 (m), 1601 (m), 1589 (m), 1560 (m), 1509 (w), 1478 (m), 
1434 (m), 1360 (m), 1312 (w), 1290 (m), 1216 (m), 1199 (m), 1126 (m), 1024 (m), 1011 (m), 852 (m), 824 
(s), 699 (s); MS (EI, 70 eV): 251.2 (46.7%), 236.1 (100%); HRMS: calculated: 251.1669; found: 251.1670; 
EA: calc. C, 86.01; H, 8.42; N, 5.57; found: C, 85.83; H, 8.49; N, 5.59. 
 
 
N-(1-(p-tolyl)ethylidene)aniline (314)[143] 
 
By general method 4-methyl acetophenone (1.3 mL, 10 mmol, 1 eq.) and 
aniline (1.1 ml, 12 mmol, 1.2 eq.) were dissolved in dry benzene (5 mL). 
Purification by Kugelrohr distillation (130 °C at 0.08 mbar) afforded 1.67 g 
(7.98 mmol, 79 %) of 314 as a yellow oil. 
 
C15H15N (MW = 209.29 g/mol): 
1H-NMR (400 MHz, CD2Cl2): 7.90 (d, J = 8.0 Hz, 2H,CHArCArC=N); 7.37 (t, J = 7.25 Hz, 2H, 
CHArCHArCAr-N); 7.28 (d, J = 7.75 Hz, 2H, CHArCArCH3); 7.10 (t, J = 7.5 Hz, 1H, CHArCHArCHArCAr-N); 
6.81 (d, J = 7.75 Hz, 2H, CHArCAr-N); 2.43 (s, 3H, CArCH3); 2.21 (s, 3H, CH3C=N); 13C{1H}-NMR (100 
MHz, CD2Cl2): 164.9 (C=N); 152.0 (CAr-N); 140.7 (CArCH3); 136.8 (CArC=N); 128.9 (CHArCArCH3); 128.8 
N
N
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(CHArCHArCAr-N); 127.0 (CHArCArC=N); 122.9 (CHArCHArCHArCAr-N); 119.3 (CHArCAr-N); 21.1 (CArCH3); 
16.9 (CH3C=N). 
 
N-(1-(4-chlorophenyl)ethylidene)aniline (323)[144] 
 
By general method 1-(4-chlorophenyl)ethanone (1.3 mL, 10 mmol, 1 eq.) 
and aniline (1.1 mL, 12 mmol, 1.2 eq.) were dissolved in dry benzene (5 
mL). Purification by Kugelrohr distillation (145 °C at 0.08 mbar) afforded 
1.87 g (8.1 mmol, 81 %) of 323 as a yellow solid. 
 
C14H12ClN (MW = 229.70 g/mol): 
m.p.: 93 °C (Lit. 93-95°C); 1H-NMR (600 MHz, CD2Cl2): 7.95 (d, J = 8.0 Hz, 2H, CHArCArC=N); 7.45 (d, J 
= 8.0 Hz, 2H, CHArCArCl); 7.38 (t, J = 7.75 Hz, 2H, CHArCHArCAr-N); 7.12 (t, J = 7.25 Hz, 1H, 
CHArCHArCHArCAr-N); 6.79 (d, J = 7.75 Hz, 2H, CHArCAr-N); 2.21 (s, 3H, CH3C=N); 13C{1H}-NMR (100 
MHz, CD2Cl2): 163.88 (C=N); 151.40 (CAr-N); 137.87 (CArC=N); 136.21 (CArCl); 128.81 (CHArCHArCAr-N); 
128.45 (CHArCArC=N); 128.27 (CHArCArCl); 123.11 (CHArCHArCHArCAr-N); 119.08 (CHArCAr-N); 16.81 
(CH3C=N).  
 
N-(1-(4-fluorophenyl)ethylidene)aniline (310)[141]  
 
By general method 1-(4-fluorophenyl)ethanone (2.517 g, 18.22 mmol, 1.0 eq.) 
and aniline (2 g, 21.9 mmol, 1.2 eq.) were dissolved in dry benzene (7 mL). 
Purification by Kugelrohr distillation (120-160° C at 0.1 mbar) afforded 3.21 
g (15 mmol, 82 %) of 310 as a off-white solid. 
 
C14H12FN (MW = 213.25 g/mol): 
m.p.: 81 °C (Lit. 86-87°C); 1H-NMR (500 MHz, CD2Cl2) δ 8.03 – 7.81 (m, 2H, CHArCArC=N), 7.27 (t, J = 
7.2 Hz, 2H, CHArCHArCAr-N), 7.03 (m, 3H, CHArCArF&CHArCHArCHArCAr-N), 6.69 (d, J = 7.4 Hz, 2H, 
CHArCAr-N), 2.12 (s, 3H, CH3C=N); 13C{1H}-NMR (126 MHz, CD2Cl2) δ 164.64 (d, J = 249.7 Hz, CAr-F), 
164.33 (C=N), 152.07 (CAr-N), 136.22 (CArC=N), 129.69 (d, J = 8.6 Hz, CHArCArC=N), 129.34 
(CHArCHArCAr-N), 123.56 (CHArCHArCHArCAr-N), 119.68 (CHArCAr-N), 115.50 (d, J = 21.6 Hz, CHArCArF), 
17.41 (CH3C=N). 
 
 
N-(1-(4-(trifluoromethyl)phenyl)ethylidene)aniline (324)[144]  
 
By general method 1-(4-trifluoromethylphenyl)ethanone (1.135 g, 6.03 
mmol, 1.0 eq.) and aniline (0.67 g, 7.2 mmol, 1.2 eq.) were dissolved in dry 
benzene (7 mL). Purification by Kugelrohr distillation (100-150 °C at 0.07 
mbar) afforded 1.23 g (4.7 mmol, 78 %) of 324 as a yellow white solid.  
 
C15H12F3N (MW = 263.26 g/mol): 
m.p.: 72-74 °C (Lit. 75-77°C); 1H-NMR (400 MHz, CD2Cl2) δ 8.13 (d, J = 8.0 Hz, 2H, CHArCArC=N), 7.73 
(d, J = 8.0 Hz, 2H, CHArCAr-CF3), 7.39 (t, J = 7.5 Hz, 2H, CHArCHArCAr-N), 7.13 (t, J = 7.2 Hz, 1H, 
CHArCHArCHArCAr-N), 6.82 (t, J = 7.0, 2H, CHArCAr-N), 2.27 (s, 3H, CH3=N); 13C{1H}-NMR (126 MHz, 
CD2Cl2) δ 164.61 (C=N), 151.72 (CAr-N), 143.24 (CArC=N), 131.98 (q, J = 32.5 Hz, CAr-CF3), 129.41 
(CHArCHArCAr-N), 127.98 (CHArCArC=N), 125.62 (q, J = 3.8 Hz, CHArCAr-CF3), 123.90 (CHArCHArCHArCAr-
N), 119.52 (CHArCAr-N), 17.57 (CH3C=N); 19F{1H}-NMR (376 MHz, CD2Cl2) δ -64.16. 
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N-(1-(4-nitrophenyl)ethylidene)aniline (529)[140]  
 
By general method 4-nitroacetophenone (0.5 g, 3.03 mmol, 1.0 eq.) and 
aniline (0.33 g, 3.55 mmol, 1.2 eq.) were dissolved in dry toluene (10 mL). 
Purification by recrystallisation from ethanol and pentane-washing 
afforded 0.456 g (1.89 mmol, 63 %) of 529 as an orange solid.  
 
C14H12N2O2 (MW = 240.26 g/mol): 
m.p.: 110-114 °C (Lit. 113-115°C); 1H-NMR (400 MHz, CDCl3) δ 8.30 (d, J = 8.8 Hz, 2H, CHArCAr-NO2), 
8.14 (d, J = 8.8 Hz, 2H, CHArCArC=N), 7.38 (t, J = 7.7 Hz, 2H, CHArCHArCAr-N), 7.14 (t, J = 7.4 Hz, 1H, 
CHArCHArCHArCAr-N), 6.80 (d, J = 7.5 Hz, 2H, CHArCAr-N), 2.29 (s, 3H, CH3C=N); 13C{1H}-NMR (101 
MHz, CDCl3) δ 163.77 (C=N), 150.93 (CAr-N), 149.12 (CAr-NO2), 145.10 (CArC=N), 129.25 (CHArCHArCAr-
N), 128.29 (CHArCArC=N), 124.10 (CHArCHArCHArCAr-N), 123.70 (CHArCAr-NO2), 119.21 (CHArCAr-N), 
17.67 (CH3C=N). 
 
 
N-(2-bromophenyl)-1-(p-tolyl)ethan-1-imine (535) 
 
By general method 4-methylacetophenone (1.0 g, 0.745 mmol, 1.0 eq.) and 2-
bromoaniline (1.28 g, 0.745 mmol, 1.0 eq.) were dissolved in dry toluene (10 
mL). Purification by Kugelrohr distillation (190 °C at 0.1 mbar) afforded 0.215 
g (0.75 mmol, 10 %) of 535 as yellow oil. 
 
C15H14BrN (MW = 287.03 g/mol): 
b.p.: 190 °C at 0.1 mbar; 1H-NMR (500 MHz, CDCl3) δ 7.92 (d, J = 8.1 Hz, 2H, CHArCArC=N), 7.59 (d, J = 
8.0 Hz, 1H, CHArCAr-Br), 7.28 (m, 1H, CHArCHArCAr-N), 7.26 (d, J = 8.0 Hz, CHArCAr-CH3), 6.94 (t, J = 7.7 
Hz, 1H, CHArCHArCAr-Br), 6.79 (d, J = 7.8 Hz, 1H, CHArCAr-N), 2.42 (s, 3H, CH3); 13C{1H}-NMR (126 
MHz, CDCl3) δ 167.29 (C=N), 150.27 (CAr-N), 141.31 (CAr-CH3), 136.32 (CArC=N), 132.97 (CHArCAr-Br), 
129.27 (CHArCAr-CH3), 128.09 (CHArCHArCAr-N), 127.54 (CHArCArC=N), 124.44 (CHArCHArCAr-Br), 120.64 
(CHArCAr-N), 114.01 (CAr-Br), 21.58 (CArCH3), 18.16 (CH3C=N); IR (neat, ATR) ν/cm-1 =  3058 (2), 3027 
(w), 2920 (w), 1636 (s), 1608 (m), 1582 (m), 1572 (m), 1462 (s), 1434 (m), 1405 (w), 1365 (m), 1310 (m), 
1295 (m), 1256 (m), 1213 (m), 1183 (m), 1116 (w), 1044 (w), 1026 (m); GC-MS: (EI, 70 eV, PhMeSi, 
100.2/10.270/10): tR = 17.8 min, m/z = 287 ([M]+), 274, 155; EA: calc. C, 62.52; H, 4.90; N, 4.86; found: C, 
62.20; H, 4.90; N, 4.87. 
 
 
2-Methyl-N-(1-phenylethylidene)aniline (536)[145]  
 
By general method acetophenone (0.515 g, 4.29 mmol, 1.15 eq.) and o-toluidine 
(0.4 g, 3.74 mmol, 1.0 eq.) were dissolved in dry toluene (10 mL). Purification by 
Kugelrohr distillation (125 °C at 0.08 mbar) afforded 0.678 g (3.24 mmol, 76 %) 
of 536 as yellow oil. 
 
C15H15N (MW = 209.29 g/mol): 
b.p.: 125°C at 0.08 mbar; 1H-NMR (400 MHz, CDCl3) δ 8.09 – 7.91 (m, 2H, CHArCC=N), 7.45 (m, 3H, 
CHAr&CHArCHCC=N), 7.19 (m, 2H, CAr(CH3)CHAr&CHArCHArCHAr), 7.00 (t, J = 7.4 Hz, 1H, 
CAr(CH3)CHArCHAr), 6.65 (d, J = 7.7 Hz, 1H, CHArC-N), 2.16 (s, 3H, CArCH3), 2.10 (s, 3H, C=NCH3). 
 
 
N-(1-phenylethylidene)-4-(trifluoromethyl)aniline (532)[37] 
 
By general method acetophenone (0.373 g, 3.1 mmol, 1.0 eq.) and 4-
(trifluoromethyl)aniline (0.5 g, 3.1 mmol, 1.0 eq.) were dissolved in dry 
toluene (10 mL). Purification by Kugelrohr distillation (150 °C at 0.2 
mbar) afforded 0.056 g (0.21 mmol, 6 %) of 532 as yellow-orange solid. 
 
C15H12F3N (MW = 263.26 g/mol): 
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m.p.: 51-52 °C (Lit. 80-81°C); 1H-NMR (500 MHz, CDCl3) δ 8.01 – 7.94 (m, 2H, CHArCC=N), 7.61 (d, J = 
8.3 Hz, 2H, CHArC(CF3)), 7.54 – 7.42 (m, 3H, CHAr&CHArCHArCArC=N), 6.88 (d, J = 8.2 Hz, 2H, CHArC-
N), 2.24 (s, 3H, CH3C=N); 13C{1H}-NMR (126 MHz, CDCl3) δ 166.34 (s, C=N), 154.98 (s, CAr-N), 138.98 
(s, CArC=N), 131.06 (s, 1CHAr), 128.62 (s, 2CHAr), 127.40 (s, 2CHArCC=N), 126.42 (d, J = 3.7 Hz, 
CHArC(CF3)), 125.66 (d, J = 13.5 Hz, CC(CF3)), 124.45 (q, J = 225.2 Hz, CF3), 119.54 (s, CHArC-N), 17.75 
(s, CH3C=N); GC-MS: (Rtx-5MS, 100.2/10.270/10): tR = 21.2 min, m/z = 263 ([M]+);  
 
 
2-Isopropyl-N-(1-phenylethylidene)aniline (537)  
 
By general method acetophenone (0.515 g, 4.29 mmol, 1.4 eq.) and 2-
isopropylaniline (0.418 g, 3.1 mmol, 1.0 eq.) were dissolved in dry toluene (10 
mL). Purification by Kugelrohr distillation (138 °C at 0.1 mbar) afforded 0.654 g 
(2.76 mmol, 89%) of 537 as yellow oil. 
 
C17H19N (MW = 237.34 g/mol): 
b.p.: 138 °C at 0.1 mbar; 1H-NMR (400 MHz, CDCl3) δ: 8.08 – 7.96 (m, 2H CHArCC=N), 7.56 – 7.42 (m, 
3H, CHAr&CHArCHCC=N), 7.32 (dd, J = 7.6, 1.2 Hz, 1H, CAr(CH(CH3)2)CHAr), 7.18 (td, J = 7.5, 1.5 Hz, 
1H, CAr(CH(CH3)2)CHAr CHAr), 7.10 (td, J = 7.5, 1.3 Hz, 1H, CAr(CH(CH3)2)CHAr CHArCHAr), 6.61 (dd, J = 
7.7, 1.3 Hz, 1H, CAr-NCHAr), 3.09 – 2.92 (m, 1H, CArCH(CH3)2), 2.23 (s, 3H, C=NCH3), 1.19 (d, J = 6.9 Hz, 
6H, CArCH3); 13C{1H}-NMR (101 MHz, CDCl3) δ 164.66 (C=N), 149.16 (CAr-N), 139.66 (CArC=N), 138.27 
(CArCH(CH3)2), 130.50 (CHArCHArCHArCArC=N), 128.51 (CHArCHArCArC=N), 127.28 (CHArCArC=N), 
126.19 (CHArCHArCHArCArCH(CH3)2), 125.76 (CHArCHArCArCH(CH3)2), 123.78 (CHArCArCH(CH3)2), 
118.78 (CHArCAr-N), 28.48 (CArCH(CH3)2), 22.97 (CArCH(CH3)2), 17.71 (CH3C=N); IR (neat, ATR) ν/cm-1 
= 3060 (w), 3021 (w), 2959 (m), 2925 (w), 2866 (w), 1645 (m), 1633 (s), 1594 (m), 1578 (m), 1480 (m), 
1447 (m), 1365 (m), 1287 (m), 1220 (m), 1192 (w), 1084 (w), 1033 (w), 753 (m), 692 (m); MS (EI, 70 eV): 
237.1 (16.5%), 222.1 (100%), 207.1 (15.1%); HRMS: calculated: 237.1512; found: 237.1515; EA: calc. C, 
86.40; H, 7.68; N, 5.93; found: C, 85.90; H, 8.11; N, 5.90. 
 
 
2,6-Dimethyl-N-(1-phenylethylidene)aniline (340)[145] 
 
By general method acetophenone (0.98 g, 8.1 mmol, 1.0 eq.) and 2,6-
dimethylaniline (0.98 g, 8.1 mmol, 1.0 eq.) were dissolved in dry toluene (10 mL). 
Purification by Kugelrohr distillation (137.5 °C at 0.1 mbar) afforded 0.4 g (1.8 
mmol, 21 %) of 340 as yellow-white solid. 
 
C16H17N (MW = 223.31 g/mol): 
m.p.: 61-62 °C (Lit. 59-60°C); 1H-NMR (500 MHz, CDCl3) δ 8.08 – 7.99 (m, 2H, CHArCC=N), 7.54 – 7.42 
(m, 3H, CHAr&CHArCHArCArC=N), 7.06 (d, J = 7.5 Hz, 2H, CHArCAr(CH3)), 6.92 (t, J = 7.5 Hz, 1H, 
CAr(CH3)CHArCHAr), 2.07 (s, 3H, C=NCH3), 2.03 (s, 6H, CAr(CH3)); 13C{1H}-NMR (126 MHz, CDCl3) δ 
165.39 (C=N), 149.13 (CAr-N), 139.27 (CArC=N), 130.60 (CHAr), 128.54 (CHAr), 127.96 (CHAr), 127.22 
(CHAr), 125.88 (CHAr), 122.88 (CHAr), 18.11 (CAr(CH3)), 17.63(CH3C=N);  
 
 
N-(3-methylbutan-2-ylidene)aniline (330)[140]  
 
By general method 3-methyl-2-butanone (2.11 g, 24.5 mmol, 1.14 eq.) and aniline 
(2.0 g, 21.5 mmol, 1.0 eq.) were dissolved in dry benzene (6 mL). Purification by 
Kugelrohr distillation (75° C at 0.15 mbar) afforded 2.01 g (12.47 mmol, 58%) of 330 
as a colourless oil. 
 
C11H15N (MW = 161.24 g/mol): 
E/Z mixture  6:1; Major: 1H-NMR (400 MHz, CDCl3) δ 7.32 – 7.24 (m, 2H), 7.05 – 6.98 (m, 1H), 6.70 – 
6.64 (m, 2H), 2.62 (hept, J = 6.9 Hz, 1H), 1.73 (s, 3H), 1.20 (d, J = 6.9 Hz, 6H); 13C{1H}-NMR (101 MHz, 
CDCl3) δ 176.31, 151.88, 128.98, 122.95, 119.47, 119.32, 39.32, 20.02, 17.14; Minor: 1H-NMR (400 MHz, 
CDCl3) δ 7.18 – 7.12 (m, 2H), 6.75 (tt, J = 7.5, 1.1 Hz, 1H), 6.71 – 6.64 (m, 2H), 2.72 (dt, J = 13.7, 6.9 Hz, 
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1H), 2.07 (s, 3H), 1.02 (d, J = 6.9 Hz, 6H); GC (Machary-Nagel Optima-5-Amin (0.50 µm x 0.25 µm x 30 
m), 60 kPa H2, 100 °C/2 min, 10°C/min, 250 °C/7 min): tR = 12.0 min; GC-MS (EI, 70 eV, PhMeSi, 
80.2/10.270/10): tR = 9.2 min, m/z = 161 ([M]+), 146, 118 ([M-(C(CH3)3)]+); HRMS: calculated: 161.1199; 
found: 161.1200 
 
 
N-(4-methylpentan-2-ylidene)aniline (540) 
 
By general method 4-methyl-2-pentanone (3.0 g, 30 mmol, 1.0 eq.) and aniline 
(2.79 g, 30 mmol, 1.0 eq.) were dissolved in dry toluene (10 mL). Purification by 
Kugelrohr distillation (95° C at 0.1 mbar) afforded 1.14 g (6.5 mmol, 21%) of 540 as a colourless oil. 
 
C12H17N (MW = 175.27 g/mol): 
E/Z mixture 3.2:1; Major: 1H-NMR (500 MHz, CDCl3) δ 7.30 (t, J = 7.8 Hz, 2H), 7.05 (t, J = 7.3 Hz, 1H), 
6.71 (dd, J = 8.3, 1.0 Hz, 2H), 2.31 (d, J = 7.3 Hz, 2H), 2.20 – 2.11 (sept, J = 7.0 Hz, 1H), 1.78 (s, 3H), 1.03 
(d, J = 6.6 Hz, 6H); 13C{1H}-NMR (101 MHz, CDCl3) δ 171.75 (C=N), 151.73 (CAr-N), 128.99 
(CHArCHArCAr-N), 123.08 (CHArCHArCHArCAr-N), 119.64 (CHArCAr-N), 50.85 (CH2CH(CH3)2), 26.39 
(CH(CH3)2), 22.66 (CH(CH3)2), 19.90 (CH3C=N); Minor: 1H-NMR (500 MHz, CDCl3) δ 7.28 (m, 2H, 
CHArCHArCAr-N), 7.03 (m, 1H, CHArCHArCHArCAr-N), 6.68 (dd, J = 8.3, 1.0 Hz, 2H, CHArCAr-N), 2.17 (s, 
3H, CH3C=N), 2.08 (d, J = 7.2 Hz, 2H, CH2C(CH3)C=N), 2.00 (sept, J = 6.5 Hz, 1H, (CH3)2CHCH2), 0.84 
(d, J = 6.5 Hz, 6H, (CH3)2CHCH2); 13C{1H}-NMR
  (101 MHz, CDCl3) δ 171.99 (C=N), 151.13 (CAr-N), 
128.88 (CHArCHArCAr-N), 122.86 (CHArCHArCHArCAr-N), 119.75 (CHArCAr-N), 43.07 (CH2CH(CH3)2), 
26.37 (CH(CH3)2), 26.16 (CH3C=N), 22.64 (CH(CH3)2); IR (neat, ATR) ν/cm-1 = 3075 (w), 3028 (w), 2955 
(m), 2869 (w), 1656 (s), 1593 (s), 1483 (m), 1464 (w), 1366 (m), 1252 (w), 1188  (w), 1168 (w), 1103 (w), 
1070 (w), 900 (w), 794 (m), 744 (s), 696 (s); GC (Machary-Nagel Optima-5-Amin (0.50 µm x 0.25 µm x 30 
m), 60 kPa H2, 100 °C/2 min, 10 °C/min, 250 °C/7 min): tR = 13.6 min; GC-MS: (Rtx-5MS, 
100.2/10.270/10): tR = 8.8 min, m/z = 175 ([M]+), 160, 132, 118, 104, 92; EA: calc. C, 82.23; H, 9.78; N, 
7.99; found: C, 81.84; H, 9.60; N, 8.32 
 
 
N-(1-phenylpropan-2-ylidene)aniline (550)[146] 
 
By general method phenylacetone (2.7 g, 20 mmol, 1.0 eq.) and aniline (2 g, 
22 mmol, 1.1 eq.) were dissolved in dry benzene (7 mL). Purification by 
Kugelrohr distillation (125° C at 0.1 mbar) afforded 1.58 g (7.55 mmol, 38%) of 550 as a yellow-orange 
clear oil. 
 
C15H15N (MW = 209.29 g/mol): 
E/Z mixture 3:1, Major: 1H-NMR (400 MHz, CD2Cl2) δ 7.42 – 7.28 (m, 7H), 7.10 – 7.04 (m, 1H), 6.73 (d, J 
= 7.7 Hz, 2H), 3.74 (s, 2H), 1.74 (s, 3H); 13C{1H}-NMR (126 MHz, CD2Cl2) δ 170.63, 151.93, 137.74, 
129.63, 129.23, 128.93, 127.02, 123.34, 119.70, 48.73, 19.02; Minor: 1H-NMR (400 MHz, CD2Cl2) δ 7.14 
(d, J = 7.5 Hz, 1H), 6.81 (d, J = 7.7 Hz, 1H), 3.51 (s, 1H), 2.07 (s, 2H), other signals overlayed by major 
isomer; 13C{1H}-NMR (126 MHz, CD2Cl2) δ 169.58, 151.60, 137.27, 129.41, 129.38, 129.02, 126.87, 
119.82, 115.15, 40.65, 25.99; GC (Machary-Nagel Optima-5-Amin (0.50 µm x 0.25 µm x 30 m), 60 kPa H2, 
100 °C/2 min, 10°C/min, 250 °C/10 min): tR = 20.2 min; GC-MS (Rtx-5MS, 50.2/30.250/5): tR = 8.9 min, 
m/z = 209 ([M]+), 193, 167, 118, 91, 77. 
 
 
N-(pentan-2-ylidene)aniline (331) 
 
By general method 2-pentanone (1.62 g, 18.8 mmol, 1.0 eq.) and aniline (2 g, 21.5 
mmol, 1.14 eq.) were dissolved in dry toluene (10 mL). Purification by Kugelrohr 
distillation (75° C at 0.1 mbar) afforded 1.16 g (7.2 mmol, 38%) of 331 as a 
colourless oil. 
 
C11H15N (MW = 161.24 g/mol): 
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3:1 E/Z mixture, Major: 1H-NMR (400 MHz, CDCl3) δ 7.30 (m, 2H, CHArCHArCAr-N), 7.03 (t, J = 7.4 Hz, 
1H, CHArCHArCHArCAr-N), 6.68 (d, J = 7.3, 2H, CHArCAr-N), 2.41 (t, J = 7.5 Hz, 2H, CH2C=N), 1.77 (s, 3H, 
CH3C=N), 1.70 (tq (m), 2H, CH2CH2C=N), 1.02 (t, J = 7.4 Hz, 3H, CH3CH2CH2C=N); 13C{1H}-NMR (101 
MHz, CDCl3) δ 172.12 (C=N), 151.75 (CAr-N), 128.96 (CHArCHArCAr-N), 123.05 (CHArCHArCHArCAr-N), 
119.64 (CHArCAr-N), 43.74 (CH2C=N), 19.83 (CH3C=N), 19.52 (CH2CH2C=N), 13.91 (CH3CH2CH2C=N); 
Minor: 1H-NMR (400 MHz, CDCl3) δ 7.30 (m, 2H, CHArCHArCAr-N), 7.03 (t, J = 7.4 Hz, 1H, 
CHArCHArCHArCAr-N), 6.66 (d, J = 7.2 Hz, 2H, CHArCAr-N), 2.15 (s, 3H, CH3C=N), 2.11 (dd, J = 8.7, 6.9 
Hz, 2H, CH2C=N), 1.52 (qt (m), 2H, CH2CH2C=N), 0.83 (t, J = 7.4 Hz, 3H, CH3CH2CH2C=N); 13C{1H}-
NMR (101 MHz, CDCl3) δ 173.64 (C=N), 151.21 (CAr-N), 129.39 (CHArCHArCAr-N), 122.94 
(CHArCHArCHArCAr-N), 115.20 (CHArCAr-N), 36.12 (CH2C=N), 25.97 (CH3C=N), 20.39 (CH2CH2C=N), 
14.14 (CH3CH2CH2C=N); IR (neat, ATR) ν/cm-1 = 3075 (w), 3060 (w), 3028 (w), 3018 (w), 2959 (m), 2931 
(w), 2872 (w), 1658 (s), 1594 (s), 1483 (m), 1366 (m), 1252 (m), 1225 (w), 1186 (m), 1168 (w), 1093 (w), 
1071 (m), 900 (w), 797 (m), 746 (m), 698 (s); GC (Machary-Nagel Optima-5-Amin (0.50 µm x 0.25 µm x 
30 m), 60 kPa H2, 100 °C/2 min, 10 °C/min, 250 °C/7 min): tR = 12.7 min; GC-MS (EI, 70 eV, PhMeSi, 
100.2/10.270/10): tR = 7.1 min, m/z = 161 ([M]+);  
EA: calc. C, 81.94; H, 9.38; N, 8.69; found: C, 81.72; H, 9.33; N, 8.65. 
 
N-(6-methylhept-5-en-2-ylidene)aniline (542) 
 
By general method 6-methylhept-5-en-2-one (1.71 g, 13.55 mmol, 1.0 eq.) 
and aniline (1.26 g, 13.55 mmol, 1.0 eq.) were dissolved in dry toluene (10 
mL). Purification by Kugelrohr distillation (112.5° C at 0.1 mbar) afforded 600 mg (3.0 mmol, 22%) of 542 
as a yellow clear oil. 
 
C14H19N (MW = 201.31 g/mol): 
E/Z mixture 3:1, Major: 1H-NMR (400 MHz, CDCl3) δ 7.33 – 7.28 (m, 2H), 7.05 (tt, J = 7.5, 1.2 Hz, 1H), 
6.70 (dd, J = 8.4, 1.1 Hz, 2H), 5.22 (dddt, J = 6.8, 5.3, 2.8, 1.4 Hz, 1H), 2.48 – 2.43 (m, 2H), 2.42 – 2.37 (m, 
2H), 1.79 (s, 3H), 1.74 (d, J = 1.2 Hz, 3H), 1.68 (d, J = 1.2 Hz, 3H); 13C{1H}-NMR (101 MHz, CDCl3) δ 
171.71, 151.63, 132.37, 128.86, 123.28, 122.95, 119.51, 41.59, 25.77, 25.04, 19.66, 17.79;  
Minor: 1H-NMR (400 MHz, CDCl3) δ 7.31 – 7.27 (m, 2H), 7.06 – 7.02 (m, 1H), 6.72 – 6.68 (m, 2H), 4.97 
(dddt, J = 7.0, 5.5, 3.0, 1.5 Hz, 1H), 2.47 – 2.45 (m, 2H), 2.39 – 2.36 (m, 2H), 2.18 (s, 3H), 1.67 (d, J = 1.1 
Hz, 3H), 1.53 (d, J = 1.2 Hz, 3H); 13C{1H}-NMR (101 MHz, CDCl3) δ 172.26, 151.09, 132.91, 128.79, 
122.85, 122.66, 119.51, 34.02, 26.04, 25.64, 25.43, 17.56; GC (Machary-Nagel Optima-5-Amin (0.50 µm x 
0.25 µm x 30 m), 60 kPa H2, 100 °C/2 min, 10°C/min, 250 °C/10 min): tR = 17.2 min; GC-MS (Rtx-5MS, 
50.2/30.250/5): tR = 8.1 min, m/z = 201 ([M]+), 186, 158, 144, 132, 118, 109, 93, 77;  
IR (neat, ATR) ν/cm-1 = 3072 (w), 3057 (w), 3022 (w), 2966 (m), 2914 (m), 2854 (m), 1663 (s), 1593 (m), 
1483 (m), 1443 (w), 1367 (w), 1246 (w), 1169 (w); EA: calculated: C, 83.53; H, 9.51; N, 6.96, found: C, 
83.45; H, 9.31; N, 6.87. 
 
 
N-(octan-2-ylidene)aniline (334)[147] 
 
By general method 2-octanone (1.64 g, 12.8 mmol, 1.0 eq.) and aniline 
(1.19 g, 12.8 mmol, 1.0 eq.) were dissolved in dry toluene (10 mL). 
Purification by Kugelrohr distillation (125° C at 0.1 mbar) afforded 847 mg (4.17 mmol, 32%) of 334 as a 
slighty yellowish clear oil. 
 
C14H21N (MW = 203.32 g/mol): 
E/Z mixture 3:1, Major: 1H-NMR 
(400 MHz, CDCl3) δ 7.30 (m, 2H), 
7.05 (m, 1H), 6.70 (m, 2H), 2.42 (m, 
2H), 1.79 (s, 3H), 1.69 (m, 2H), 1.41 
(m, 2H), 1.36 (m, 4H), 0.92 (m, 3H); 
13C{1H}-NMR (101 MHz, CDCl3) δ 
172.35, 151.77, 128.96, 123.03, 119.65, 41.88, 31.83, 29.16, 26.48, 22.73, 19.55, 14.22; Minor: 1H-NMR 
(400 MHz, CDCl3) δ 7.30 (m, 2H), 7.05 (m, 1H), 6.70 (m, 2H), 2.17 (s, 3H), 2.14 (m, 2H), 1.49 (m, 2H), 
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1.18 (m, 4H), 1.26 (m, 2H), 0.86 (m, 3H); 13C{1H}-NMR (101 MHz, CDCl3) δ 172.89, 151.22, 128.91, 
122.95, 119.63, 34.21, 31.52, 29.27, 27.00, 26.05, 22.55, 14.13; GC (Machary-Nagel Optima-5-Amin (0.50 
µm x 0.25 µm x 30 m), 60 kPa H2, 100 °C/2 min, 10°C/min, 250 °C/10 min): tR = 17.3 min; GC-MS (Rtx-
5MS, 100.2/10.270/10): tR = 13.3 min, m/z = 203 ([M]+), 188, 174, 160, 146, 132, 118, 92, 77. 
 
 
N-(1-cyclopentylethylidene)aniline (538) 
 
By general method cyclopentyl methyl ketone (0.34 g, 3.125 mmol, 1.0 eq.) and 
aniline (0.32 g, 3.43 mmol, 1.1 eq.) were dissolved in dry toluene (10 mL). 
Purification by Kugelrohr distillation (100° C at 0.15 mbar) afforded 0.25 g (1.33 
mmol, 42%) of 538 as a colourless oil. 
 
C13H17N (MW = 187.28 g/mol): 
6:1 E/Z mixture, Major: 1H-NMR (500 MHz, CDCl3) δ 
7.27 (m, 2H, CHArCHArCAr-N), 7.02 (d, J = 7.4 Hz, 1H, 
CHArCHArCHArCAr-N), 6.67 (dd, J = 8.3, 1.1 Hz, 2H, 
CHArCAr-N), 2.81 (pent, J = 8.1 Hz, 1H, CHC=N), 1.95 
(m, 2H, CHHCHC=N), 1.77 (m, 4H, CHHCHHCHC=N), 
1.76 (s, 3H, CH3), 1.67 (m, 2H, CHHCHHCHC=N); 
13C{1H}-NMR (126 MHz, CDCl3) δ 174.36 (C=N), 
151.90 (CAr-N), 128.85 (CHArCHArCAr-N), 122.75 
(CHArCHArCHArCAr-N), 119.41 (CHArCAr-N), 50.61 
(CHC=N), 30.13 (CH2CHC=N), 25.64 (CH2CH2CHC=N), 18.24 (CH3); Minor: 1H-NMR (500 MHz, CDCl3) 
δ 7.27 (m, 2H, CHArCHArCAr-N), 7.02 (d, J = 7.4 Hz, 1H, CHArCHArCHArCAr-N), 6.67 (dd, J = 8.3, 1.1 Hz, 
2H, CHArCAr-N), 2.70 (pent, J = 8.0 Hz, 1H, CHC=N), 2.10 (s, 3H, CH3), 1.71 (m, 2H, CHHCHHCHC=N), 
1.70 (m, 2H, CHHCHC=N), 1.61 (m, 2H, CHHCHC=N), 1.49 (m, 2H, CHHCHHCHC=N); 13C{1H}-NMR 
(126 MHz, CDCl3) δ 175.40 (C=N), 151.90 (CAr-N), 128.81 (CHArCHArCAr-N), 122.71 (CHArCHArCHArCAr-
N), 119.34 (CHArCAr-N), 43.12 (CHC=N), 31.12 (CH2CHC=N), 26.16 (CH2CH2CHC=N), 22.04 (CH3); GC 
(Machary-Nagel Optima-5-Amin (0.50 µm x 0.25 µm x 30 m), 60 kPa H2, 100 °C/2 min, 10 °C/min, 250 
°C/7 min): tR = 16.8 min; GC-MS: (Rtx-5MS, 100.2/10.270/10): tR = 12.7 min, m/z = 187 ([M]+), 146, 118; 
IR (neat, ATR) ν/cm-1 = 3060 (w), 3018 (w), 2950 (m), 2866 (m), 1567 (s), 1594 (s), 1578 (w), 1483 (m), 
1447 (w), 1364 (m), 1192 (m), 1166 (m), 1070 (w), 1025 (w), 899 (w), 798 (w), 697 (s); EA: calc. C, 83.37; 
H, 9.15; N, 7.48; found: C, 82.26; H, 8.96; N, 7.88. 
 
 
N-(3,3-dimethylbutan-2-ylidene)aniline (541)[148] 
 
By general method pinacolone (2.15 g, 21.4 mmol, 1.0 eq.) and aniline (2.0 g, 21.5 
mmol, 1.0 eq.) were dissolved in dry benzene (6 mL). Purification by Kugelrohr 
distillation (100-150° C at 0.07 mbar) afforded 1.5 g (8.56 mmol, 40%) of 541 as a 
colourless oil. 
 
C12H17N (MW = 175.27 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 7.27 (m, 2H, CHArCHArCAr-N), 7.00 (m, 1H, CHArCHArCHArCAr-N), 6.63 (m, 
2H, CHArCAr-N), 1.74 (s, 3H, CH3), 1.22 (s, 9H, C(CH3)3); 13C{1H}-NMR (101 MHz, CDCl3) δ 177.60 
(C=N), 152.34 (CAr-N), 129.00 (CHArCHArCAr-N), 122.69 (CHArCHArCHArCAr-N), 119.15 (CHArCAr-N), 
40.35 (C(CH3)3), 27.95 (CH3C=N), 15.38 (C(CH3)3); GC (Machary-Nagel Optima-5-Amin (0.50 µm x 0.25 
µm x 30 m), 60 kPa H2, 100 °C/2 min, 10°C/min, 250 °C/10 min): tR = 12.7 min; GC-MS (EI, 70 eV, 
PhMeSi, 100.2/10.270/10): tR = 7.9 min, m/z = 175 ([M]+), 118; HRMS: calculated: 175.1356; found: 
175.1357. 
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N-(1-cyclohexylethylidene)-1-phenylmethanamine (551)[149] 
 
By general method cyclohexyl methyl ketone (1.09 g, 8.6 mmol, 1.0 eq.) and 
benzylamine (1.02 g, 9.5 mmol, 1.1 eq.) were dissolved in dry toluene (10 
mL). Purification by Kugelrohr distillation (125° C at 0.1 mbar) afforded 0.84 
g (3.9 mmol, 45%) of 551 as a colourless clear oil. 
 
C15H21N (MW = 215.33 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 7.31 (m, 5H, CHAr), 4.49 (s, 2H, CH2), 2.25 (tt, J = 11.6, 3.3 Hz, 1H, 
CHC=N), 1.84 (s, 3H, CH3), 1.77 (m, 4H, CHAliph), 1.32 (m, 6H, CHAliph); GC (Machary-Nagel Optima-5-
Amin (0.50 µm x 0.25 µm x 30 m), 60 kPa H2, 100 °C/2 min, 10°C/min, 250 °C/7 min): tR = 20.6 min (I34); 
GC-MS (Rtx-5MS, 100.2/10.270/10): tR = 16.8 min, m/z = 215 ([M]+), 200, 186, 174, 160, 147, 124, 91.  
 
 
N-(1-cyclohexylethylidene)butan-1-amine (552) 
 
By general method cyclohexyl methyl ketone (0.92 g, 7.27 mmol, 1.0 eq.) and 
n-butylamine (1.6 g, 21.8 mmol, 3.0 eq.) were dissolved in dry toluene (10 
mL). Purification by Kugelrohr distillation (87° C at 0.15 mbar) afforded 0.75 
g (4.11 mmol, 56%) of 552 as a colourless clear oil. 
 
C12H23N (MW = 181.32 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 3.23 (t, J = 7.3 Hz, 2H), 2.17 (ddt, J = 
11.3, 6.6, 3.3 Hz, 1H), 1.83 – 1.73 (m, 4H), 1.76 (s, 3H), 1.72 – 1.66 (m, 
1H), 1.60 (p, J = 7.4 Hz, 2H), 1.39 – 1.34 (m, 2H), 1.30 (ddd, J = 12.2, 8.5, 
3.0 Hz, 4H), 1.19 (dddd, J = 15.9, 12.3, 7.4, 3.4 Hz, 1H), 0.94 (t, J = 7.3 
Hz, 3H); 13C{1H}-NMR (101 MHz, CDCl3) δ 173.36, 51.07, 50.87, 33.20, 
30.32, 26.31, 26.29, 20.87, 14.91, 14.19; GC (Machary-Nagel Optima-5-
Amin (0.50 µm x 0.25 µm x 30 m), 60 kPa H2, 100 °C/2 min, 10°C/min, 
250 °C/10 min): tR = 13.8 min (I35); GC-MS (Rtx-5MS, 50.2/30.250/5): tR = 7.0 min, m/z = 181 ([M]+), 
166, 152, 126, 98; IR (neat, ATR) ν/cm-1 = 2955 (s), 2924 (s), 2851 (s), 1663 (m), 1643 (w), 1447 (m), 1369 
(w), 1248 (w), 1198 (w); EA: calculated: C, 79.49; H, 12.79; N, 7.72, found: C, 79.61; H, 12.63; N, 7.76. 
 
 
N-(1-cyclohexylethylidene)propan-2-amine (554) 
 
By general method cyclohexyl methyl ketone (0.92 g, 7.27 mmol, 1.0 eq.) and 
isoproylamine (2.15 g, 36.33 mmol, 5.0 eq.) were dissolved in dry toluene (10 mL) 
and stirred at room temperature for four days. Purification by Kugelrohr distillation 
(100° C at 0.15 mbar) afforded 0.52 g (3.1 mmol, 43%) of 554 as a colourless clear 
oil. 
 
C11H21N (MW = 167.29 g/mol): 
E/Z mixture 16:1, Major: 1H-NMR (400 MHz, CDCl3) δ 3.60 (hept, J = 6.3 Hz, 1H), 2.16 (td, J = 9.6, 8.9, 
4.8 Hz, 1H), 1.75 (s, 3H), 1.81 – 1.65 (m, 6H), 1.36 – 1.25 (m, 4H), 1.10 (s, 3H), 1.09 (s, 3H); 13C{1H}-
NMR (101 MHz, CDCl3) δ 170.70, 51.16, 49.81, 30.25, 26.26, 26.20, 23.63, 13.78; GC (Machary-Nagel 
Optima-5-Amin (0.50 µm x 0.25 µm x 30 m), 60 kPa H2, 100 °C/2 min, 10°C/min, 250 °C/10 min): tR = 10.8 
min; GC-MS (Rtx-5MS, 50.2/30.250/5): tR = 6.0 min, m/z = 167 ([M]+), 152, 126, 112, 99, 84; IR (neat, 
ATR) ν/cm-1 = 2964 (m), 1924 (s), 1853 (m), 1663 (m), 1643 (m), 1448 (m), 1373 (w), 1364 (w), 1246 (w), 
1202 (w), 1159 (w), 808 (w); EA: calculated: C, 78.97; H, 12.65; N, 8.37, found: C, 78.44; H, 12.50; N, 
8.34. 
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N-(1-cyclohexylethylidene)cyclohexanamine (556) 
 
By general method cyclohexyl methyl ketone (1.834 g, 14.53 mmol, 1.0 eq.) and 
cyclohexylamine (1.439 g, 14.53 mmol, 1.0 eq.) were dissolved in dry toluene (10 
mL). Purification by Kugelrohr distillation (100° C at 0.1 mbar) afforded 1.153 g 
(5.56 mmol, 38%) of 556 as a colourless clear oil. 
 
C14H25N (MW = 207.35 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 3.22 (m, 1H, CHC-N), 2.19 – 2.12 (m, 1H, 
CHC=N), 1.82 – 1.61 (m, 11H), 1.61 – 1.54 (m, 2H), 1.45 – 1.13 (m, 10H); 
13C{1H}-NMR (101 MHz, CDCl3) δ 171.13, 58.93, 51.29, 33.85, 30.41, 
26.36, 26.30, 25.99, 25.33, 14.01; GC (Machary-Nagel Optima-5-Amin (0.50 
µm x 0.25 µm x 30 m), 60 kPa H2, 100 °C/2 min, 10°C/min, 250 °C/10 min): 
tR = 17.4 min; GC-MS (Rtx-5MS, 100.2/10.270/10): tR = 13.2 min, m/z = 207 
([M]+), 192, 178, 166, 152, 126, 124, 83; IR (neat, ATR) ν/cm-1 = 2922 (s), 
2851 (s), 1657 (m), 1447 (m), 1369 (w), 1358 (w), 1240 (w), 1196 (w), 1028 
(w), 889 (w), 843 (w); EA: calculated: C, 81.09; H, 12.15; N, 6.75, found: C, 80.69; H, 12.04; N, 6.94. 
 
 
N-(2-methyl-1-phenylpropylidene)aniline (411)[150] 
 
By general method, isobutyrophenone (1.964 g, 1.325 mmol, 1.1 eq.) and aniline 
(1.12 g, 1.2 mmol, 1.0 eq.) were dissolved in benzene (16 mL). Purification by 
Kugelrohr distillation (95 °C, 0.1 torr) afforded 1.28 g (0.576 mmol, 48 %) of 441 as 
a yellowish oil. 
 
C16H17N (MW = 223.31 g/mol): 
1H-NMR (500 MHz, CDCl3) δ 7.20 – 7.17 (m, 3H), 7.08 (t, J = 7.6 Hz, 2H), 7.01 (dd, J = 7.0, 2.8 Hz, 2H), 
6.86 (d, J = 7.4 Hz, 1H), 6.59 (d, J = 8.1 Hz, 2H), 3.03 (hept, J = 6.9 Hz, 1H), 1.24 (d, J = 6.9 Hz, 6H); GC-
MS: (Optima-5-Amine, 80.2/7.270/10): tR = 19.5 min, m/z = 223 [M]+, 208 [M-CH3]+, 180 [M-C3H7]+. 
 
 
N-(2,2-difluoro-1-phenylethylidene)aniline (412)[151] 
 
An oven-dried 50 mL two-necked round-bottom flask was purged with Argon three 
times before being charged with dry THF (2 mL) and cooled to -78 °C. 
Trimethyl(trifluoromethyl)silane (860 mg, 6.04 mmol, 1.5 eq.) dissolved in fry THF 
(2.0 M) was added slowly. N-benzylideneaniline (730 mg, 4.03 mmol, 1.0 eq.) was 
dissolved in THF (5 mL) and added dropwise before stirring was continued at -78 °C 
for 15 minutes. The reaction was warmed to -60 °C and tetramethyl ammonium 
fluoride (500 mg, 5.37 mmol, 1.33 eq.) was added in 10 portions over the course of 90 minutes. The reaction 
was then warmed to -50 °C and stirred for an additional 2 hours. It was then allowed to warm up to room 
temperature while stirring overnight. The reaction mixture was filtered, the filter cake washed with pentane 
(25 mL) and solvents reduced under reduced pressure. Purification by flash chromatography afforded 400 
mg (1.73 mmol, 43 %) of 412 as a yellow solid. 
 
C14H11F2N (MW = 231.24 g/mol): 
E/Z mixture 1:1.5: 1H-NMR (400 MHz, CDCl3) δ 8.08 (d, J = 8.1 Hz, 0.7H), 7.68 – 7.26 (m, 4H), 7.26 – 
7.13 (m, 2.6H), 7.03 (t, J = 7.4 Hz, 0.7H), 6.94 – 6.86 (m, 0.7H), 6.81 – 6.70 (m, 1.2H), 6.38 (t, J = 53.0 Hz, 
0.4H), 6.37 (t, J = 55.3 Hz, 0.6H); 19F-NMR (376 MHz, CDCl3) δ -116.01 (0.4F), -117.40 (0.6F). 
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Diethyl 2-(phenyl(phenylimino)methyl)malonate (413) 
 
By general method, diethyl 2-benzoylmalonate (1.0 g, 4.8 mmol, 1.0 eq.) and aniline 
(536 mg, 5.76 mmol, 1.2 eq.) were dissolved in benzene (5 mL). Purification by 
Kugelrohr distillation (125 °C, 0.1 torr) afforded 310 mg (1.094 mmol, 23 %) of 413 
as a yellow oil. 
 
C18H21NO2 (MW = 283.37 g/mol): 
1H-NMR (500 MHz, CDCl3) δ 8.22 (d, J = 7.3 Hz, 2H), 7.45 – 7.38 (m, 3H), 7.34 (t, J = 7.6 Hz, 2H), 7.24 
(s, 1H), 7.23 – 7.17 (m, 2H), 7.12 (dt, J = 15.1, 7.6 Hz, 2H), 6.86 (d, J = 7.9 Hz, 2H), 6.70 (d, J = 7.9 Hz, 
1H), 5.18 (s, 1H), 5.11 (s, 1H), 3.84 (dq, J = 14.3, 7.2 Hz, 1H), 3.75 – 3.67 (m, 1H), 3.58 (dq, J = 14.5, 7.1 
Hz, 2H), 3.43 – 3.34 (m, 2H), 1.26 (t, J = 7.0 Hz, 4H), 1.14 (t, J = 7.0 Hz, 6H); GC-MS: (Optima-5-Amine, 
50.2/10.270/10): tR = 21.2 min, m/z = 283 [M]+, 281, 255. 
 
 
N-((4-fluorophenyl)(phenyl)methylene)aniline (414) 
 
An oven-dried Argon-purged 50 mL two-necked round-bottom flask was charged 
with (4-fluorophenyl)(phenyl)methanone (1.0 g, 5 mmol, 1.0 eq.), aniline (545 
mg, 6 mmol, 1.2 eq.) and dissolved in benzene (10 mL). It was heated to reflux 
for 24 hours. Purification by Kugelrohr disitllation (165 °C, 0.07 torr) afforded 
700 mg (2.55 mmol, 51%) of 414 as a yellow solid. 
 
C19H14FN (MW = 275.32 g/mol): 
m.p.: 124-125 °C; E/Z mixture 1:1, signals overlaying: 1H NMR (400 MHz, CDCl3) δ 7.74 (m, 4H), 7.48 
(m, 1H), 7.42 (dd, J = 8.2, 6.5 Hz, 2H), 7.26 (m, 5H), 7.12 (m, 10H), 6.94 (m, 4H), 6.71 (m, 4H); 13C{1H}-
NMR (125 MHz, CDCl3) δ 167.35, 167.15, 151.25, 151.18, 139.71, 136.11, 136.01, 132.25, 131.75, 131.67, 
131.59, 131.50, 130.99, 129.54, 129.42, 128.83, 128.75, 128.63, 128.41, 128.13, 123.42, 123.36, 121.07, 
120.96, 115.44, 115.34, 115.22, 115.13; 19F-NMR (376 MHz, CDCl3) δ -110.04 (major), -111.83 (minor); 
IR (neat, ATR) ν/cm-1 = 3061 (w), 1613 (m), 1590 (s), 1502 (s), 1485 (m), 1444 (m), 1407 (m), 1296 (m), 
1270 (m), 1217 (s), 1154 (m), 1144 (m), 1097 (w), 1071 (m), 960 (m); GC-MS: (Optima-5-Amine, 
80.2/10.270/10): tR = 20.1 min, m/z = 275; MS (EI, 70 eV): 275.1 (100%), 198.1 (59%), 183.1 (47%), 180.1 
(39%); EA: calc.: C, 82.89; H, 5.13; N, 5.09; found: C, 82.70; H, 5.21; N, 4.83 
 
 
N-(2-(tert-butyl)-3,4-dihydronaphthalen-1(2H)-ylidene)aniline (383) 
 
An oven-dried and Argon-purged 25 mL two-necked round-bottom flask was 
charged with 2-(tert-butyl)-3,4-dihydronaphthalen-1(2H)-one (350 mg, 1.73 mmol, 
1.0 eq.) and aniline (472 mg, 5.19 mmol, 3.0 eq.) It was dissolved in dry Et2O (10 
mL) and cooled to 0 °C. A precooled solution (0 °C) of TiCl4 (344 mg, 1.82 mmol, 
1.05 eq.) in Et2O (1.0 M) was added dropwise before the cooling bath was removed 
and the reaction mixture heated to reflux for 3 days. After cooling to room 
temperature, the reaction mixture was filtered and the filter cake washed with Et2O 
(50 mL). The etheral solution was then washed with NaOH (1.0 M, 20 mL), the aequeous layer re-extracted 
with Et2O (2x15 mL) and the combined organic layers dried over K2CO3, filtered and solvents removed 
under reduced pressure. Purification by Kugelrohr distillation (150 °C, 0.08 mbar) afforded 140 mg (0.5 
mmol, 29 %) of 383 as a yellow oil. 
 
C20H23N (MW = 277.40 g/mol):  
1H-NMR (500 MHz, DMSO-d6) 7.96 (d, J = 7.7 Hz, 1H, H15), 7.38 (t, J = 7.3 Hz, 1H, H13), 7.33 (t, J = 7.7 
Hz, 2H, H2), 7.27 (t, J = 7.4 Hz, 1H, H14), 7.20 (d, J = 7.6 Hz, 1H, H12), 7.02 (t, J = 7.4 Hz, 1H, H1), 6.76 
(d, J = 7.6 Hz, 2H, H3), 3.07 (ddd, J = 18.2, 11.9, 6.5 Hz, 1H, H10), 2.98 (dd, J = 4.9, 2.3 Hz, 1H, H6), 2.88 
(dd, J = 18.0, 6.9 Hz, 1H, H10’), 2.27 (dd, J = 14.4, 6.4 Hz, 1H, H9), 2.11 (ddd, J = 19.6, 12.6, 7.1 Hz, 1H, 
H9’), 0.66 (s, 9H, H8); 13C{1H}-NMR (126 MHz, DMSO-d6) 168.44 (C5), 150.80 (C4), 139.82 (CAr), 
136.54 (CAr), 130.08 (CHAr), 128.58 (C2), 128.40 (CHAr), 125.94 (CHAr), 125.60 (CHAr), 122.42 (CHAr), 
119.57 (C3), 42.54 (C6), 33.98 (C7), 29.19 (C8), 25.13 (C10), 24.15 (C9). 
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N-((E)-4-phenylbut-3-en-2-ylidene)aniline (545)[152] 
 
By general method, (E)-4-phenylbut-3-en-2-one (2.016 g, 13.79 mmol, 1.0 
eq.), aniline (1.282 g, 13.79 mmol, 1.0 eq.) and zinc chloride (20 mg, 0.147 
mmol, 0.01 eq.) were dissolved in toluene (10 mL). Purification by 
recrystallisation from ethanol afforded 80 mg (0.36 mmol, 2.6 %) of 545 as a 
yellow solid. 
 
C16H15N (MW = 221.30 g/mol): 
E/Z mixture (2:1); 1H-NMR (400 MHz, CDCl3) δ 7.55 (d, J = 7.2 Hz, 2H), 7.39 (t, J = 7.3 Hz, 2H), 7.37 – 
7.27 (m, 6H), 7.19 (d, J = 16.5 Hz, 1H), 7.12 – 7.09 (m, 1H), 7.10 – 7.06 (m, 1H), 7.02 (d, J = 16.5 Hz, 1H), 
6.84 – 6.80 (m, 1H), 6.80 – 6.76 (m, 2H), 6.71 (d, J = 16.3 Hz, 1H), 2.46 (s, 1H), 2.07 (s, 3H); GC-MS: 
(Rtx-5MS, 50.2/30.250/5): tR = 10.2 min, m/z = 220, 206. 
 
 
(S)-1-(naphthalen-1-yl)-N-(1-phenylethylidene)ethanamine (346)[90] 
 
By general method acetophenone (1.03 g, 8.5 mmol, 2.3 eq.) and (S)-1-
(naphthalen-1-yl)ethanamine (640 mg, 3.74 mmol, 1.0 eq.) were dissolved in 
dry benzene (10 mL). Purification by Kugelrohr distillation (185 °C at 0.08 
torr) afforded 690 mg (2.52 mmol, 75 %) of 346 a as clear oil. 
 
C20H19N (MW = 273.37 g/mol): 
1H-NMR (500 MHz, CDCl3) δ 8.30 (d, J = 8.5 Hz, 1H), 7.89 (dd, J = 8.0, 5.8 Hz, 3H), 7.80 (d, J = 7.2 Hz, 
1H), 7.74 (d, J = 8.0 Hz, 1H), 7.54 (t, J = 7.6 Hz, 1H), 7.47 (dt, J = 15.3, 7.8 Hz, 2H), 7.40 (d, J = 4.2 Hz, 
3H), 5.55 (q, J = 6.5 Hz, 1H), 2.26 (s, 3H), 1.73 (d, J = 6.6 Hz, 3H); GC-MS: (Optima-5-Amine, 
100.2/10.270/10): tR = 20.3 min, m/z = 272, 258, 155; HPLC (Daicel Chiracel OD-H, n-heptane/iso-
propanol 99:1, 0.5 mL/min, 25 °C, 208/243 nm): tR = 11.6 min (S); Optical rotation: [] = +54.5 (c = 2.0 
in EtOH) 
 
 
(R)-1-(naphthalen-1-yl)-N-(1-phenylethylidene)ethanamine (346)[90]  
 
 
By general method acetophenone (1.05 g, 8.76 mmol, 1.5 eq.) and (R)-1-
(naphthalen-1-yl)ethanamine (1.0 g, 5.84 mmol, 1.0 eq.) were dissolved in dry 
benzene (10 mL). Purification by Kugelrohr distillation (185 °C at 0.08 torr) 
afforded 600 mg (2.2 mmol, 37 %) of 346 a as clear oil. 
 
C20H19N (MW = 273.37 g/mol): 
1H-NMR (500 MHz, CDCl3) δ 8.33 (d, J = 8.5 Hz, 1H), 7.91 (dd, J = 9.8, 6.2 Hz, 3H), 7.83 (d, J = 7.2 Hz, 
1H), 7.76 (d, J = 8.1 Hz, 1H), 7.56 (t, J = 7.6 Hz, 1H), 7.53 – 7.45 (m, 2H), 7.42 (dd, J = 7.1, 3.6 Hz, 3H), 
5.58 (q, J = 6.5 Hz, 1H), 2.28 (s, 3H), 1.75 (d, J = 6.6 Hz, 3H); 13C{1H}-NMR (126 MHz, CDCl3) δ 164.43, 
142.49, 141.65, 134.12, 130.80, 129.62, 129.14, 128.36, 127.14, 126.97, 125.96, 125.87, 125.40, 124.14, 
123.66, 56.66, 24.82, 16.16; GC-MS: (Rtx-1701, 100.2/10.270/10): tR = 18.6 min, m/z = 272, 258, 155; 
Optical rotation: [] = -284.5 (c 2.2 in CHCl3, 0.75% EtOH). 
 
 
  
Chapter 6 – Experimental Part 
202 
 
(R)-N-benzylidene-1-(naphthalen-1-yl)ethanamine (370)[153]  
 
By general method benzaldehyde (277 mg, 2.61 mmol, 1.2 eq.) and (R)-1-
(naphthalen-1-yl)ethanamine (373 mg, 2.18 mmol, 1.0 eq.) were dissolved in 
dry benzene (5 mL). Purification by Kugelrohr distillation (165 °C at 0.08 torr) 
afforded 320 mg (1.23 mmol, 57 %) of 370 as a white solid. 
 
C19H17N (MW = 259.34 g/mol): 
m.p.: 92 °C; 1H-NMR (500 MHz, CDCl3) δ 8.45 (s, 1H), 8.27 (d, J = 8.4 Hz, 1H), 7.91 – 7.86 (m, 1H), 7.86 
– 7.80 (m, 3H), 7.78 (d, J = 8.2 Hz, 1H), 7.55 (ddd, J = 8.4, 6.8, 1.5 Hz, 1H), 7.52 – 7.47 (m, 2H), 7.45 – 
7.40 (m, 3H), 5.38 (q, J = 6.6 Hz, 1H), 1.76 (d, J = 6.7 Hz, 3H); 13C{1H}-NMR (126 MHz, CDCl3) δ 159.79, 
141.30, 136.65, 134.13, 130.80, 130.74, 129.08, 128.69, 128.42, 127.48, 125.95, 125.84, 125.46, 124.17, 
123.76, 65.73, 24.68; GC-MS: (Optima-5-Amine, 100.2/10.270/10): tR = 22.0 min, m/z = 259, 244, 155; 
Optical rotation: [] = -218.5 (c 2.2 in CHCl3, 0.75% EtOH). 
 
 
(S)-N-benzylidene-1-phenylethanamine (352)[154] 
 
By general method benzaldehyde (478 mg, 4.51 mmol, 1.0 eq.) and (S)-1-
phenylethanamine (546 mg, 4.51 mmol, 1.0 eq.) were dissolved in dry benzene 
(15 mL). Purification by Kugelrohr distillation (110 °C at 0.08 torr) afforded 820 
mg (3.92 mmol, 87 %) of 352 as a clear oil. 
 
C15H15N (MW = 209.29 g/mol): 
1H-NMR (500 MHz, CDCl3) δ 8.38 (s, 1H), 7.79 (dd, J = 6.5, 2.7 Hz, 2H), 7.46 – 7.38 (m, 5H), 7.34 (t, J = 
7.6 Hz, 2H), 7.28 – 7.21 (m, 1H), 4.55 (q, J = 6.6 Hz, 1H), 1.60 (d, J = 6.7 Hz, 4H). 
 
  
(S)-1-phenyl-N-(1-phenylethylidene)ethanamine (353)[154] 
 
By general method acetophenone (1.96 g, 16.32 mmol, 1.2 eq.) and (S)-1-
phenylethanamine (1.65 g, 13.6 mmol, 1.0 eq.) were dissolved in dry benzene (20 
mL). Purification by Kugelrohr distillation (135 °C at 0.15 mbar) afforded 1.92 g 
(8.6 mmol, 63 %) of 353 as a clear oil. 
 
C16H17N (MW = 223.31 g/mol):  
b.p.: 135 °C (0.15 mbar); 10:1 E/Z mixture, Major: 1H-NMR (500 MHz, CDCl3) δ: 7.84 (m, 2H, 
CHArCArC=N), 7.47 (d, J = 7.8 Hz, 2H, CHArCHArCArC=N), 7.39 (m, 3H, CHArCArCH(CH3) and 
CHArCHArCHArCArC=N), 7.33 (t, J = 7.5 Hz, 2H, CHArCHArCArCH(CH3)), 7.23 (t, J = 7.7 Hz, 1H, 
CHArCHArCHArCArCH(CH3)N), 4.84 (q, J = 6.5 Hz, 1H, CArCH(CH3)N=C), 2.27 (s, 3H, C=NCH3), 1.54 (d, J 
= 6.5 Hz, 3H, CH(CH3)); 13C{1H}-NMR (126 MHz, CDCl3) δ 163.68 (C=N), 146.37 (CArCH(CH3)N), 
141.68 (CArC=N), 129.56 (CHArCHArCHArCArC=N), 128.51 (CHArCHArCArCH(CH3)N), 128.33 
(CHArCHArCArC=N), 126.95 (CHArCArC=N), 126.82 (CHArCArCH(CH3)N), 126.67 
(CHArCHArCHArCArCH(CH3)N), 60.00 (CH(CH3)N), 25.25 (CH(CH3)N), 15.78 (C=NCH3); Optical 
Rotation: [] = +92.5 (c 0.75 in CHCl3, 0.75% EtOH) (Lit. +97.7 (c 1.8 in CCl4)).  
 
 
(R)-1-phenyl-N-(1-phenylethylidene)ethanamine (353)[154]  
 
By general method acetophenone (0.98 g, 8.16 mmol, 1.2 eq.) and (R)-1-
phenylethanamine (0.824 g, 6.8 mmol, 1.0 eq.) were dissolved in dry benzene (10 
mL). Purification by Kugelrohr distillation (135 °C at 0.15 mbar) afforded 0.925 g 
(4.14 mmol, 61 %) of 353 as a clear oil. 
 
C16H17N (MW = 223.31 g/mol): 
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1H-NMR (500 MHz, CDCl3) δ: 7.84 (m, 2H, CHArCArC=N), 7.47 (d, J = 7.8 Hz, 2H, CHArCHArCArC=N), 
7.39 (m, 3H, CHArCArCH(CH3) and CHArCHArCHArCArC=N), 7.33 (t, J = 7.5 Hz, 2H, 
CHArCHArCArCH(CH3)N), 7.23 (t, J = 7.7 Hz, 1H, CHArCHArCHArCArCH(CH3)), 4.84 (q, J = 6.5 Hz, 1H, 
CArCH(CH3)N=C), 2.27 (s, 3H, C=NCH3), 1.54 (d, J = 6.5 Hz, 3H, CH(CH3)); Optical Rotation: [] = -
94.0 (c 0.75 in CHCl3, 0.75% EtOH) (Lit. -97.7 (c 1.8 in CCl4)). 
 
 
(R)-N-benzylidene-1-phenylpropan-1-amine (362) 
 
By general method benzaldehyde (1.044 g, 9.84 mmol, 1.0 eq.) and (R)-1-
phenylpropan-1-amine (1.6 g, 11.8 mmol, 1.2 eq.) were dissolved in dry benzene 
(10 mL). Purification by Kugelrohr distillation (135 °C at 0.1 mbar) afforded 1.8 g 
(8.07 mmol, 82 %) of 362 as a clear oil. 
 
C16H17N (MW = 223.31 g/mol): 
1H-NMR (500 MHz, CDCl3) δ 8.35 (s, 1H), 7.83 – 7.76 (m, 2H), 7.45 (dd, J = 8.1, 1.0 Hz, 2H), 7.43 – 7.39 
(m, 3H), 7.37 – 7.32 (m, 2H), 7.27 – 7.21 (m, 1H), 4.19 (t, J = 6.8 Hz, 1H), 1.97 (p, J = 7.3 Hz, 2H), 0.90 (t, 
J = 7.4 Hz, 3H); 13C{1H}-NMR (101 MHz, CDCl3) δ 159.81, 144.65, 136.57, 130.62, 128.64, 128.47, 
128.41, 127.19, 126.94, 77.28, 31.81, 11.28; IR (NaCl) ν/cm-1 = 3082 (m), 3060 (m), 3026 (m), 2964 (s), 
2930 (s), 2871 (m), 2845 (m), 1647 (s), 1602 (m), 1580 (s), 1492 (s), 1451 (s), 1380 (m), 1309 (m), 1218 
(m), 1169 (w), 1072 (w), 1027 (m), 970 (m); GC-MS: (Optima-5-Amine, 100.2/10.270/10): tR = 21.1 min, 
m/z = 222, 194, 167; MS (EI, 70 eV): 223.1 (2.2%, [M]+). 194.1 (100%); EA: calc. C, 86.06; H, 7.67; N, 
6.27; found: C, 85.93; H, 7.68; N, 6.26. 
 
 
(R)-1-phenyl-N-(1-phenylethylidene)propan-1-amine (363) 
 
By general method acetophenone (1.03 g, 8.57 mmol, 1.2 eq.) and (R)-1-
phenylpropan-1-amine (966 mg, 7.14 mmol, 1.0 eq.) were dissolved in dry 
benzene (10 mL). Purification by Kugelrohr distillation (112 °C at 0.08 torr) 
afforded 1.1 g (4.64 mmol, 65 %) of 363 as a clear oil. 
 
C17H19N (MW = 237.34 g/mol): 
1H-NMR (500 MHz, CDCl3) δ 7.83 (dd, J = 6.6, 3.0 Hz, 2H), 7.42 (d, J = 7.4 Hz, 2H), 7.40 – 7.35 (m, 3H), 
7.32 (t, J = 7.6 Hz, 2H), 7.22 (t, J = 7.3 Hz, 1H), 4.54 (t, J = 6.7 Hz, 1H), 2.24 (s, 3H), 1.99 – 1.89 (m, 2H), 
0.89 (t, J = 7.4 Hz, 3H); 13C{1H}-NMR (126 MHz, CDCl3) δ 164.01, 145.08, 141.81, 129.47, 128.38, 
128.30, 127.41, 126.95, 126.69, 66.79, 32.75, 16.12, 11.28; IR (neat, ATR) ν/cm-1 = 3081 (w), 3058 (w), 
3024 (w), 2960 (m), 2929 (m), 2871 (m), 1632 (s), 1601 (m), 1578 (m), 1491 (s), 1447 (s), 1373 (m), 1284 
(m), 1264 (m), 1078 (w), 1027 (m), 916 (w), 901 (w), 814 (m); GC-MS: (Optima-5-Amine, 80.2/10.270/10): 
tR = 17.2 min, m/z = 236, 209, 208, 167; Optical rotation: [] = -55.0 (c = 1.0 in CHCl3 with 0.75% 
EtOH); EA: calc.: C, 86.03; H, 8.07; N, 5.90; found: C, 86.03; H, 8.07; N, 5.71. 
 
 
(S)-N-(2,6-dimethylbenzylidene)-1-phenylpropan-1-amine (371) 
 
By general method 2,6-dimethylbenzaldehyde (500 mg, 3.73 mmol, 1.0 eq.) and 
(S)-1-phenylpropan-1-amine (504 mg, 3.73 mmol, 1.0 eq.) were dissolved in dry 
toluene (10 mL). Purification by Kugelrohr distillation (175 °C at 0.08 mbar) 
afforded 280 mg (1.1 mmol, 30 %) of 371 as a clear oil. 
 
C18H21N (MW = 251.37 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 8.66 (s, 1H, H8), 7.44 (d, J = 7.7 Hz, 2H, H3), 7.34 
(t, J = 7.5 Hz, 2H, H2), 7.24 (m, 1H, H1), 7.13 (t, J = 7.5 Hz, 1H, H13), 7.03 (d, J 
= 7.4 Hz, 2H, H12), 4.17 (t, J = 6.8 Hz, 1H, H5), 2.39 (s, 6H, H10), 1.96 (p, J = 7.2 
Hz, 2H, H6), 0.93 (t, J = 7.4 Hz, 3H, H7); 13C{1H}-NMR (101 MHz, CDCl3) δ 160.10 (C8), 144.74 (C4), 
137.42 (C11), 134.31 (C9), 128.87 (C13), 128.57 (C12), 128.49 (C2), 127.18 (C3), 126.92 (C1), 78.97 (C5), 
32.03 (C6), 20.79 (C10), 11.39 (C7); IR (neat, ATR) ν/cm-1 = 3063 (w), 3023 (w), 2961 (m), 2920 (m), 2871 
N
1
2
3
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6
8
9
11
10
12
13
7
Chapter 6 – Experimental Part 
204 
(w), 2851 (w), 1644 (s), 1594 (w), 1580 (w), 1491 (m), 1463 (m), 1451 (m), 1375 (m), 807 (m); GC-MS: 
(Rtx-1701, 100.2/10.270/10): tR = 15.5 min, m/z = 251, 222, 132; Optical rotation: [] = +3.2 (c = 1.0 in 
CHCl3 with 0.75% EtOH). 
 
 
(R)-N-(2,6-dimethylbenzylidene)-1-(naphthalen-2-yl)ethanamine (372) 
 
By general method 2,6-dimethylbenzaldehyde (500 mg, 3.73 mmol, 1.28 eq.) 
and (R)-1-(naphthalen-2-yl)ethanamine (500 mg, 2.92 mmol, 1.0 eq.) were 
dissolved in dry toluene (10 mL). Purification by Kugelrohr distillation (200 °C 
at 0.15 mbar) afforded 566 mg (1.97 mmol, 67 %) of 372 as a white solid. 
 
C21H21N (MW = 287.40 g/mol): 
m.p.: 53 °C; 1H-NMR (500 MHz, CDCl3) δ 8.77 (s, 1H, H13), 7.88 (sbr, 1H, 
H10), 7.84 (m, 3H, H5, H1), 7.62 (d, J = 8.5 Hz, 1H, H6), 7.45 (m, 2H), 7.14 (t, 
J = 7.5 Hz, 1H, H18), 7.04 (d, J = 7.6 Hz, 2H, H17), 4.71 (q, J = 6.6 Hz, 1H, H11), 2.41 (s, 6H, H16), 1.70 
(d, J = 6.6 Hz, 3H, H12); 13C{1H}-NMR (126 MHz, CDCl3) δ 160.02 (C13), 142.87 (C7), 137.34 (C15), 
134.35 (C14), 133.67 (C3), 132.77 (C8), 128.93 (C18), 128.55 (C17), 128.24 (CHAr), 128.03 (CHAr), 127.78 
(CHAr), 126.07 (CHAr), 125.65 (CHAr), 125.47 (CHAr), 124.98 (C6), 71.62 (C11), 25.67 (C12), 20.71 (C16); 
IR (neat, ATR) ν/cm-1 = 3046 (w), 2973 (w), 2922 (w), 2876 (w), 2861 (w), 1639 (s), 1460 (w), 1374 (m), 
1362 (m), 1113 (m), 1073 (w), 960 (m), 928 (w); EA: calc.: C, 87.76; H, 7.36; N, 4.87; found: C, 87.81; H, 
7.38; N, 5.19; Optical rotation: [] = -4.5 (c = 1.0 in CHCl3 with 0.75% EtOH). 
 
 
Cyclic Imines 
 
5-methyl-3,4-dihydro-2H-pyrrole (566) 
  
Was purchased and distilled prior to use.  
 
 
5-cyclohexyl-3,4-dihydro-2H-pyrrole (567) 
 
Was obtained from Valentin Köhler, Ward Group, Uni Basel 
 
 
5-benzyl-3,4-dihydro-2H-pyrrole (568) 
 
Was obtained from Valentin Köhler, Ward Group, Uni Basel 
 
 
5-phenyl-3,4-dihydro-2H-pyrrole (569) 
 
Was obtained from Valentin Köhler, Ward Group, Uni Basel 
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6-methyl-2,3,4,5-tetrahydropyridine (560)[155] 
 
 
A two-necked 100 mL round-bottom flask was charged with a stirrer, gas inlet and a thermometer and flame-
dried with a bunsen burner while evacuating. After cooling to room temperature, the flask was purged with 
argon three times and 1-(trimethylsilyl)piperidin-2-one (2 g, 11.7 mmol, 1.0 eq.) was added and dissolved in 
anhydrous Et2O (15 mL). The reaction mixture was cooled to -20 °C with the aid of an ice/salt bath and 
methyl lithium (12.8 mmol, 1.6 M, 1.1 eq.) was added dropwise. The reaction mixture was stirred for 30 
minutes at -20 °C and then allowed to warm to room temperature to stir for another 4 hours. The reaction 
mixture was quenched with saturated NH4Cl (25 mL) and stirred for another hour at room temperature. The 
organic layer was extracted with CH2Cl2 (3x25 mL) and solvents were removed under reduced pressure. 
Distillation (1 bar, 125 °C) afforded 560 (0.74 g, 7.6 mmol, 65%) as a clear colourless liquid. 
 
C6H11N (MW = 97.16 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 3.36 (ddd, J = 10.3, 6.0, 3.5 Hz, 2H), 1.96 (t, J = 6.6 Hz, 2H), 1.75 (s, 3H), 
1.55 – 1.47 (m, 2H), 1.43 – 1.35 (m, 2H); GC (Machary-Nagel Optima-5-Amin (0.50 µm x 0.25 µm x 30 m), 
60 kPa H2, 60 °C/3 min, 10°C/min to 250 °C/10 min): tR = 9.4 min; GC-MS (Rtx-5MS, 50.2/30.250/5): tR = 
3.7 min, m/z = 97 ([M]+), 69. 
 
 
6-butyl-2,3,4,5-tetrahydropyridine (565)[156] 
 
 
tert-Butyl (5-oxononyl)carbamate (0.86 g, 3.34 mmol, 1.0 eq.) was dissolved in trifluoroacetic acid (2 mL) 
and stirred for two hours. The reaction mixture was quenched with NaOH (10% wt.) until a pH of 13-14 was 
observed. Extraction with CH2Cl2 (3x10 mL) was followed by drying over MgSO4, filtering and removal of 
solvents under reduced pressure afforded 565 as a yellow oil. 
 
C9H17N (MW = 139.24 g/mol): 
1H-NMR (400 MHz, CDCl3) δ  3.55 (t, J = 5.8 Hz, 2H), 2.18 – 2.09 (m, 4H), 1.71 – 1.62 (m, 2H), 1.59 – 
1.46 (m, 4H), 1.33 (h, J = 7.4 Hz, 2H), 0.91 (t, J = 7.3 Hz, 3H); GC (Machary-Nagel Optima-5-Amin (0.50 
µm x 0.25 µm x 30 m), 60 kPa H2, 100 °C/2 min, 10°C/min, 250 °C/10 min): tR = 10.2 min; GC-MS (Rtx-
5MS, 100.2/10.270/10): tR = 5.3 min, m/z = 138 ([M-1]+), 124, 110, 97, 82. 
 
 
6-phenyl-2,3,4,5-tetrahydropyridine (563)[157] 
 
tert-Butyl (5-oxo-5-phenylpentyl)carbamate (0.5 g, 1.8 mmol, 1.0 eq.) was dissolved in 
trifluoroacetic acid (2 mL) and stirred for two hours at room temperature. The reaction 
mixture was quenched with NaOH (10% wt.) until a pH of 13-14 and organic 
components were extracted with CH2Cl2 (3x10 mL). After drying over MgSO4, filtration 
and removal of volatile components under reduced pressure afforded 563 as a yellow oil. 
 
C11H13N (MW = 159.23 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 7.76 (dd, J = 6.5, 3.1 Hz, 2H), 7.40 – 7.34 (m, 3H), 3.83 (t, J = 5.8 Hz, 2H), 
2.63 (t, J = 6.6 Hz, 2H), 1.84 (p, J = 6.4 Hz, 2H), 1.73 – 1.62 (m, 2H); GC-MS (Rtx-5MS, 100.2/10.270/10): 
tR = 11.9 min, m/z = 159 ([M]+), 144, 130, 103, 91. 
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Metal Complexes 
 
(ƞ4-1,5-cyclooctadiene)-{2-(2-(diphenylphosphino)phenyl)-4,4-dimethyl-4,5-dihydrooxazole}-
iridium(I)-tetrakis(3,5-bis(trifluoromethyl)phenyl)borate (348)[98] 
 
General method: 
In an oven-dried and argon-purged 25 mL round-
bottomed two-necked flask was placed 2-(2-
(diphenyl-phosphanyl)phenyl)-4,4-dimethyl-4,5-
dihydrooxazole (100 mg, 0.278 mmol, 2.0 eq.) and 
[Ir(COD)Cl]2 (93.6 mg, 0.139 mmol, 1.0 eq.) and 
dissolved in anhydrous CH2Cl2 (5 mL). The 
reaction mixture was heated to reflux for one hour. 
After cooling to room temperature, NaBArF (321 
mg, 0.362 mmol, 2.6 eq.) was added and the 
resultant suspension stirred vigorously. After 5 minutes, water (5 mL) was added and vigorous stirring 
continued. The organic components were extracted with CH2Cl2 (3x20 mL), washed with water (10 mL), 
dried over MgSO4, filtered and solvent removed under reduced pressure. The residue was purified by elution 
chromatography (SiO2, CH2Cl2) to afford 348 (294 mg, 0.193 mmol, 69%) as a red solid. Recrystallisation 
from CH2Cl2 to n-pentane afforded air-stable needles. 
 
C63H46BF24IrNOP (MW = 1523.03 g/mol): 
1H-NMR (500 MHz, CD2Cl2) δ 7.87 – 7.82 (m, 1H), 7.66 – 7.62 (m, 8H), 7.60 (dt, J = 7.7, 1.3 Hz, 1H), 7.56 
(tt, J = 7.6, 1.4 Hz, 1H), 7.53 – 7.49 (m, 2H), 7.47 (dt, J = 2.3, 1.3 Hz, 4H), 7.46 – 7.42 (m, 4H), 7.41 – 7.37 
(m, 1H), 7.26 (m, 4H), 5.40 – 5.33 (m, 2H), 3.86 (s, 2H), 3.23 – 3.15 (m, 2H), 2.24 – 2.08 (m, 4H), 1.96 (s, 
2H), 1.76 (d, J = 9.8 Hz, 2H), 1.28 (s, 6H); 31P{1H}-NMR (202 MHz, CD2Cl2) δ 20.98. 
 
 
(ƞ4-1,5-cyclooctadiene)-{2-(2-(diphenylphosphino)phenyl)-4,5-dihydrooxazole}-iridium(I)-tetrakis(3,5-
bis(trifluoromethyl)phenyl)borate (336)[98]  
 
By general method, 2-(2-
(diphenylphosphanyl)phenyl)-4,5-dihydrooxazole 
(400 mg, 1.207 mmol, 2.0 eq.), [Ir(COD)Cl]2 
(405.4 mg, 0.604 mmol, 1.0 eq.) and NaBArF (1.39 
g, 1.57 mmol, 2.6 eq.) afforded 336 (1.543 g, 1.027 
mmol, 85%) as a red amorphous solid. 
Recrystallisation from CH2Cl2 to n-pentane 
afforded air-stable crystals which are required to 
be stored in the fridge under an atmosphere of 
argon. 
 
C61H42BF24IrNOP (MW = 1494.98 g/mol): 
1H-NMR (500 MHz, CD2Cl2) δ 8.05 (ddd, J = 7.4, 4.0, 1.6 Hz, 1H), 7.64 (dt, J = 4.7, 2.3 Hz, 8H), 7.58 (dtd, 
J = 9.0, 7.6, 6.1 Hz, 2H), 7.50 (dd, J = 7.2, 1.8 Hz, 1H), 7.49 – 7.46 (m, 5H), 7.43 (tt, J = 7.3, 2.8 Hz, 5H), 
7.41 – 7.34 (m, 4H), 5.07 (ddd, J = 7.8, 4.9, 2.4 Hz, 2H), 4.51 (t, J = 9.9 Hz, 2H), 4.09 (t, J = 10.0 Hz, 2H), 
3.10 (q, J = 3.4 Hz, 2H), 2.31 – 2.14 (m, 4H), 2.07 – 1.98 (m, 2H), 1.88 (dt, J = 13.6, 5.9 Hz, 2H); 31P{1H}-
NMR (202 MHz, CD2Cl2) δ 15.96. 
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(ƞ4-1,5-cyclooctadiene)-{(S)-2-(2-(diphenylphosphino)phenyl)-4-isopropyl-4,5-dihydrooxazole}-
iridium(I)-tetrakis(3,5-bis(trifluoromethyl)phenyl)borate (86)[158] 
 
By general method, (S)-2-(2-
(diphenylphosphanyl)phenyl)-4-isopropyl-4,5-
dihydrooxazole (200 mg, 0.536 mmol, 2.0 eq.), 
[Ir(COD)Cl]2 (180 mg, 0.27 mmol, 1.0 eq.) and 
NaBArF (621 mg, 0.7 mmol, 2.6 eq.) afforded 86 
(655 mg, 0.426 mmol, 80%) as a red amorphous 
solid. Recrystallisation from CH2Cl2 to n-pentane 
afforded air-stable crystals. 
 
C64H48BF24IrNOP (MW = 1537.06 g/mol): 
1H-NMR (500 MHz, CD2Cl2) δ 8.14 – 8.08 (m, 1H), 7.67 – 7.60 (m, 9H), 7.57 (ddt, J = 7.6, 6.3, 1.3 Hz, 
3H), 7.54 – 7.49 (m, 1H), 7.47 (q, J = 1.4 Hz, 4H), 7.45 (dddd, J = 7.8, 6.6, 1.8, 1.0 Hz, 3H), 7.41 – 7.37 (m, 
2H), 7.37 – 7.33 (m, 1H), 7.09 – 6.98 (m, 2H), 5.03 – 4.94 (m, 1H), 4.94 – 4.83 (m, 1H), 4.41 (dd, J = 9.6, 
3.6 Hz, 1H), 4.32 (t, J = 9.5 Hz, 1H), 4.09 (ddd, J = 9.4, 3.6, 2.4 Hz, 1H), 3.30 – 3.21 (m, 1H), 3.05 – 2.93 
(m, 1H), 2.60 – 2.48 (m, 1H), 2.48 – 2.35 (m, 3H), 2.05 (dt, J = 12.9, 8.9 Hz, 1H), 2.00 – 1.88 (m, 2H), 1.62 
(tt, J = 13.8, 7.6 Hz, 1H), 1.50 – 1.35 (m, 2H), 0.80 (d, J = 7.1 Hz, 3H), -0.15 (d, J = 6.7 Hz, 3H); 31P{1H}-
NMR (202 MHz, CD2Cl2) δ 15.90. 
 
 
(ƞ4-1,5-cyclooctadiene-{(S)-2-(2-((dicyclohexylphosphino)oxy)propan-2-yl)-4-isopropyl-4,5-
dihydrooxazole}-iridium(I)-tetrakis(3,5-bis(trifluoromethyl)phenyl)borate (87)[159] 
 
An oven-dried and argon-purged 25 mL Schlenk 
tube was charged with a magnetic stir bar and 
brought to the glove box. Dicyclohexyl 
phosphine (149.6 mg, 0.643 mmol, 1.1 eq.) and 
NaH (21 mg, 0.876 mmol, 1.5 eq.) and dissolved 
in anhydrous THF (0.9 mL) and DMF (0.1 mL). 
Outside the glove box (S)-2-(4-isopropyl-4,5-
dihydrooxazol-2-yl)propan-2-ol (100 mg, 0.584 
mmol, 1.0 eq.) and the reaction mixture stirred 
overnight at room temperature. The solvents 
removed in vacuo and the reaction mixture suspended in anhydrous toluene. Inside the glove box, the 
suspension was filtered through a CHROMAFIL HPLC filter and rinsed with anhydrous toluene (2x2 mL). 
The solvent was removed in vacuo and redissolved in anhydrous CH2Cl2 (3 mL). In another 25 mL Schlenk 
tube was placed [Ir(COD)Cl]2 (130 mg, 0.193 mmol, 1.0 eq.) and dissolved in CH2Cl2 (1 mL). The ligand 
mixture was added dropwise and the resultant mixture stirred for one hour before NaBArF (444.7 mg, 0.502 
mmol, 1.3 eq.) was added and stirring continued for another 60 minutes. Silica gel (3g) was added and 
solvents removed under reduced pressure. The residue was purified by elution chromatography (SiO2, 15x2.5 
cm, 1st TBME (200 mL), then CH2Cl2 (200 mL)) to afford 87 as a dark red oil after removal of solvents. 
Recrystallisation from CH2Cl2 to n-pentane afforded air-stable orange crystals (495 mg, 0.323 mmol, 83%). 
 
C61H62BF24IrNO2P2 (MW = 1562.11 g/mol): 
1H-NMR (400 MHz, CD2Cl2) δ 7.64 (dt, J = 5.0, 2.2 Hz, 8H), 7.48 (s, 4H), 4.95 (dp, J = 8.7, 3.9 Hz, 1H), 
4.60 (tt, J = 7.6, 3.8 Hz, 1H), 4.53 (dd, J = 9.7, 3.9 Hz, 1H), 4.29 (t, J = 9.7 Hz, 1H), 3.87 (ddt, J = 12.8, 8.8, 
3.8 Hz, 2H), 3.42 (tdd, J = 8.0, 4.9, 2.6 Hz, 1H), 2.41 – 2.29 (m, 2H), 2.24 (td, J = 8.8, 8.3, 5.3 Hz, 2H), 2.08 
(dddd, J = 20.8, 12.2, 8.7, 3.6 Hz, 2H), 2.01 – 1.92 (m, 1H), 1.87 (ddq, J = 10.2, 6.8, 3.4 Hz, 3H), 1.82 – 1.70 
(m, 9H), 1.64 (ddt, J = 14.2, 8.9, 4.1 Hz, 5H), 1.52 (d, J = 1.5 Hz, 3H), 1.39 – 1.09 (m, 10H), 0.96 (d, J = 7.0 
Hz, 3H), 0.76 (d, J = 6.7 Hz, 3H); 31P{1H}-NMR (162 MHz, CD2Cl2) δ 121.27. 
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(ƞ4-1,5-cyclooctadiene)-{2-(2-(diphenylphosphino)phenyl)-4,5-dihydrooxazole}-iridium(I)-
hexafluorophosphate (357) 
 
By general method, 2-(2-(diphenylphosphanyl)phenyl)-4,5-dihydrooxazole 
(200 mg, 0.6 mmol, 2.0 eq.), [Ir(COD)Cl]2 (203 mg, 0.3 mmol, 1.0 eq.) were 
dissolved in CH2Cl2 (5 mL). After cooling to room temperature the reaction 
mixture was washed with NH4PF6 solution (0.4 M, 2x5 mL, 8 mmol). 
Subsequently the reaction mixture was washed with water (5 mL), dried over 
Na2SO4, filtered and solvents removed under reduced pressure. Crystallisation 
from CH2Cl2 to Et2O afforded 357 (342 mg, 0.44 mmol, 73%) as dark red 
crystals. 
 
C29H30F6IrNOP2 (MW = 776.72 g/mol): 
1H-NMR (500 MHz, CD2Cl2) δ 8.08 (dd, J = 7.9, 4.0 Hz, 1H), 7.61 (t, J = 7.6 Hz, 1H), 7.56 (t, J = 7.6 Hz, 
1H), 7.50 (dd, J = 8.2, 6.2 Hz, 2H), 7.42 (ddt, J = 18.9, 11.7, 5.2 Hz, 9H), 5.18 (dt, J = 4.8, 2.6 Hz, 2H), 4.56 
(t, J = 9.9 Hz, 2H), 4.16 (t, J = 10.0 Hz, 2H), 3.09 – 3.01 (m, 2H), 2.33 – 2.24 (m, 2H), 2.20 (ddd, J = 15.7, 
11.3, 5.6 Hz, 2H), 2.08 – 1.98 (m, 2H), 1.88 (dd, J = 14.2, 6.8 Hz, 2H); 13C{1H}-NMR (126 MHz, CD2Cl2) δ 
165.87, 165.81, 134.88, 134.79, 134.03, 133.98, 133.57, 133.51, 133.49, 132.53, 132.51, 132.42, 132.40, 
130.02, 129.65, 129.62, 129.60, 129.53, 129.49, 127.15, 126.70, 96.18, 96.09, 69.46, 63.99, 55.28, 32.49, 
32.46, 30.19, 30.18; 31P{1H}-NMR (202 MHz, CD2Cl2) δ 16.00 , -145.68 (sept, 1JP,F = 714 Hz). 
 
 
(ƞ4-1,5-cyclooctadiene)-{2-(2-(diphenylphosphino)phenyl)-4,5-dihydrooxazole}-iridium(I)-chloride 
(358) 
 
By general method, 2-(2-(diphenylphosphanyl)phenyl)-4,5-dihydrooxazole (200 
mg, 0.6 mmol, 2.0 eq.), [Ir(COD)Cl]2 (203 mg, 0.3 mmol, 1.0 eq.) were dissolved 
in CH2Cl2 (5 mL). 358 was isolated as a brown amorphous solid (366 mg, 0.549 
mmol, 91%). 
  
C29H30ClIrNOP (MW = 667.21 g/mol): 
31P{1H}-NMR (202 MHz, CD2Cl2) δ 9.45. 
 
 
[{2-(2-(diphenylphosphino)phenyl)-4,5-dihydrooxazole}-iridium(III)-((S)-N-benzylidene-1-
phenylethanamine)(hydrido)(chloride)] (356) 
 
General method: 
To an over-dried argon-purged 8 mL vial equipped with a magnetic 
stirrer and a septum was added 336 (75 mg, 0.1124 mmol, 1.0 eq.) 
and 352 (47 mg, 0.2248 mmol, 2.0 eq.). The vial was evacuated and 
purged with hydrogen. Anhydrous THF (2 mL) was added and the 
reaction mixture stirred at room temperature for two hours. Solvents 
were evaporated by a stream of nitrogen and the crude was suspended 
in EtOAc and subjected to elution chromatography (SiO2, EtOAc) to 
afford an oil. Trituration with n-pentane gave a yellow amorphous 
solid which was dried in vacuo affording 356 (3 mg, 3.8 µmol, 3.4%). 
 
C36H33ClIrN2OP (MW = 768.31 g/mol): 
1H-NMR (500 MHz, CH2Cl2) δ -18.70 (dd, J = 21.4, 2.6 Hz, 1H). 
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[{2-(2-(diphenylphosphino)phenyl)-4,5-dihydrooxazole}-iridium(III)-((S)-1-phenyl-N-(1-
phenylethylidene)ethanamine)(hydrido)(chloride)] (359) 
 
By general method, 336 (75 mg, 0.05 mmol, 1.0 eq.) and 353 (22.3 
mg, 0.1 mmol, 2.0 eq.) were reacted to afford 359 (33 mg, 0.042 
mmol, 83%) as a yellow solid. 
 
C37H35ClIrN2OP (MW = 782.34 g/mol): 
1H-NMR (500 MHz, CD2Cl2) δ -18.25 (d, J = 22.7 Hz, 1H), -19.47 (d, 
J = 21.7 Hz, 1H); 31P{1H}-NMR (202 MHz, CD2Cl2) δ 5.25 (d, J = 
20.2 Hz), 3.50 (d, J = 19.8 Hz); MS (EI, 70 eV): 745.2 (49.6%); MS 
(MALDI): 780.2253 ([M-H]+). 746.2364 ([M-Cl]+); 
MS (ESI): m/z (%) = 747.13 (100, [M-Cl]+). 
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[[{2-(2-(diphenylphosphino)phenyl)-4,5-dihydrooxazole}-iridium(III)-((S)-1-phenyl-N-(1-
phenylethylidene)ethanamine)(H)(CH2Cl2)]-tetrakis(3,5-bis(trifluoromethyl)phenyl)borate (360) 
 
In the glove box, 359 (5 mg, 6.3 µmol, 1.0 eq.) and NaBArF (6 
mg, 6.8 µmol, 1.08 eq.) were added to a young’s NMR tube and 
dissolved in CD2Cl2 (0.4 mL) at room temperature.The mixture 
was shaken until it turned homogenous and NMR spectra of 360 
were recorded. 
 
C70H49BCl2F24IrN2OP (1694.23 g/mol): 
1H-NMR (500 MHz, CD2Cl2) δ 8.23 – 8.17 (m, 1H), 7.87 (dd, J 
= 12.1, 7.7 Hz, 2H), 7.77 (dt, J = 5.1, 2.3 Hz, 13H), 7.75 – 7.69 
(m, 2H), 7.67 (dd, J = 8.4, 6.4 Hz, 1H), 7.61 (s, 6H), 7.56 (ddt, J 
= 10.5, 7.8, 3.8 Hz, 4H), 7.43 (d, J = 7.8 Hz, 1H), 7.35 – 7.27 
(m, 2H), 7.04 (t, J = 7.6 Hz, 1H), 6.96 (t, J = 7.5 Hz, 1H), 6.62 
(t, J = 7.6 Hz, 1H), 6.42 (d, J = 8.1 Hz, 1H), 5.35 – 5.29 (m, 1H), 
4.14 – 4.03 (m, 1H), 3.97 (dt, J = 10.8, 8.6 Hz, 1H), 3.01 (ddd, J 
= 13.6, 11.0, 8.6 Hz, 1H), 2.77 (s, 3H), 1.76 (d, J = 6.6 Hz, 3H), 1.47 (dt, J = 13.6, 10.3 Hz, 1H), -16.85 (d, J 
= 14.6 Hz, 1H); 31P{1H}-NMR (202 MHz, CD2Cl2) δ 10.28 (d, J = 5.7 Hz). 
 
 
 
 
 
  
N
Ir
S
H
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S = CH2Cl2
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[{2-(2-(diphenylphosphino)phenyl)-4,5-dihydrooxazole}-iridium(III)-((R)-N-benzylidene-1-
phenylpropan-1-amine)(hydrido)(chloride)] (364) 
 
By general method, 336 (75 mg, 0.05 mmol, 1.0 eq.) and 362 (33.47 
mg, 0.15 mmol, 3.0 eq.) were reacted to afford 364 (3.5 mg, 4.5 µmol, 
9%) as a yellow solid. 
 
C37H35ClIrN2OP (MW = 782.34 g/mol): 
1H-NMR (600 MHz, CD2Cl2) δ 8.39 (ddd, J = 8.2, 4.0, 1.3 Hz, 1H), 
7.95 (t, J = 2.0 Hz, 1H), 7.79 (ddt, J = 12.0, 6.0, 1.8 Hz, 2H), 7.66 – 
7.62 (m, 1H), 7.51 – 7.48 (m, 1H), 7.44 – 7.18 (m), 7.16 (dd, J = 7.4, 
1.5 Hz, 1H), 7.12 – 7.10 (m, 2H), 7.07 (td, J = 7.7, 2.4 Hz, 2H), 7.05 
(d, J = 7.5 Hz, 1H), 6.74 (td, J = 7.4, 1.2 Hz, 1H), 6.60 (td, J = 7.4, 1.5 Hz, 1H), 6.39 – 6.33 (m, 2H), 4.29 
(ddd, J = 9.6, 6.3, 3.4 Hz, 1H), 3.95 – 3.89 (m, 1H), 3.61 (d, J = 13.2 Hz, 1H), 3.54 – 3.50 (m, 1H), 1.77 – 
1.69 (m, 1H), 1.62 (dp, J = 13.5, 7.5 Hz, 1H), 0.80 (t, J = 7.4 Hz, 3H), 0.52 (t, J = 7.3 Hz, 3H), -18.87 (dd, J 
= 21.4, 2.6 Hz, 1H); MS (ESI): m/z (%) = 747.03 (72.84, [M-Cl]+), 745.01 (100, [M-H-Cl]+). 
 
 
 
[{2-(2-(diphenylphosphino)phenyl)-4,5-dihydrooxazole}-iridium(III)-((R)-1-phenyl-N-(1-
phenylethylidene)propan-1-amine)(hydrido)(chloride)] (365) 
 
By general method, 336 (50 mg, 0.033 mmol, 1.0 eq.) and 363 (23.7 
mg, 0.1 mmol, 3.0 eq.) were reacted to afford 365 (22 mg, 0.028 
mmol, 83%) as a yellow solid. 
 
C38H37ClIrN2OP (MW = 796.37 g/mol): 
1H-NMR (500 MHz, CD2Cl2) δ 8.24 (dd, J = 8.0, 4.1 Hz, 1H), 7.82 – 
7.69 (m, 3H), 7.57 – 6.98 (m), 6.65 (t, J = 7.4 Hz, 1H), 6.53 (t, J = 7.3 
Hz, 1H), 6.36 (dd, J = 10.6, 7.7 Hz, 2H), 4.82 (dt, J = 15.4, 10.7 Hz, 
1H), 4.63 (ddd, J = 15.9, 10.6, 7.5 Hz, 1H), 4.56 – 4.44 (m, 1H), 4.31 
(q, J = 10.0 Hz, 1H), 3.78 (d, J = 11.1 Hz, 1H), 1.73 (s, 3H), 0.84 – 0.76 (m, 2H), 0.48 (t, J = 7.3 Hz, 3H), -
19.86 (d, J = 20.9 Hz, 1H); 31P{1H}-NMR (202 MHz, CD2Cl2) δ 6.67 (s); MS (ESI): m/z (%) = 761.34 
(80.56, [M-Cl]+), 759.32 (100, [M-H-Cl]+). 
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[{2-(2-(diphenylphosphino)phenyl)-4,5-dihydrooxazole}-iridium(III)-((R)-N-benzylidene-1-
(naphthalen-1-yl)ethanamine)(hydrido)(chloride)] (376) 
 
By general method, 336 (25 mg, 0.0167 mmol, 1.0 eq.) and 372 
(10.8 mg, 0.042 mmol, 3.0 eq.) were reacted to afford 376 as a 
yellow solid. No yield was determined. 
 
C40H35ClIrN2OP (MW = 818.37 g/mol): 
1H-NMR (400 MHz, CD2Cl2) δ 8.24 (dd, J = 7.9, 4.2 Hz, 1H), 
8.04 (t, J = 2.0 Hz, 1H), 7.95 – 7.06 (m, 20H), 6.81 (t, J = 7.5 Hz, 
1H), 6.68 (td, J = 7.4, 1.5 Hz, 1H), 6.43 (dd, J = 10.6, 7.8 Hz, 2H), 
5.47 (q, J = 6.9 Hz, 1H), 4.19 (dt, J = 15.2, 10.9 Hz, 1H), 3.98 (dt, 
J = 11.2, 7.4 Hz, 1H), 3.06 (ddd, J = 15.1, 10.8, 6.9 Hz, 1H), 2.76 (td, J = 10.7, 8.0 Hz, 1H), 1.06 (d, J = 6.8 
Hz, 3H), -18.70 (dd, J = 21.0, 2.6 Hz, 1H); 31P{1H}-NMR (162 MHz, CD2Cl2) δ 6.05 (s); MS (ESI): m/z (%) 
= 783.16 (100, [M-Cl]+). 
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[{(S)-2-(2-(diphenylphosphino)phenyl)-4-isopropyl-4,5-
dihydrooxazole}-iridium(III)-(N-(2-(tert-butyl)-3,4-
dihydronaphthalen-1(2H)-ylidene)aniline)(hydrido)(chloride)] (384) 
 
By general method, 86 (125 mg, 0.081 mmol, 1.0 eq.) and 383 (67 mg, 
0.244 mmol, 3.0 eq.) were reacted to afford 384 (25.2 mg, 0.0287 mmol, 
35%) as a yellow solid. 
 
C44H47ClIrN2OP (MW = 878.51 g/mol): 
1H-NMR (500 MHz, CD2Cl2) δ -18.40 (d, J = 19.9 Hz), -23.13 (d, J = 
16.2 Hz); MS (ESI): m/z (%) = 877.17 (100, [M-H]+). 
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[{(S)-2-(2-(diphenylphosphino)phenyl)-4-isopropyl-4,5-
dihydrooxazole}-iridium(III)-(N-(1-(naphthalen-2-
yl)ethylidene)aniline)(hydrido)(chloride)] ([Ir(PHOX)(80)(H)(Cl)] 
 
By general method, 86 (50 mg, 0.0325 mmol, 1.0 eq.) and 80 (24 mg, 
0.0976 mmol, 3.0 eq.) were reacted to afford [Ir(PHOX)(80)(H)(Cl)] as 
a yellow solid. No yield was determined. 
 
C42H39ClIrN2OP (MW = 846.43 g/mol): 
 
 
 
 
 
[{(S)-2-(2-(diphenylphosphino)phenyl)-4-isopropyl-4,5-
dihydrooxazole}-iridium(III)-(N-(1-(4-
methoxyphenyl)ethylidene)aniline)(hydrido)(chloride)] 
([Ir(PHOX)(322)(H)(Cl)] 
 
By general method, 86 (50 mg, 0.0325 mmol, 1.0 eq.) and 322 (22 mg, 
0.0976 mmol, 3.0 eq.) were reacted to afford ([Ir(PHOX)(322)(H)(Cl)] 
as a yellow solid. No yield was determined. 
 
C39H39ClIrN2O2P (MW = 826.39 g/mol): 
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[{2-(2-(diphenylphosphino)phenyl)-4,5-dihydrooxazole}-iridium(III)-((3aS,8aR)-2-phenyl-8,8a-
dihydro-3aH-indeno[1,2-d]oxazole)(hydrido)(chloride)] (373) 
 
By general method, 336 (25 mg, 0.0167 mmol, 1.0 eq.) and 367 (9.8 
mg, 0.042 mmol, 2.5 eq.) were reacted to afford 373 (14 mg, 0.0176 
mmol, >99%) as a yellow solid. 19F-NMR displayed residual BArF.  
 
C37H31ClIrN2O2P (MW = 794.31 g/mol): 
1H-NMR (400 MHz, CD2Cl2) δ -19.13 (d, J = 21.6 Hz), -19.36 (d, J = 
18.7 Hz), -19.51 (d, J = 16.0 Hz), -22.81 (d, J = 24.3 Hz); 31P{1H}-
NMR (162 MHz, CD2Cl2) δ 12.93 (s), 6.24 (d, J = 4.9 Hz), 6.04 (m), 
4.61 (m); MS (ESI): m/z (%) = 759.18 (100, [M-Cl]+). 
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[{2-(2-(diphenylphosphino)phenyl)-4,5-dihydrooxazole}-iridium(III)-
((S)-N-(2,6-dimethylbenzylidene)-1-phenylpropan-1-
amine)(hydrido)(chloride)] (377) 
 
By general method, 336 (25 mg, 0.0167 mmol, 1.0 eq.) and 371 (12.6 
mg, 0.05 mmol, 3.0 eq.) were reacted to afford 377 as a yellow solid. No 
yield was determined. 
 
C39H39ClIrN2OP (MW = 810.39 g/mol): 
1H-NMR (500 MHz, CD2Cl2) δ -19.70 (d, J = 17.0 Hz), -19.77 (d, J = 
17.5 Hz), -21.85 (d, J = 18.1 Hz). 
 
 
 
[{(S)-2-(2-((dicyclohexylphosphino)oxy)propan-2-yl)-4-isopropyl-4,5-
dihydrooxazole}-iridium(III)-(N-(1-
phenylethylidene)aniline)(hydrido)(chloride)] (391) 
 
By general method 87 (50 mg, 0.03 mmol, 1.0 eq.) and 59 (13 mg, 0.06 
mmol, 2.0 eq.) afforded 391 (18 mg, 0.03 mmol, 76%) as a yellow solid. X-
Ray quality crystals were obtained by redissolving the precipitate in 
CH2Cl2 and layering with n-pentane. After evaporation of solvents an oily 
residue was observed which solidified into a crystalline material in the 
course of a few weeks. 
 
C35H51ClIrN2O2P (790.45 g/mol): 
1H-NMR (500 MHz, CD2Cl2) δ 7.72 (s, 1H), 7.68 – 7.61 (m, 1H), 7.56 – 7.49 (m, 1H), 7.36 (s, 2H), 7.17 (t, 
J = 7.4 Hz, 1H), 6.94 (dd, J = 8.3, 4.4 Hz, 2H), 6.90 (s, 1H), 5.13 (d, J = 9.3 Hz, 1H), 4.28 (dd, J = 8.7, 3.1 
Hz, 1H), 3.83 (t, J = 9.1 Hz, 1H), 2.90 – 2.69 (m, 1H), 2.42 (s, 3H), 2.32 (d, J = 7.7 Hz, 1H), 2.16 (d, J = 12.1 
Hz, 1H), 1.91 – 1.45 (m, 10H), 1.35 – 1.18 (m, 6H), 1.15 (s, 6H), 0.90 (d, J = 7.1 Hz, 3H), 0.69 (d, J = 6.9 
Hz, 3H), -19.50 (d, J = 24.3 Hz, 1H); 31P{1H}-NMR (202 MHz, CD2Cl2) δ 101.41 (d, J = 21.9 Hz); X-Ray: 
Crystal data for 391: formula C22.77Cl2.12Ir0.75N1.50O1.50P0.75, M = 561.22, F(000) = 4227.800, ? ?, size ? ·  ? ·  ? 
mm3, triclinic, space group P 1 , Z = 16, a = 20.3432(8) Å, b = 20.3463(8) Å, c = 32.2232(19) Å, α = 
91.006(3)°, β = 99.548(3)°, γ = 119.941(2)°, V = 11318.5(10) Å3, Dcalc. = 1.317 Mg ·  m-3. The crystal was 
measured on a Unknown diffractometer at 193K using graphite-monochromated Mo Kα-radiation with λ = 
0.71073 Å, Θmax = 26.434°. Minimal/maximal transmission 1.0000/1.0000, µ = 3.804 mm-1. The USER 
DEFINED DATA COLLECTION suite has been used for datacollection and integration. From a total of 
149545 reflections, 87895 were independent (merging r = 0.049). From these, 52759 were considered as 
observed (I>2.0σ(I)) and were used to refine 1886 parameters. The structure was solved by Other methods 
using the program Superflip. Least-squares refinement against F was carried out on all non-hydrogen atoms 
using the program CRYSTALS. R = 0.1539 (observed data), wR = 0.2405 (all data), GOF = 0.5291. 
Minimal/maximal residual electron density = -8.07/14.87 e Å-3. Chebychev polynomial weights were used to 
complete the refinement. Plots were produced using CAMERON. 
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[{(S)-2-(2-(diphenylphosphino)phenyl)-4-isopropyl-4,5-
dihydrooxazole}-iridium(III)-(N-(1-
phenylethylidene)aniline)(hydrido)(chloride)] (325) 
 
By general method 86 (100 mg, 0.065 mmol, 1.0 eq.) and 59 (25.3 mg, 
0.13 mmol, 2.0 eq.) afforded 325 (24 mg, 0.03 mmol, 46%) as a yellow 
solid. 
 
C38H37ClIrN2OP (796.36 g/mol): 
 
1H-NMR (400 MHz, CD2Cl2) δ 7.70 – 7.61 (m, 2H), 7.59 (d, J = 7.5 Hz, 
1H), 7.55 – 7.49 (m, 1H), 7.47 (d, J = 7.4 Hz, 1H), 7.36 (m, 6H), 7.12 (t, J = 7.2 Hz, 1H), 7.05 (t, J = 7.4 Hz, 
1H), 6.96 (td, J = 8.0, 2.4 Hz, 2H), 6.86 – 6.80 (m, 1H), 6.72 (m, 2H), 6.62 (t, J = 7.1 Hz, 1H), 6.49 (dd, J = 
11.3, 7.8 Hz, 2H), 5.88 (d, J = 7.2 Hz, 1H), 5.26 (ddd, J = 10.0, 4.2, 3.1 Hz, 1H), 4.22 (dd, J = 8.8, 4.5 Hz, 
1H), 4.02 – 3.94 (m, 1H), 2.76 – 2.66 (m, 1H), 2.28 (s, 3H), 0.81 (d, J = 7.1 Hz, 3H), -0.03 (d, J = 6.8 Hz, 
3H), -18.21 (d, J = 20.7 Hz, 1H); 13C{1H}-NMR (126 MHz, CD2Cl2) δ 180.57, 159.73, 148.50, 148.28, 
141.70, 134.04, 133.95, 132.80, 132.72, 132.67, 132.65, 131.57, 131.51, 131.44, 131.03, 130.91, 130.89, 
130.77, 130.75, 130.59, 130.00, 129.75, 128.97, 128.54, 128.37, 128.28, 127.75, 127.66, 124.99, 123.28, 
121.47, 120.04, 72.82, 70.52, 67.53, 49.46, 28.94, 27.12, 19.05, 17.80, 12.76; 31P{1H}-NMR (162 MHz, 
CD2Cl2) δ 2.63 (d, J = 14.5 Hz); EA: calc.: C, 57.31; H, 4.68; N, 3.52; found: C, 54.95; H, 4.90; N, 3.10 
 
 
[{(S)-2-(2-(diphenylphosphino)phenyl)-4-isopropyl-4,5-
dihydrooxazole}-iridium(III)-(N-(1-
phenylethylidene)aniline)(hydrido)(tetrahydrofuran)])-
tetrakis(3,5-bis(trifluoro-methyl)phenyl)borate (308) 
 
In the glove box, 325 (10 mg, 0.0126 mmol, 1.0 eq.) and 
NaBArF (11.1 mg, 0.0126 mmol, 1.0 eq.) were added to a 
young’s NMR tube and dissolved in THF-d8 at room 
temperature.The mixture was shaken until it turned homogenous 
and NMR spectra were recorded. 
 
C74H57BF24IrN2O2P (MW = 1696.34 g/mol): 
1H-NMR (500 MHz, THF) δ 7.68 (s, 8H), 7.59 – 7.50 (m, 3H), 7.46 (s, 4H), 7.44 (d, J = 2.9 Hz, 1H), 7.35 – 
7.28 (m, 3H), 7.24 (d, J = 18.7 Hz, 4H), 7.19 (d, J = 7.9 Hz, 1H), 6.98 (t, J = 7.4 Hz, 1H), 6.92 (t, J = 7.4 Hz, 
1H), 6.83 (t, J = 7.1 Hz, 2H), 6.81 – 6.76 (m, 1H), 6.64 (d, J = 7.3 Hz, 1H), 6.52 (t, J = 7.4 Hz, 1H), 6.41 (t, J 
= 9.0 Hz, 3H), 5.83 (d, J = 7.2 Hz, 1H), 5.30 – 5.17 (m, 1H), 4.16 (dd, J = 8.6, 4.5 Hz, 1H), 3.87 (t, J = 9.4 
Hz, 1H), 2.72 – 2.63 (m, 1H), 2.14 (s, 3H), 0.68 (d, J = 7.1 Hz, 3H), -0.09 (d, J = 6.9 Hz, 3H), -18.30 (d, J = 
20.7 Hz, 1H); 31P{1H}-NMR (202 MHz, THF) δ 0.80 (d, J = 19.8 Hz). 
 
  
 
[{(S)-4-(tert-butyl)-2-(2-(diphenylphosphino)phenyl)-4,5-dihydrooxazole}-iridium(III)-(N-(1-
phenylethylidene)aniline)(hydrido)(chloride)] (337) 
 
By general method 388 (50.4 mg, 0.325 mmol, 1.0 eq.) and 59 (12.6 mg, 
0.065 mmol, 2.0 eq.) afforded 337 (20.7 mg, 0.0255 mmol, 78%) as a 
yellow solid. 
 
C39H39ClIrN2OP (MW = 810.39 g/mol): 
1H-NMR (400 MHz, CD2Cl2) δ 7.58 – 7.46 (m, 4H), 7.36 – 7.23 (m, 8H), 
7.07 – 6.99 (m, 2H), 6.85 (td, J = 7.7, 2.4 Hz, 2H), 6.73 – 6.67 (m, 1H), 
6.67 – 6.61 (m, 2H), 6.50 (td, J = 7.4, 1.5 Hz, 1H), 6.40 (ddt, J = 11.7, 
6.7, 1.4 Hz, 2H), 5.76 – 5.66 (m, 1H), 5.21 (dd, J = 9.0, 2.6 Hz, 1H), 4.29 
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(dd, J = 9.0, 2.7 Hz, 1H), 3.81 (t, J = 9.0 Hz, 1H), 2.15 (s, 3H), 0.61 (s, 9H), -18.62 (d, J = 22.1 Hz, 1H); 
13C{1H}-NMR (126 MHz, CD2Cl2) δ 180.46, 163.33, 163.30, 148.84, 147.75, 141.94, 134.78, 134.25, 
133.78, 133.69, 132.97, 132.89, 132.55, 132.53, 132.19, 132.13, 131.88, 131.82, 131.16, 131.04, 130.85, 
130.83, 130.79, 130.74, 130.73, 130.60, 130.15, 130.12, 130.07, 129.74, 129.72, 128.89, 128.84, 128.79, 
128.37, 128.28, 127.69, 127.61, 125.09, 122.99, 122.06, 120.00, 72.82, 71.95, 70.31, 49.46, 35.32, 30.08, 
27.12, 26.28, 17.95; 31P{1H}-NMR (162 MHz, CD2Cl2) δ 3.00 (dt, J = 8.9, 4.3 Hz). 
 
 
[{(S)-2-(2-(diphenylphosphino)phenyl)-4-isopropyl-4,5-
dihydrooxazole}-iridium(III)-(2,6-dimethyl-N-(1-
phenylethylidene)aniline)(hydrido)(chloride)] (389) 
 
By general method 86 (100 mg, 0.065 mmol, 1.0 eq.) and 340 (29 mg, 
0.13 mmol, 2.0 eq.) afforded 389 (62 mg, 0.075 mmol, >99%) as a 
yellow solid. Trituration with n-pentane gave 25 mg (0.03 mmol, 46%) of 
pure material. 
 
C40H41ClIrN2OP (824.41 g/mol): 
1H-NMR (500 MHz, CD2Cl2) δ 7.68 (dd, J = 7.7, 1.4 Hz, 13H), 7.63 (d, J = 7.5 Hz, 12H), 7.57 – 7.30 (m, 
517H), 7.30 – 7.25 (m, 20H), 7.21 (d, J = 7.6 Hz, 39H), 7.14 (t, J = 7.4 Hz, 40H), 7.11 (s, 19H), 7.09 (d, J = 
7.4 Hz, 120H), 7.06 (d, J = 7.3 Hz, 12H), 7.02 (qd, J = 7.8, 1.8 Hz, 35H), 6.94 (t, J = 7.7 Hz, 90H), 6.90 (dd, 
J = 7.3, 1.3 Hz, 11H), 6.81 (d, J = 7.5 Hz, 11H), 6.77 (t, J = 7.3 Hz, 39H), 6.67 – 6.61 (m, 25H), 6.59 – 6.56 
(m, 7H), 6.56 – 6.52 (m, 33H), 6.36 (td, J = 7.5, 1.4 Hz, 28H), 6.25 (d, J = 7.5 Hz, 9H), 5.30 (ddd, J = 10.0, 
4.3, 2.7 Hz, 9H), 4.28 (dd, J = 8.8, 4.2 Hz, 10H), 4.16 (t, J = 9.3 Hz, 10H), 4.02 (dd, J = 8.8, 2.5 Hz, 29H), 
3.67 (t, J = 8.8 Hz, 30H), 3.20 (s, 36H), 2.66 (s, 86H), 2.58 (s, 8H), 2.55 (s, 29H), 2.38 (dt, J = 8.8, 2.6 Hz, 
31H), 2.31 (s, 31H), 2.28 (s, 8H), 2.23 (s, 86H), 2.17 (s, 10H), 2.09 (s, 190H), 2.08 (s, 87H), 2.04 (s, 372H), 
1.69 (pd, J = 7.0, 2.5 Hz, 31H), 1.57 (s, 18H), 1.29 (s, 31H), 1.20 (s, 122H), 0.77 (d, J = 7.1 Hz, 32H), 0.56 
(d, J = 7.1 Hz, 7H), 0.39 (d, J = 7.0 Hz, 90H), -0.25 (d, J = 6.9 Hz, 30H), -0.34 (d, J = 7.0 Hz, 8H), -0.48 (d, 
J = 6.7 Hz, 90H), -19.34 (d, J = 23.1 Hz, 9H), -22.44 (d, J = 27.7 Hz, 1H), -22.52 (d, J = 15.6 Hz, 30H); 
31P{1H}-NMR (202 MHz,CD2Cl2) δ 4.16 (d, J = 14.3 Hz), -0.34 (dd, J = 18.1, 4.6 Hz), -3.65 (d, J = 25.5 
Hz); EA: calc.: C, 58.28; H, 5.01, N, 3.40; found: C, 64.18; H, 5.74, N, 4.32; HRMS: calculated: 789.2586 
[M-Cl]+, found: 789.2595. 
 
 
[{(S)-4-(tert-butyl)-2-(2-(diphenylphosphino)phenyl)-4,5-
dihydrooxazole}-iridium(III)-(2,6-dimethyl-N-(1-
phenylethylidene)aniline)(hydrido)(chloride)] (390) 
 
By general method 388 (50.4 mg, 0.325 mmol, 1.0 eq.) and 340 (14.5 
mg, 0.065 mmol, 2.0 eq.) afforded 390 (11.9 mg, 0.0142 mmol, 43%) as 
a yellow solid. 
 
C41H43ClIrN2OP (MW = 838.45 g/mol): 
1H-NMR (500 MHz, CD2Cl2) δ 8.15 (ddd, J = 7.7, 3.9, 1.3 Hz, 2H), 7.64 
(dd, J = 7.7, 1.4 Hz, 1H), 7.57 – 7.29 (m, 31H), 7.29 – 7.25 (m, 2H), 7.20 – 7.14 (m, 5H), 7.13 – 7.09 (m, 
4H), 7.03 (td, J = 7.9, 2.3 Hz, 3H), 6.98 – 6.93 (m, 2H), 6.91 – 6.82 (m, 6H), 6.76 (t, J = 7.4 Hz, 3H), 6.69 – 
6.63 (m, 2H), 6.60 – 6.55 (m, 3H), 6.35 (td, J = 7.6, 1.6 Hz, 3H), 5.28 (dd, J = 8.8, 2.4 Hz, 1H), 4.41 (dd, J = 
8.9, 2.4 Hz, 1H), 4.19 (dd, J = 9.0, 1.8 Hz, 2H), 4.09 (d, J = 8.9 Hz, 1H), 3.76 – 3.70 (m, 2H), 2.68 (s, 7H), 
2.55 (s, 4H), 2.26 (d, J = 11.5 Hz, 10H), 0.61 (s, 11H), 0.22 (s, 21H), -19.75 (d, J = 24.8 Hz, 1H), -22.74 (d, 
J = 16.8 Hz, 2H); 13C{1H}-NMR (126 MHz, CD2Cl2) δ 183.66, 181.13, 166.85, 149.38, 148.64, 147.78, 
146.42, 142.03, 140.31, 140.28, 135.71, 135.63, 135.30, 135.28, 133.67, 133.59, 133.30, 133.01, 132.96, 
132.93, 132.90, 132.59, 132.51, 132.36, 132.33, 132.28, 132.25, 131.89, 131.77, 131.71, 131.67, 131.59, 
131.38, 131.06, 131.00, 130.87, 130.85, 130.80, 130.78, 130.71, 130.69, 130.63, 130.60, 130.41, 130.15, 
129.46, 129.37, 129.15, 128.89, 128.79, 128.61, 128.46, 128.31, 128.25, 128.16, 127.73, 127.65, 126.83, 
125.01, 120.33, 119.88, 100.37, 73.38, 72.82, 72.76, 70.11, 69.41, 49.46, 35.34, 34.76, 30.08, 27.12, 25.92, 
25.58, 21.85, 21.06, 19.17, 18.21, 18.08, 17.07, 17.04; 31P{1H}-NMR (162 MHz, CD2Cl2) δ 3.89 (s), -0.03 
(d, J = 9.2 Hz). 
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[{(S)-2-(2-(diphenylphosphino)phenyl)-4-isopropyl-4,5-
dihydrooxazole}-iridium(III)-(d10-N-(1-
phenylethylidene)aniline)(hydrido)(hydrido)(chloride)]  
(d10-325) 
 
By general method 86 (50 mg, 0.0325 mmol, 1.0 eq.) and d10-59 (12.1 
mg, 0.065 mmol, 2.0 eq.) afforded d10-325 (4.7 mg, 0.0058 mmol, 
18%) as a yellow solid. 
 
C38H28D9ClIrN2OP (MW = 805.42 g/mol): 
1H-NMR (500 MHz, CD2Cl2) δ 7.68 (ddt, J = 12.1, 6.3, 1.8 Hz, 2H), 
7.54 (tdd, J = 4.2, 3.3, 1.3 Hz, 1H), 7.45 – 7.35 (m, 5H), 7.15 (tt, J = 7.2, 1.5 Hz, 1H), 6.99 (td, J = 7.9, 2.5 
Hz, 2H), 6.90 – 6.82 (m, 1H), 6.53 (ddd, J = 11.6, 8.0, 1.4 Hz, 2H), 5.29 (ddd, J = 10.3, 4.7, 3.1 Hz, 1H), 
4.26 (dd, J = 8.7, 4.5 Hz, 1H), 4.01 (ddd, J = 10.5, 8.7, 2.0 Hz, 1H), 2.74 (dqd, J = 10.0, 7.0, 2.9 Hz, 1H), 
2.31 (s, 2H), 0.85 (d, J = 7.2 Hz, 3H), 0.00 (d, J = 6.9 Hz, 3H); 31P{1H}-NMR (162 MHz, CD2Cl2) δ 2.76 , 
2.64 (d, J = 14.4 Hz). 
 
 
[{(S)-2-(2-(diphenylphosphino)phenyl)-4-isopropyl-4,5-
dihydrooxazole}-iridium(III)-(N-(1-(3,5-
dimethylphenyl)ethylidene)aniline)(hydrido)(chloride)] (514) 
 
By general method 86 (50 mg, 0.0325 mmol, 1.0 eq.) and 512 (15 mg, 
0.065 mmol, 2.0 eq.) afforded 514 as a yellow solid. No yield was 
determined. 
 
C40H41ClIrN2OP (MW = 824.42 g/mol) 
1H-NMR (400 MHz, CD2Cl2) δ 7.85 – 7.69 (m, 2H), 7.59 – 7.45 (m, 1H), 
7.36 – 7.30 (m, 1H), 7.25 (dddd, J = 13.7, 10.8, 7.6, 1.5 Hz, 5H), 7.02 (td, 
J = 7.4, 1.6 Hz, 1H), 6.98 – 6.92 (m, 2H), 6.92 – 6.86 (m, 2H), 6.82 (td, J 
= 7.8, 2.5 Hz, 2H), 6.63 (td, J = 7.6, 1.5 Hz, 1H), 6.45 (s, 1H), 6.43 – 6.38 (m, 2H), 5.79 – 5.72 (m, 1H), 5.26 
(ddt, J = 6.7, 3.8, 1.9 Hz, 1H), 4.13 (dd, J = 8.7, 4.3 Hz, 1H), 3.88 (dd, J = 10.1, 8.7 Hz, 1H), 2.70 (pd, J = 
6.9, 2.7 Hz, 1H), 2.16 (s, 3H), 2.11 (s, 3H), 2.07 (s, 3H), 0.79 (d, J = 5.5 Hz, 4H), 0.01 (d, J = 6.8 Hz, 3H), -
17.80 (d, J = 19.7 Hz, 1H); 31P{1H}-NMR (162 MHz, CD2Cl2) δ 4.28 (d, J = 11.8 Hz). 
 
 
N
Ir
H Cl
P
N
O
Ph
Ph
Chapter 6 – Experimental Part 
220 
 
 
[{(S)-2-(2-((dicyclohexylphosphino)oxy)propan-2-yl)-4-isopropyl-4,5-
dihydrooxazole}-iridium(III)-(N-(1-(3,5-
dimethylphenyl)ethylidene)aniline)(hydrido)(chloride)] (515) 
 
By general method 87 (50 mg, 0.0325 mmol, 1.0 eq.) and 512 (15 mg, 
0.065 mmol, 2.0 eq.) afforded 515 as a yellow solid. No yield was 
determined. 
 
C37H55ClIrN2O2P (MW = 818.50 g/mol): 
1H-NMR (400 MHz, CD2Cl2) δ 7.64 (s, 1H), 7.50 (d, J = 1.6 Hz, 1H), 7.47 
(s, 0H), 7.26 (td, J = 8.1, 4.1 Hz, 3H), 7.16 (d, J = 1.8 Hz, 1H), 7.13 (d, J = 
2.0 Hz, 0H), 7.08 (tt, J = 7.4, 1.4 Hz, 1H), 7.04 (s, 0H), 7.01 – 6.93 (m, 1H), 6.88 (s, 1H), 6.85 – 6.81 (m, 
1H), 6.78 (s, 1H), 6.70 – 6.64 (m, 1H), 6.51 (t, J = 7.3 Hz, 0H), 6.45 – 6.39 (m, 1H), 5.06 (dt, J = 9.3, 3.0 Hz, 
1H), 4.31 (p, J = 6.5 Hz, 1H), 4.17 (dd, J = 8.7, 3.2 Hz, 1H), 4.02 (q, J = 5.8, 4.9 Hz, 0H), 3.70 (t, J = 9.0 Hz, 
1H), 2.99 – 2.86 (m, 1H), 2.77 (pd, J = 7.0, 2.8 Hz, 1H), 2.39 (s, 3H), 2.33 (s, 3H), 2.29 (s, 2H), 2.19 (d, J = 
1.4 Hz, 5H), 2.09 (s, 1H), 2.05 – 1.91 (m, 1H), 1.83 (dddt, J = 16.6, 13.3, 7.1, 2.9 Hz, 2H), 1.31 (s, 4H), 0.82 
(d, J = 7.1 Hz, 3H), 0.77 (s, 3H), 0.61 (d, J = 6.9 Hz, 4H), -18.86 (d, J = 22.5 Hz, 1H); 31P{1H}-NMR (162 
MHz, CD2Cl2) δ 103.61 (d, J = 17.1 Hz). 
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[{(S)-2-(2-(diphenylphosphino)phenyl)-4-isopropyl-4,5-dihydrooxazole}-iridium(III)-(N-(1-(3,5-
diisopropylphenyl)ethylidene)aniline)(hydrido)(chloride)] (527) 
 
By general method 87 (50 mg, 0.0325 mmol, 1.0 eq.) and 522 (15 mg, 
0.065 mmol, 2.0 eq.) afforded 527 (5.1 mg, 0.0058 mmol, 18%) as a 
yellow solid. 
 
C44H49ClIrN2OP (MW = 880.53 g/mol): 
1H-NMR (500 MHz, CD2Cl2) δ 7.85 (ddt, J = 9.8, 5.7, 2.1 Hz, 2H), 7.72 
– 7.68 (m, 1H), 7.53 (ddd, J = 7.8, 3.9, 1.5 Hz, 1H), 7.42 (d, J = 7.5 Hz, 
1H), 7.41 – 7.35 (m, 5H), 7.13 – 7.06 (m, 7H), 7.01 (t, J = 1.8 Hz, 1H), 
6.92 (td, J = 7.9, 2.5 Hz, 2H), 6.80 (td, J = 7.8, 1.7 Hz, 1H), 6.66 (s, 1H), 
6.65 – 6.62 (m, 1H), 6.57 (d, J = 8.1 Hz, 2H), 6.49 (dd, J = 11.4, 7.7 Hz, 
2H), 5.91 (dt, J = 7.7, 1.5 Hz, 1H), 5.40 (ddd, J = 10.1, 4.2, 2.6 Hz, 1H), 
4.49 (q, J = 6.7 Hz, 1H), 4.27 (dd, J = 8.7, 4.2 Hz, 1H), 4.12 (q, J = 7.1 Hz, 2H), 3.97 (dd, J = 10.0, 8.6 Hz, 
1H), 3.85 – 3.74 (m, 1H), 2.94 – 2.75 (m, 3H), 2.23 (s, 3H), 1.34 (dd, J = 6.9, 3.6 Hz, 3H), 1.28 – 1.24 (m, 
18H), 0.94 (d, J = 7.1 Hz, 3H), 0.77 (d, J = 6.9 Hz, 3H), 0.20 (d, J = 6.9 Hz, 3H), -17.60 (d, J = 19.6 Hz, 
1H); 31P{1H}-NMR (162 MHz, CD2Cl2) δ 3.80 (d, J = 12.0 Hz). 
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[{(S)-2-(2-(diphenylphosphino)phenyl)-4-isopropyl-4,5-dihydrooxazole}-
iridium(III)-((E)-4-phenylbut-3-en-2-one)(hydrido)(chloride)] (387) 
 
By general method 87 (50 mg, 0.0325 mmol, 1.0 eq.) and 386 (14.4 mg, 0.065 
mmol, 2.0 eq.) afforded 387 as a yellow solid. No yield was determined. 
 
C34H34ClIrNO2P (MW = 747.29 g/mol): 
1H-NMR (400 MHz, CD2Cl2) δ 7.57 – 7.24 (m, 12H), 7.21 – 7.16 (m, 3H), 7.13 
(t, J = 7.2 Hz, 1H), 6.97 (ddd, J = 9.5, 7.3, 1.7 Hz, 1H), 6.86 – 6.79 (m, 2H), 
6.77 (s, 1H), 5.50 (ddd, J = 10.1, 4.6, 2.9 Hz, 1H), 4.34 (dd, J = 8.7, 4.6 Hz, 
1H), 4.19 (dd, J = 10.2, 8.7 Hz, 1H), 2.80 (ddq, J = 9.9, 7.0, 3.5, 2.9 Hz, 1H), 2.27 (s, 3H), 0.95 (d, J = 7.0 
Hz, 3H), -0.01 (d, J = 6.8 Hz, 3H), -17.93 (d, J = 19.4 Hz, 1H); 13C{1H}-NMR (126 MHz, CD2Cl2) δ 180.46, 
159.96, 151.22, 148.69, 148.15, 142.64, 134.14, 133.81, 133.72, 133.35, 133.27, 132.72, 132.70, 131.48, 
131.42, 130.81, 130.79, 130.76, 130.40, 130.37, 129.55, 128.77, 128.68, 128.38, 128.21, 128.13, 128.10, 
127.93, 127.84, 127.08, 126.99, 126.12, 124.39, 117.03, 113.38, 70.15, 67.63, 48.25, 39.24, 32.82, 20.89; 
31P{1H}-NMR (162 MHz, CD2Cl2) δ -0.02 (d, J = 5.2 Hz). 
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[{2-(2-(diphenylphosphino)phenyl)-4,5-dihydrooxazole}-iridium(III)-(1-isopropyl-4,4-dimethyl-3-
phenyl-1,4-dihydroisoquinoline)(hydrido)(chloride)] (393) 
 
By general method, 336 (25 mg, 0.0167 mmol, 1.0 eq.) and (R)-392 (5 
mg, 0.018 mmol, 1.1 eq.) were reacted to afford 393 as a yellow solid. 
No yield was determined. 
 
C41H41ClIrN2OP (MW = 836.43 g/mol): 
1H-NMR (500 MHz, CD2Cl2) δ 7.99 – 7.92 (m, 3H), 7.88 – 7.84 (m, 
1H), 7.67 – 7.63 (m, 1H), 7.58 (q, J = 6.7, 6.3 Hz, 2H), 7.54 – 7.47 
(m, 4H), 7.41 – 7.37 (m, 1H), 7.34 – 7.30 (m, 1H), 7.29 – 7.23 (m, 
3H), 7.21 (dd, J = 7.8, 1.6 Hz, 1H), 7.08 – 6.99 (m, 2H), 6.92 (dt, J = 
8.1, 1.7 Hz, 1H), 6.69 (t, J = 7.6 Hz, 1H), 6.55 (t, J = 2.4 Hz, 1H), 6.28 (t, J = 7.5 Hz, 1H), 4.54 – 4.45 (m, 
1H), 4.38 (dt, J = 10.9, 8.0 Hz, 1H), 4.20 (dt, J = 11.1, 8.7 Hz, 1H), 3.56 (ddd, J = 13.5, 10.9, 8.0 Hz, 1H), 
3.24 (ddq, J = 12.5, 8.6, 5.3, 4.2 Hz, 1H), 2.19 (s, 3H), 1.93 (s, 3H), 1.17 (d, J = 7.1 Hz, 3H), 0.94 – 0.83 (m, 
3H), 0.46 (d, J = 6.9 Hz, 3H), -19.13 (d, J = 15.4 Hz, 1H); 31P{1H}-NMR (202 MHz, CD2Cl2) δ 13.76 (d, J = 
13.2 Hz). 
 
 
[{2-(2-(diphenylphosphino)phenyl)-4,5-dihydrooxazole}-iridium(III)-
((R)-2-isopropyl-6-phenyl-2,3,4,5-
tetrahydropyridine)(hydrido)(chloride)] (396) 
 
By general method, 336 (50 mg, 0.0335 mmol, 1.0 eq.) and (R)-394 (7 mg, 
0.035 mmol, 1.1 eq.) were reacted to afford 396 as a yellow solid. No yield 
was determined. 
 
C35H37ClIrN2OP (MW = 760.33 g/mol): 
1H-NMR (400 MHz, CD2Cl2) δ -19.62 (d, J = 15.4 Hz, 1H); 31P{1H}-NMR 
(162 MHz, CD2Cl2) δ -3.05 (s) . 
 
 
[{ƞ5-pentamethylcyclopentadienyl}-iridium(III)-((R)-2-isopropyl-6-phenyl-2,3,4,5-
tetrahydropyridine)(chloride)] (397)[160]  
 
In a 10 mL flame-dried and argon-purged Schlenk vial were placed 279 (14 mg, 
0.0175 mmol, 0.5 eq), (R)-394 (7 mg, 0.035 mmol, 1.1 eq.) and NaOAc (7.2 mg, 
0.0875 mmol, 2.5 eq.). Anhydrous CH2Cl2 (2.5 mL) was added and the reaction 
mixture was stirred at 23 °C for 18 hours. The reaction mixture was filtered over a 
pad of Cellite and a clear orange solution was obtained. After removal of solvents 
under reduced pressure, crystallisation of 397 (10 mg, 0.0173 mmol, 99%) from 
CHCl3 to n-pentane failed. 
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C25H36ClIrN (MW = 578.24 g/mol): 
1H-NMR (500 MHz, CD2Cl2) δ 7.70 (ddd, J = 7.6, 1.2, 0.5 Hz, 1H), 7.43 (dd, J = 7.7, 1.4 Hz, 1H), 7.18 (td, 
J = 7.4, 1.4 Hz, 1H), 7.00 (ddd, J = 7.7, 7.2, 1.2 Hz, 1H), 3.96 (tdt, J = 6.6, 3.3, 1.5 Hz, 1H, H12), 3.13 (dtt, J 
= 17.9, 5.6, 1.5 Hz, 1H, H8), 3.06 (ddp, J = 10.5, 6.9, 3.7 Hz, 1H, H12), 2.88 (dddd, J = 18.0, 7.9, 5.8, 1.7 
Hz, 1H, H8), 2.03 (m, 1H, H9), 1.94 (m, 1H, H10), 1.91 (m, 1H, H10), 1.69 (m, 1H, H9), 1.65 (s, 15H, H15), 
1.13 (d, J = 7.1 Hz, 3H, H13), 0.75 (d, J = 6.6 Hz, 3H, H14). 
 
 
[{ƞ5-pentamethylcyclopentadienyl}-iridium(III)-((R)-2-isopropyl-6-phenyl-2,3,4,5-
tetrahydropyridine)(acetonitrile)]hexafluorophosphate (398)[160]  
 
In a 10 mL flame-dried and argon-purged Schlenk vial were 
placed 397 (10 mg, 0.0175 mmol, 1.0 eq) and KPF6 (13 mg, 
0.053 mmol, 3.0 eq.). Anhydrous MeCN/CH2Cl2 (1:1, 1 mL) 
was added and the reaction mixture was stirred at 23 °C for 18 
hours. The reaction mixture was filtered over a pad of Cellite 
and a clear orange solution was obtained. After removal of 
solvents under reduced pressure, crystallisation to afford 398 
from CHCl3 to n-pentane failed. During recrystallisation the 
product decomposed. 
 
C27H39F6IrN2P (MW = 728.80 g/mol): 
1H-NMR (400 MHz, CD2Cl2) δ 7.62 (dd, J = 7.6, 1.2 Hz, 1H, H4), 7.41 (dd, J = 7.7, 1.4 Hz, 1H, H1), 7.19 
(td, J = 7.4, 1.4 Hz, 1H, H3), 7.07 (td, J = 7.5, 1.2 Hz, 1H, H2), 3.70 (dq, J = 7.8, 3.3, 2.6 Hz, 1H, H11), 3.14 
– 3.03 (m, 1H), 2.76 (dddd, J = 18.4, 9.6, 5.7, 2.1 Hz, 1H), 2.65 – 2.58 (m, 1H), 2.30 (s, 3H, H18), 1.59 (s, 
15H, H15), 1.09 (d, J = 7.0 Hz, 3H, H13), 0.58 (d, J = 6.7 Hz, 3H, H14).  
 
[{2-(2-(diphenylphosphino)phenyl)-4,5-dihydrooxazole}-iridium(III)-((S)-4-Methyl-2-phenyl-4H-
benzo[e][1,3]oxazine)(hydrido)(chloride)] (401) 
 
By general method 336 (25 mg, 0.017 mmol, 1.0 eq.) and (S)-399 (3 
mg, 0.013 mmol, 0.8 eq.) afforded 6 mg (0.008 mmol, 59%) of 401 as 
a yellow solid. 
 
C36H31ClIrN2O2P (782.29 g/mol): 
1H-NMR (400 MHz, CD2Cl2) δ 7.89 (dd, J = 7.7, 3.2 Hz, 1H), 7.73 
(dd, J = 11.4, 7.3 Hz, 2H), 7.57 – 7.08 (m, 21H), 6.93 (dd, J = 11.1, 
6.9 Hz, 2H), 6.66 (t, J = 7.4 Hz, 1H), 6.59 (d, J = 7.9 Hz, 1H), 6.38 – 
6.30 (m, 1H), 5.77 (dd, J = 12.4, 5.9 Hz, 1H), 4.52 – 4.39 (m, 2H), 
4.29 (ddd, J = 16.4, 12.9, 10.0 Hz, 2H), 4.17 (dt, J = 17.7, 8.9 Hz, 
1H), 3.60 (ddd, J = 13.6, 11.1, 8.5 Hz, 2H), 1.58 (d, J = 6.6 Hz, 3H), -
19.09 (d, J = 15.9 Hz, 1H); 31P{1H}-NMR (162 MHz, CD2Cl2) δ 
12.44 (sbr). 
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[{2-(2-(diphenylphosphino)phenyl)-4,5-dihydrooxazole}-iridium(III)-((S)-4-Isopropyl-2-phenyl-4H-
benzo[e][1,3]oxazine)(hydrido)(chloride)] (402) 
 
By general method 336 (25 mg, 0.017 mmol, 1.0 eq.) and (S)-395 
(10.5 mg, 0.042 mmol, 2.5 eq.) afforded 10.4 mg (0.013 mmol, 
75%) of 402 as a yellow solid. 
 
C38H35ClIrN2O2P (810.34 g/mol): 
1H-NMR (400 MHz, CD2Cl2) δ 7.88 (dd, J = 6.9, 3.5 Hz, 1H), 7.75 
(dd, J = 11.4, 7.4 Hz, 2H), 7.55 – 7.38 (m, 5H), 7.34 (td, J = 7.6, 2.0 
Hz, 2H), 7.31 – 7.25 (m, 1H), 7.25 – 7.09 (m, 5H), 6.98 – 6.86 (m, 
2H), 6.64 (t, J = 7.3 Hz, 1H), 6.59 (d, J = 7.9 Hz, 1H), 6.34 (td, J = 
7.7, 1.6 Hz, 1H), 5.59 – 5.51 (m, 1H), 4.44 (ddd, J = 13.6, 10.9, 9.4 
Hz, 1H), 4.31 – 4.22 (m, 1H), 4.14 (dt, J = 10.9, 9.0 Hz, 1H), 3.57 
(ddd, J = 13.6, 11.1, 8.3 Hz, 1H), 2.96 – 2.84 (m, 1H), 0.94 (d, J = 
7.1 Hz, 3H), 0.56 (d, J = 6.9 Hz, 3H), -19.19 (d, J = 15.9 Hz, 1H); 31P{1H}-NMR (162 MHz, CD2Cl2) δ 
12.49 (s).  
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[{2-(2-(diphenylphosphino)phenyl)-4,5-dihydrooxazole}-iridium(III)-((S)-4-tert-butyl-2-phenyl-4H-
benzo[e][1,3]oxazine)(hydrido)(chloride)] (403) 
 
By general method 336 (50 mg, 0.0334 mmol, 1.0 eq.) and (S)-400 
(17.2 mg, 0.067 mmol, 2.0 eq.) afforded 15.1 mg (0.018 mmol, 55%) 
of 403 as a yellow solid. 
 
C39H37ClIrN2O2P (824.37 g/mol): 
1H-NMR (500 MHz, CD2Cl2) δ 7.80 (dd, J = 11.6, 7.6 Hz, 2H), 7.73 
(dd, J = 8.0, 3.7 Hz, 1H), 7.55 – 7.33 (m, 8H), 7.33 – 7.10 (m, 8H), 
6.94 (dd, J = 11.2, 7.5 Hz, 2H), 6.63 (dd, J = 8.1, 5.3 Hz, 2H), 6.33 (t, 
J = 7.5 Hz, 1H), 5.75 (d, J = 2.5 Hz, 1H), 4.27 (ddd, J = 13.8, 11.0, 
8.7 Hz, 1H), 4.17 – 4.06 (m, 1H), 3.96 (dt, J = 11.1, 8.5 Hz, 1H), 3.03 (ddd, J = 13.7, 10.9, 8.6 Hz, 1H), 1.01 
(s, 9H), -19.44 (d, J = 16.7 Hz, 1H); 31P{1H}-NMR (202 MHz, CD2Cl2) δ 12.41 (d, J = 10.9 Hz). 
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[{ƞ5-pentamethylcyclopentadienyl}-iridium(III)-((S)-4-isopropyl-2-phenyl-4H-
benzo[e][1,3]oxazine)(chloride)] (404) 
 
In a 10 mL flame-dried and argon-purged Schlenk vial were placed 279 (22.3 
mg, 0.028 mmol, 0.5 eq), (S)-395 (14.7 mg, 0.059 mmol, 2.02 eq.) and NaOAc 
(4 mg, 0.048 mmol, 2.4 eq.). Anhydrous CH2Cl2 (2.5 mL) was added and the 
reaction mixture was stirred at 23 °C for 18 hours. The reaction mixture was 
filtered over a pad of Cellite and a clear orange solution was obtained. After 
removal of solvents under reduced pressure, crystallisation of 404 from CHCl3 
to n-pentane afforded orange crystals suitable for X-Ray crystal structure 
analysis. 
 
C28H34ClIrNO (MW = 628.25 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 7.76 (d, J = 7.4 Hz, 1H), 7.64 (dd, J = 7.7, 1.4 Hz, 1H), 7.36 (td, J = 8.0, 1.6 
Hz, 1H), 7.28 – 7.24 (m, 1H), 7.24 – 7.20 (m, 1H), 7.18 (dd, J = 8.1, 1.2 Hz, 1H), 7.11 (dd, J = 7.6, 1.6 Hz, 
1H), 7.03 (td, J = 7.6, 1.1 Hz, 1H), 4.76 (d, J = 3.0 Hz, 1H), 3.06 (pd, J = 6.9, 3.1 Hz, 1H), 1.71 (s, 15H), 
1.04 (d, J = 7.2 Hz, 3H), 0.61 (d, J = 6.6 Hz, 3H); 13C{1H}-NMR (101 MHz, CDCl3) δ 170.09, 162.97, 
149.34, 137.01, 134.52, 132.45, 128.86, 126.99, 126.80, 124.93, 121.69, 119.33, 115.96, 87.90, 66.42, 31.89, 
19.84, 15.70, 9.62, 9.21; X-Ray: formula C27H31Cl Ir NO, M = 613.22, F(000) = 1208, orange needle, size 
0.030 ·  0.040 ·  0.210 mm3, monoclinic, space group P 21, Z = 4, a = 9.1793(7) Å, b = 14.6017(12) Å, c = 
18.2189(15) Å, α = 90°, β = 99.183(5)°, γ = 90°, V = 2410.6(3) Å3, Dcalc. = 1.690 Mg ·  m-3. The crystal was 
measured on a Bruker Kappa Apex2 diffractometer at 123K using graphite-monochromated Mo Kα-radiation 
with λ = 0.71073 Å, Θmax = 30.033°. Minimal/maximal transmission 0.80/0.84, µ = 5.668 mm-1. The Apex2 
suite has been used for datacollection and integration. From a total of 52809 reflections, 14034 were 
independent (merging r = 0.083). From these, 10430 were considered as observed (I>2.0σ(I)) and were used 
to refine 560 parameters. The structure was solved by direct methods using the program SIR92. Least-
squares refinement against F was carried out on all non-hydrogen atoms using the program CRYSTALS. R = 
0.0422 (observed data), wR = 0.0549 (all data), GOF = 1.0993. Minimal/maximal residual electron density = 
-1.82/2.70 e Å-3. Chebychev polynomial weights were used to complete the refinement. Plots were produced 
using CAMERON. 
 
 
[{ƞ5-pentamethylcyclopentadienyl}-iridium(III)-((R)-N-benzylidene-1-(naphthalen-1-
yl)ethanamine)(chloride)] (379) 
 
In a 10 mL flame-dried and argon-purged Schlenk vial were placed 279 (32 
mg, 0.04 mmol, 0.5 eq), 370 (20.7 mg, 0.08 mmol, 2.02 eq.) and NaOAc 
(16.4 mg, 0.2 mmol, 5.0 eq.). Anhydrous CH2Cl2 (2.5 mL) was added and 
the reaction mixture was stirred at 23 °C for 18 hours. The reaction mixture 
was filtered over a pad of Cellite and a clear orange solution was obtained. 
After removal of solvents under reduced pressure, crystallisation of 379 
from CHCl3 to n-pentane afforded orange crystals suitable for X-Ray 
crystal structure analysis. 
 
C30H34ClIrN (MW = 636.28 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 7.99 (s, 1H), 7.94 (dd, J = 8.1, 1.1 Hz, 1H), 7.90 (d, J = 8.1 Hz, 2H), 7.77 (d, 
J = 7.6 Hz, 1H), 7.57 (d, J = 6.7 Hz, 1H), 7.55 – 7.44 (m, 3H), 7.31 (dd, J = 7.5, 1.1 Hz, 1H), 7.15 (td, J = 
7.5, 1.4 Hz, 1H), 6.90 (td, J = 7.4, 0.9 Hz, 1H), 6.04 (q, J = 7.0 Hz, 1H), 2.08 (d, J = 7.0 Hz, 3H), 1.73 (s, 
15H); 13C{1H}-NMR (101 MHz, CDCl3) δ 174.36, 167.72, 147.08, 136.21, 134.83, 134.20, 131.63, 131.26, 
129.33, 129.15, 128.82, 126.69, 126.02, 125.63, 125.49, 123.77, 121.88, 89.39, 65.42, 21.80, 9.53; X-Ray: 
formula C29H31Cl1Ir1N1, M = 621.24, F(000) = 1224, orange plate, size 0.030 ·  0.110 ·  0.240 mm3, 
orthorhombic, space group P 21 21 21, Z = 4, a = 8.6842(10) Å, b = 13.0346(14) Å, c = 21.364(2) Å, α = 90°, 
β = 90°, γ = 90°, V = 2418.3(5) Å3, Dcalc. = 1.706 Mg ·  m-3. The crystal was measured on a Bruker Kappa 
Apex2 diffractometer at 123K using graphite-monochromated Mo Kα-radiation with λ = 0.71073 Å, Θmax = 
45.392°. Minimal/maximal transmission 0.54/0.84, µ = 5.649 mm-1. The Apex2 suite has been used for 
datacollection and integration. From a total of 147574 reflections, 20281 were independent (merging r = 
0.044). From these, 18362 were considered as observed (I>2.0σ(I)) and were used to refine 290 parameters. 
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The structure was solved by Other methods using the program Superflip. Least-squares refinement against F 
was carried out on all non-hydrogen atoms using the program CRYSTALS. R = 0.0167 (observed data), wR 
= 0.0186 (all data), GOF = 1.0872. Minimal/maximal residual electron density = -1.95/1.74 e Å-3. 
Chebychev polynomial weights were used to complete the refinement. Plots were produced using 
CAMERON. 
 
 
Hydrogenations 
 
All hydrogenation reactions were carried out in anhydrous crown-cap dichloromethane, which was used 
without further purification. 
 
Procedure for the hydrogenation at elevated pressure: Imine (0.1 mmol), catalyst (2 µmol), addtive (2 µmol), 
and a stir bar were added to an oven-dried glass vial that had been placed in an autoclave (60 mL) and 
purged with argon for 5 min. Anhydrous CH2Cl2 (1 mL) was added by syringe under a stream of argon and 
the autoclave was closed. For reactions at low temperature the autoclave was immersed in a cooling bath for 
60 min before starting the reaction. The autoclave was pressurized with hydrogen gas, hydrogen was released 
and the autoclave pressurized again. It was then placed on a stirring plate for the time indicated. After 
pressure release the solvent was evaporated under a stream of nitrogen.  
 
Procedure for the hydrogenation at atmospheric pressure: 
Same procedure as above, but the vials were placed in a flask equipped with 24/40 joint which was closed 
with a rubber septum. The flask was evacuated and purged with hydrogen gas via H2-filled balloon (Dräger 
1.5 L) three times. The solvent (1 mL) was added via syringe and the flask placed on a stirring plate for the 
time indicated.  
 
The residue was suspended in pentane/ether (5:1) and filtered through a short elution plug (cotton bottom, 
40x5 mm silica gel). The crude filtrate was analysed by GC for conversion before being purified by flash 
chromatography (SiO2, pentane/ether 20:1, 15x2 cm) and analysed by HPLC on a chiral stationary phase for 
determination of the enantiomeric excess.  
 
Derivatization for the determination of enantiomeric excess: 
N-(1-cyclohexylethyl)propan-2-amine was dissolved in CH2Cl2 (1 mL) before acetic anhydride and 
triethylamine (4 drops each) were added. The solution was stirred for 30 minutes at room temperature and 
solvents evaporated by a stream of nitrogen. The residue was suspended in pentane/ether (5:1) and filtered 
through a CHROMAPHIL HPLC filter prior to GC analysis. 
N-benzyl-1-cyclohexylethanamine and N-(1-cyclohexylethyl)cyclohexanamine was dissolved in CH2Cl2 (1 
mL) before 1-naphtoyl chloride and triethylamine (4 drops each) were added. The solution was stirred for 30 
minutes at room temperature. The product was purified by flash chromatography prior to HPLC analysis. 
 
Assignment of the absolute configuration: 
 
The absolute configuration of (R)-(-)-N-(1-cyclohexylethyl)aniline, (R)-(-)-N-(3-methylbutan-2-yl)aniline, 
(S)-(+)-N-(octan-2-yl)aniline and (R)-(-)-N-(3,3-dimethylbutan-2-yl)aniline was determined by comparison 
of optical rotation as well as the chiral staionary phase GC or HPLC data obtained after conducting a 
Buchwald-Hartwig amination.[161] 
 
 
 
The absolute configuration of (R)-N-benzyl-1-cyclohexylethanamine, (R)-N-(1-cyclohexylethyl)butan-1-
amine,  (R)-N-(1-cyclohexylethyl)propan-2-amine and (R)-N-(1-cyclohexylethyl)cyclohexanamine was 
determined by comparison of the optical rotation and the chiral staionary phase GC or HPLC data obtained 
after condensation of (R)-cyclohexylethylamine with the corresonding aldehyde and subsequent reduction 
with NaBH4 or LiAlH4. 
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N-(1-phenylethyl)aniline (60)[30] 
  
C14H15N (MW = 197.28 g/mol): 
GC (Machary-Nagel Optima-5-Amin (0.50 µm x 0.25 µm x 30 m), 60 kPa He, 
150 °C min, 7°C/min, 250 °C/10 min): tR = 12.8 min; HPLC (Daicel Chiracel 
OD-H (2.6 x 250 mm), n-heptane/iso-propanol 99:1, 0.5 mL/min, 20 °C, 210 nm): 
tR = 24.6 min (S), tR = 33.0 min (R). 
 
 
N-(1-(4-methoxyphenyl)ethyl)aniline (323)[[Schnider, 1997 #1]]  
  
C15H17NO (MW = 227.31 g/mol): 
GC (Machary-Nagel Optima-5-Amin (0.50 µm x 0.25 µm x 30 m), 60 kPa 
He, 150 °C min, 7°C/min, 250 °C/10 min): tR = 19.6 min. 
 
 
(R)-(-)-N-(1-cyclohexylethyl)aniline (97)[148] 
 
C14H21N (MW = 203.32 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 7.19 – 7.10 (m, 2H), 6.64 (t, J = 7.3 Hz, 1H), 6.57 
(d, J = 7.7 Hz, 2H), 3.48 (s, 1H), 3.39 – 3.25 (m, 1H), 1.88 – 1.61 (m, 5H), 1.51 – 
1.39 (m, 1H), 1.32 – 1.15 (m, 3H), 1.12 (d, J = 6.5 Hz, 3H), 1.10 – 0.99 (m, 2H); 13C{1H}-NMR (101 MHz, 
CDCl3) δ 148.10, 129.40, 116.63, 113.07, 53.10, 43.10, 29.93, 28.54, 26.79, 26.63, 26.49, 17.55; GC 
(Machary-Nagel Optima-5-Amin (0.50 µm x 0.25 µm x 30 m), 60 kPa H2, 100 °C/2 min, 10°C/min, 250 
°C/10 min): tR = 19.6 min; GC-MS: (Rtx-5MS, 100.2/10.270/10): tR = 15.7 min, m/z = 203 ([M]+), 120; 
HPLC (Daicel Chiracel OJ-H, n-heptane/iso-propanol 99:1, 0.5 mL/min, 25 °C, 247/297 nm): tR = 21.0 min 
((R)-(-)), tR = 24.0 min ((S)-(+)); Optical Rotation: [] = - 19.0 (c 1.0 in CHCl3, 0.75% EtOH). 
 
 
(R)-(-)-N-(3-methylbutan-2-yl)aniline (513)[141]  
 
C11H17N (MW = 163.26 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 7.16 (t, J = 7.9 Hz, 2H), 6.65 (t, J = 7.3 Hz, 1H), 6.58 
(d, J = 7.8 Hz, 2H), 3.48 (s, 1H), 3.42 – 3.27 (m, 1H), 1.93 – 1.77 (m, 1H), 1.10 (d, J 
= 6.4 Hz, 3H), 0.98 (d, J = 6.9 Hz, 3H), 0.92 (d, J = 6.8 Hz, 3H); 13C{1H}-NMR (101 MHz, CDCl3) δ 
147.98, 129.41, 116.75, 113.18, 53.55, 32.35, 19.34, 17.65, 16.71; GC-MS (EI, 70 eV, PhMeSi, 
80.2/10.270/10): tR = 10.4 min, m/z = 163 ([M]+), 120 ([M-(C(CH3)3)]+); GC (Machary-Nagel Optima-5-
Amin (0.50 µm x 0.25 µm x 30 m), 60 kPa H2, 100 °C/2 min, 10°C/min, 250 °C/7 min): tR = 13.3 min; 
HPLC (Daicel Chiracel OJ, n-heptane/iso-propanol 100:0, 0.5 mL/min, 25 °C, 247/297 nm): tR = 31.2 min 
((R)-(-)), tR = 36.1 min ((S)-(+)); Optical Rotation: [] = - 49.4 (c 1.0 in CHCl3, 0.75% EtOH). 
 
 
(-)-N-(4-methylpentan-2-yl)aniline (119)[162] 
 
C12H19N (MW = 177.29 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 7.16 (t, J = 7.9 Hz, 2H), 6.66 (t, J = 7.3 Hz, 1H), 
6.58 (d, J = 7.8 Hz, 2H), 3.60 – 3.47 (m, 1H), 3.36 (s, 1H), 1.84 – 1.68 (m, 1H), 
1.48 (dt, J = 14.0, 7.1 Hz, 1H), 1.26 (dt, J = 13.7, 6.9 Hz, 1H), 1.16 (d, J = 6.2 Hz, 
3H), 0.95 (d, J = 6.6 Hz, 3H), 0.91 (d, J = 6.6 Hz, 3H); 13C{1H}-NMR (101 MHz, CDCl3) δ 147.85, 129.42, 
N
H
O
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116.86, 113.15, 47.07, 46.58, 25.23, 23.10, 22.72, 21.21; GC-MS: (Rtx-5MS, 100.2/10.270/10): tR = 9.8 
min, m/z = 177 ([M]+), 162, 120; GC (Machary-Nagel Optima-5-Amin (0.50 µm x 0.25 µm x 30 m), 60 kPa 
H2, 100 °C/2 min, 10°C/min, 250 °C/7 min): tR = 14.4 min; HPLC (Daicel Chiracel OJ-H, n-heptane/iso-
propanol 99:1, 0.5 mL/min, 25 °C, 247/297 nm): tR = 19.6 min (+), tR = 22.5 min (-); Optical Rotation: [] = - 24.6 (c 1.10 in CHCl3 0.75% EtOH), 69% ee. 
 
 
N-(1-phenylpropan-2-yl)aniline (82)[148] 
 
C15H17N (MW = 211.30 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 7.30 (m, 2H, CHAr), 7.20 (m, 5H, CHAr), 6.69 
(t, J = 7.3 Hz, 1H, CHArCHArCHArCAr-N), 6.63 (dd, J = 8.5, 0.9 Hz, 2H, 
CHArCAr-N)), 3.77 (qdd (m), 1H, CHNH), 3.53 (sbr, 1H, NH), 2.95 (dd, J = 
13.4, 4.7 Hz, 1H, CH2Ph), 2.70 (dd, J = 13.4, 7.3 Hz, 1H, CH2Ph), 1.16 (d, J = 6.4 Hz, 3H, CH3CHNH); 
13C{1H}-NMR (101 MHz, CDCl3) δ 147.37, 138.69, 129.66, 129.51, 128.47, 126.42, 117.32, 113.50, 49.49, 
42.46, 20.35; GC-MS: (Rtx-5MS, 100.2/10.270/10): tR = 17.3 min, m/z = 211 ([M]+), 120, 103, 91; GC 
(Machary-Nagel Optima-5-Amin (0.50 µm x 0.25 µm x 30 m), 60 kPa H2, 100 °C/2 min, 10°C/min, 250 °C/7 
min): tR = 21.1 min; HPLC (Daicel Chiracel OJ-H, n-heptane/iso-propanol 97:3, 0.5 mL/min, 25 °C, 
208/243 nm): tR = 21.2 min (+), tR = 23.2 min (-); Optical Rotation: [] = +1.3 (c 0.65 in CHCl3 0.75% 
EtOH), 72% ee. 
 
 
(-)-N-(pentan-2-yl)aniline (67)[162] 
 
C11H17N (MW = 163.26 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 7.21 - 7.11 (m, 2H), 6.69 - 6.63 (m, 1H), 6.61 - 
6.55 (m, 2H), 3.48 (dq, J = 21.1, 5.9 Hz, H), 3.42 (s, 1H), 1.60 - 1.51 (m, 1H), 
1.48 - 1.36 (m, 3H), 1.18 (d, J = 6.3 Hz, 3H), 0.94 (ddd, J = 7.1, 4.1, 3.2 Hz, 3H); 
13C{1H}-NMR (101 MHz, CDCl3) δ 147.87 (CAr-N), 129.41 (CHArCHArCAr-N), 116.86 (CHArCHArCHArCAr-
N), 113.18 (CHArCAr-N), 48.30 (CHNH), 39.60 (CH2CHNH), 20.92 (CH2CH2CHNH), 19.47 (CH3CHNH), 
14.27 (CH3CH2); GC-MS (EI, 70 eV, PhMeSi, 100.2/10.270/10): tR = 7.9 min, m/z = 163 ([M]+), 148, 132, 
120; GC (Machary-Nagel Optima-5-Amin (0.50 µm x 0.25 µm x 30 m), 60 kPa H2, 100 °C/2 min, 10°C/min, 
250 °C/7 min): tR = 13.6 min; HPLC (Daicel Chiracel OJ-H, n-heptane/iso-propanol 99:1, 0.5 mL/min, 25 
°C, 247/297 nm): tR = 19.1 min (+), tR = 21.6 min (-);  
Optical Rotation: [] = -14.5 (c 2.565 in CHCl3 0.75% EtOH), 40% ee. 
 
 
N-(6-methylhept-5-en-2-yl)aniline (543)[42] 
 
C14H21N (MW = 203.32 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 7.16 (t, J = 7.7 Hz, 2H, CHArCHArCAr-N), 
6.66 (t, J = 7.3 Hz, 1H, CHArCHArCHArCAr-N), 6.57 (d, J = 7.9 Hz, 2H, 
CHArCAr-N), 5.13 (t, J = 7.3 Hz, 1H, (CH3)2C=CHCH2), 3.47 (qd, J = 12.8, 
6.4 Hz, 1H, CHNH), 3.42 (sbr, 1H, NH), 2.09 (dd, J = 14.7, 7.5 Hz, 2H, (CH3)2C=CHCH2CH2), 1.70 (s, 3H, 
(CH3)2C=CH), 1.60 (m, 1H, CH2CH2CHNH), 1.59 (s, 3H, (CH3)2C=CH), 1.48 (dt, J = 13.9, 7.1 Hz, 1H, 
CH2CH2CHNH), 1.19 (d, J = 6.2 Hz, 3H, CH3CHNH); 13C{1H}-NMR (101 MHz, CDCl3) δ 147.86 (CAr-N), 
132.14 ((CH3)2C=CH), 129.39 (CHArCHArCAr-N), 124.14 ((CH3)2C=CH), 116.91 (CHArCHArCHArCAr-N), 
113.25 (CHArCAr-N), 48.23 (CHNH), 37.34 (CH2CHNH), 25.86 ((CH3)2C=CH), 24.87 (C=CHCH2), 20.93 
(CH3CHNH), 17.82 ((CH3)2C=CH); GC-MS: (Rtx-5MS, 100.2/10.270/10): tR = 14.2 min, m/z = 203 ([M]+), 
188, 160, 1446, 133, 120; GC (Machary-Nagel Optima-5-Amin (0.50 µm x 0.25 µm x 30 m), 60 kPa H2, 100 
°C/2 min, 10°C/min, 250 °C/7 min): tR = 17.9 min; HPLC (Daicel Chiracel OJ-H, n-heptane/iso-propanol 
99:1, 0.5 mL/min, 25 °C, 247/297 nm): tR = 16.1 min (+), tR = 18.6 min (-); Optical Rotation: [] = -0.8 
(c 1.0 in CHCl3 0.75% EtOH), 50% ee. 
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(S)-(+)-N-(octan-2-yl)aniline (335)[163] 
 
C14H23N (MW = 205.34 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 7.19 – 7.13 (m, 2H), 6.68 – 6.63 (m, 
1H), 6.60 – 6.55 (m, 2H), 3.46 (dt, J = 12.6, 6.2 Hz, 1H), 3.43 – 3.37 
(m, 1H), 1.62 – 1.52 (m, 1H), 1.47 – 1.34 (m, 3H), 1.34 – 1.24 (m, 6H), 
1.17 (d, J = 6.2 Hz, 3H), 0.92 – 0.85 (m, 3H); 13C{1H}-NMR (101 MHz, CDCl3) δ 147.85, 129.40, 116.85, 
113.19, 48.59, 37.38, 32.00, 29.52, 26.29, 22.78, 20.93, 14.25; GC-MS: (Rtx-5MS, 100.2/10.270/10): tR = 
14.2 min, m/z = 205 ([M]+), 190, 132, 120; GC (Machary-Nagel Optima-5-Amin (0.50 µm x 0.25 µm x 30 
m), 60 kPa H2, 100 °C/2 min, 10°C/min, 250 °C/7 min): tR = 18.07 min; HPLC (Daicel Chiracel OB-H, n-
heptane/iso-propanol 99:1, 0.5 mL/min, 40 °C, 247/297 nm): tR = 9.97 min ((R)-(-)), tR = 10.71 min ((S)-(+)); 
Optical Rotation: [] = +14.8 (c 1.0 in CHCl3, 0.75% EtOH). 
 
 
(-)-N-(1-cyclopentylethyl)aniline (539) 
 
C13H19N (MW = 189.30 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 7.15 (t, J = 7.9 Hz, 2H), 6.64 (t, J = 7.3 Hz, 1H), 
6.58 (d, J = 7.7 Hz, 2H), 3.47 (s, 1H), 3.32 (s, 1H), 1.92 (dq, J = 16.3, 8.0 Hz, 1H), 
1.86 – 1.70 (m, 2H), 1.69 – 1.48 (m, 4H), 1.37 – 1.23 (m, 2H), 1.16 (d, J = 6.2 Hz, 3H); 13C{1H}-NMR (101 
MHz, CDCl3) δ 148.10, 129.39, 116.73, 113.14, 53.07, 46.80, 29.91, 29.62, 25.84, 25.65, 19.49; IR (neat, 
ATR) ν/cm-1 = 3401 (wbr), 3050 (w), 3017 (w), 2950 (m), 2864 (m), 1600 (s), 1502 (s), 1450 (w), 1426 (w), 
1318 (m), 1250 (w), 1178 (w), 1144 (m), 1074 (w), 993 (w), 745 (s), 692 (m); GC-MS: (Rtx-5MS, 
100.2/10.270/10): tR = 13.8 min, m/z = 189 ([M]+), 120; GC (Machary-Nagel Optima-5-Amin (0.50 µm x 
0.25 µm x 30 m), 60 kPa H2, 100 °C/2 min, 10°C/min, 250 °C/7 min): tR = 17.8 min; HPLC (Daicel Chiracel 
OJ-H, n-heptane/iso-propanol 99:1, 0.5 mL/min, 25 °C, 247/297 nm): tR = 23.1 min (+), tR = 26.1 min (-): 
EA: calc. C, 82.48; H, 10.12; N, 7.40; found: C, 82.19; H, 9.95; N, 7.58; Optical Rotation: [] = - 0.5 (c 
0.05 in CHCl3 0.75% EtOH), 76% ee. 
 
 
(R)-(-)-N-(3,3-dimethylbutan-2-yl)aniline (98)[148] 
 
C12H19N (MW = 177.29 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 7.15 (t, J = 7.9 Hz, 2H, CHArCHArCAr-N), 6.63 (t, J = 
7.4 Hz, 1H, CHArCHArCHArCAr-N), 6.59 (d, J = 8.5 Hz, 2H, CHArCAr-N), 3.39 (sbr, 
1H, NH), 3.24 (q, J = 6.5 Hz, 1H, CH3CH), 1.09 (d, J = 6.4 Hz, 3H, CH3CHNH), 0.96 (s, 9H, C(CH3)3); 
13C{1H}-NMR (101 MHz, CDCl3) δ 148.63 (CAr-N), 129.40 (CHArCHArCAr-N), 116.65 (CHArCHArCHArCAr-
N), 113.13 (CHArCAr-N), 57.32 (CHNH), 34.92 (C(CH3)3), 26.68 (C(CH3)3), 15.98 (CH3CHNH); GC-MS: 
(Rtx-5MS, 100.2/10.270/10): tR = 9.3 min, m/z = 177 ([M]+), 120; GC (Machary-Nagel Optima-5-Amin 
(0.50 µm x 0.25 µm x 30 m), 60 kPa H2, 100 °C/2 min, 10°C/min, 250 °C/10 min): tR = 14.1 min; HPLC 
(Daicel Chiracel OJ-H, n-heptane/iso-propanol 99:1, 0.5 mL/min, 25 °C, 247/297 nm): tR = 15.1 min ((R)-(-
)), tR = 18.4 min ((S)-(+)); Optical Rotation: [] = - 65.6 (c 1.0 in CHCl3, 0.75% EtOH). 
 
 
(R)-N-benzyl-1-cyclohexylethanamine (84)[62] 
 
C15H23N (MW = 217.35 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 7.35 – 7.28 (m, 4H), 7.26 – 7.21 (m, 1H), 3.84 
(d, J = 13.1 Hz, 1H), 3.71 (d, J = 13.1 Hz, 1H), 2.50 (p, J = 6.3 Hz, 1H), 1.80 – 
1.62 (m, 5H), 1.36 (tdt, J = 11.5, 5.6, 3.1 Hz, 1H), 1.30 – 1.19 (m, 2H), 1.19 – 1.10 (m, 2H), 1.03 (m, 2H), 
1.03 (d, J = 6.5 Hz, 3H); GC (Machary-Nagel Optima-5-Amin (0.50 µm x 0.25 µm x 30 m), 60 kPa H2, 100 
°C/2 min, 10°C/min, 250 °C/7 min): tR = 20.0 min; GC-MS: (Rtx-5MS, 100.2/10.270/10): tR = 16.2 min, m/z 
= 202 ([M-CH3]+), 134 ([M-C6H11]+), 91; HPLC (Daicel Chiracel OD-H, n-heptane/iso-propanol 95:5, 0.8 
mL/min, 25 °C, 225/287 nm): tR = 15.9 min ((R)-1-naphtamide), tR = 19.9 min ((S)-1-naphtamide); Optical 
Rotation: [] = - 23.7° (c 1.0 in CHCl3 0.75% EtOH) 
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(R)-N-(1-cyclohexylethyl)butan-1-amine (553) 
 
C12H25N (MW = 183.33 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 2.63 (dt, J = 13.9, 7.3 Hz, 1H), 2.50 (dt, J = 
11.3, 7.2 Hz, 1H), 2.42 (p, J = 6.2 Hz, 1H), 1.75 (dt, J = 12.4, 3.4 Hz, 2H), 1.71 
– 1.61 (m, 3H), 1.45 (p, J = 7.1 Hz, 2H), 1.34 (h, J = 7.5 Hz, 3H), 1.27 – 0.98 (m, 5H), 0.97 (d, J = 6.6 Hz, 
3H), 0.91 (t, J = 7.1 Hz, 3H), 0.81 (s, 1H, NH); 13C{1H}-NMR (101 MHz, CDCl3) δ 58.03, 47.54, 43.06, 
32.79, 30.18, 28.10, 26.96, 26.85, 26.69, 20.76, 16.98, 14.19; IR (neat, ATR) ν/cm-1 = 2956 (m), 2920 (s), 
2851 (s), 2809 (w), 1463 (w), 1447 (m), 1370 (m), 1154 (w), 1124 (w), 890 (w), 834 (w); GC (Machary-
Nagel Optima-5-Amin (0.50 µm x 0.25 µm x 30 m), 60 kPa H2, 100 °C/2 min, 10°C/min, 250 °C/7 min): tR = 
13.7 min; GC-MS: (Rtx-5MS, 100.2/10.270/10): tR = 9.0 min, m/z = 168 ([M-CH3]+), 140, 100 ([M-
C6H11]+); GC (MEGA Diethyl-terbutylsilyl-b-086 (0.25 µm x 0.25 mm x 25 m), 60 kPa H2, 90 °C/10 min, 
1°C/min to 120°C, 10°C/min to 180°C, 10 min): tR = 21.7 min (S), tR = 22.1 min (R); HRMS: calc. 
183.1987, found: 184.2062 (M+H); Optical Rotation: [] = - 12.2° (c 1.0 in CHCl3 0.75% EtOH) 
 
 
(R)-N-(1-cyclohexylethyl)propan-2-amine (555) 
 
C11H23N (MW = 169.31 g/mol): 
1H-NMR (500 MHz, CDCl3) δ 2.84 (hept, J = 6.3 Hz, 1H), 2.48 (p, J = 6.3 Hz, 1H), 
1.73 (dt, J = 11.8, 3.5 Hz, 2H), 1.64 (q, J = 11.4 Hz, 3H), 1.28 (tq, J = 11.3, 3.4 Hz, 
1H), 1.20 (dddd, J = 15.9, 9.7, 5.1, 3.3 Hz, 2H), 1.16 – 1.08 (m, 1H), 1.02 (d, J = 6.3 Hz, 3H), 0.99 (d, J = 
6.2 Hz, 3H), 0.97 (m, 1H), 0.96 (m, H), 0.94 (d, J = 6.5 Hz, 3H), 0.63 (s, 1H, NH); 13C{1H}-NMR (101 
MHz, CDCl3) δ 54.64, 45.69, 43.23, 30.33, 27.93, 26.97, 26.86, 26.67, 23.99, 23.27, 17.54; GC-MS: (Rtx-
5MS, 100.2/10.270/10): tR = 6.1 min, m/z = 154 ([M-CH3]+), 86; GC (Machary-Nagel Optima-5-Amin (0.50 
µm x 0.25 µm x 30 m), 60 kPa H2, 100 °C/2 min, 10°C/min, 250 °C/7 min): tR = 11.1 min; GC (MEGA 
Diethyl-tert-butylsilyl-β-086 (0.25 µm x 0.25 mm x 25 m), 60 kPa H2, 100 °C/2 min, 1 °C/min to 135°C, 
10°C/min to 180 °C, 10 min): tR = 32.1 min ((R)-acetamide), tR = 32.4 min ((S)-acetamide); IR (neat, ATR) 
ν/cm-1 = 2959 (m), 2921 (s), 2851 (s), 1465 (m), 1448 (m), 1377 (m), 1336 (w), 1168 (m), 1134 (w), 890 (w), 
834 (w), 713 (m); HRMS: calc. 169.1830, found: 170.1901 (M+H); Optical Rotation: [] = - 13.6 (c 1.0 
in CHCl3 0.75% EtOH). 
 
 
(R)-N-(1-cyclohexylethyl)cyclohexanamine (557) 
 
C14H27N (MW = 209.37 g/mol): 
1H-NMR (500 MHz, CDCl3) δ 2.59 – 2.49 (m, 1H), 2.49 – 2.38 (m, 1H), 1.83 (t, J 
= 14.5 Hz, 2H), 1.77 – 1.55 (m, 8H), 1.33 – 0.96 (m, 11H), 0.95 (d, J = 6.5 Hz, 
3H), 0.66 (s, 1H); 13C{1H}-NMR (101 MHz, CDCl3) δ 54.23, 54.09, 43.36, 34.79, 34.05, 30.32, 28.10, 
26.96, 26.84, 26.67, 26.40, 25.51, 25.35, 17.85; GC-MS (Rtx-5MS, 50.2/30.250/5): tR = 8.2 min, m/z = 209 
([M]+), 194, 166, 127, 126, 44; GC (Machary-Nagel Optima-5-Amin (0.50 µm x 0.25 µm x 30 m), 60 kPa 
H2, 100 °C/2 min, 10 °C/min, 250 °C/7 min): tR = 17.6 min; HPLC (Daicel Chiracel OD-H, n-heptane/iso-
propanol 97:3, 0.5 mL/min, 40 °C, 225/284 nm): tR = 19.2 min ((S)-1-naphtamide), tR = 21.3 min ((R)-1-
naphtamide); IR (neat, ATR) ν/cm-1 = 2919 (s), 2848 (s), 1463 (m), 1447 (m), 1371 (m), 1155 (w), 1115 (w), 
888 (w), 843 (w); HRMS: calc. 209.2143, found: 210.2217 (M+H); Optical Rotation: [] = - 17.3 (c 1.0 
in CHCl3 0.75% EtOH). 
 
2-methylpyrrolidine[164] 
 
C5H11N (MW = 85.15 g/mol): 
GC (Machary-Nagel Optima-5-Amin (0.50 µm x 0.25 µm x 30 m), 60 kPa H2, 100 °C/2 min, 
10 °C/min, 250 °C/7 min): tR = 10.9 min (N-acetamide); GC-MS: (Rtx-5MS, 100.2/10.270/10): tR = 7.3 min 
(N-acetamide), m/z = 127 ([M]+), 112, 99, 94, 70. 
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2-cyclohexylpyrrolidine (570)[165] 
 
C10H19N (MW = 153.26 g/mol): 
GC (Machary-Nagel Optima-5-Amin (0.50 µm x 0.25 µm x 30 m), 60 kPa H2, 100 °C/2 
min, 10 °C/min, 250 °C/7 min): tR = 16.3 min (N-trifluoroacetamide)[166]; GC (MEGA 
Diethyl-tert-butylsilyl-β-086 (0.25 µm x 0.25 mm x 25 m), 60 kPa H2, 115 °C/20 min, 10 
°C/min to 180 °C, 10 min): tR = 15.4 (N-trifluoroacetamide), tR = 16.2 (N-
trifluoroacetamide). 
 
 
2-benzylpyrrolidine[167] 
 
C11H15N (MW = 161.24 g/mol): 
GC (Machary-Nagel Optima-5-Amin (0.50 µm x 0.25 µm x 30 m), 60 kPa H2, 100 °C/2 min, 10 °C/min, 250 
°C/7 min): tR = 21.6 min (N-acetamide); GC-MS: (Rtx-5MS, 100.2/10.270/10): tR = 17.4 min (N-acetamide), 
m/z = 203 ([M]+), 112, 91, 70. 
 
 
2-phenylpyrrolidine (573)[137]  
 
C10H13N (MW = 147.22 g/mol): 
GC (Machary-Nagel Optima-5-Amin (0.50 µm x 0.25 µm x 30 m), 60 kPa H2, 100 °C/2 
min, 10 °C/min, 250 °C/7 min): tR = 19.7 min (N-acetamide); GC-MS: (Rtx-5MS, 
100.2/10.270/10): tR = 15.9 min (N-acetamide), m/z = 189 ([M]+), 161, 146, 130, 119, 104; GC (MEGA 
Diethyl-tert-butylsilyl-β-086 (0.25 µm x 0.25 mm x 25 m), 60 kPa H2, 100 °C/2 min, 1 °C/min to 150°C, 10 
°C/min to 180 °C, 10 min): tR = 46.8 min (N-acetamide), tR = 49.7 min (N-acetamide). 
 
 
2-methylpiperidine (571)[168],[169] 
 
C6H13N (MW = 99.17 g/mol): 
GC (Machary-Nagel Optima-5-Amin (0.50 µm x 0.25 µm x 30 m), 60 kPa H2, 100 °C/2 min, 10 °C/min, 250 
°C/7 min): tR = 12.4 min (N-acetamide); GC (CP-Chiralsil-Dex CB (0.25 µm x 0.25 mm x 25 m), 60 kPa H2, 
100 °C/5 min, 3 °C/min to 155 °C, 5 min. 10 °C/min to 180 °C, 10 min): tR = 13.4 min ((R)-N-acetamide), tR 
= 13.9 min ((S)-N-acetamide). 
 
 
2-butylpiperidine[170] 
 
C9H19N (MW = 141.25 g/mol): 
GC (Machary-Nagel Optima-5-Amin (0.50 µm x 0.25 µm x 30 m), 60 kPa H2, 100 °C/2 min, 10°C/min, 250 
°C/7 min): tR = 16.5 min (A42-acetamide); GC-MS: (Rtx-5MS, 100.2/10.270/10): tR = 7.9 min (A42-
acetamide), m/z = 183 ([M]+), 468, 140, 126, 84. 
 
 
2-phenylpiperidine (572)[171]  
 
C11H15N (MW = 161.24 g/mol): 
GC (Machary-Nagel Optima-5-Amin (0.50 µm x 0.25 µm x 30 m), 60 kPa H2, 100 °C/2 
min, 10 °C/min, 250 °C/7 min): tR = 21.4 min (N-acetamide); GC-MS: (Rtx-5MS, 
100.2/10.270/10): tR = 17.5 min (N-acetamide), m/z = 203 ([M]+), 174, 160, 145, 132, 104, 84, 77; HPLC 
(Daicel Chiracel OJ-H, n-heptane/iso-propanol 95:5, 0.5 mL/min, 25 °C, 210/254 nm): tR = 25.1 min (N-
acetamide), tR = 33.7 min (N-acetamide). 
 
 
  
Chapter 6 – Experimental Part 
234 
Quinolines 
 
2-(2-Bromophenyl)-1-phenylpropan-1-one (432)[104] 
 
A oven-dried 50 mL Schlenk vial was evacuated and purged with Argon three 
times before it was transferred to the glove box. Pd2(dba)3 (58 mg, 0.063 mmol, 
0.005 eq.), [(tBu)3PH][BF4] (92 mg, 0.32 mmol, 0.025 eq.) and NaOtBu (1.6 g, 
16.56 mmol, 1.3 eq.) were added. Outside the glove box the reaction mixture was 
suspended in dry 1,4-dioxane (12.7 mL) before 1-bromo-2-iodobenzene 431 (3.6 g, 12.74 mmol, 1.0 eq.) and 
propiophenone 426 (2.05 g, 15.28 mmol, 1.2 eq.) were added via syringe. The reaction mixture was placed in 
an oil bath (90 °C) and heated for 14 hours. After cooling to room temperature, the reaction mixture was 
diluted with Et2O (50 mL), washed with water (100 mL) and the organic components extracted with Et2O 
(3x100 mL). After washing with brine (100 mL) the organic layer was dried over Na2SO4, filtered and 
solvents removed under reduced pressure. The residue was subjected to flash chromatography (SiO2, n-
hexane/Et2O 25:1 to 10:1 gradient, 17x3.5 cm, 20 mL fractions) to afford 432 (1.28 g, 6.52 mmol, 70%) as a 
colourless oil. 
 
C15H13BrO (MW = 289.17 g/mol): 
m.p.: 56.5 °C; 1H-NMR (400 MHz, CDCl3) δ 7.95 – 7.91 (m, 1H), 7.60 (d, J = 8.0 Hz, 1H), 7.48 (t, J = 7.4 
Hz, 1H), 7.39 (t, J = 7.6 Hz, 1H), 7.19 (t, J = 8.0 Hz, 1H), 7.12 (dd, J = 7.8, 1.8 Hz, 1H), 7.06 (td, J = 7.6, 
1.8 Hz, 1H), 5.11 (q, J = 6.8 Hz, 1H), 1.48 (d, J = 6.8 Hz, 2H); GC-MS: (Optima-5-Amine, 80.2/10.270/10): 
tR = 18.2 min, m/z = 209 ([M-Br]+), 105. 
 
 
2-(2-Bromophenyl)-2-methyl-1-phenylpropan-1-one (433) 
 
An oven-dried 50 mL three necked round-bottom flask was evacuated and 
purged with Argon three times before being charged with KOtBu (6.2 g, 55.3 
mmol, 4.0 eq.), 18-crown-6 ether (364 mg, 1.38 mmol, 0.1 eq.) and suspended 
in dry THF (120 mL). The reaction mixture was cooled to 0 °C by the aid of a water/ice bath. Subsequently 
432 (4.0 g, 13.83 mmol, 1.0 eq.) was dissolved in dry THF (30 mL) and cooled to 0 °C. Methyliodide (7.85 
g, 55.3 mmol, 4.0 eq.) was added thereto and the resultant mixture transferred to the reaction mixture. The 
ice bath was removed and the resultant suspension stirred for one hour while warming to room temperature. 
A colour change from from clear yellow to milky white is observed. After TLC control (SiO2, 
pentane/EtOAc 10:1) the suspension was filtered, the filter cake rinsed with ethyl acetate (150 mL) and 
solvents removed under reduced pressure. The residue was subjected to flash chromatography (SiO2, n-
hexane/EtOAc 20:1, 18x4.5 cm, 20 mL fractions) to afford 433 (790 mg, 2.6 mmol, 19%) as a colourless 
solid. Furthermore, 436 (3.02 g, 10 mmol, 72%) was isolated. 
 
C16H15BrO (MW = 303.19 g/mol): 
m.p.: 92 °C; 1H-NMR (500 MHz, CDCl3) δ 7.58 (d, J = 7.8 Hz, 1H, H9), 7.55 (d, J = 8.0 Hz, 2H, H3), 7.35 
(m, 2H, H10, H12), 7.28 (t, J = 7.4 Hz, 1H, H1), 7.12 (t, J = 7.5 Hz, 2H, H2), 7.04 (t, J = 7.6 Hz, 1H, H11), 
1.66 (s, 6H, H7); 13C{1H}-NMR (126 MHz, CDCl3) δ 202.66 (C5), 145.45 (C8), 136.06 (C4), 134.96 (C12), 
132.08 (C1), 129.33 (C3), 128.62 (C11), 128.29 (C10), 127.96 (C2), 126.95 (C9), 123.90 (C13), 52.89 (C6), 
27.53 (C7); IR (neat, ATR) ν/cm-1 = 3059 (w), 2979 (w), 2934 (w), 2907 (w), 1673 (s), 1596 (w), 1577 (w), 
1464 (m), 1446 (m), 1425 (m), 1383 (m), 1362 (w), 1238 (s), 1163 (m), 1140 (m), 1022 (s), 969 (s), 909 (m), 
898 (m); MS (EI, 70 eV): 223.1 (9.6%, [M]+), 170.9 (7.5%), 168.9 (7.9%), 105 (100%); EA: calc. C, 63.38; 
H, 4.99; found: C, 62.99; H, 5.08. 
 
 
(Z)-1-Bromo-2-(1-methoxy-1-phenylprop-1-en-2-yl)benzene (436) 
 
C16H15BrO (MW = 303.19 g/mol): 
1H-NMR (500 MHz, CDCl3) δ 7.49 (d, J = 7.8 Hz, 1H, H13), 7.1343 (m, 2H, 
H3), 7.139 (m, 2H, H2), 7.12 (m, 1H, H1), 7.06 (t, J = 7.4 Hz, 1H, H11), 6.98 
(m, 1H, H12), 6.95 (d, J = 7.5 Hz, 1H, H10), 3.47 (s, 3H, H6), 2.12 (s, 3H, H8); 
13C{1H}-NMR (126 MHz, CDCl3) δ 152.22 (C5), 143.07 (C9), 134.85 (C4), 132.68 (C13), 131.83 (C10), 
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129.24 (C2), 128.07 (C12), 127.79 (C3), 127.68 (C1), 127.39 (C11), 124.49 (C14), 121.09 (C7), 57.68 (C6), 
17.64 (C8); GC-MS: (Optima-5-Amine, 100.2/10.270/10): tR = 15.0 min, m/z = 302 ([M-1]+), 223, 208; IR 
(neat, ATR) ν/cm-1 = 3054 (w), 2989 (w), 2932 (w), 2829 (w), 1649 (w), 1599 (w), 1557 (w), 1490 (m), 1466 
(m), 1426 (m), 1312 (w), 1257 (m), 1237 (s), 1189 (w), 1125 (s), 1083 (s), 1024 (s), 962 (m), 919 (w). 
 
 
(Z)-1-Bromo-2-(1-bromo-1-phenylprop-1-en-2-yl)benzene (437) 
 
C15H12Br2 (MW = 352.07 g/mol): 
1H-NMR (500 MHz, CDCl3) δ 7.37 (dd, J = 7.0, 0.9 Hz, 1H, H13), 7.13 (dd, J 
= 8.0, 1.5 Hz, 2H, H3), 7.01 (m, 2H, H2), 6.98 (m, 1H, H1), 6.96 (td, J = 7.5, 
1.2 Hz, 1H, H10), 6.90 (dd, J = 7.8, 1.7 Hz, 1H, H11), 6.85 (dd, J = 7.5, 1.6 Hz, 1H, H9), 2.24 (s, 3H, H7); 
13C{1H}-NMR (126 MHz, CDCl3) δ 142.75 (C8), 140.51 (C4), 138.46 (C6), 132.77 (C12), 130.77 (C9), 
129.21 (C3), 128.62 (C11), 127.88 (C1), 127.78 (C2), 127.30 (C10), 123.02 (C5), 122.71 (C13), 25.58 (C7); 
GC-MS: (Optima-5-Amine, 100.2/10.270/10): tR = 16.4 min, m/z = 352 ([M]+), 271, 192, 165; IR (neat, 
ATR) ν/cm-1 = 3053 (w), 2909 (w), 2845 (w), 1596 (w), 1586 (w), 1577 (w), 1559 (w), 1486 (w), 1467 (m), 
1441 (w), 1432 (w), 1369 (w), 1278 (w), 1216 (w), 1025 (m), 1010 (m), 907 (m), 875 (m), 746 (s). 
 
 
2-((E)-((4-Methoxyphenyl)imino)methyl)-3,4,4-trimethyl-1-phenyl-1,2,3,4 tetrahydronaphthalen-1-ol 
(444) 
 
In a flame-dried and argon-purged 25 mL two-necked round-
bottomed flask was placed 433 (92 mg, 0.32 mmol, 1.0 eq.) and 
dissolved in anhydrous THF (3 mL). The reaction mixture was 
cooled to -78 °C by the aid of a dry ice/acetone bath and n-BuLi 
(0.24 mL, 1.6 M, 0.38 mmol, 1.2 eq.) was added. It was stirred for 30 
minutes at -78 °C. Subsequently, 443 (66.5 mg, 0.47 mmol, 1.4 eq) 
was added dropwise. The reaction mixture was stirred at -78 °C for 
30 minutes before being allowed to warm to room temperature while 
stirring overnight. It was quenched with water (2 mL), extracted with CH2Cl2 (3x50 mL), washed with brine 
(20 mL), dried over Na2SO4, filtered and solvents removed under reduced pressure. The residue was purified 
by flash chromatography (SiO2, CH2Cl2/TBME 6:1, 15x2.5 cm, 10 mL frctns) to afford 444 (59 mg, 0.148 
mmol, 46%) as a white amorphous solid. 
 
C27H29NO2 (MW = 399.53 g/mol): 
1H-NMR (600 MHz, CDCl3) δ 7.44 (dd, J = 8.6, 1.3 Hz, 1H, H9), 7.29 (m, 2H, H10&H12), 7.25 (m, 2H, 
H17), 7.22 (m, 1H, H18), 7.20 (m, 1H, H1), 7.15 (td, J = 7.4, 1.3 Hz, 1H, H11), 7.11 (m, 2H, H16), 6.92 (d, J 
= 8.8 Hz, 2H, H20), 6.82 (d, J = 8.8 Hz, 2H, H21), 4.06 (s, 1H, OH), 3.81 (s, 3H, H23), 3.02 (dd, J = 12.6, 
7.4 Hz, 1H, H2), 2.24 (dq, J = 13.4, 6.8 Hz, 1H, H3), 1.50 (s, 3H, H5), 1.25 (s, 3H, H6), 0.92 (d, J = 6.8 Hz, 
3H, H4); 13C{1H}-NMR (126 MHz, CDCl3) δ 165.76 (C1), 158.10 (C22), 145.36 (C8), 145.10 (C13), 144.16 
(C19), 141.40 (C15), 128.51 (C16), 128.14 (C10/C12), 127.80 (C10/C12), 127.52 (C17), 127.07 (C18), 
126.62 (C11), 126.45 (C9), 122.35 (C20), 114.29 (C21), 77.01 (C14), 55.60 (C23), 54.93 (C2), 37.83 (C7), 
36.82 (C3), 28.87 (C5), 26.09 (C6), 14.34 (C4); GC-MS: (Optima-5-Amine, 100.2/10.270/25): tR = 28.7 
min, m/z = 380 ([M-19]+), 366 ([M-33]+), 243; MS (EI, 70 eV): 399.3 (17.6%, [M]+), 380.2 (20.6%), 366.2 
(16.5%), 212.1 (100%); IR (neat, ATR) ν/cm-1 = 3185 (wbr), 3061 (w), 3029 (w), 2941 (w), 2827 (w), 1650 
(m), 1609 (w), 1582 (w), 1503 (s), 1488 (m), 1464 (m), 1447 (m), 1440 (m), 1364 (m), 1296 (w), 1244 (s), 
1214 (m), 1204 (m), 1177 (m), 1166 (m), 1036 (s), 1010 (m), 830 (m), 820 (s); HPLC (Daicel Chiracel OD-
H, n-heptane/iso-propanol 98:2, 0.5 mL/min, 20 °C, 210/260 nm): tR = 13.1 min (enantiomer 1), tR = 18.4 
min (enantiomer 2). 
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N-(1-(2-Bromophenyl)ethylidene)-1-phenylmethanamine (445)[172] 
 
A 25mL oven-dried two-neck round-bottom flask equipped with a stirrer, reflux 
condenser and a stopper was evacuated and purged with Argon gas three times. 
Freshly activated 4Å mol sieves were added under an argon counterflow. The 
stopper was replaced with a septum and 1-(2-bromophenyl)ethanone (1.0 g, 5 
mmol, 1.0 eq.), benzylamine (535 mg, 5 mmol, 1.0 eq.) were added and dissolved in dry CH2Cl2 (7 mL). The 
reaction mixture was stirred three days until GC-MS analysis indicated completion. The mixture was filtered, 
the filter cake washed with CH2Cl2 (20 mL) and solvents removed under reduced pressure. Kugelrohr 
distillation (150 °C, 0.08 mbar) afforded 445 (517 mg, 1.8 mmol, 36%) as a colourless oil. 
 
C15H14BrN (MW = 288.18 g/mol): 
E/Z isomers 2:1, signals overlaying: E-isomer: 1H-NMR (400 MHz, CDCl3) δ 7.63 (dd, J = 8.0, 1.1 Hz, 1H), 
7.44 – 7.15 (m, 7H), 7.07 (dd, J = 7.6, 1.7 Hz, 1H), 4.34 (dd, J = 15.0, 1.8 Hz, 1H, CH2), 4.18 (d, J = 14.9 
Hz, 1H, CH2), 2.35 (t, J = 1.3 Hz, 3H, CH3),; Z-isomer: 1H-NMR (400 MHz, CDCl3) δ 7.63 (dd, J = 8.0, 1.1 
Hz, 1H), 7.55 (d, J = 8.0 Hz, 1H), 7.44 – 7.15 (m, 8H), 4.71 (m, 2H, CH2), 2.32 (d, J = 1.0 Hz, 3H, CH3); 
GC-MS: (Optima-5-Amine, 100.2/10.270/10): tR = 15.3 min, m/z = 287 ([M-1]+), 208, 91. 
 
 
1-(2-Bromophenyl)ethanone O-benzyl oxime[110] 
 
A 250 mL round bottom flask was equipped with a stirrer and charged with 
1-(2-bromophenyl)ethanone (2.95 g, 14.33 mmol, 1.0 eq.), O-
benzylhydroxylamine hydrochloride (2.6 g, 16.32 mmol, 1.1 eq.) and 
NaOAc (1.34 g, 16.32 mmol, 1.1 eq.). The resultant mixture was dissolved in ethanol (15 mL) and water (7.5 
mL) and heated to 90 °C for 1 hour. After cooling to room temperature, diluted HCl (1.0 M, 60 mL) was 
added and the organic components extracted with EtOAc (100 mL). After washing with diluted HCl (1.0 M, 
60 mL), diluted NaOH (1.0 M, 60 mL) and water (50 mL) the organic layer was dried over anhydrous 
MgSO4 and filtered. Solvents were removed under reduced pressure to afford 1-(2-bromophenyl)ethanone O-
benzyl oxime (3.9 g, 12.8 mmol, 86%) as a white solid. 
 
C15H14BrNO (MW = 304.18 g/mol): 
E/Z isomers, signals overlaying: 1H-NMR (400 MHz, Chloroform-d) δ 7.58 (ddd, J = 7.9, 6.6, 1.2 Hz, 1H), 
7.44 – 7.40 (m, 2H), 7.37 (tt, J = 8.1, 1.7 Hz, 2H), 7.34 – 7.28 (m, 4H), 7.28 – 7.23 (m, 2H), 7.20 (dddd, J = 
8.1, 7.3, 5.1, 1.9 Hz, 1H), 7.07 (dd, J = 7.6, 1.7 Hz, 0H), 5.24 (s, 2H), 5.07 (s, 1H), 2.26 (s, 3H), 2.16 (s, 1H); 
E-isomer: 13C{1H}-NMR (101 MHz, CDCl3) δ 157.69, 139.03, 138.06, 133.23, 130.43, 130.12, 128.49, 
128.29, 128.12, 127.52, 121.98, 76.23, 17.01; Z-isomer: 13C{1H}-NMR (101 MHz, CDCl3) δ 155.00, 138.37, 
138.13, 132.76, 129.68, 128.14, 127.88, 127.86, 127.59, 127.44, 119.94, 75.79, 21.34. 
 
 
1-(2-Bromophenyl)ethanamine[110] 
 
An oven-dried 100 mL 3-necked round-bottom flask was evacuated and purged with Argon 
three times before being charged with 1-(2-bromophenyl)ethanone O-benzyl oxime (3.9 g, 
12.8 mmol, 1.0 eq.) and dissolved in dry THF (21 mL). Borane dimethyl sulfide complex 
(2.05 g, 27 mmol, 2.1 eq.) was added dropwise over the course of 30 minutes. The reaction mixture was 
stirred for 17 hours at room temperature. GC-MS analysis indicated complete conversion. The reaction was 
quenched by the dropwise addition of HCl (4.0 M, 13.5 mL) and neutralized by addition of NaOH (10% 
w/w, 35 mL). The organic layer was decanted and solvents removed under reduced pressure to afford 1-(2-
bromophenyl)ethanamine (1.64 g, 8.2 mmol, 64%) as a colourless oil. 
 
C8H10BrN (MW = 200.08 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 7.52 (m, 2H), 7.32 (t, J = 7.6 Hz, 1H), 7.09 (t, J = 7.7 Hz, 1H), 4.50 (q, J = 
6.6 Hz, 1H), 1.56 (s, 3H), 1.38 (d, J = 6.6 Hz, 3H); 13C{1H}-NMR (101 MHz, CDCl3) δ 146.32, 133.01, 
128.35, 127.96, 126.64, 123.26, 50.14, 23.92; GC-MS: (Optima-5-Amine, 100.2/10.270/10): tR = 8.5 min, 
m/z = 184 ([M-CH3]+), 157, 108. 
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tert-Butyl (1-(2-bromophenyl)ethyl)carbamate (448) 
 
In a 50 mL round-bottom flask was placed 1-(2-bromophenyl)ethanamine (500 
mg, 2.5 mmol, 1.0 eq.) and dissolved in a water/THF mixture (1:1, 15 mL). 
After cooling to 0 °C, NaHCO3 (630 mg, 7.5 mmol, 3.0 eq.) and di-tert-butyl 
dicarbonate (654 mg, 3 mmol, 1.2 eq.) were added. The reaction mixture was 
stirred at 0 °C for 30 minutes before the cooling bath was removed and stirring 
continued at room temperature overnight. GC-MS analysis indicated full conversion. The reaction mixture 
was transferred to a separation funnel and organic components extracted with Et2O (2x100 mL). The 
combined organic layers were dried over Na2SO4, filtered and solvents removed under reduced pressure. The 
residue was subjected to flash chromatography (SiO2, pentane/EtOAc (4:1), 16x3.5 cm, 20 mL fractions) to 
afford 448 (600 mg, 2 mmol, 80%) as a white solid. 
 
C13H18BrNO2 (MW = 300.19 g/mol): 
m.p.: 97 °C; 1H-NMR (500 MHz, CDCl3) δ 7.52 (d, J = 7.9 Hz, 1H, H2), 7.33 (d, J = 7.8 Hz, 1H, H5), 7.28 
(t, J = 7.5 Hz, 1H, H4), 7.09 (td, J = 7.5, 1.9 Hz, 1H, H3), 5.11 (m, 1H, H7), 4.99 (s, 1H, NH), 1.44 (sbr, 9H, 
H10), 1.42 (mbr, 3H, H8); 13C{1H}-NMR (125 MHz, CDCl3)  δ C=O not detected, 143.26 (C6), 133.35 
(C2), 128.57 (C3), 127.83 (C4), 126.52 (C5), 122.73 (C1), 50.34 (C7), 28.49 (C10), 27.54 (C9), 21.86 (C8); 
IR (neat, ATR) ν/cm-1 = 3438 (wbr), 3337 (wbr), 3059 (w), 2981 (m), 2927 (m), 2854 (w), 1676 (m), 1663 
(m), 1519 (m), 1444 (s), 1363 (s), 1301 (m), 1245 (s), 1233 (m), 1118 (m), 1104 (m), 1064 (s), 1000 (m), 
971 (m), 753 (s); GC-MS: (Optima-5-Amine, 100.2/10.270/10): tR = 14.2 min, m/z = 230, 210, 184, 164; 
EA: calc.: C, 52.01; H, 6.04; N, 4.67; found: C, 53.55; H, 6.25; N, 5.04. 
 
 
N-(1-(2-Bromophenyl)ethyl)-4-methylbenzenesulfonamide (447) 
 
In a 50 mL round-bottom flask was placed 1-(2-bromophenyl)ethanamine 
(500 mg, 2.5 mmol, 1.0 eq.), 4-methylbenzene-1-sulfonyl chloride (491 mg, 
2.575 mmol, 1.03 eq.) and K2CO3 (1.1 g, 8 mmol, 4.0 eq.). The reaction 
mixture was dissolved in a water/Et2O mixture (1:1, 7 mL) and vigorously 
stirred at room temperature for 2 hours. TLC analysis (SiO2, pentane/EtOAc 
2:1) indicated complete consumption of starting material. The organic 
components were extracted with dichlormethane (3x 20 mL) and the 
combined organic layers dried over anhydrous MgSO4. After filtration and solvent removal under reduced 
the residue was subjected to flash chromatography (SiO2, pentane/EtOAc (2 :1), 15x3.5 cm, 20 mL fractions) 
to afford 447 (512 mg, 1.45 mmol, 58%) as a white solid. 
 
C15H16BrNO2S (MW = 354.26 g/mol): 
m.p.: 120 °C; 1H-NMR (400 MHz, CDCl3) δ 7.63 (d, J = 8.3 Hz, 2H, H10), 7.37 (dd, J = 8.0, 1.1 Hz, 1H, 
H2), 7.22 (dd, J = 7.8, 1.6 Hz, 1H, H5), 7.13 (m, 3H, H4, H11), 6.99 (td, J = 7.9, 1.7 Hz, 1H, H3), 5.50 (d, J 
= 7.3 Hz, 1H, NH), 4.87 (m, 1H, H7), 2.35 (s, 3H, H13), 1.39 (d, J = 6.9 Hz, 3H, H8); 13C{1H}-NMR (101 
MHz, CDCl3) δ 143.32 (C6), 141.30 (C9), 137.12 (C12), 132.97 (C2), 129.49 (C11), 128.71 (CHAr), 127.88 
(CHAr), 127.83 (CHAr), 127.26 (C10), 122.08 (C1), 53.21 (C7), 23.09 (C13), 21.58 (C8); IR (neat, ATR) 
ν/cm-1 = 3432 (wbr), 3337 (wbr), 3058 (w), 2981 (w), 2926 (m), 2854 (w), 1663 (m), 1463 (m), 1444 (m), 
1363 (m), 1257 (m), 1246 (m), 1231 (m), 1076 (m), 1064 (s), 1052 (s), 1031 (m), 1001 (m), 971 (m), 823 
(m), 756 (s); EA: calc.: C, 50.86; H, 4.55; N, 3.95; found: C, 51.31; H, 4.68; N, 4.23.  
 
 
(1-(2-Bromophenyl)ethoxy)(tert-butyl)dimethylsilane (419)[100] 
 
In a 25 mL round-bottom flask was placed imidazole (1.02 g, 15.0 mmol, 3.0 eq.) and 
425 (804 mg, 6.0 mmol, 1.2 eq.). The flask was evacuated and purged with argon 
three times before 424 (1.0 g, 5.0 mmol, 1.0 eq.) was added and the resultant mixture 
dissolved in dry DMF (5 mL). The reaction mixture was stirred overnight. TLC 
control (SiO2, n-pentane/EtOAc 5:1) indicated complete consumption of starting 
material. DMF was removed by aid of a second cooling trap under high vacuum and the residue was 
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suspended in n-pentane/EtOAc (5:1) and subjected to flash chromatography (SiO2, 12x3.5 cm, 20 mL 
fractions) to afford 419 (1.6 g, 5 mmol, 99%) as a colourless oil. 
 
C14H23BrOSi (MW = 315.32 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 7.61 (dd, J = 7.8, 1.4 Hz, 1H), 7.46 (dd, J = 8.0, 0.7 Hz, 1H), 7.31 (t, J = 7.5 
Hz, 1H), 7.08 (td, J = 7.9, 1.6 Hz, 1H), 5.16 (q, J = 6.2 Hz, 1H), 1.38 (d, J = 6.2 Hz, 3H), 0.90 (s, 10H), 0.06 
(s, 3H), -0.03 (s, 3H); 13C{1H}-NMR (101 MHz, CDCl3) δ 146.04, 132.31, 128.33, 127.71, 127.55, 120.89, 
70.02, 26.01, 25.70, 18.37, -4.75, -4.81; GC-MS: (Optima-5-Amine, 100.2/7.270/10): tR = 14.1 min, m/z = 
301 ([M-CH3]+). 
 
 
2-(2-(1-((tert-Butyldimethylsilyl)oxy)ethyl)phenyl)-1-phenylpropan-1-one (428) 
 
A oven-dried 25 mL Schlenk tube was evacuated and purged with argon 
three times and transferred to the glove box. Pd(dba)2 (60 mg, 0.1 
mmol, 0.05 eq.), DtBuPF (60 mg, 0.125 mmol, 0.06 eq.) and NaOtBu 
(310 mg, 3.33 mmo, 1.6 eq.) were added and the vial brought out of the 
glove box to add 419 (656 mg, 2.08 mmol, 1.0 eq.) and 426 (300 mg, 
2.5 mmol, 1.2 eq.). The reaction mixture was then suspended in dry 1,4-
dioxane (5 mL), sealed and heated to 90 °C for 24 hours. The reaction 
was allowed to cool to room temperature, quenched with water and organic components extracted with tert-
butylmethylether (3 x 25 mL). Solvents were reduced under reduced pressure and the sticky brown residue 
was subjected to flash chromatography (SiO2, 19x3 cm, cyclohexane/Et2O 20:1, 20 mL fractions) to afford 
428 (652.4 mg, 1.77 mmol, 85%) as a colourless oil. 
 
C23H32O2Si (MW = 368.58 g/mol): 
mixture of 2 diastereomers and 2 rotamers overlaying:1H-NMR (500 MHz, CDCl3) δ 7.86 (d, J = 7.5 Hz, 
1H), 7.83 (d, J = 7.5 Hz, 1H), 7.60 (d, J = 7.7 Hz, 1H), 7.57 (d, J = 7.8 Hz, 1H), 7.47 (t, J = 7.4 Hz, 1H), 
7.36 (t, J = 7.7 Hz, 2H), 7.31 (q, J = 7.9 Hz, 1H), 7.23 (t, J = 7.0 Hz, 1H), 7.14 (dd, J = 17.6, 7.7 Hz, 1H), 
7.04 (d, J = 7.6 Hz, 1H), 5.32 (q, J = 6.2 Hz, 1H), 5.21 (q, J = 6.3 Hz, 1H), 4.92 – 4.83 (m, 1H), 1.55 (d, J = 
5.3 Hz, 2H), 1.52 (d, J = 6.8 Hz, 2H), 1.48 (d, J = 6.3 Hz, 1H), 1.45 (d, J = 6.3 Hz, 2H), 1.41 (d, J = 6.4 Hz, 
1H), 0.89 (d, J = 6.3 Hz, 5H), 0.08 (s, 1H), 0.06 (s, 1H), 0.05 (s, 1H), -0.03 (s, 2H), -0.06 (s, 1H); GC-MS: 
(Optima-5-Amine, 100.2/10.270/10): tR = 19.8 min, m/z = 353 ([M-CH3]+), 311 ([M-C4H9]+), 219. 
 
 
2-(2-(1-((tert-butyldimethylsilyl)oxy)ethyl)phenyl)-2-methyl-1-phenylpropan-1-one (427) 
 
A oven-dried 50 mL Schlenk vial was evacuated and purged with 
Argon three times before it was transferred to the glove box. Pd(dba)2 
(132 mg, 0.32 mmol, 0.1 eq.), [(tBu)3PH][BF4] (202 mg, 0.7 mmol, 
0.22 eq.) and NaOtBu (487 mg, 5.07 mmol, 1.6 eq.) were added. 
Outside the glove box the reaction mixture was suspended in dry 1,4-
dioxane (3 mL) before 419 (1.0 g, 3.17 mmol, 1.0 eq.) and 418 (564 
mg, 3.81 mmol, 1.2 eq.) were added via syringe. The reaction mixture 
was placed in an oil bath (100 °C) and heated for 2 days. After 
cooling to room temperature, the reaction mixture was transferred to a separating funnel, the Schlenk vial 
rinsed with Et2O (10 mL) and the reaction quenched with water (20 mL). The organic components were 
extracted with Et2O (3x20 mL) and the combined organic layers dried over anhydrous MgSO4. After 
filtration and solvent removal under reduced pressure the residue was subjected to flash chromatography 
(SiO2, cyclohexane/Et2O 50:1, 19x5.5 cm, 20 mL fractions) to afford 427 (522 mg, 1.36 mmol, 43%) as a 
white solid. 
 
C24H34O2Si (MW = 382.61 g/mol): 
1H-NMR (500 MHz, CDCl3) δ 7.62 (m, 1H, H13), 7.59 (m, 2H, H3), 7.56 (m, 1H, H10), 7.39 (m, 1H, H1), 
7.36 (m, 1H, H11), 7.35 (m, 1H, H12), 7.21 (t, J = 7.6 Hz, 2H, H2), 4.99 (q, J = 6.0 Hz, 1H, H15), 1.63 (s, 
3H, H7), 1.60 (s, 3H, H8), 0.93 (d, J = 6.0 Hz, 3H, H16), 0.72 (s, 9H, H19), 0.00 (s, 3H, H17), -0.27 (s, 3H, 
H18); 13C{1H}-NMR (126 MHz, CDCl3) δ 204.25 (C5), 146.32 (C14), 140.19 (C9), 136.08 (C4), 132.35 
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(C1), 129.99 (C3), 128.75 (C13), 128.25 (C2), 127.80 (C11), 127.61 (C12), 66.03 (C15), 51.71 (C6), 29.27 
(C8), 28.91 (C7), 27.39 (C16), 25.80(C19), 17.96 (C20), -3.98 (C18), -4.77 (C17); GC-MS: (Optima-5-
Amine, 100.2/10.270/10): tR = 19.8 min, m/z = 367 ([M-CH3]+), 325 ([M-C4H9]+), 233, 205; IR (neat, ATR) 
ν/cm-1 = 2955 (w), 2926 (w), 2845 (w), 1663 (s), 1462 (m), 1444 (m), 1256 (m), 1246 (m), 1102 (s), 1075 
(s), 1052 (m), 1020 (m), 1007 (m), 957 (s), 823 (s); EA: calc.: C, 75.34; H, 8.96; found: C, 75.04; H, 8.99; 
HRMS: calculated: 405.2220 [M+Na]+, found: 405.2225. 
 
 
1,4,4-trimethyl-3-phenylisochroman-3-ol (435) 
 
An oven-dried and Argon-purged 25 mL 2-neck round-bottom flask was 
charged with 427 (572 mg, 1.495 mmol, 1.0 eq.) and dissolved in dry THF (5 
mL). Then TBAF (430 mg, 1.65 mmol, 1.1 eq.) was added and the resultant 
reaction mixture heated to 50 °C for 2 hours. TLC control (SiO2, 
pentane/EtOAc 10:1) indicated complete consumption of starting material. The 
reaction mixture was allowed to cool to room temperature and transferred to a 
separation funnel. Water (5 mL) was added and organic components were extracted with CH2Cl2 (3x10 mL). 
After drying over MgSO4, filtration, removal of solvents under reduced pressure the residue was subjected to 
flash chromatography (SiO2, pentane/Et2O 4:1, 17x3.5 cm, 20 mL fractions) to afford 435 (347 mg, 1.295 
mmol, 86%) as a white crystalline solid. 
 
C18H20O2 (MW = 268.35 g/mol): 
m.p.: 115 °C; 1H-NMR (500 MHz, CDCl3) δ 7.70 (m, 2H, H3), 7.40 (m, 1H, H10), 7.38 (m, 2H, H2), 7.35 
(m, 1H, H1), 7.25 (m, 1H, H11), 7.23 (m, 1H, H12), 7.13 (m, 1H, H13), 5.26 (q, J = 6.6 Hz, 1H, H15), 2.68 
(s, 1H, OH), 1.67 (d, J = 6.6 Hz, 3H, H16), 1.36 (s, 3H, H7), 1.09 (s, 3H, H8); 13C{1H}-NMR (126 MHz, 
CDCl3) δ 141.89 (C4), 141.78 (C9), 137.26 (C14), 128.09 (C1), 128.06 (C3), 127.36 (C2), 126.89 (C11), 
125.92 (C12), 125.68 (C10), 124.19 (C13), 100.50 (C5), 68.30 (C15), 41.53 (C6), 30.70 (C8), 23.04 (C16), 
22.19 (C7); IR (neat, ATR) ν/cm-1 = 3439 (wbr), 3057 (w), 2981 (w), 2926 (w), 2853 (w), 1663 (w), 1491 
(w), 1463 (w), 1444 (w), 1361 (w), 1257 (w), 1230 (m), 1102 (w), 1081 (w), 1052 (w), 970 (m), 833 (w); 
EA: calc.: C, 80.56; H, 7.51; found: C, 80.20; H, 7.57. 
 
 
[{di-ƞ5-cyclopentadienyl}(dimethyl)titanocene][116] 
’’Petasis reagent’’ 
 
A 100 mL oven-dried three-neck round bottom flask was charged with a stirrer, 
dropping funnel, claisen adapter, thermometer and a septum before being charged with 
[{di-ƞ5-cyclopentadienyl}(dichloro)titanocene] (4.15 g, 16.7 mmol, 1.0 eq.) and 
suspended in dry toluene (50 mL). The reaction mixture was cooled to 0 °C and methyl 
magnesium chloride (3.0 M, 12.6 mL, 37.8 mmol, 2.25 eq.) was added dropwise not 
allowing the reaction mixture to warm up more than 8 °C. After addition stirring was continued for 1 hour at 
0 °C. Another 250 mL three-necked round-bottom flask was equipped with a thermometer, septum and a gas 
inlet, evacuated and purged with argon three times. NH4Cl (700 mg, 13 mmol, 0.78 eq.), dissolved in water 
(11.7 mL), was added and cooled to 0 °C. The titanocene solution was transferred slowly via cannula not 
allowing the reaction mixture to warm up to more than 5 °C. The titanocene flask was rinsed with dry 
toluene (3 mL). A 250 mL separation funnel was charged with the quenched reaction mixture, the aequeous 
layer separated and the organic layer washed with cold water (3x10 mL), brine (3x10 mL) sequentually. The 
organic layer was then dried over anhydrous Na2SO4, filtered and the solvents carefully removed under 
reduced pressure to afford the Petasis reagent as a 15.4 % w/w solution in toluene. 
 
1H-NMR (400 MHz, CDCl3) δ 6.06 (s, 10H), -0.15 (s, 6H). 
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tert-Butyldimethyl(1-(2-(2-methyl-3-phenylbut-3-en-2-yl)phenyl)ethoxy)silane (449) 
 
A 25 mL Schlenk vial equipped with a magnetic stirrer was oven-dried, 
evacuated and purged with Argon three times before being charged with 
427 (300 mg, 0.784 mmol, 1.0 eq.) and dissolved in dry toluene (2 mL). 
Subsequently Petasis reagent (408 mg, 1.96 mmol, 2.5 eq.) was added 
and the Schlenk tube wrapped up in alumina foil. It was then placed in a 
oil bath and heated to 70 °C for 41 hours. After cooling to room 
temperature, the crude reaction mixture was subjected to elution 
chromatography (SiO2, EtOAc) to afford a orange solution. After 
removal of solvent under reduced pressure the residue was purified by flash chromatography (SiO2, 
cyclohexane/Et2O 10:1, 17x2.5 cm, 20 mL fractions) to afford 449 (115 mg, 0.302 mmol, 39%) as an orange 
oil. The product could not be obtained in a pure fashion and therefore the crude was directly used in the 
deprotection step. The silyl protection group readily comes off in CDCl3. 
 
C25H36OSi (MW = 380.64 g/mol): 
1H-NMR (500 MHz, CDCl3) δ 7.70 (d, J = 7.8 Hz, 1H), 7.33 – 7.28 (m, 1H), 7.24 (d, J = 7.8 Hz, 1H), 7.19 – 
7.15 (m, 2H), 7.12 (t, J = 7.4 Hz, 2H), 6.87 (d, J = 7.3 Hz, 2H), 5.72 (q, J = 6.0 Hz, 1H), 5.27 (s, 1H), 5.14 
(s, 1H), 1.52 (s, 3H), 1.51 (s, 3H), 1.36 (d, J = 5.9 Hz, 3H), 0.86 (s, 9H), 0.09 (s, 3H), -0.10 (s, 3H); 13C{1H}-
NMR (126 MHz, CDCl3) δ 158.22, 146.89, 142.59, 141.93, 128.87, 128.45, 127.51, 126.98, 126.89, 126.80, 
126.10, 113.92, 66.50, 44.56, 31.09, 30.86, 27.44, 25.96, 18.09, -3.67, -4.13; GC-MS: (Optima-5-Amine, 
100.2/10.270/10): tR = 18.6 min, m/z = 365 ([M-CH3]+), 323 ([M-C4H9]+), 305, 205; IR (neat, ATR) ν/cm-1 = 
3435 (wbr), 3059 (w), 2955 (m), 2927 (m), 2854 (m), 1663 (m), 1490 (w), 1462 (m), 1444 (m), 1386 (w), 
1363 (m), 1251 (m), 1102 (m), 1075 (s), 957 (m), 831 (m); HRMS: calculated: 403.2428 [M+Na]+, found: 
403.2430. 
 
 
1-(2-(2-Methyl-3-phenylbut-3-en-2-yl)phenyl)ethanol (451) 
 
An oven-dried 25 mL 2-necked round-bottomed flask was evacuated and 
purged with Argon three times before being charged with 449 (250 mg, 0.657 
mmol, 1.0 eq.) and dissolved in dry THF (10 mL). TBAF (430 mg, 1.642 
mmol, 2.5 eq.) was added and instantly the reaction mixture turned black. The 
reaction mixture was heated to 50 °C for 20 hours until TLC analysis (SiO2, 
pentane/Et2O 10:1) indicated complete consumption of starting material. Purification by elution 
chromatography (SiO2, 5x2 cm, cyclohexane/Et2O 20:1, then 1:1) afforded 451 (88 mg, 0.33 mmol, 50%) as 
an orange-brown oil. 
 
C19H22O (MW = 266.38 g/mol): 
1H-NMR (400 MHz, CDCl3, d/ppm): 7.57 (dd, 3J = 7.7 Hz, 4J = 1.6 Hz, 1H, H16), 7.40 (dd, 3J = 7.8 Hz, 4J = 
1.4 Hz, 1H, H13), 7.30 (td, 3J = 7.4 Hz, 4J = 1.4 Hz, 1H, H14), 7.26-7.21 (m, 1H, H15), 7.21-7.17 (m, 3H, 
H1, H2), 7.11-7.06 (m, 2H, H3), 5.53 (q, 3J = 6.3 Hz, 1H, H18), 5.18 (d, 2J = 1.2 Hz, 1H, H7), 5.15 (d, 2J = 
1.2 Hz, 1H, H8), 1.67 (s, 3H, H10/H11), 1.51 (s, 3H, H10/H11), 1.44 (d, 3J = 6.3 Hz, 3H, H19). 13C{1H}-
NMR (126 MHz, CDCl3) δ 158.3, 146.6, 143.6, 142.5, 129.0, 128.8, 128.5, 128.4, 126.9, 126.3, 126.3, 
114.0, 63.9, 44.2, 31.6, 30.8, 25.3; GC-MS: (Optima-5-Amine, 100.2/10.270/10): tR = 15.8 min, m/z = 250 
([M-OH]+), 145 ([M-C8H9O]+), 129 ([M-C9H12O]+); IR (neat, ATR) ν/cm-1 = 3360 (wbr), 3058 (w), 2969 (w), 
2925 (w), 2851 (w), 1489 (w), 1448 (w), 1381 (w), 1364 (w), 1067 (m), 1001 (w), 904 (w); HRMS: 
calculated: 289.1563 [M+Na]+, found: 289.1566. 
 
 
1-(2-methyl-3-phenylbut-3-en-2-yl)-2-vinylbenzene (452) 
 
A 10 mL Schlenk tube equipped with a stirring bar under argon atmosphere 
was charged with 451 (20 mg, 75.1 µmol, 1.0 eq), Boc2NH (65.2 mg, 0.300 
mmol, 4.0 eq), PPh3 (78.8 mg, 0.300 mmol, 4.0 eq) and CH2Cl2 (1.1 mL). 
The mixture was cooled to 0 °C, diisopropyl azodicarboxylate (74 µL, 
0.375 mmol, 5.0 eq) was added. After stirring overnight and warming to 
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room temperature, 1 M HCl (2 mL) was added. The mixture was poured on saturated aqueous NaHCO3 (10 
mL) and extracted with CH2Cl2 (3x20 mL). The combined oragnic layers were dried over Na2SO4 and the 
solvent was removed under reduced pressure. Flash chromatography (SiO2, 18 cm x 2.5 cm, 
cyclohexane/Et2O 2:1) gave 452. No yield was determined. 
 
C19H20 (MW = 248.37 g/mol): 
1H-NMR (500 MHz, CDCl3) δ 7.56 (dd, J = 10.9 Hz, 17.3 Hz, 1H, H17), 7.45 (dd, J = 7.2 Hz, 4J = 2.0 Hz, 
1H, H15), 7.29 (dd, J = 7.3 Hz, 4J = 1.6 Hz, 1H, H12), 7.24-7.19 (m, 3H, H1, H2), 7.15-7.11 (m, 2H, H13, 
H14), 6.91 (dd, J = 7.9 Hz, 4J = 1.2 Hz, 2H, H3), 5.51 (dd, J = 17.3 Hz, 2J = 1.6 Hz, 1H, H19), 5.28 (d, 2J = 
1.2 Hz, 1H, H7), 5.19 (dd, J = 10.9 Hz, 2J = 1.6 Hz, 1H, H20), 5.12 (d, 2J = 1.2 Hz, 1H, H8), 1.54 (s, 6H, 
H10); 13C{1H}-NMR (126 MHz, CDCl3) δ 157.3 (C5), 144.2 (C11), 142.8 (C4), 138.5 (C16), 138.2 (C17), 
128.8 (C3), 128.2 (C15), 127.8 (C13), 127.4 (C2), 126.8 (C14), 126.7 (C1), 126.6 (C12), 114.6 (C18), 114.3 
(C6), 44.8 (C9), 30.2 (C10); IR (neat, ATR) ν/cm-1 = 2985 (w), 2929 (w), 1771 (s), 1683 (w), 1469 (w), 
1456 (w), 1378 (w), 1232 (ss), 1183 (m), 1093 (s), 893 (m). 
 
 
2-(2-bromophenyl)-2-methyl-1,3-dioxane (446) 
 
An ovendried two-necked round bottomed flask, equipped with a magnetic stirrer and a 
septum, was evacuated and purged with Argon three times before being charged with ZrCl4 
(37.7 mg, 0.1 mmol, 0.02 eq.). Dry CH2Cl2 (15 mL), 1-(2-bromophenyl)ethanone (1.0 g, 5 
mmol, 1.0 eq.), propane-1,3-diol (761 mg, 10 mmol, 2.0 eq.) and triethoxymethane (741 
mg, 5 mmol, 1.0 eq.) were added and the reaction mixture stirred at room temperature for 
18 hours. Again triethoxymethane (446 mg, 3 mmol, 0.6 eq.) was added an stirring continued for 24 hours at 
room temperature. GC-MS analysis indicated ~65% consumption of starting material. The reaction mixture 
was quenched with NaOH (10% w/w, 25 mL) and organic components extracted with CH2Cl2 (3x40 mL). 
After washing with water (2x15 mL) the organic layer was dried over anhydrous MgSO4, filtered and 
solvents removed under reduced pressure. Purification by Kugelrohr distillation (75 °C, 0.08 mbar) afforded 
446 (437 mg, 1.7 mmol, 34 %) as a viscous colourless oil. 
 
C11H13BrO2 (MW = 257.12 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 7.64 (d, J = 8.0 Hz, 1H), 7.62 – 7.57 (m, 1H), 7.35 (t, J = 7.6 Hz, 1H), 7.15 
(t, J = 7.6 Hz, 1H), 3.90 (dd, J = 11.5, 4.7 Hz, 2H), 3.78 – 3.68 (m, 2H), 2.25 – 2.10 (m, 1H), 1.59 (s, 3H), 
1.28 (d, J = 13.2 Hz, 1H); GC-MS: (Optima-5-Amine, 100.2/10.270/10): tR = 11.8 min, m/z = 243, 183, 157, 
101. 
 
 
2-methyl-1-phenyl-2-(2-vinylphenyl)propan-1-one (454) 
 
A 50 mL Schlenk vial was charged with a magnetic stirrer, evacuated and 
flame-dried with a bunsen burner before being purged with Argon three 
times. It was then transferred to the glove box where Pd(dba)2 (92 mg, 0.16 
mmol, 0.1 eq.), [(tBu)3PH][BF4] (102 mg, 0.352 mmol, 0.22 eq.) and 
NaOtBu (246 mg, 2.56 mmol, 1.6 eq.) were added. Outside the glove box 
the reaction mixture was suspended in dry 1,4-dioxane (8 mL) before 418 
(282 mg, 1.91 mmol, 1.2 eq.) and 453 (292 mg, 1.6 mmol, 1.0 eq.) were added via syringe. The reaction 
mixture was heated to 100 °C for 3 days. After cooling to room temperature, the reaction mixture was diluted 
with Et2O (30 mL), washed with water (20 mL), and the aequeous layer was extracted with Et2O (20 mL). 
The combined organic layers were dried over Na2SO4, filtered and solvents removed under reduced pressure. 
The residue was subjected to flash chromatography (SiO2, cyclohexane/Et2O 50:1, 20x3.5 cm, 20 mL 
fractions) to afford 454 (305 mg, 1.22 mmol, 76 %) as a yellow oil. 
 
C18H18O (MW= 250.33 g/mol): 
1H-NMR (500 MHz, CDCl3) δ 7.62 (d, J = 8.2 Hz, 1H, H9), 7.59 (d, J = 7.5 Hz, 2H, H3), 7.42 (t, J = 7.6 Hz, 
1H, H10), 7.37 (m, 1H, H12), 7.36 (m, 1H, H1), 7.30 (d, J = 7.5 Hz, 1H, H11), 7.19 (t, J = 7.8 Hz, 2H, H2), 
6.79 (dd, J = 16.9 Hz, 10.9 Hz, 1H, H14), 5.30 (dd, J = 16.9 Hz, 2J = 1.0 Hz, 1H, H15), 5.10 (dd, J = 10.9 
Hz, 2J = 1.0 Hz, 1H, H16), 1.66 (s, 6H, H7); 13C{1H}-NMR (125 MHz, CDCl3) δ 204.32 (C5), 142.83 (C8), 
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137.87 (C13), 135.97 (C4), 135.37 (C14), 132.12 (C1), 129.59 (C3), 128.64 (C10), 128.22 (C12), 128.01 
(C2), 127.41 (C11), 117.51 (C15), 28.31 (C7); GC-MS (EI, 70 eV, PhMeSi, 100.2/10.270/10): tR = 18.6 
min, m/z = 250 ([M]+); IR (neat, ATR) ν/cm-1 = 3087 (w), 3059 (w), 3023 (w), 2974 (m), 2932 (w), 2867 
(w), 1673 (s), 1596 (w), 1466 (w), 1446 (w), 1384 (w), 1240 (m), 1164 (w), 1117 (w), 969 (m), 917 (w); 
HRMS: calculated: 273.1250 [M+Na]+, found: 273.1250; EA: calc.: C, 86.36; H, 7.25; found: C, 86.23; H, 
7.53. 
 
 
2-(2-methyl-1-oxo-1-phenylpropan-2-yl)benzaldehyde (455) 
 
A 25 mL three necked round-bottomed flask was charged with 454 (200 mg, 
0.8 mmol, 1.0 eq.) and dissolved in CH2Cl2/methanol (5:1, 8 mL). After 
cooling to -78 °C, ozone was bubbled through until the solution became dark 
blue. Stirring was continued for 5 minutes before oxygen, and then argon were 
bubbled through until the solution became clear again. TLC control (SiO2, pentane/EtOAc 20:1) indicated 
complete consumption of starting material. Triphenylphosphine (1.0 g, 4 mmol, 5.0 eq.) was added and the 
reaction mixture allowed to warm up while stirring overnight. After removal of solvents under reduced 
pressure the residue was subjected to flash chromatography (SiO2, cyclohexane/Et2O 10:1 gradient to 5:1, 
18.5x3 cm, 20 mL fractions) to afford 455 (179 mg, 0.71 mmol, 89%) as a white powder. 
 
C17H16O2 (MW = 252.31 g/mol): 
m.p.: 124 °C; 1H-NMR (400 MHz, CDCl3) δ 9.91 (s, 1H, H14), 7.78 (m, 1H, H10), 7.76 (m, 1H, H9), 7.71 
(td, J = 7.5, 1.5 Hz, 1H, H12), 7.53 (dt, J = 8.6, 1.6 Hz, 2H, H3), 7.46 (td, J = 7.5, 1.0 Hz, 1H, H11), 7.32 (m, 
1H, H1), 7.18 (m, 2H, H1), 1.77 (s, 6H, H7); 13C{1H}-NMR (101 MHz, CDCl3) δ 203.03 (C5), 191.79 
(C14), 148.06 (C8), 135.91 (C4), 134.82 (C12), 134.18 (C13), 133.35 (C10), 131.99 (C1), 129.77 (C3), 
128.02 (C2), 127.53 (C11), 126.18 (C9), 51.42 (C6), 29.34 (C7); GC-MS: (Optima-5-Amine, 
100.2/10.270/10): tR = 17.4 min, m/z = 252, 147, 129, 105; IR (neat, ATR) ν/cm-1 = 3058 (w), 2974 (w), 
2928 (w), 2835 (w), 2741 (m), 1700 (s), 1677 (s), 1595 (m), 1570 (m), 1469 (m), 1443 (m), 1381 (m), 1359 
(m), 1296 (m), 1246 (m), 1236 (m), 1190 (m), 1166 (m), 971 (m); HRMS: calculated: 275.1043 [M+Na]+, 
found: 275.1043; EA: calc.: C, 80.93; H, 6.39; found: C, 80.25; H, 6.47. 
 
 
2-(2-(((4-methoxyphenyl)imino)methyl)phenyl)-2-methyl-1-phenylpropan-1-one (456) 
 
An oven-dried 50 mL Schlenk tube was charged with 4Å mol 
sieves and purged with Argon three times before being charged 
with 455 (450 mg, 1.78 mmol, 1.0 eq.) and 118 (241.6 mg, 1.96 
mmol, 1.1 eq.). Dry toluene (10 mL) was added and the reaction 
mixture stirred at room temperature for 24 hours. Solvents were 
removed under reduced pressure and the residue was dried under 
high vacuum to afford 456 as a sticky orange solid. Crude NMR 
analysis indicated >95% conversion to the aldimine which was directly used in the next step without 
purification. 
 
C24H23NO2 (MW = 357.44 g/mol): 
1H-NMR (500 MHz, CDCl3) δ 8.59 (s, 1H, H14), 8.09 (d, J = 7.7 Hz, 1H, H12), 7.71 (d, J = 7.9 Hz, 1H, 
H9), 7.57 (dd, J = 11.5, 7.9 Hz, 3H, H10, H3), 7.38 (m, 1H, H11), 7.32 (m, 1H, H1), 7.17 (t, J = 7.8 Hz, 2H, 
H2), 7.07 (d, J = 8.8 Hz, 2H, H16), 6.90 (d, J = 8.8 Hz, 2H, H17), 3.82 (s, 3H, H19), 1.77 (s, 6H, H7); 
13C{1H}-NMR (126 MHz, CDCl3) δ 204,39 (C5), 158.55 (C18), 156.19 (C14), 145.60 (C8), 144.49 (C15), 
135.43 (C4), 135.14 (C13), 132.45 (C1), 131.45 (C10), 129.80 (C3), 129.18 (C12), 128.23 (C2), 127.56 
(C11), 125.22 (C9), 122.53 (C16), 114.51 (C17), 55.59 (C19), 51.68 (C6), 29.35 (C7); GC-MS: (Optima-5-
Amine, 100.2/10.270/20): tR = 31.0 min, m/z = 357 ([M]+), 252, 129, 105. 
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2-(2-(1-((4-methoxyphenyl)amino)-2-methylpropyl)phenyl)-2-methyl-1-phenylpropan-1-one (459) 
 
A crude reaction mixture of 456 (~1.78 mmol, 1.0 eq.) was 
dissolved in dry THF (20 mL) and transferred to a 100 mL oven-
dried round-bottomed flask purged with argon. After cooling to 0 
°C, isopropyl magnesium chloride (2.05 mmol, 1.2 eq.) was added 
dropwise and the reaction mixture stirred at 0 °C for 15 minutes 
before being allowed to warm up to room temperature while 
stirring overnight. After cooling to 0 °C the reaction was quenched 
with NaHCO3 (10 mL) and organic components were extracted 
with Et2O (3x25 mL). The combined organic layers were washed 
with brine (20 mL), dried over Na2SO4, filtered and solvents removed under reduced pressure. The residue 
was subjected to flash chromatography (SiO2, cyclohexane/EtOAc 8:1, 16x3 cm, 20 mL fractions) to afford 
459 (420 mg, 1.05 mmol, 58%) as a red-brownish solid. Purification by semipreparative HPLC yields a 
white solid which rapidly degrades to a sticky yellow solid upon exposure to air. Spectral data dies not agree 
with the crude isolated material prior to HPLC separation. 
 
C27H31NO2 (MW = 401.54 g/mol): 
1H-NMR (500 MHz, CDCl3) δ 7.67 (dd, J = 7.8, 1.6 Hz, 1H, H9), 7.55 (dd, J = 8.3, 1.0 Hz, 2H, H3), 7.47 
(dd, J = 7.5, 1.9 Hz, 1H, H12), 7.39 (td, J = 7.5, 1.9 Hz, 1H, H10), 7.35 (td, J = 7.3, 1.6 Hz, 1H, H11), 7.32 
(tt, J = 7.4, 1.3 Hz, 1H, H1), 7.14 (dd, J = 8.4, 7.2 Hz, 2H, H2), 6.64 (m, 2H, H20), 6.40 (m, 2H, H21), 4.41 
(d, J = 7.2 Hz, 1H, H14), 3.72 (s, 3H, H23), 3.24 (sbr, 1H, NH), 1.92 (dq, J = 12.8, 6.4, 6.0 Hz, 1H, H15), 
1.71 (s, 3H, H7), 1.57 (s, 3H, H7‘), 0.89 (d, J = 6.7 Hz, 3H, H16), 0.49 (d, J = 6.8 Hz, 3H, H17); 13C{1H}-
NMR (101 MHz, CDCl3) δ 203.57 (C5), 151.62 (C22), 143.38 (C13), 142.42 (C8), 142.17 (C19), 135.90 
(C4), 132.19 (C1), 130.07 (C3), 127.95 (C2), 127.89 (C12), 127.77 (C11), 127.70 (C10), 126.12 (C9), 
114.59 (C21), 114.56 (C20), 58.21 (C14), 55.86 (C23), 52.06 (C6), 36.53 (C15), 29.60 (C7), 29.35 (C7‘), 
20.53 (C17), 19.20 (C16); IR (neat, ATR) ν/cm-1 = 3061 (w), 3025 (w), 2964 (w), 2928 (w), 2905 (w), 2854 
(w), 2830 (w), 1601 (w), 1580 (w), 1502 (s), 1463 (m), 1450 (m), 1385 (m), 1361 (m), 1279 (m), 1232 (s), 
1194 (w), 1174 (m), 1146 (m), 1039 (s), 822 (s), 763 (s); GC-MS: (Optima-5-Amine, 100.2/10.270/20): tR = 
27.5 min, m/z = 382 ([M]+), 248, 197; HPLC (semipreparative : Daicel Chiracel OD, n-heptane/iso-propanol 
90:10, 6.0 mL/min, 20 °C, 265 nm): tR = 21.0 min (+), tR = 25.0 min (-); Optical Rotation: [] = -246 (c 
1.0 in CHCl3 0.75% EtOH). 
 
 
2-(2-(1-((4-methoxyphenyl)amino)-2,2-dimethylpropyl)phenyl)-2-methyl-1-phenylpropan-1-one (460) 
 
An oven-dried 10 mL Schlenk tube was purged with Argon three 
times before being charged with 455 (150 mg, 0.595 mmol, 1.0 
eq.) and 118 (80.5 mg, 0.655 mmol, 1.1 eq.). Dry toluene (3 mL) 
was added and the reaction mixture stirred at room temperature 
for 24 hours. Solvents were removed under reduced pressure and 
the residue dried under high vacuum before being suspended in 
dry THF (3 mL). The reaction mixture was cooled to 0 °C and 
tert-butyl magnesium chloride (0.9 mmol, 1.5 eq.) was added. An 
instant colourchange from towards yellow-orange was observed. The reaction mixture was allowed to warm 
to room temperature while stirring for 22 hours. The reaction was quenched with NaHCO3 (2 mL) and 
organic components extracted with Et2O (3x10 mL) before the combined organic layers were dried over 
anhydrous MgSO4, filtered and solvents removed under reduced pressure.The residue was subjected to flash 
chromatography (SiO2, cyclohexane/EtOAc 20:1 gradient to 5:1, 18x4 cm, 25 mL fractions) to afford 460 
(61 mg, 0.15 mmol, 25%) as a off-white yellowish solid.   
 
C28H33NO2 (MW = 415.57 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 7.62 (dd, J = 7.5, 1.9 Hz, 2H, H11), 7.56 (d, J = 7.5 Hz, 2H, H3), 7.50 (dd, J 
= 7.3, 2.1 Hz, 1H, H12), 7.34 (m, 1H, H10), 7.33 (m, 1H, H9), 7.30 (dd, J = 7.4, 1.1 Hz, 1H, H1), 7.11 (dd, J 
= 8.4, 7.3 Hz, 2H, H2), 6.71 (ddd, J = 9.0, 3.6, 2.2 Hz, 2H, H20), 6.60 (dt, J = 8.9, 3.5, 2.2 Hz, 2H, H19), 
4.73 (s, 1H, H14), 3.74 (s, 3H, H22), 3.41 (sbr, 1H, NH), 1.74 (s, 3H, H7), 1.53 (s, 3H, H7’), 0.80 (s, 9H, 
H16); 13C{1H}-NMR (101 MHz, CDCl3) δ 203.98 (C5), 151.57 (C21), 143.52 (C13), 142.33 (C8), 142.32 
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(C18), 136.06 (C4), 132.12 (C1), 130.23 (C3), 128.11 (C12), 127.88 (C2), 127.68 (C10), 127.25 (C9), 
126.64 (C11), 114.93 (C19), 114.64 (C20), 59.60 (C14), 55.86 (C22), 52.40 (C6), 38.75 (C15), 29.89 (C7), 
29.81 (C7’), 29.16 (C16); IR (neat, ATR) ν/cm-1 = 3061 (w), 3024 (w), 2962 (w), 2929 (m), 2905 (m), 2865 
(w), 2855 (w), 2830 (w), 1668 (m), 1597 (w), 1577 (w), 1503 (s), 1465 (m), 1449 (m), 1385 (m), 1362 (m), 
1232 (s), 1175 (m), 1038 (m); MS (EI, 70 eV): 223.1 (9.6%, [M]+). 415.1 (2.3%), 359.2 (26.6%), 358.2 
(100%); GC-MS: (Optima-5-Amine, 100.2/10.270/20): tR = 26.2 min, m/z = 382 ([M-CH3]+), 340, 325, 217; 
HRMS: calculated: 416.2584 [M+H]+; found: 416.2585. 
 
 
1-isopropyl-4,4-dimethyl-3-phenyl-1,4-dihydroisoquinoline (392) 
 
A 25 mL round-bottomed flask was charged with 459 (100 mg, 0.25 mmol, 1.0 
eq.) and dissolved in methanol/water (6:1, 17.5 mL) before being cooled to 0 
°C. Cerium ammonium nitrate (1.37 g, 2.5 mmol, 10 eq.) was added and the 
resultant suspension stirred 24 hours where again cerium ammonium nitrate (1 
g, 1.8 mmol, 7.3 eq.) was added and stirring continued for another 20 hours. 
The reaction mixture as then diluted with water (10 mL) and CH2Cl2 (10 mL) 
and transferred to a separation funnel. The aequeous layer was basified with NaOH (1M, 10 mL) and organic 
components extracted with EtOAc (3x30 mL). The combined organic layers were washed with brine (25 mL 
and dried over anhydrous MgSO4, filtered and and solvents removed under reduced pressure. The residue 
was subjected to flash chromatography (SiO2, cyclohexane/EtOAc 4:1, 18x2 cm, 7 mL fractions) to afford 
392 (15.5 mg, 0.056 mmol, 22%) as a clear oil. 
 
C20H23N (MW = 277.40 g/mol): 
1H-NMR (500 MHz, CDCl3) δ 7.40 (m, 1H, H10), 7.39 (m, 2H, H2), 7.36 (m, 2H, H3), 7.29 (m, 1H, H11), 
7.27 (m, 1H, H1), 7.25 (m, 1H, H12), 7.23 (m, 1H, H13), 4.84 (d, J = 4.4 Hz, 1H, H15), 2.31 (heptd, J = 6.8, 
4.6 Hz, 1H, H16), 1.52 (s, 3H, H7), 1.47 (s, 3H, H8), 1.23 (d, J = 6.8 Hz, 3H, H18), 0.84 (d, J = 6.8 Hz, 3H, 
H17); 13C{1H}-NMR (101 MHz, CDCl3) δ 174.00 (C5), 141.92 (C4), 141.20 (C9), 134.75 (C14), 128.20 
(C3), 127.91 (C2), 127.61 (C13), 126.92 (C11), 126.04 (C1), 125.73 (C12), 125.08 (C10), 65.39 (C15), 
38.01 (C6), 35.87 (C16), 29.92 (C7), 29.53 (C8), 21.07 (C18), 17.56 (C17); GC-MS: (Optima-5-Amine, 
100.2/10.270/20): tR = 17.7 min, m/z = 277 ([M]+), 262, 234, 174, 159; HPLC (Daicel Chiracel OD-H, n-
heptane/iso-propanol 99:1, 0.5 mL/min, 25 °C, 206/238 nm): tR = 9.2 min (-), tR = 11.2 min (+); IR (neat, 
ATR) ν/cm-1 = 2974 (w), 2925 (m), 2851 (w), 2742 (w), 1700 (s), 1677 (s), 1595 (m), 1569 (s), 1443 (m), 
1381 (m), 1359 (m), 1297 (m), 1246 (m), 1236 (m), 1190 (m), 1166 (m), 1077 (w), 971 (s), 903 (m); HRMS: 
calculated: 278.1903 [M+H]+; found: 278.1903; Optical Rotation: [] = -15.6 (c 0.035 in CHCl3 0.75% 
EtOH); Optical Rotation: [] = +12.2 (c 0.035 in CHCl3 0.75% EtOH). 
 
 
Benzoxazines 
 
2-(1-aminoethyl)phenol (490)[173] 
In a 500 mL three-neck round bottom flask equipped with a magnetic stirrer and a reflux 
condenser was inserted 2-methoxybenzonitrile 488 (4.50 g, 33.8 mmol, 1.0 eq), CuBr (98.0 mg, 0.683 mmol, 
0.02 eq) and dissolved in dry THF (75 mL). A solution of MeMgCl in THF (3M, 21.4 mL, 4.81 g MeMgCl, 
64.3 mmol, 1.9 eq) was added and the resultant mixture heated to reflux for 16 hours. A short reaction 
control via TLC depicted all the starting material had not been consumed and therefore again a solution of 
MeMgCl in THF (3M, 5.00 mL, 1.12 g, 15.0 mmol, 0.4 eq; total 5.93 g MeMgCl) was added and refluxing 
continued for further 5 hours. Afterwards the reaction mixture was allowed to cool to room temperature. A 
mechanical stirrer, a ammonia condensation vessel and washing bottles were mounted and the mixture 
cooled to -78 °C. Subsequently ammonia (approx. 200 mL) was condensed into the reaction mixture. 
Lithium (1.19 g, 169 mmol, 5.0 eq) was added in small pieces until the reaction mixture turned blue. The 
cooling bath was removed and the reaction mixture was allowed to warm up overnight while stirring and 
evaporating all ammonia. tert-Butylmethylether (MTBE) was added to the mixture, cooled to 0 °C and 
titrated with concentrated HCl to pH 8. The organic layer was separated, the aequeous layer salted out and 
extracted with MTBE (3 x 100 mL). The combined organic layers were washed with brine (100 mL), 0.5 M 
HCl (3 x 150 mL) and the acidic aequeous phase extracted with MTBE (3 x 50 mL). The acidic aequeous 
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layer was set to pH 11 with 10% NaOH (10%), salted out and extracted with MTBE (3 x 50 mL). The 
combined organic layers were dried over MgSO4, solvents removed under reduced pressure and the residue 
was purified via distillation (60-65 °C at 0.08 mbar). 490 was obtained as a greenish oil (1.03 g, 7.5 mmol, 
22%). The product contained 1-(2-Methoxyphenyl)ethanamine 489 as an impurity (0.265 g, 1.8 mmol, 4%). 
 
C8H11NO (137.18 g/mol): 
b.p.: 65°C (0.08 mbar); 1H-NMR (400 MHz, CDCl3) δ 7.15 (td, 3J = 7.9 Hz, 4J = 1.7 Hz, 1H, 
CHArCHArCArCH(NH2)); 6.97 (dd, 3J = 7.5 Hz, 4J = 1.5 Hz, 1H, CHArCAr(OH)); 6.84 (dd, 3J = 8.1 Hz, 4J = 
0.9 Hz, 1H, CHArCArCH(NH2)); 6.78 (td, 3J = 7.4 Hz, 4J = 1.1 Hz, 1H, CHArCHArCAr(OH)); 4.33 (q, J = 6.6 
Hz, 1H, CH(NH2)(CH3)); 3.85 (s, 2H, NH2); 1.48 (d, J = 6.7 Hz, 3H, CH3); 13C{1H}-NMR (126 MHz, 
CDCl3) δ 157.76 (CAr(OH), 128.59 (CArCH); 128.23 (CHAr); 127.31 (CHAr); 119.13 (CHAr); 117.35 (CHAr); 
51.87 (CH(NH2)(CH3)); 24.01 (CH3). 
 
 
N-(1-(2-hydroxyphenyl)ethyl)benzamide (495) 
 
In a 25 mL two-neck round bottom flash equipped with a magnetic stirrer and 
a septum was placed crude 490 (1.295 g, 9.3 mmol, 1.24 eq), dissolved in 
CH2Cl2 (10 mL) and cooled to 0 °C. Benzoylchloride (1.05 g, 7.50 mmol, 1.0 
eq) and triethylamine (0.833 g, 8.25 mmol, 1.1 eq) were added via syringe pump over a period of 5 minutes. 
After another 10 minutes the cooling bath was removed and the reaction mixture allowed to warm to room 
temperature while stirring overnight. Solvents were removed at the rotavap and the crude was purified via 
elution chromatography (7 cm x 4 cm, SiO2, EtOAc) to give 495 as a yellow oil. The product contained N-(1-
(2-Methoxy-phenyl)ethyl)benzamide as an impurity of about 25%. Thus, the crude product was transferred 
to an 25 mL oven-dried argon-purged two-neck round bottom flask, dissolved in 5 mL CH2Cl2 and cooled to 
-78 °C. A solution of BBr3 (1M in CH2Cl2) was added dropwise via syringe and the resultant mixture stirred 
for 15 minutes. The cooling bath was removed and reaction mixture allowed warming up to room 
temperature overnight. 10% NaOH (10 mL) were added dropwise and the resultant mixture stirred for 10 
minutes. Layers were separated and the aequeous layer was acidified with 1M HCl (25 mL), set to pH 8 via 
addition of saturated NaHCO3 solution and extracted with CH2Cl2 (2 x 25 mL). The combined organic layers 
were dried over MgSO4, solvents removed under reduced pressure and 495 obtained as a yellow oil (1.54 g, 
6.4 mmol, 85%). Enantiomers were separated by semipreparative HPLC. 495 was dissolved in a mixture of 
heptane/2-propanol (9:1) to a concentration of 0.3g mL-1. Daicel Chiralcel OD (2 cm x 25 cm), n-hexane : 2-
propanol (90:10), 6 mL min-1, 40 °C, 0.25 mL injection volume, tR = 41.0 min (S)-(+), tR = 49.0 min (R)-(-). 
 
C15H15NO2  (241.29 g/mol): 
m.p.: 131-133 °C; 1H-NMR (500 MHz, CDCl3) δ 9.23 (s, 1H, CAr(OH)), 7.75 (m, 2H, CHArCArC=O), 7.51 
(m, 1H, CHArCHArCHArCArC=O), 7.43 (m, 2H, CHArCHArCArC=O), 7.28 (dd, 3J = 7.7, 4J = 1.7 Hz, 1H, 
CHArCArCHNH), 7.20 (ddd, 3J = 8.1, 7.3, 4J = 1.7 Hz, 1H, CHArCHArCAr(OH)), 6.97 (dd, 3J = 8.1, 4J = 1.3 
Hz, 1H, CHArCAr(OH)), 6.90 (td, 3J = 7.5, 4J = 1.3 Hz, 1H, CHArCHArCArCHNH), 6.53 (d, 3J = 8.5 Hz, 1H, 
NH), 5.51 (dq, 3J = 8.6, 7.1 Hz, 1H, CHNH), 1.73 (d, 3J = 7.0 Hz, 3H, CH3); 13C{1H}-NMR (101 MHz, 
CDCl3) δ 168.73 (C=O); 155.47 (CAr(OH)); 133.12 (CArC=O); 132.31 (CHArCHArCHArCArC=O); 129.48 
(CHArCHArCAr(OH)); 128.82 (CHArCHArCArC=O); 128.57 (CArCHNH); 127.26 (CHArCArC=O); 125.91 
(CHArCArCHNH); 120.39 (CHArCHArCArCHNH); 118.60 (CHArCAr(OH)); 43.64 (CHNH); 19.79 (CH3); IR 
(neat, ATR) ν/cm-1 = 3350 (m), 3065 (w), 2932 (w), 2733 (w), 2677 (w), 2620 (w), 1623 (m), 1602 (m), 
1568 (w), 1538 (s), 1488 (s), 1409 (m), 1349 (m), 1277 (m), 1232 (s), 1188 (m), 1132 (m), 1102 (m), 1019 
(m), 928 (w), 872 (w), 838 (m), 765 (s), 705 (s), 696 (s); MS (EI, 70 eV): 241.1 (45.8%, [M]+). 226.1 (11%, 
[M-CH3]+); HRMS: calculated: 241.1098 [M]+; found: 241.1102; EA: calculated: C: 74.67, H: 6.27, N: 5.81; 
found: C: 74.39, H: 6.45, N: 5.67; Optical Rotation (R)-isomer: [] = -26.5 (c 0.75 in CHCl3, 0.75% 
EtOH); Optical Rotation (S)-isomer: [] = +24.8 (c 0.75 in CHCl3, 0.75% EtOH).  
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4-Methyl-2-phenyl-4H-benzo[e][1,3]oxazine (399) 
 
In a 10 mL 2-neck round bottom flask was placed (R)-495 (61.3 mg, 0.254 mmol, 
1.0 eq.), dissolved in CH2Cl2 (2 mL) and cooled to -40 °C. POCl3 (0.63 mL of a 
0.4M solution, 0.254 mmol, 1.0 eq.) was added and the reaction mixture stirred 
for 30 minutes. Then pyridine (125 uL, 120 mg, 1.524 mmol, 6.0 eq) was added 
and stirring continued for 15 minutes. Afterwards the cooling bath was removed 
and the mixture allowed to warm to room temperature while stirring overnight. Reaction was quenched with 
1M NaOH (2.5 mL), extracted with diethylether (2 x 5 mL) and solvents removed under reduced pressure. 
Purification via flash chromatography (SiO2, 18 x 2.5 cm, 7 mL frctns, cyclohexane/EtOAc 10:1, frctns 12-
14) gave (R)-399 as a clear oil (1.3 mg, 0.0058 mmol, 2%). With the identical procedure, (S)-495 (58.9 mg, 
0.244 mmol, 1.0 eq.) gave (S)-399 (3.3 mg, 0.015 mmol, 6%) as a clear oil. 
 
C15H13NO (223.27 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 8.10 (m, 2H, CHArCArC=N), 7.47 (m, 3H, CHArCHArCArC=N and 
CHArCHArCHArCArC=N), 7.23 (m, 1H, CHArCHArCAr-O), 7.14 (m, 2H, CHArCArCH(CH3)N and 
CHArCHArCArCH(CH3)N), 7.04 (d, J = 8.0 Hz, 1H, CHArCAr-O), 4.83 (q, J = 6.9 Hz, 1H, CH(CH3)N), 1.58 
(d, J = 6.9 Hz, 3H, CH(CH3)N); 13C{1H}-NMR (101 MHz, CDCl3) δ 151.72 (O-C=N), 148.97 (CAr-O), 
132.55 (CArC=N), 131.05 (CHArCHArCHArCArC=N), 128.36 (CHArCHArCArC=N), 128.04 (CHArCHArCAr-O), 
127.55 (CHArCArC=N), 126.12 (CHArCArCH(CH3)N), 124.89 (CHArCHArCArCH(CH3)N), 115.62 (CHArCAr-
O), 50.16 (CH(CH3)N), 25.51 (CH3); IR (neat, ATR) ν/cm-1 = 3059 (w), 2964 (m), 2925 (m), 2854 (w), 1670 
(s), 1585 (w), 1488 (m), 1462 (w), 1449 (m), 1347 (m), 1289 (w), 1248 (m), 1226 (s), 1198 (m), 1112 (m), 
1055 (m), 1023 (m); HRMS: calculated: 223.0992 [M]+; found: 223.0986; Optical Rotation (R)-isomer: [] = -8.6 (c 0.13 in CHCl3, 0.75% EtOH); Optical Rotation (S)-isomer: [] = +10.3 (c 0.165 in CHCl3, 
0.75% EtOH). 
 
 
1-(2-methoxyphenyl)-2-methylpropan-1-amine (479)[130] 
 
In a 500 mL three-neck round bottom flask equipped with a magnetic stirrer and a 
reflux condenser was inserted 488 (4.50 g, 33.8 mmol, 1.0 eq), CuBr (98.0 mg, 0.683 
mmol, 0.02 eq) and dissolved in dry THF (75 mL). A solution of isopropyl magnesium 
chloride in THF (2 M, 32 mL, 6.61 g iPrMgCl, 64.27 mmol, 1.9 eq) was added and the 
resultant mixture heated to reflux for 16 hours. Afterwards the reaction mixture was allowed to cool to room 
temperature. A mechanical stirrer, an ammonia condensation vessel and washing bottles were mounted and 
the mixture cooled to -78 °C. Subsequently ammonia (approx. 200 mL) was condensed into the reaction 
mixture. Lithium (735 mg, 105 mmol, 3.1 eq) was added in small pieces until the reaction mixture turned 
blue. The cooling bath was removed and the reaction mixture was allowed to warm up overnight while 
stirring and evaporating all ammonia. Tert-butylmethylether (MTBE) was added to the mixture, cooled to 0 
°C and titrated with concentrated HCl to pH 8. The organic layer was separated and the aequeous layer salted 
out and extracted with MTBE (3 x 100 mL). The combined organic layers were washed with brine (100 mL), 
0.5 M HCl (3 x 150 mL) and the acidic aequeous phase extracted with MTBE (3 x 50 mL). The acidic 
aequeous layer was set to pH 11 with 10% NaOH (10%), salted out and extracted with MTBE (3 x 50 mL). 
The combined organic layers were dried over anhydrous MgSO4, solvents removed at the rotavap and the 
residue was purified via distillation (63 °C at 0.08 mbar) to afford 479 (5.21 g, 29 mmol, 86%) as a yellow 
oil. 
 
C11H17NO (179.26 g/mol): 
b.p.: 65 °C at 0.08 mbar; 1H-NMR (400 MHz, CDCl3) δ 7.24 (m, 1H, CHArCArCH(NH2)), 7.19 (m, 1H, 
CHArCHArCArCH(NH2)), 6.93 (t, J = 7.5, 1H, CHArCHArCAr(OCH3)), 6.85 (d, J = 8.2 Hz, 1H, 
CHArCAr(OCH3)), 3.88 (d, J = 7.6 Hz, 1H, CH(NH2)), 3.82 (s, 3H, OCH3), 1.97 (m, 1H, CH(CH3)2), 1.50 (s, 
2H, NH2), 0.99 (d, J = 6.7 Hz, 3H, CH(CH3)2), 0.79 (d, J = 6.8 Hz, 3H, CH(CH3)2). 
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N-(1-(2-hydroxyphenyl)-2-methylpropyl)benzamide (497) 
 
In a 25 mL round-bottom flask was placed 479 (1.0 g, 5.59 mmol, 1.0 eq.) and 
cooled to 0 °C. Benzoyl chloride (782 mg, 5.59 mmol, 1.0 eq.) and 
triethylamine (621 mg, 6.15 mmol, 1.1 eq.) were added dropwise and the 
reaction mixture was stirred at room temperature for 24 hours. Elution 
chromatography (SiO2, EtOAc) and removal of solvents under reduced 
pressure afforded N-(1-(2-methoxyphenyl)-2-methylpropyl)benzamide (1.52 g, 5.36 mmol, 96 %) which was 
dissolved in dry dichloromethane (12 mL) and cooled to -78 °C. Boron tribromide (1.0 M in CH2Cl2, 16.1 
mmol, 3.0 eq.) was added dropwise, the cooling bath removed and the reaction mixture allowed warming up 
to room temperature while stirring overnight. It was then cooled to 0 °C and quenched by addition NaOH 
(10% w/w, 30 mL). After seizure of gas evolution layers were separated and the aequeous layer acidified 
with concentrated HCl (8 mL). It was then basified to pH of 8 by addition of NaHCO3 (150 mL) and 
extracted with CH2Cl2 (2 x 25 mL). The combined organic layers were dried over anhydrous MgSO4, filtered 
and solvents removed under reduced pressure. The residue was dried in vacuo to afford 497 (1.2 g, 4.46 
mmol, 83 %) as a white solid. Enantiomers were separated via semipreparative HPLC (Daicel Chiralcel AD 
(2 cm x 25 cm), n-hexane : 2-propanol (90:10), 6 mL min-1, 25 °C, 0.4 mL injection volume, tR = 43.0 min 
(+), tR = 52.0 min (-), 497 was dissolved in a mixture of heptane/2-propanol (9:1) to a concentration of 0.3g 
mL-1. 
 
C17H19NO2  (269.34 g/mol): 
m.p.: 138 °C; 1H-NMR (500 MHz, CDCl3) δ 8.56 (s, 1H, OH), 7.75 (m, 2H, CHArCArC=O), 7.48 (m, 1H, 
CHArCHArCHArCArC=O), 7.39 (m, 2H, CHArCHArCArC=O), 7.17 (dd, J = 7.6, 1.6 Hz, 1H, CHArCArCHNH), 
7.14 (m, 1H, CHArCHArCAr(OH)), 7.02 (d, J = 9.1 Hz, 1H, NH), 6.94 (dd, J = 8.1, 1.2 Hz, 1H, 
CHArCAr(OH)), 6.87 (td, J = 7.5, 1.2 Hz, 1H, CHArCHArCArCHNH), 4.91 (dd, J = 10.3, 9.1 Hz, 1H, CHNH), 
2.43 (dhept, J = 10.3, 6.6 Hz, 1H, CH(CH3)2), 1.18 (d, J = 6.6 Hz, 3H, CH3), 0.87 (d, J = 6.6 Hz, 3H, CH3); 
13C{1H}-NMR (101 MHz, CDCl3) δ 168.46 (C=O), 155.22 (CAr(OH)), 133.87 (CArC=O), 131.96 
(CHArCHArCHArCArC=O), 128.85 (CHArCHArCAr(OH)), 128.75 (CHArCHArCArC=O), 128.14 
(CHArCArCHNH), 127.44 (CArCHNH), 127.19 (CHArCArC=O), 120.54 (CHArCHArCArCHNH), 118.02 
(CHArCAr(OH)), 56.86 (CHNH), 31.32 (CH(CH3)2), 20.61 (CH3), 20.51 (CH3); IR (neat, ATR) ν/cm-1 = 3401 
(m), 3155 (w), 3103 (w), 3076 (w), 2955 (w), 2870 (w), 1633 (s), 1603 (s), 1576 (m), 1487 (m), 1453 (s), 
1380 (m), 1311 (m), 1259 (m), 1252 (m), 1188 (m), 1130 (m), 1116 (s), 1104 (w), 1040 (m), 930 (m), 857 
(m), 756 (s), 704 (s), 685 (s); MS (EI, 70 eV): 269.1 (3.4%, [M]+). 226.1 (49%, [M-C3H7]+); HRMS: 
calculated: 269.1411 [M]+; found: 269.1413; EA: calculated: C, 75.81; H, 7.11; N, 5.20; found: C, 74.60 H, 
7.13; N, 5.13; Optical Rotation (R)-isomer: [] = -24.3 (c 0.75 in CHCl3, 0.75% EtOH); Optical 
Rotation (S)-isomer: [] = +25.7 (c 0.75 in CHCl3, 0.75% EtOH).  
 
 
4-Isopropyl-2-phenyl-4H-benzo[e][1,3]oxazine (398) 
 
In a 10 mL Schlenk vial was placed (R)-497 (100 mg, 0.37 mmol, 1.0 eq.)  and 
dissolved in CH2Cl2 (1 mL). The solution was cooled to -40 °C with the aid of 
a cryostat. Then a solution of POCl3 (0.4 M in CH2Cl2, 1 mL, 0.4 mmol, 1.08 
eq.) was added dropwise. The reaction mixture was stirred at -40 °C for 2 
hours. Pyridine (176 mg, 2.23 mmol, 6.0 eq.) was added dropwise and stirring 
continued for one hour. The cryostat was removed and the reaction mixture allowed warming to room 
temperature while stirring overnight. It was then cooled to 0 °C and quenched with NaOH solution (1 M,  
5 mL, 5 mmol). After ether extraction (3 x 25 mL) the combined organic layers were dried over MgSO4, 
filtered and solvents removed under reduced pressure. The residue was purified by flash chromatography to 
afford (R)-398 (39 mg, 0.155 mmol, 42%) as an off-white oil. Identical to the procedure above, (S)-497 (538 
mg, 2.0 mmol, 1.0 eq.) , a solution of POCl3 (306 mg, 2.0 mmol, 1.0 eq.) and pyridine (949 mg, 12 mmol, 
6.0 eq.) gave (S)-398 (114 mg, 0.45 mmol, 23%) as a clear oil.  
 
C17H17NO (251.32 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 8.10 (m, 2H, H12), 7.46 (m, 3H, H13 and H14), 7.25 (td, J = 7.7, 1.8 Hz, 1H, 
H7), 7.14 (td, J = 7.4, 1.2 Hz, 1H, H6), 7.09 (dd, J = 7.5, 1.7 Hz, 1H, H5), 7.04 (dd, J = 8.1, 1.0 Hz, 1H, H8), 
4.67 (d, J = 3.9 Hz, 1H, H3), 2.14 (m, 1H, H2), 1.09 (d, J = 6.8 Hz, 3H, H1), 0.86 (d, J = 6.8 Hz, 3H, H1ˈ); 
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13C{1H}-NMR (101 MHz, CDCl3) δ 152.10 (C10), 149.90 (C9), 132.53 (C11), 131.04 (C14), 128.36 (C13), 
127.96 (C7), 127.62 (C12), 126.80 (C5), 124.56 (C6), 122.50 (C4), 115.39 (C8), 60.06 (C3), 36.56 (C2), 
18.93 (C1), 17.20 (C1ˈ); IR (neat, ATR) ν/cm-1 = 3066 (w), 3044 (w), 2959 (m), 2928 (w), 2871 (w), 1675 
(s), 1586 (w), 1486 (m), 1458 (m), 1355 (m), 1291 (m), 1243 (m), 1224 (s), 1194 (m), 1063 (m), 1028 (w); 
HRMS: calculated: 251.1305 [M]+; found: 251.1308; EA: calc. C, 81.24; H, 6.82; N, 5.57; O, 6.37; found: 
C, 80.91; H, 7.48; N, 5.20; Optical Rotation (R)-isomer: [] = -44.4 (c 1.65 in CHCl3, 0.75% EtOH); 
Optical Rotation (S)-isomer: [] = +20.4 (c 0.75 in CHCl3, 0.75% EtOH). 
 
 
N-(2-methoxybenzylidene)-1-phenylmethanamine (492)[128] 
 
A 50 mL two-necked round-bottom flask equipped with a stirring bar and a 
Schlenk bridge was set under argon atmosphere and charged with 4 Å 
molecular sieves (4.00 g). Benzylamine (8.0 mL, 73.4 mmol, 1.0 eq) was added and dissolved in CH2Cl2 (19 
mL). To the stirred mixture was added a solution of 2-methoxybenzaldehyde 491 (10.0 g, 73.4 mmol, 1.0 eq) 
in CH2Cl2 (4.3 mL) and stirring continued for three hours.The reaction mixture was filtered through a pad of 
celite and the solvent was removed under reduced pressure. Distillation (0.09-0.10 mbar, 136-138 °C) of the 
filtrate gave 492 (14.5 g, 64.4 mmol, 88%) as a colourless oil. 
 
C15H15NO (225.29 g/mol): 
b.p.: 136-138 °C at 0.09-0.10 mbar; 1H-NMR (400 MHz, CDCl3) δ 8.85 (s, 1H, CH=N), 8.01 (dd, 3J = 7.7 
Hz, 4J = 1.6 Hz, 1H, CHArCArCH=N), 7.39 (m, 1H, CHArCHArCAr(OCH3)), 7.33 (m, 4H, CHArCH2 and 
CHArCHArCH2), 7.24 (m, 1H, CHArCHArCHArCH2), 6.98 (t, 3J = 7.5 Hz, 1H, CHArCAr(OCH3)), 6.92 (d, J = 
8.3 Hz, 1H, CHArCHArCArCH=N), 4.82 (s, 2H, CH2), 3.88 (s, 3H, OCH3); GC-MS (EI, 70 eV, PhMeSi, 
100.2/10.270/10): tR = 16.9 min, m/z = 224 ([M-H]+). 
 
 
N-benzyl-1-(2-methoxyphenyl)-2,2-dimethylpropan-1-amine (493)[128]  
 
A 250 mL two-necked round-bottom flask equipped with a stirring bar and a 
Schlenk bridge was set under argon atmosphere and charged with tert-BuLi 
(22 mL of a 1.7 M solution in pentane, 37.8 mmol, 1.7 eq). The solution was 
cooled to -30 °C and via a cooling trap the solvent was removed in vacuo. The 
resulting colourless solid was cooled to -78 °C and THF (22 mL) was added slowly resulting in a yellow 
suspension. Afterwards a solution of 492 (5.00 g, 22.2 mmol, 1.0 eq) in THF (11 mL) was added over a 
period of two hours using a syringe pump and causing the mixture to turn purple. After three hours h the 
mixture was allowed to warm to 0 °C and stirring was continued overnight. A saturated aqueous solution of 
NH4Cl (11 mL) was added and the mixture turned yellow. Layers were separated, the aqueous layer was 
extracted with Et2O (2 x 20 mL), the combined organic layers were dried over Na2SO4 and solvent was 
removed under reduced pressure. Distillation (0.06-0.08 mbar, 131-142 °C) of the residue gave 493 (4.82 g, 
17.0 mmol, 77%) as a yellow oil. 
 
C19H25NO (283.41 g/mol): 
b.p.: 131-142 °C at 0.06-0.08 mbar; 1H-NMR (400 MHz, CDCl3) δ 7.45 (d, J = 7.3 Hz, 1H, 
CHArCArCHNH), 7.18 (m, 4H, CHArCArCH2 and CHArCHArCArCH2), 7.21 (m, 2H, CHArCHArCArCHNH and 
CHArCHArCHArCArCH2), 6.97 (t, J = 7.2 Hz, 1H, CHArCHArCAr(OCH3)), 6.87 (d, J = 8.1 Hz, 1H, 
CHArCAr(OCH3)), 4.06 (s, 1H, CHNH), 3.77 (s, 3H, OCH3), 3.55 (d, J = 13.2 Hz, 1H, CH2), 3.39 (d, J = 13.2 
Hz, 1H, CH2), 0.89 (s, 9H, C(CH3)3). 
 
 
1-(2-methoxyphenyl)-2,2-dimethylpropan-1-amine (494)[128]  
 
A 50 mL round-bottom flask equipped with a stirring bar and an argon tube was 
charged with Pd/C (Degussa type 101 NE/W, 0.343 g), 493 (4.82 g, 17.0 mmol, 1.0 eq) 
and EtOH (15 mL). The mixture was degassed performing three “freeze-pump-thaw” 
cycles purging with hydrogen each time. Afterwards the mixture was heated to 60 °C 
and stirred for 26 hours under ambient hydrogen pressure. After cooling to room temperature the mixture 
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was filtered through a pad of celite and the solvent was removed under reduced pressure. Distillation (0.06-
0.08 mbar, 82-85 °C) of the residue gave 494 (2.93 g, 15.2 mmol, 89%). Enantiomers were separated by 
recrystallisation. A 25 mL round-bottom flask equipped with a stirring bar and a reflux condenser was 
charged with 494 (2.93 g, 15.2 mmol, 1.0 eq), (S)-mandelic acid 498 (2.31 g, 15.2 mmol, 1.0 eq) and AcOEt 
(4.5 mL). The mixture was heated to reflux until all the solid was dissolved and the stirring bar was removed 
from the hot solution. After 22 hours the mother liquor was decanted and the remaining crystals were washed 
with Et2O and n-pentane and dried in vacuo. Afterwards the obtained (R,S)-salt was recrystallized twice as 
follows. A 50 mL round-bottom flask with a stirring bar was charged with the (R,S)-salt (1.95 g, 5.64 mmol), 
AcOEt (14.5 mL) and EtOH (1.16 mL). The mixture was heated until all salt dissolved and the stirring bar 
was removed. After 40 hours the mother liquor was decanted and the precipitated crystals were washed with 
Et2O and n-pentane and dried in vacuo. A diastereomeric excess >96% was detected by 1H-NMR. The 
enantiomerically enriched (R,S)-salt (0.980 g, 2.84 mmol) was put into a separating funnel and 10% aqueous 
NaOH (10 mL) was added. Extraction of this mixture with AcOEt (3 x 25 mL), drying over Na2SO4 and 
evaporation of the solvent gave (R)-494 (0.544 g, 2.81 mmol, 37%) as a colourless oil. The mother liquors 
from the preceeding recrystallisations were combined in a separating funnel, diluted with TBME (40 mL) 
and washed with 10% aqueous NaOH (2 x 20 mL). The combined aqeuos layers were extracted with TBME 
(3 x 40 mL). The combined organic layers were dried over Na2SO4 and evaporation of the solvent gave 
already partially enantiomerically enriched (S)-494 (2.37 g, 12.3 mmol). A 50 mL round-bottom flask was 
charged with partially enantiomerically enriched (S)-494, (R)-mandelic acid 498 (1.86 g, 12.3 mmol), AcOEt 
(26.3 mL) and EtOH (0.7 mL) and the mixture was heated until all solid dissolved. After 20 hours the mother 
liquor was decanted and the crystals were washed with Et2O and n-pentane. This recrystallisation procedure 
was repeated once. A diastereomeric excess >96% was detected by 1H-NMR. The free amine was obtained 
from the (S,R)-salt (0.727 g, 2.11 mmol) by addition of 10% aqueous NaOH and subsequent extraction with 
AcOEt as described above to afford (S)-494 (0.381 g, 1.97 mmol, 26%) as a colourless oil. 
 
C12H19NO (193.29 g/mol): 
b.p.: 82-85 °C at 0.06-0.08 mbar; 1H-NMR (500 MHz, CDCl3) δ 7.34 (mbr, 1H, CHArCArCHNH2), 7.19 (t, J 
= 7.8 Hz, 1H, CHArCHArCArCHNH2), 6.93 (t, J = 7.4 Hz, 1H, CHArCHArCAr(OCH3)), 6.84 (d, J = 8.2 Hz, 1H, 
CHArCAr(OCH3)), 4.26 (s, 1H, CHNH2), 3.79 (s, 3H, OCH3), 1.52 (sbr, 2H, NH2), 0.91 (s, 9H, C(CH3)3); GC-
MS (EI, 70 eV, PhMeSi, 100.2/10.270/10): tR = 10.3 min, m/z = 136 ([M-(C(CH3)3)]+).  
Optical Rotation (R)-isomer: [] = +37.0 (c 2.02 in EtOH); Optical Rotation (S)-isomer: [] = -37.1 (c 
2.02 in EtOH). 
 
  
(R)-(-)-2-(1-amino-2,2-dimethylpropyl)phenol (499)[128]  
 
In a 25 mL two-necked round-bottom flask equipped with a stirring bar and a Schlenk 
bridge (R)-494 (0.537 g, 2.78 mmol, 1.0 eq) was dissolved in CH2Cl2 (4.7 mL) and 
cooled to -78 °C. BBr3 (7.5 mL of a 1 M solution in CH2Cl2) was added dropwise and 
the mixture was stirred overnight. The reaction mixture was poured on a saturated 
aqueous solution of NaHCO3 (20 mL) and ice. Additional NaHCO3 solution was added until a pH at 9 was 
observed. Phase separation, extraction with CH2Cl2 (3 x 30 mL), drying over Na2SO4 and evaporation of the 
solvent gave crude (R)-499 (511 mg, 2.78 mmol, 99%) as a brown solid. 
  
C11H17NO (179.26 g/mol): 
1H-NMR (250 MHz, CDCl3) δ 7.14 (t, J = 7.3 Hz, 1H, CHArCHArCArCH(NH2)), 6.90 (d, J = 7.1 Hz, 1H, 
CHArCArCH(NH2)), 6.81 (d, J = 8.0 Hz, 1H, CHArCAr(OH)), 6.74 (t, J = 7.2 Hz, 1H, CHArCHArCAr(OH)), 3.87 
(s, 1H, CH(NH2)), 0.96 (s, 9H, C(CH3)3); Optical Rotation (R)-isomer: [] = -37.6 (c 2.06 in CDCl3, 
0.75% EtOH). 
 
  
(R)-(-)-N-(1-(2-hydroxyphenyl)-2,2-dimethylpropyl)benzamide (500)[127] 
 
In a 25 mL two-necked round-bottom flask equipped with a stirring bar and a 
Schlenk bridge a solution of crude (R)-499 (0.470 g, 2.62 mmol, 1.0 eq) in 
CH2Cl2 (7.5 mL) was cooled to 0 °C and benzoyl chloride (0.33 mL, 2,88 
mmol, 1.1 eq) and triethylamine (0.44 mL, 3.15 mmol, 1.2 eq) were added. 
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The cooling bath was removed after 5 min. and the mixture was stirred at room temperature for 18 hours. 
Elution of the reaction mixture with AcOEt through a short silica gel column gave (R)-500 (435 mg, 1.54 
mmol, 59%) as a grey solid.  
 
C18H21NO2 (283.36 g/mol): 
m.p.: 151-152 °C; 1H-NMR (400 MHz, CDCl3) δ 8.23 (d, J = 7.2 Hz, 1H, NH), 7.80 (d, J = 6.9 Hz, 2H, 
CHArCArC=O), 7.52 (t, J = 7.7 Hz, 1H, CHArCHArCHArCArC=O), 7.40 (t, J = 7.7 Hz, 2H, CHArCHArCArC=O), 
7.13 (t, J = 7.3 Hz, 1H, CHArCHArCAr(OH)), 6.89 (t, J = 7.5 Hz, 1H, CHArCHArCArCHNH), 6.78 (d, J = 8.1 
Hz, 1H, CHArCAr(OH)), 5.25 (d, J = 9.9 Hz, 1H, CHNH), 1.06 (s, 9H, C(CH3)3); IR (neat, ATR) ν/cm-1 = 
3395 (m), 3236 (w), 3185 (w), 2961 (m), 2866 (w), 1639 (s), 1625 (s), 1600 (m), 1531 (s), 1487 (m), 1453 
(s), 1356 (m), 1245 (m), 1208 (m), 1174 (m), 1110 (m), 1063 (m), 1024 (m), 838 (m), 751 (s), 704 (s), 691 
(s); MS (EI, 70 eV): 283.1 (1.4%, [M]+). 226.1 (100%, [M-C4H9]+); Optical Rotation (R)-isomer: [] = -
114.0 (c 3.26 in EtOH). 
  
 
(R)-(-)-4-(tert-butyl)-2-phenyl-4H-benzo[e][1,3]oxazine (400)[127]  
 
In a 10 mL Schlenk vial was placed (R)-500 (75 mg, 0.265 mmol, 1.0 eq.) and 
dissolved in CH2Cl2 (2.6 mL). The solution was cooled to -40 °C with the aid 
of a cryostat. Then a solution of POCl3 (40 mg, 0.265 mmol, 1.0 eq.) was added 
dropwise. The reaction mixture was stirred at -40 °C for 30 minutes. Pyridine 
(126 mg, 1.59 mmol, 6.0 eq.) was added dropwise and stirring continued for 
one hour. The cryostat was removed and the reaction mixture allowed to warm 
to room temperature while stirring overnight. It was then cooled to 0 °C and 
quenched with NaOH solution (1 M, 5 mL, 5 mmol). After ether extraction (3 x 25 mL) the combined 
organic layers were dried over MgSO4, filtered and solvents removed under reduced pressure. The residue 
was purified by flash chromatography (SiO2, cyclohexane/EtOAc 20:1, 20x2 cm, 7 mL fractions) to afford 
(R)-500 (20 mg, 0.073 mmol, 28%) as a clear oil.  
 
C18H19NO (265.35 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 8.13 (m, 2H, H12), 7.50 (m, 1H, H14) 7.47 (m, 2H, H13), 7.30 (m, 1H, H7), 
7.16 (m, 1H, H6), 7.13 (m, 1H, H5), 7.08 (d, J = 7.9 Hz, 1H, H8), 4.46 (s, 1H, H3), 0.99 (s, 9H, H1); 
13C{1H}-NMR (101 MHz, CDCl3) δ 152.32 (C10), 150.39 (C9), 132.37 (C11), 131.12 (C14), 128.68 (C5), 
128.40 (C13), 128.02 (C7), 127.79 (C12), 123.96 (C6), 121.61 (C4), 115.50 (C8), 64.71 (C3), 38.88 (C2), 
26.18 C(1); IR (neat, ATR) ν/cm-1 = 3058 (w), 3032 (w), 2950 (m), 2930 (w), 2905 (m), 1667 (s), 1583 (w), 
1494 (m), 1486 (m), 1477 (m), 1458 (m), 1449 (m), 1391 (w), 1363 (m), 1348 (s), 1287 (w), 1244 (s), 1221 
(s), 1193 (s), 1177 (m), 1091 (s), 1066 (s), 1023 (m); HRMS: calculated: 265.1462 [M]+ ; found: 265.1464; 
Optical Rotation (R)-isomer: [] = -11.0 (c 1.1 in CHCl3, 0.75% EtOH).  
 
 
Tetrahydropyridines 
 
(R)-N-(3,3-dimethylbutan-2-ylidene)-2-methylpropane-2-sulfinamide (474)[124] 
 
A 50 mL Schlenk tube was equipped with a magnetic stirrer and evacuated. It was then 
dried with a bunsen burner, allowed to cool to room temperature and purged with argon 
three times. It was then charged with Ti(OEt)4 (1.86 g, 8.25 mmol, 2.0 eq.) and dissolved in dry THF (16.5 
mL). 3,3-dimethylbutan-2-one 473 (413 mg, 4.125 mmol, 1.0 eq.) and (R)-2-methylpropane-2-sulfinamide 
468 (500 mg, 4.125 mmol, 1.0 eq.) were added and the reaction mixture heated to 70 °C for 24 hours. After 
cooling to room temperature, the reaction mixture was poured into brine (17 mL) and the resultant 
suspension filtered over Cellite. The filter cake was washed with EtOAc (20 mL) and the aequeous layer 
decanted. The organic layer was washed with brine (20 mL) and the combined aequous layers extracted with 
EtOAc (20 mL). The combined organic layers were dried over Na2SO4, filtered and solvents removed under 
reduced pressure. The residue was subjected to flash chromatography (SiO2, cyclohexane/Et2O 1:1, 18x3 cm, 
20 mL fractions) to afford (R)-465 (313 mg, 1.54 mmol, 37%) as a clear oil. 
 
C10H21NOS (MW = 203.34 g/mol): 
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1H-NMR (500 MHz, CDCl3) δ 2.31 (s, 3H), 1.23 (s, 9H), 1.16 (s, 9H); Optical Rotation: [] = -188 (c 1.0 
in CHCl3, 0.75% EtOH; Lit:[174] -192, c 1.0 in CH2Cl2).  
 
 
(R)-2-methyl-N-(3-methylbutan-2-ylidene)propane-2-sulfinamide (465)[124] 
 
A 50 mL Schlenk tube was equipped with a magnetic stirrer and evacuated. It was then 
dried with a bunsen burner, allowed to cool to room temperature and purged with argon 
three times. It was then charged with Ti(OEt)4 (1.86 g, 8.25 mmol, 2.0 eq.) and dissolved 
in dry THF (16.5 mL). 3-methylbutan-2-one 467 (355 mg, 4.125 mmol, 1.0 eq.) and (R)-
2-methylpropane-2-sulfinamide 468 (500 mg, 4.125 mmol, 1.0 eq.) were added and the reaction mixture 
heated to 70 °C for 24 hours. After cooling to room temperature, the reaction mixture was poured into brine 
(17 mL) and the resultant suspension filtered over Cellite. The filter cake was washed with EtOAc (20 mL) 
and the aequeous layer decanted. The organic layer was washed with brine (20 mL) and the combined 
aequous layers extracted with EtOAc (20 mL). The combined organic layers were dried over Na2SO4, 
filtered and solvents removed under reduced pressure. The residue was subjected to flash chromatography 
(SiO2, cyclohexane/Et2O 1:1, 18x3 cm, 20 mL fractions) to afford (R)-465 (700 mg, 3.7 mmol, 89%) as a 
clear oil. 
 
C9H19NOS (MW = 189.32 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 2.64 – 2.49 (m, 1H), 2.31 (s, 3H), 1.23 (s, 9H), 1.13 (d, J = 6.8 Hz, 5H), 1.12 
(d, J = 6.8 Hz, 1H); 13C{1H}-NMR (125 MHz, CDCl3) δ 189.34, 56.56, 41.45, 22.31, 21.21, 19.92, 19.69; 
Optical Rotation: [] = -185 (c 1.0 in CHCl3, 0.75% EtOH; Lit:[175] -185.7, c 1.0 in CHCl3).  
 
 
1-phenylprop-2-en-1-one (466) 
 
Variant A:[125] 
A 250 mL round-bottom flask equipped with a reflux condenser and a magnetic stirrer 
was charged with acetophenone 117 (6 g, 50 mmol, 1.0 eq.), para-formaldehyde 475 (3 
g, 100 mmol, 2.0 eq.) and dissolved in THF (100 mL). Diisopropylammonium 2,2,2-trifluoroacetate (10.75 
g, 50 mmol, 1.0 eq.) was added and the reaction mixture heated to reflux for 2 hours. After cooling to room 
temperature, again paraformaldehyde 475 (3 g, 100 mmol, 2.0 eq.) was added and the reaction mixture 
heated to reflux while stirring overnight. After cooling to room temperature, volatiles were removed under 
reduced pressure and the residue was dissolved in Et2O (50 mL). It was then washed with HCl (1.0 M, 25 
mL), NaOH (1.0 M, 25 mL) and brine (25 mL) before being dried over Na2SO4, filtered and solvents 
removed under reduced pressure. The residue was subjected flash chromatography (SiO2, 
cyclohexane/EtOAc 20:1 gradient to 8:1, 23x6 cm, 50 mL fractions) to afford 466 (3.02 g, 22.88 mmol, 
45%) as a clear oil. 
 
Variant B:[126] 
An oven-dried 250 mL three-necked round-bottom flask was equipped ith a magnetic stirrer and purged with 
argon three times. It was then charged with 3-chloro-1-phenylpropan-1-one 476 (2.5 g, 14.83 mmol, 1.0 eq.) 
and dissolved in CH2Cl2 (33 mL). Triethylamine (3.6 g, 35.57 mmol, 2.4 eq.) was added dropwise via 
syringe over a time course of 5 minutes. The reaction mixture was stirred at room temperature for 18 hours 
before being quenched with HCl (4.0 M, 3x 150 mL), washed with water (150 mL), NaHCO3 (150 mL) and 
brine (150 mL). The organic layer was dried over Na2SO4, filtered and solvents removed under reduced 
pressure. The residue was purified by distillation (35 °C, 0.06 mbar) to afford 466 (1.39 g, 10.48 mmol, 
70%) as a clear oil. It was directly dissolved in dry THF (10.5 mL) and stored as 1.0 M solution in the 
freezer. 
 
C9H8O (MW = 132.16 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 7.95 (dt, J = 8.5, 1.7 Hz, 1H), 7.62 – 7.54 (m, 1H), 7.53 – 7.44 (m, 1H), 7.16 
(dd, J = 17.1, 10.6 Hz, 1H), 6.44 (dd, J = 17.1, 1.7 Hz, 1H), 5.94 (dd, J = 10.6, 1.7 Hz, 1H); 13C{1H}-NMR 
(125 MHz, CDCl3) δ 191.19, 137.39, 133.12, 132.50, 130.34, 128.83, 128.77, 128.75. 
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(S)-2-methyl-N-(2-methyl-7-oxo-7-phenylheptan-3-ylidene)propane-2-sulfinamide (464) 
 
A 50 mL Schlenk tube was equipped with a magnetic stirrer and 
evacuated before being flame-dried with a bunsen burner. After purging 
with Argon three times, it was charged with dry THF (5.3 mL), 
diisopropylamine (352 mg, 3.49 mmol, 1.2 eq.) and cooled to  
-10 °C. n-butyl lithium (1.6 M, 3.2 mmol, 1.1 eq.) was added dropwise 
and the reaction mixture stirred for 20 minutes. It was then cooled to  
-78 °C and (S)-465 (550 mg, 2.91 mmol, 1.0 eq.) was added. The reaction 
mixture was stirred for 30 minutes. Zinc bromide (786 mg, 3.49 mmol, 
1.2 eq.) was added and stirring continued at -78° C for 45 minutes. A 
solution of 466 (1.0 M in THF, 3.78 mmol, 1.3 eq.) was colled to -78° C and added dropwise via cannula to 
the reaction mixture. Stirring was continued at -78 °C for 6 hours. The reaction was quenched with a 
THF/acetic acid mixture (4:1) at -78°C until the pH reached ~6. It was diluted with EtOAc (30 mL) and 
washed with brine (3x20 mL). The organic layer was dried over Na2SO4, dissolved in dry toluene (20 mL) 
and volatiles removed under reduced pressure (procedure repeated twice). The residue was subjected to flash 
chromatography (SiO2, cyclohexane/EtOAc 4:1, 18x6 cm, 20 mL fractions) to afford (R)-464 (502 mg, 1.575 
mmol, 54 %) as a clear oil. It was further purified by sempreparative HPLC. Flash chromatography was 
hampered by co-elution of sideproducts. 
 
C18H27NO2S (MW = 321.48 g/mol): 
1H-NMR (500 MHz, CDCl3) δ 7.95 (m, 2H, H3), 7.56 (t, J = 7.4 Hz, 1H, H1), 7.46 (t, J = 7.7 Hz, 2H, H2), 
3.08 (t, J = 7.0 Hz, 2H, H6), 2.87 (td, J = 11.4, 5.3 Hz, 1H, H8), 2.74 (m, 1H, H8’), 2.70 (m, 1H, H10), 2.06 
(m, 2H, H7), 1.24 (s, 9H, H12), 1.13 (m, 6H, H11); 13C{1H}-NMR (125 MHz, CDCl3) δ 199.40 (C5), 191.05 
(C9), 136.75 (C4), 133.07 (C1), 128.55 (C2), 127.99 (C3), 56.29 (C13), 39.04 (C10), 38.12 (C6), 34.19 (C8), 
22.17 (C12), 21.89 (C7), 20.37 (C11); HPLC (Silica, n-hexane/iso-propanol 98:2, 6.0 mL/min, 25 °C, 
207/240 nm): tR = 93.0 min; HRMS: calculated: 322.1835 [M+H]+; found: 322.1829; IR (neat, ATR) ν/cm-1 
= 2963 (m), 2928 (w), 2903 (w), 2869 (w), 1705 (w), 1684 (s), 1619 (m), 1598 (m), 1580 (w), 1448 (m), 
1362 (m), 1259 (w), 1208 (m), 1180 (m), 1068 (s), 825 (m), 755 (m); Optical rotation: [] = -74.0 (c = 
2.17 in CHCl3 with 0.75% EtOH) 
 
 
(S)-N-((3R)-7-hydroxy-2-methyl-7-phenylheptan-3-yl)-2-methylpropane-2-sulfinamide (477) 
 
An oven-dried 10 mL two-necked round-bottom flask was equipped with a 
magnetic stirrer and a septum before being charged with (S)-464 (166 mg, 
0.517 mmol, 1.0 eq.), dissolved in dry THF (3 mL) and cooled to -50 °C. 
L-Selectride (1.0 M, 2.6 mmol, 5 eq.) was added dropwise and the reaction 
mixture stirred at -50 °C overnight. It was then warmed to 0 °C and 
quenched by slowly adding methanol (2 mL). After warming to room 
temperature while stirring the reaction mixture was diluted with Et2O (10 
mL) and washed with brine (2x25 mL). Organic components were 
extracted with EtOAc (2x25 mL) and the combined organic layers were 
dried over anhydrous MgSO4, filtered and solvents removed under reduced pressure. The residue was 
subjected to flash chromatography (SiO2, cyclohex/EtOAc 3:1 gradient to 1:1, 21.5x3.5 cm, 20 mL fractions) 
to afford (S)-477 (226 mg, 0.695 mmol, 44 %) as a mixture of diastereomers. 
 
C18H31NO2S (MW = 325.51 g/mol): 
mixture of diastereomers, partially superimposed:1H-NMR (400 MHz, CDCl3) δ 7.39 – 7.35 (m, 4H), 7.35 – 
7.32 (m, 4H), 7.26 – 7.21 (m, 2H), 4.78 (dd, J = 7.7, 4.8 Hz, 1H), 4.66 (dd, J = 9.1, 3.6 Hz, 1H), 3.10 – 3.01 
(m, 2H), 2.93 (d, J = 7.9 Hz, 1H), 2.89 (d, J = 7.6 Hz, 1H), 1.89 – 1.45 (m, 14H), 1.24 (s, 9H), 1.23 (s, 9H), 
0.89 (d, J = 6.8 Hz, 3H), 0.88 (d, J = 6.7 Hz, 3H), 0.86 (d, J = 6.8 Hz, 3H), 0.84 (d, J = 6.9 Hz, 3H); 
13C{1H}-NMR (101 MHz, CDCl3) δ 145.75, 145.17, 128.42, 128.38, 127.21, 127.19, 125.91, 125.83, 74.00, 
73.20, 62.17, 61.47, 56.39, 56.36, 38.82, 38.48, 33.00, 32.66, 32.59, 32.40, 23.05, 22.99, 22.86, 22.33, 20.67, 
19.39, 17.66, 17.23; IR (neat, ATR) ν/cm-1 = 3325 (mbr), 3062 (w), 3027 (w), 2959 (m), 2928 (m), 2870 
(m), 2455 (m), 1388 (w), 1364 (m), 1043 (s), 953 (w), 820 (m), 760 (m), 701 (s); HRMS: calculated: 
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348.1968 [M+Na]+; found: 348.1968; HPLC (Daicel Chiracel IC, n-heptane/iso-propanol 90:10, 0.5 
mL/min, 25 °C, 209/258 nm): tR = 24.47 min, tR = 30.21, tR = 38.50. 
 
 
(S)-2-methyl-N-((R)-2-methyl-7-oxo-7-phenylheptan-3-yl)propane-2-sulfinamide (463)  
 
A 25 mL round-bottom flask was equipped with a magnetic stirrer, 
charged with (S)-477 (266 mg, 0.695 mmol, 1.0 eq.) and dissolved in 
CH2Cl2 (2.5 mL, saturated with water). Dess-Martin-Periodane (593 mg, 
1.4 mmol, 2.0 eq.) was added in one portion and the reaction mixture 
stirred for 2 hours at room temperature. The reaction mixture was diluted 
with CH2Cl2 (1.5 mL, saturated with water) being added over the course 
of 15 minutes before Na2S2O3 (2.2 g, 6 mmol, 8.7 eq.) dissolved in sat. 
NaHCO3 solution was added. The resulting suspension was stirred 
vigorously until both phases became clear. The organic components were 
extracted with Et2O (2x10 mL) and the combined organic layers washed with NaHCO3 (2x10 mL), brine 
(2x10 mL), dried over anhydrous MgSO4, filtered and solvents removed under reduced pressure. The residue 
was purified by flash chromatography (SiO2, cyclohexane/EtOAc 1:1, 15x4 cm, 20 mL fractions) to afford 
(S)-463 (169 mg, 0.523 mmol, 75%) as a sticky yellow solid. Diastereomeric excess was determind to >97:3 
by 1H-NMR. 
 
C18H29NO2S (MW = 323.49 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 7.95 (d, J = 7.1 Hz, 1H, H3), 7.54 (t, J = 7.4 Hz, 1H, H1), 7.45 (t, J = 7.8 Hz, 
2H, H2), 3.16 (d, J = 7.2 Hz, 1H, NH), 3.10 (td, J = 7.2, 3.5 Hz, 1H, H9), 3.02 (td, J = 6.9, 2.2 Hz, 2H, H6), 
1.94 (m, 1H, H7), 1.78 (m, 2H, H7‘), 1.65 (ddt, J = 13.9, 11.0, 5.6 Hz, 1H, H8), 1.55 (dddd, J = 13.8, 10.7, 
7.7, 4.6 Hz, 1H, H8‘), 1.24 (s, 9H, H13), 0.89 (d, J = 6.8 Hz, 3H, H11), 0.86 (d, J = 6.8 Hz, 3H, H12); 
13C{1H}-NMR (101 MHz, CDCl3) δ 200.16 (C5), 137.13 (C4), 133.11 (C1), 128.71 (C2), 128.15 (C3), 61.90 
(C9), 56.23 (C14), 38.10 (C6), 32.97 (C8), 32.09 (C10), 23.03 (C13), 20.40 (C7), 19.26 (C11), 17.13 (C12); 
IR (neat, ATR) ν/cm-1 = 3544 (w), 2974 (w), 2958 (w), 2928 (w), 2869 (w), 1700 (m), 1680 (s), 1595 (m), 
1570 (m), 1469 (m), 1443 (m), 1407 (w), 1381 (m), 1359 (m), 1247 (m), 1231 (m), 1190 (m), 1166 (m), 
1039 (m), 972 (m); MS (FAB, NBA): 324.2 (100%); HRMS: calculated: 324.1992 [M+H]+; found: 
324.1995; EA: calc.: C, 66.83; H, 9.04; N, 4.33; found: C, 65.17; H, 8.94; N, 4.48; Optical rotation: [] = 
-44.6 (c = 0.7 in CHCl3 with 0.75% EtOH); HPLC (Silica, n-hexane/iso-propanol 90:10, 8.0 mL/min, 25 °C, 
207/240 nm): tR = 20.8 min. 
 
 
(R)-2-isopropyl-6-phenyl-2,3,4,5-tetrahydropyridine (392) 
 
In a 25 mL round-bottom flask was placed (R)-463 (24.8 mg, 0.077 mmol, 1.0 eq.) and 
dissolved in methanol (2.5 mL). HCl (4.0 M in 1,4-dioxane, 0.77 mmol, 10 eq.) was 
added and the reaction mixture stirred for two hours at room temperature. The reaction 
was quenched by adding NaOH (1.0 M, 2 mL) and organic components were extracted 
with CH2Cl2 (3x5 mL). The combined organic layers were dried over anhydrous 
MgSO4, filtered and solvents removed under reduced pressure. The residue was dried 
in vacuo to afford (R)-392 which was used directly without further purification. 
 
C14H19N (MW = 201.31 g/mol): 
1H-NMR (500 MHz, CD2Cl2) δ 7.82 (m, 2H, H3), 7.36 (m, 3H, H1, H2), 3.28 (dddd, J = 10.2, 7.8, 3.5, 2.2 
Hz, 1H, H9), 2.69 (ddtd, J = 18.0, 6.0, 2.3, 1.2 Hz, 1H, H6), 2.43 (dddd, J = 17.9, 10.6, 6.9, 3.4 Hz, 1H, 
H6’), 1.96 (dtdd, J = 10.3, 7.8, 5.3, 2.8 Hz, 1H, H7), 1.87 (pd, J = 6.9, 5.7 Hz, 1H, H10), 1.77 (dtdd, J = 
13.8, 4.3, 3.5, 1.2 Hz, 1H, H8), 1.67 (tddd, J = 13.0, 10.9, 6.3, 3.6 Hz, 1H, H7’), 1.23 (tdd, J = 12.7, 10.6, 3.5 
Hz, 1H, H8’), 1.04 (d, J = 6.8 Hz, 3H, H12), 1.00 (d, J = 6.8 Hz, 3H, H11); 13C{1H}-NMR (125 MHz, 
CD2Cl2) δ 164.01 (C5), 140.82 (C4), 129.55 (C1), 128.35 (C2), 126.36 (C3), 64.15 (C9), 34.71 (C10), 27.08 
(C6), 24.35 (C8), 20.19 (C7), 19.22 (C11), 19.16 (C12); GC-MS: (Optima-5-Amine, 100.2/10.270/10): tR = 
8.0 min, m/z = 201 ([M]+), 186, 158, 104; HRMS: calculated: 202.1590 [M+H]+; found: 202.1589; IR (neat, 
ATR) ν/cm-1 = 01 (w), 3057 (w), 3024 (w), 2953 (m), 2934 (m), 2868 (m), 1695 (w), 1635 (m), 1577 (w), 
1491 (w), 1467 (w), 1445 (m), 1380 (w), 1362 (m), 1340 (w), 1261 (m), 1203 (w), 1177 (w), 1162 (w), 1126 
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(w), 1104 (w), 1086 (w), 1061 (w), 1030 (w), 1017 (w), 1005 (w), 753 (m),  692 (s); HPLC (Daicel Chiracel 
OD-H, n-heptane/iso-propanol 99:1, 0.5 mL/min, 20 °C, 208/243 nm): tR = 8.0 min (R), tR = 8.6 min (S); 
Optical rotation: [] = +72.6 (c = 0.42 CHCl3 with 0.75% EtOH); 
 
Phosphoric acids 
 
(R)-2,2'-dimethoxy-1,1'-binaphthalene (502)[135] 
 
A 250 mL round-bottomed flask was equipped with a magnetic stirrer, charged with 
(R)-[1,1'-binaphthalene]-2,2'-diol 501 (5 g, 17.5 mmol, 1.0 eq.) and dissolved in 
acetone (70 mL). K2CO3 (9.76 g, 70.67 mmol, 4.0 eq.) was added, the flask equipped 
with a reflux condenser and then heated to reflux to effect dissolution. Methyliodide 
(15 g, 106 mmol, 6.0 eq.) was added via syringe in two portions and stirring 
continued while heating to reflux for 24 hours. Solvents were removed under reduced 
pressure and the residue suspended in water (100 mL) and stirred for 8 hours at room 
temperature. The suspension was filtered, the filter cake washed with water (100 mL) and dried in vacuo to 
afford (R)-502 (5.43 g, 17.29 mmol, 98 %) as a white solid. 
 
C22H18O2 (MW = 314.38 g/mol): 
m.p.: 238 °C; 1H-NMR (400 MHz, CDCl3) δ: 7.98 (d, J = 9.0 Hz, 2H), 7.87 (d, J = 8.1 Hz, 2H), 7.46 (d, J = 
9.0 Hz, 2H), 7.31 (ddd, J = 8.1 Hz, 6.7 Hz, 1.2 Hz, 2H), 7.21 (ddd, J = 8.1 Hz, 6.7 Hz, 1.3 Hz, 2H), 7.10 (d, J 
= 8.5 Hz, 2H), 3.77 (s, 6H, 7); 13C{1H}-NMR (101 MHz, CDCl3) δ 155.10, 134.14, 129.53, 129.35, 128.05, 
126.43, 125.39, 123.64, 119.72, 114.38, 57.04; Optical rotation: [] = +55.8 (c = 1.0 CHCl3 with 0.75% 
EtOH); lit. +57.5 (c = 1.0 in CHCl3)[176] 
 
 
(R)-3,3'-diiodo-2,2'-dimethoxy-1,1'-binaphthalene (503)[133] 
 
An oven-dried 100 mL three-necked round-bottom flask was evacuated and purged 
with Argon three times before being charged with TMEDA (1.16 g, 10 mmol, 1.4 
eq.) and dissolved in dry Et2O (30 mL). n-Butyl lithium (1.6 M, 18 mmol, 2.5 eq.) 
was added dropwise and the reaction mixture stirred for 20 minutes. (R)-502 (2.26 g, 
7.2 mmol, 1.0 eq.) was added in one portion and the solution stirred at room 
temperature overnight. It was then cooled to -78 °C and iodine (1.0 M in THF, 4.55 
g, 18 mmol, 2.5 eq.) was added slowly. Stirring at -78 °C was continued for 1 hour until the reaction mixture 
was warmed to room temperature and stirred for another 12 hours. The reaction was quenched by puring into 
an ice/water mixture (60 mL) and stirred for 4 hours. The organic layer was decanted and organic 
components extracted with Et2O/THF (1:1, 3x5 mL). The combined organic layers were washed with 
Na2SO3 (3x10 mL), then water (10 mL) and dried over Na2SO4. Filtration and removal of volatiles under 
reduced pressure followed by flash chromatography (SiO2, cyclohexane/Et2O 20:1, 15x4 cm, 20 mL 
fractions) afforded an off-white solid. It was further purified by recrystallisation from CH2Cl2 to afford (R)-
503 (2.82 g, 4.98 mmol, 69 %) as a white solid. 
 
C22H16I2O2 (MW = 566.17 g/mol): 
m.p.: 196-197 °C; lit. 194-195 °C[177]; 1H-NMR (400 MHz, CDCl3) δ 8.53 (s, 2H), 7.79 (d, J = 8.2 Hz, 2H), 
7.41 (t, J = 7.5 Hz, 2H), 7.30 – 7.22 (m, 2H), 7.07 (d, J = 8.5 Hz, 2H), 3.41 (d, J = 5.6 Hz, 3H); 13C{1H}-
NMR (101 MHz, CDCl3) δ 154.60, 140.02, 133.97, 132.30, 127.22, 127.10, 125.90, 125.79, 125.50, 92.50, 
61.27; Optical rotation: [] = -26.4 (c 1.0 in CHCl3 with 0.75% EtOH); lit. -30 (c = 1.0 in CHCl3[178] 
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(R)-3,3'-dimesityl-[1,1'-binaphthalene]-2,2'-diol (507)[133] 
 
A 50 mL Schlenk tube was equipped with a magnetic stirrer and evacuated 
before being flame-dried with a bunsen burner. After cooling to room 
temperature it was purged with Argon three times and charged with (R)-503 
(200 mg, 0.353 mmol, 1.0 eq.) and Ni(acac)2 (9.1 mg, 0.035 mmol, 0.1 eq.). It 
was then dissolved in dry benzene (1.75 mL) and stirred at room temperature 
for 20 minutes. Mesityl magnesium bromide (1.0 M in Et2O, 1.41 mmol, 4.0 
eq.) was added dropwise and the reaction mixture stirred at room temperature 
for 30 minutes before being heated to reflux overnight. After cooling to room temperature the reaction 
mixture was quenched with HCl (1.0 M, 2.12 mmol, 6.0 eq.) and stirred at room temperature for 1 hour. Et2O 
(10 mL) was added and the organic layer separated. After being dried over anhydrous MgSO4, filtered the 
solution was subjected to elution chromatography (SiO2, Et2O). The filter cake was washed with Et2O (20 
mL) and solvents removed under reduced pressure. The residue was dried in vacuo before being transferred 
to a 25 mL Schlenk tube with CH2Cl2 (1.5 mL). The solution was cooled to -10 °C and boron tribromide (1.0 
M in CH2Cl2, 2.12 mmol, 6.0 eq.) was added dropwise. The cooling bath was removed and the reaction was 
allowed to warm to room temperature while stirring overnight. After quenching with water (3 mL) the 
organic components were extracted with CH2Cl2 (3x6 mL) and the combined organic layers were dried over 
Na2SO4, filtered and solvents removed under reduced pressure. The residue was subjected to flash 
chromatography (SiO2, cyclohexane/CH2Cl2 6:1 gradient to 2:1, 20x4 cm, 25 mL fractions) to afford (R)-507 
(96 mg, 0.184 mmol, 52 %) as a yellow solid. 
 
C38H34O2 (MW = 522.68 g/mol): 
m.p.: 179 °C; 1H-NMR (400 MHz, CDCl3) δ 7.87 (d, J = 7.9 Hz, 2H), 7.74 (s, 2H), 7.41 – 7.35 (m, 2H), 
7.34 – 7.29 (m, 2H), 7.24 (d, J = 8.9 Hz, 2H), 7.01 (s, 4H), 4.99 (s, 2H), 2.34 (s, 6H), 2.15 (s, 6H), 2.07 (s, 
6H); 13C{1H}-NMR (101 MHz, CDCl3) δ 150.14, 137.90, 137.29, 137.22, 133.56, 133.05, 130.81, 129.59, 
129.58, 128.66, 128.58, 128.39, 126.95, 124.69, 123.99, 113.07, 21.30, 20.68, 20.59; Optical rotation: [] = +34.2 (c = 1.0 in CHCl3 with 0.75 % EtOH); Lit. +72.3 (c = 0.97 in CHCl3)[179] 
  
 
(R)-3,3'-bis(2,4,6-triisopropylphenyl)-[1,1'-binaphthalene]-2,2'-diol (511)[134] 
 
A 10 mL Schlenk tube was equipped with a magnetic stirrer, evacuated and 
flame-dried with a Bunsen burner. After cooling to room temperature it was 
purged with argon three times before being charged with 2-bromo-1,3,5-
triisopropylbenzene (200 mg, 0.706 mmol, 2.0 eq.) and dissolved in dry 
THF (0.5 mL). It was then cooled to -78 °C and n-butyllithium (1.6 M, 
0.724 mmol, 2.05 eq.) were added. The reaction mixture was stirred for 20 
minutes before zinc bromide (1.0 M in THF, 0.942 mmol, 2.67 eq.) was 
added. The reaction mixture was warmed to room temperature and volatile 
components removed in vacuo. (R)-503 (200 mg, 0.353 mmol, 1.0 eq.) and 
(tBu3P)2Pd 509 (1.78 mg, 0.0035 mmol, 0.01 eq.) were added. The reaction 
mixture was dissolved in dry THF (2 mL) and storred at room temperature 
for 2 hours before being heated to reflux overnight. After cooling to room temperature, the reaction was 
quenched by addition of HCl, diluted with Et2O and the organic layer dried over anhydrous MgSO4. After 
filtration and elution chromatography (SiO2, Et2O) the residue was dried in vacuo. It was then redissolved in 
CH2Cl2 (1.5 mL), transferred to a 25 mL Schlenk tube, cooled to -10 °C and boron tribromide (1.0 M in 
CH2Cl2, 2.12 mmol, 6.0 eq.) was added. The reaction mixture was allowed to warm to room temperature 
while stirring overnight. It was then quenched with water (3 mL) at 0 °C and organic components were 
extracted with CH2Cl2 (2x6 mL). The combined organic layers were dried over Na2SO4, filtered and solvents 
removed under reduced pressure. The residue was subjected to flash chromatography (SiO2, 
cyclohexane/CH2Cl2 5:1, 18x2.5 cm, 12 mL fractions) to afford (R)-511 (123 mg, 0.178 mmol, 50 %) as a 
white solid. 
 
C50H58O2 (MW = 690.99 g/mol): 
m.p.: >290 °C (decomposition); 1H-NMR (400 MHz, CDCl3) δ 7.86 (d, J = 7.9 Hz, 2H), 7.76 (s, 2H), 7.41 – 
7.35 (m, 2H), 7.31 (dt, J = 15.7, 5.1 Hz, 4H), 7.13 (d, J = 6.3 Hz, 4H), 4.91 (s, 2H), 2.96 (dt, J = 13.8, 6.9 
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Hz, 2H), 2.85 (dt, J = 13.8, 6.9 Hz, 2H), 2.69 (dt, J = 13.8, 6.9 Hz, 2H), 1.31 (d, J = 6.9 Hz, 12H), 1.20 (d, J 
= 6.8 Hz, 6H), 1.11 (d, J = 6.9 Hz, 6H), 1.09 (d, J = 6.9 Hz, 6H), 1.03 (d, J = 6.9 Hz, 6H); 13C{1H}-NMR 
(101 MHz, CDCl3) δ 150.77, 149.26, 147.92, 147.87, 133.59, 130.79, 130.50, 129.24, 129.18, 128.37, 
126.76, 124.66, 123.90, 121.37, 121.31, 113.22, 34.49, 31.03, 30.99, 24.46, 24.43, 24.22, 24.15, 24.07, 
23.87; Optical rotation: [] = +52.3 (c = 1.0 in CHCl3 with 0.75% EtOH); lit. +88-89 (c = 3.0 in THF)[180] 
 
 
(R)-3,3-(dimesityl)-[1,1'-binaphthalene]-2,2'-phosphoric acid (408)[179] 
 
A 25 mL two-necked round bottom flask was equipped with a reflux 
condenser, a magnetic stirrer and a stopper. It was then evacuated and flame-
dried with a bunsen burner. After cooling to room temperature it was purged 
with argon three times and charged with (R)-507 (375 mg, 0.72 mmol, 1.0 eq.). 
Dry pyridine (3 mL) and phosphor oxychloride (336 mg, 2.15 mmol, 3.0 eq.) 
were added and the reaction mixture heated to reflux for 14 hours. After 
cooling to room temperature water (2 mL) was added and refluxing continued 
for 3 hours. After cooling to room temperature, CH2Cl2 (6 mL) was added and 
the reaction mixture washed with HCl (1.0 M, 3x6 mL). The organic layer was 
dried over anhydrous MgSO4. After filtration and removal of solvents under reduced pressure, the residue 
was recrystallized from acetonitrile to afford (R)-408 (102 mg, 0.177 mmol, 25 %) as white crystals. 
 
C38H33O4P (MW = 584.64 g/mol): 
m.p.: 156 °C; lit. 224-230 °C (decomposition)[179]; 1H-NMR (400 MHz, CD2Cl2) δ 7.93 (d, J = 8.2 Hz, 2H), 
7.76 (s, 2H), 7.53 – 7.47 (m, 2H), 7.36 (d, J = 8.0 Hz, 2H), 7.33 – 7.27 (m, 2H), 6.80 (s, 2H), 6.73 (s, 2H), 
2.09 (s, 6H), 2.01 (s, 6H), 1.94 (s, 6H); 31P{1H}-NMR (162 MHz, CD2Cl2) δ 4.16; Optical rotation: [] = 
-89.1 (c = 1.0 in CHCl3 with 0.75% EtOH); lit. : -93.1 (c = 1.08 in CHCl3)[179] 
 
 
(R)-3,3-bis(2,4,6-triisopropylphenyl)-[1,1'-binaphthalene]-2,2'-phosphoric acid (407)[135] 
(R-TRIP) 
 
A 25 mL two-necked round bottom flask was equipped with a reflux 
condenser, a magnetic stirrer and a stopper. It was then evacuated and 
flame-dried with a bunsen burner. After cooling to room temperature it was 
purged with Argon three times and charged with (R)-511 (250 mg, 0.36 
mmol, 1.0 eq.). Dry pyridine (2 mL) and phosphor oxychloride (166 mg, 
1.09 mmol, 3.0 eq.) were added and the reaction mixture heated to reflux 
for 14 hours. After cooling to room temperature water (2 mL) was added 
and refluxing continued for 3 hours. After cooling to room temperature, 
CH2Cl2 (6 mL) was added and the reaction mixture washed with HCl (1.0 
M, 3x6 mL). The organic layer was dried over anhydrous MgSO4. After 
filtration and removal of solvents under reduced pressure, the residue was 
recrystallized from acetonitrile to afford (R)-407 (148 mg, 0.197 mmol, 55 
%) as white crystals. 
 
C50H57O4P (MW = 752.96 g/mol): 
m.p.: >290 °C (decomposition); 1H-NMR (400 MHz, CD2Cl2) δ 7.90 (d, J = 8.2 Hz, 2H), 7.79 (s, 2H), 7.49 
(dd, J = 10.8, 4.0 Hz, 2H), 7.34 – 7.27 (m, 2H), 7.24 (d, J = 8.3 Hz, 2H), 6.97 (d, J = 1.6 Hz, 4H), 2.85 (dt, J 
= 13.8, 6.9 Hz, 2H), 2.56 (tt, J = 13.4, 6.8 Hz, 4H), 1.22 (dd, J = 6.9, 3.8 Hz, 12H), 1.07 (d, J = 6.8 Hz, 6H), 
0.98 (d, J = 6.8 Hz, 6H), 0.89 (d, J = 6.8 Hz, 6H), 0.81 (d, J = 6.7 Hz, 6H); 31P{1H}-NMR (162 MHz, 
CD2Cl2) δ 2.56; Optical rotation: [] = -60.2 (c = 1.0 in CHCl3 with 0.75% EtOH); lit. -59.6 (c = 1.06 in 
CHCl3)[181] 
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Imine precursors and ligands 
 
1-Cyclopentylethanone[182] 
 
Into a 25 mL two-necked round-bottom flask was placed a magnetic stirrer, the flask was 
closed with a stopper, and dried with a Bunsen burner while evacuating. After cooling to 
room temperature, the flask was purged with argon three times and cyclopentanoic acid (1 g, 
8.85 mmol, 1.0 eq.) was added and dissolved in dry diethylether (8 mL). The reaction 
mixture was cooled to -78 °C with the aid of a dry ice / acetone bath and a solution of MeLi (1.6 M, 12.5 
mL, 20.11 mmol, 2.3 eq.) was added dropwise via syringe over a period of 15 minutes. The reaction was 
allowed to warm to room temperature while stirring overnight. After quenching with saturated NH4Cl 
solution (8 mL) the mixture turned clear and layers were separated. The organic layer was washed with water 
(10 mL= and the aequeous layer washed with ether (10 mL). The combined organic phases were dried over 
MgSO4, filtered and solvents removed under reduced pressure to afford 0.5 g (4.4 mmol, 50%) of 1-
cyclopentylethanone as a clear oil. 
 
C7H12O (112.17 g/mol): 
 
1H-NMR (400 MHz, CDCl3) δ 2.94 – 2.78 (m, 1H, CH), 2.16 (s, 3H, CH3), 1.88 – 1.45 (m, 10H, CH2); 
13C{1H}-NMR (101 MHz, CDCl3) δ 211.44 (C=O), 52.40 (CH), 28.95 (CH2CH2CH), 28.86 (CH2CH2CH), 
26.10 (CH3); GC-MS: (Rtx-5MS, 100.2/10.270/10): tR = 3.3 min, m/z = 113 ([M+1]+). 
 
 
4-Bromo-2,6-diisopropylaniline (517)[183] 
 
In a 500 mL round-bottom flask was placed 2,6-diisopropylaniline 516 (6 mL, 
technical, ~90%, ~30 mmol) and dissolved in CH2Cl2 (250 mL). 
Tetrabutylammonium tribromide (15.4 g, 32 mmol) was added in one go. The 
reaction was stirred for 30 minutes before the solvent was removed under reduced 
pressure. The residue was redissolved in diethyl ether (250 mL), washed with NaOH 
(0.5 M, 150 mL), water (2 x 150 mL), dried over MgSO4, filtered and solvents 
removed under reduced pressure to afford 7.6 g (29.7 mmol, 98%) of 517 as a yellow oil. 
 
C12H18BrN (256.18 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 7.11 (s, 2H, CHAr), 3.70 (s, 2H, NH2), 2.95 – 2.81 (m, 2H, CH(CH3)2), 1.25 
(d, J = 6.8 Hz, 12H, CH3). 
 
 
1-Bromo-3,5-diisopropylbenzene (518)[183] 
 
In a 500 mL round-bottom flask was placed 517 (7.6 g, 29.7 mmol, 1.0 eq.) and 
suspended in HCl (2 M, 70 mL). The reaction mixture was cooled to -5 °C and 
sodium nitrite (5.12 g, 74 mmol, 1.05 eq) was added portionwise. After addition the 
reaction was stirred for 30 minutes before H3PO4 (50% in water, 35 mL, 300 mmol, 
4.0 eq.) was added. The mixture was stirred at 4 °C overnight. Ether (100 mL) was 
added and layers were separated. The aequeous layer was washed with ether (2 x 100 
mL) and the combined organic layers were dried over MgSO4, filtered and solvents removed under reduced 
pressure. Purification by distillation (115 °C, 0.15 mbar) afforded 4.0 g (16.6 mmol, 56%) of 518 as a yellow 
oil. 
 
C12H17Br (241.17 g/mol): 
b.p.: 115°C at 0.1 torr; 1H-NMR (400 MHz, CDCl3) δ 7.18 (d, J = 1.5 Hz, 2H, CHArCBrCHAr), 6.98 (s, 1H, 
CHAr), 2.92 – 2.77 (m, 2H, CH(CH3)2), 1.23 (d, J = 6.9 Hz, 12H, CH3). 
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3,5-Di-isopropylbenzaldehyde (519)[183] 
 
In a 100 mL three-necked round-bottom flask equipped with a magnetic stirrer, argon 
inlet, a thermometer and a stopper was placed 518 (4.0 g, 16.6 mmol, 1.0 eq.) and 
cooled to -78 °C with the aid of a dry ice / acetone bath. n-BuLi (1.6 M, 18.26 mmol, 
1.1 eq.) was added dropwise via syringe and the resultant suspension was stirred for 
20 minutes at -78 °C. Then DMF (1.33 g, 18.26 mmol, 1.1 eq.) was added dropwise 
via syringe, the mixture stirred for 10 minutes being allowed to warm to -10 °C. The 
reaction was quenched with water (12 mL) at -10 °C and the mixture warmed to room temperature. Layers 
were separated and the aequeuous layer washed with ether (100 mL). Organic layers were combined and 
solvents removed under reduced pressure. The residue was purified by flash chromatography (SiO2, 18 x 4.5 
cm, cyclohexane/EtOAc 20:1) to afford 2.05 g (10.77 mmol, 65%) of 519 as a clear oil. 
 
C13H18O (190.28 g/mol): 
Rf (SiO2, n-pentane/AcOEt 10:1, UV, Ce(SO4)2) = 0.63; 1H-NMR (400 MHz, CDCl3) δ 9.99 (s, 1H, CHO), 
7.57 (d, J = 1.7 Hz, 2H, CHArCHOCHAr), 7.35 (s, 1H, CHAr), 3.04 – 2.90 (m, 2H, CH(CH3)2), 1.29 (dd, J = 
6.9, 1.8 Hz, 12H, CH3).  
 
 
1-(3,5-Di-isopropylphenyl)ethanol (520) 
 
In a 100 mL three-necked round-bottom flask equipped with a magnetic stirrer, argon 
inlet and a stopper was placed 519 (2.05 g, 10.77 mmol, 1.0 eq.) and dissolved in dry 
diethyl ether (40 mL). The solution was cooled to 0 °C and MeMgBr (3.0 M, 16.2 
mmol, 1.5 eq.) was added dropwise via syringe. The reaction mixture was stirred at 0 
°C for 15 minutes before being allowed to warm to room temperature and stirred for 2 
hours. The mixture was cooled to 0 °C again and quenched with sat. NH4Cl (40 mL) and water (20 mL). 
After warming to room temperature, layers were separated and the aq. layer was extracted with EtOAc (3 x 
60 mL). The combined organic layers were dried over MgSO4, filtered and solvents removed under reduced 
pressure. The residue was purified via flash chromatography (SiO2, 15 x 3 cm, cyclohexane/EtOAc 5:1) to 
afford 1.89 g (9.16 mmol, 85%) of 520 as an orange viscous oil. 
 
C14H22O (206.32 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 7.06 (d, J = 1.6 Hz, 2H, CHAr), 7.01 (d, J = 1.6 Hz, 1H, CHAr), 4.87 (qd, J = 
6.4, 3.6 Hz, 1H, CH(OH)), 2.90 (hept, J = 6.9 Hz, 2H, CH(CH3)2), 1.51 (d, J = 6.4 Hz, 3H, CH3CHOH), 1.26 
(d, J = 6.9 Hz, 12H, CH(CH3)2); 13C{1H}-NMR (101 MHz, CDCl3) δ 149.30 (CCH(CH3)2), 145.89 
(CCH(OH)), 124.12 (CHArCCH(CH3)2), 121.10 (CHArCCH(CH3)2CCH(OH)), 70.98 (CH(OH)), 34.40 
(CH(CH3)2), 25.22 (C=OCH3), 24.24 (CH(CH3)2); IR (neat, ATR) ν/cm-1 = 3340 (mbr), 2961 (s), 2929 (m), 
2887 (m), 2868 (m), 1603 (w), 1467 (m), 1459 (m), 1450 (m), 1382 (w), 1363 (m), 1176 (w), 1112 (w), 1073 
(w), 1020 (w), 873 (w), 716 (m); GC-MS: (Rtx-5MS, 100.2/10.270/10): tR = 11.8 min, m/z = 206 ([M]+). 
 
 
1-(3,5-Di-isopropylphenyl)ethanone (521)[184] 
 
In a 100 mL round-bottom flask was placed 520 (1.0 g, 4.5 mmol, 1.0 eq.) and 
dissolved in CH2Cl2 (50 mL). Dess-Martin Periodane (2.7 g, 6.37 mmol, 1.4 eq.) was 
added in one portion and the resultant mixture stirred for one hour at room 
temperature. The reaction mixture was poured into a solution of pentane/EtOAc (4:1, 
80 mL) and a white precipitate was formed. The suspension was filtered over a frit 
(SiO2) and a yellow solution was obtained. The fritt was rinsed with more 
pentane/EtOAc (4:1, 100 mL) and solvents were removed under reduced pressure. The residue was purified 
by flash chromatography (SiO2, 18 x 3 cm, cyclohexane/EtOAc 20:1) to afford 1.0 g (4.31 mmol, 96%) of 
521 as an orange oil. 
 
C14H20O (204.31 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 7.64 (d, J = 1.7 Hz, 2H, CHAr), 7.29 (t, J = 1.6 Hz, 1H, CHAr), 3.03 – 2.86 (m, 
2H, CH(CH3)2), 2.60 (s, 3H, CH3C=O), 1.28 (d, J = 6.9 Hz, 12H, CH(CH3)2); 13C{1H}-NMR (101 MHz, 
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CDCl3) δ 198.83 (C=O), 149.46 (CCH(CH3)2), 137.59 (CC=O), 129.93 (CHAr), 124.07 (2 CHAr), 34.32 
(CH(CH3)2), 26.92 (C=OCH3), 24.12 (CH(CH3)2). 
 
 
1-(3,5-Di-tert-butylphenyl)ethanol (524)[185] 
 
In a 100 mL three-necked round-bottom flask equipped with a magnetic stirrer, argon 
inlet and a stopper was placed 3,5-di-tert-butylbenzaldehyde 523 (1.0 g, 4.5 mmol, 
1.0 eq.) and dissolved in dry diethyl ether (18 mL). The solution was cooled to 0 °C 
and MeMgBr (3.0 M, 6.82 mmol, 1.5 eq.) was added dropwise via syringe. The 
reaction mixture was stirred at 0 °C for 15 minutes before being allowed to warm to 
room temperature and stirred for 2 hours. The mixture was cooled to 0°C again and quenched with sat. 
NH4Cl (40 mL) and water (20 mL). After warming to room temperature, layers were separated and the aq. 
layer was extracted with EtOAc (3 x 60 mL). The combined organic layers were dried over MgSO4, filtered 
and solvents removed under reduced pressure to afford 1.05 g (4.47 mmol, 96%) of 524 as a white solid. 
 
C16H26O (234.38 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 7.36 (t, J = 1.8 Hz, 1H, CHAr), 7.23 (d, J = 1.7 Hz, 2H, CHAr), 4.90 (q, J = 6.4 
H, 1H, CHOH), 1.77 (sbr, 1H, OH), 1.52 (d, J = 6.5 Hz, 3H, CH3), 1.34 (s, 18H, C(CH3)3). 
 
 
1-(3,5-Di-tert-butylphenyl)ethanone (525)[186] 
 
In a 100 mL round-bottom flask was placed 524 (1.05 g, 4.47 mmol, 1.0 eq.) and 
dissolved in CH2Cl2 (50 mL). Dess-Martin Periodane (2.5 g, 5.9 mmol, 1.32 eq.) was 
added in one portion and the resultant mixture stirred for one hour at room 
temperature. The reaction mixture was poured into a solution of pentane/EtOAc (4:1, 
80 mL) and a white precipitate was formed. The suspension was filtered over a fritt 
(SiO2) and a yellow solution was obtained. The fritt was rinsed with more pentane/EtOAc (4:1, 100 mL) and 
solvents were removed under reduced pressure. The residue was purified by flash chromatography (SiO2, 18 
x 3 cm, cyclohexane/EtOAc 20:1) to afford 1.0 g (4.31 mmol, 96%) of 525 as a clear oil.  
 
C16H24O (232.36 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 7.81 (d, J = 1.8 Hz, 2H, CHAr), 7.65 (t, J = 1.8 Hz, 1H, CHAr), 2.62 (s, 3H, 
C=OCH3), 1.36 (s, 18H, C(CH3)3); 13C{1H}-NMR (101 MHz, CDCl3) δ 199.04 (C=O), 151.36 (CArC(CH3)3), 
137.04 (CArC=O), 127.50 (1 CHAr), 122.66 (2 CHAr), 35.13 (C(CH3)3), 31.54 (C(CH3)3), 27.07 (C=OCH3). 
 
 
1-(trimethylsilyl)piperidin-2-one (559)[155] 
 
A three-necked 500 ml round-bottom flask equipped with an overhead stirrer, thermometer 
and a septum, was dried with a bunsen burner while evacuating. After cooling to room 
temperature, the flask was purged with argon three times and charged with ∆-valerolactam 
558 (10 g, 100 mmol, 1.0 eq.) in anhydrous toluene (100 mL). Triethylamine (12.75 g, 
0.126 mol, 1.25 eq.) and TMSCl (12.06 g, 0.11 mol, 1.1 eq.) were added via syringe. The mixture was heated 
to 50 °C for 6 hours while stirring vigorously. Afterwards it was cooled to 0 °C, diluted with hexane/ether 
(1:1, 100 mL) and filtered through cellite. The filtrate was concentrated under reduced pressure and the 
residue was distilled (80 °C, 0.4 mbar) to afford 11.64 g (68 mmol, 68%) of 559 as a colourless oil. 
 
C8H17NOSi (MW = 171.31 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 3.20 (t, J = 5.8 Hz, 2H), 2.36 (t, J = 6.7 Hz, 2H), 1.78 (p, J = 6.5 Hz, 2H), 
1.71 (tq, J = 8.9, 5.3, 4.3 Hz, 2H), 0.27 (s, 9H); 13C{1H}-NMR (126 MHz, CDCl3) δ 177.29, 44.27, 32.73, 
23.46, 20.99, -0.09. 
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tert-Butyl 2-oxopiperidine-1-carboxylate (561)[187] 
 
To a stirred solution of 558 (5 g, 50 mmol, 1.0 eq.) in anhydrous THF (100 mL) at -
78ºC was added dropwise n-BuLi (50 mmol, 31.25 mL, 1.6M, 1.0 eq.). The mixture 
was allowed to stir at -78 ºC for one h before a solution of di-tert-butyldicarbonate 
(10.9 g, 11.5 mL, 50 mmol, 1.0 eq.) in THF (25 mL) was added dropwise. The reaction was allowed to stir 
for another two hours and then warmed to room temperature. Saturated NH4Cl solution (50 mL) and water 
(25 mL) were added and the organic layer was separated. The aqueous phase was extracted with Et2O (3 x 50 
mL). The combined organic phases were dried over MgSO4 and solvents removed under reduced pressure. 
The residue was purified by flash chromatography (SiO2, 15x4 cm, 5:1 ethyl acetate/pentane) to afford 561 
(7.12 g, 3.6 mmol, 71%) as a clear oil. 
 
C10H17NO3 (MW = 199.25 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 3.70 – 3.60 (m, 2H), 2.51 (td, J = 6.7, 5.5, 2.9 Hz, 2H), 1.87 – 1.75 (m, 4H), 
1.53 (s, 9H); 13C{1H}-NMR (101 MHz, CDCl3) δ 171.44, 152.87, 82.95, 46.42, 35.01, 28.14, 22.91, 20.63. 
 
 
tert-Butyl (5-oxononyl)carbamate (564)[187]  
 
To a solution of 561 (2 g, 10 mmol, 1.0 eq.) in anhydrous 
THF (40 mL), cooled to -78 °C, was added n-BuMgCl (7.14 
mL, 12 mmol, 1.2 eq. 20% wt) dropwise and stirred for a total of 90 minutes. The reaction mixture was 
allowed to warm to room temperature and then quenched with HCl (2M) until a pH of 1-3 was observed. The 
aqueous layer was washed with CH2Cl2 (3x50 mL) and the combined organic layers were dried over MgSO4, 
filtered and solvents removed under reduced pressure. The product was purified via flash chromatography 
(SiO2, 18x3 cm, 4:1 cyclohexane/ethyl acetate) to afford 564 (0.86 g, 3.34 mmol, 33%) as a viscous 
colourless oil. 
 
C14H27NO3 (MW = 257.37 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 3.56 (t, J = 6.7 Hz, 2H), 2.46 – 2.35 (m, 4H), 1.59 – 1.54 (m, 4H), 1.50 (s, 
9H), 1.29 (dt, J = 14.8, 7.5 Hz, 2H), 0.90 (t, J = 7.3 Hz, 3H); 13C{1H}-NMR (101 MHz, CDCl3) δ 211.12, 
152.82, 82.30, 46.15, 42.67, 42.42, 28.70, 28.22, 26.11, 22.50, 21.10, 13.99. 
 
 
tert-Butyl (5-oxo-5-phenylpentyl)carbamate (562)[187] 
 
To a solution of 561 (2 g, 10 mmol, 1.0 eq.) in anhydrous THF 
(40 mL), cooled to -78 °C, was added PhMgBr (4.6 mL, 12 
mmol, 1.2 eq. 2.6M) dropwise and the reaction mixture stirred 
for 90 minutes. It was allowed to warm to room temperature 
before being quenched with HCl (2M) until pH of 1-3 was observed. The aqueous layer was washed with 
CH2Cl2 (3x50 mL) and the combined organic layers were dried over MgSO4, filtered and solvents removed 
under reduced pressure. The product was purified via recrystallisation from CH2Cl2 layered with n-pentane 
to afford 562 (1.25 g, 4.5 mmol, 45%) as white needles. 
 
C16H23NO3 (MW = 277.36 g/mol): 
m.p.: 89 °C; 1H-NMR (400 MHz, CDCl3) δ 7.96 (d, J = 7.8 Hz, 2H), 7.56 (t, J = 7.4 Hz, 1H), 7.46 (t, J = 7.6 
Hz, 2H), 4.60 (s, 1H, NH), 3.17 (d, J = 5.8 Hz, 2H), 3.00 (t, J = 7.2 Hz, 2H), 1.78 (dt, J = 15.1, 7.2 Hz, 2H), 
1.58 (p, J = 7.1 Hz, 2H), 1.44 (s, 9H); 13C{1H}-NMR (101 MHz, CDCl3) δ 200.12, 156.12, 137.01, 133.12, 
128.69, 128.13, 79.24, 40.34, 38.09, 29.76, 28.53, 21.35. 
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(3aS,8aR)-2-phenyl-8,8a-dihydro-3aH-indeno[1,2-d]oxazole (367)[188] 
 
An oven-dried 50 two-neck round-bottomed flask was charged with (1S,2R)-1-
amino-2,3-dihydro-1H-inden-2-ol (447 mg, 3 mmol, 1.0 eq.), 4Å mol sieves 
(4.5 g) and dissolved in dry CH2Cl2 (20 mL). Subsequently freshly distilled 
benzaldehyde (310 mg, 3 mmol, 1.0 eq.) and the reaction mixture was stirred at 
room temperature for 14 hours. TLC control (SiO2, CH2Cl2/EtOAc 10:1) 
indicated complete consumption of starting material. Afterwards, N-bromosuccinimide (534 mg, 3 mmol, 1.0 
eq.) was added and stirring continued for another four hours. The reaction was quenched by pouring the 
reaction mixture over saturated NaHCO3. The organic layer was washed with water, dried over anhydrous 
MgSO4, filtered and solvents removed under reduced pressure. The residue was subjected to flash 
chromatography (SiO2, cyclohexane/tert-butylmethylether 1 :1, 12.5x3.5 cm, 20 mL fractions) to afford 367 
(390 mg, 1.66 mmol, 55%) as a white solid. 
 
C16H13NO (MW = 235.28 g/mol): 
m.p.: 123 °C; 1H-NMR (400 MHz, CDCl3) δ 7.92 (dd, J = 5.3, 3.3 Hz, 2H), 7.62 – 7.54 (m, 1H), 7.43 (ddd, 
J = 6.4, 3.8, 1.3 Hz, 1H), 7.41 – 7.33 (m, 2H), 7.31 – 7.23 (m, 3H), 5.74 (d, J = 7.9 Hz, 1H), 5.53 – 5.44 (m, 
1H), 3.51 (dd, J = 17.9, 6.8 Hz, 1H), 3.37 (d, J = 17.8 Hz, 1H); 13C{1H}-NMR (101 MHz, CDCl3) δ 164.12, 
142.18, 139.88, 131.40, 128.59, 128.48, 128.36, 128.01, 127.61, 125.76, 125.42, 83.29, 39.97. 
 
 
(S)-4-benzyl-2-(tert-butyl)-4,5-dihydrooxazole (369)[188] 
 
An oven-dried 50 two-neck round-bottomed flask was charged (S)-2-amino-3-
phenylpropan-1-ol (500 mg, 3.3 mmol, 1.0 eq.), 4Å mol sieves (4.5 g) and 
dissolved in dry CH2Cl2 (20 mL). Subsequently freshly distilled pivalaldehyde (284 
mg, 3.3 mmol, 1.0 eq.) and the reaction mixture was stirred at room temperature for 
14 hours. TLC control (SiO2, CH2Cl2/EtOAc 10:1) indicated complete consumption of starting material. 
Afterwards, N-bromosuccinimide (588 mg, 3.3 mmol, 1.0 eq.) was added and stirring continued for another 
four hours. The reaction was quenched by pouring the reaction mixture over saturated NaHCO3. The organic 
layer was washed with water, dried over anhydrous MgSO4, filtered and solvents removed under reduced 
pressure. The residue was subjected to flash chromatography (SiO2, cyclohexane/tert-
butylmethylether/triethylamine 9:1:0.1, 18x3.5 cm, 20 mL fractions) to afford (S)-369 (140 mg, 0.65 mmol, 
20%) as a clear oil. 
 
C14H19NO (MW = 217.31 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 7.29 (t, J = 7.3 Hz, 2H), 7.20 (dd, J = 10.4, 6.6 Hz, 3H), 4.35 (dtd, J = 8.9, 
6.9, 4.5 Hz, 1H), 4.11 (t, J = 8.9 Hz, 1H), 3.96 (dd, J = 8.4, 6.9 Hz, 1H), 3.09 (dd, J = 13.7, 4.4 Hz, 1H), 2.64 
(dd, J = 13.6, 8.6 Hz, 1H), 1.19 (s, 9H). 
 
 
((3,4-dihydronaphthalen-1-yl)oxy)trimethylsilane (381)[93] 
 
A 250 mL Schlenk tube was charged with LiCl (580 mg, 13.68 mmol, 2.0 eq.) and 
evacuated while being heated out with a bunsen burner. After cooling to room 
temperature and three Argon purge cycles it was charged mesityl magnesium bromide 
(6.84 mmol, 1.0 eq.) and dissolved in 1,4-dioxane (10 mL) and tetrahydrofuran (60 mL). 
The resultant suspension was stirred for 15 minutes before it was cooled to 0 °C. 
Trimethylsilylchloride (742 mg, 6.84 mmol, 1.0 eq.) was added and stirring was continued for 5 minutes 
before 3,4-dihydronaphthalen-1(2H)-one 380 (1.0 g, 6.84 mmol, 1.0 eq.), dissolved in dry THF (15 mL), was 
added via syringe pump over the course of 35 minutes. The reaction mixture was stirred overnight at 0 °C 
before being quenched with NaHCO3 (50 mL) at 0 °C. After warming up to room temperature, the organic 
components were extracted with tertbutylmethylether (3x50 mL), dried over anhydrous MgSO4, filtered and 
solvent removed under reduced pressure. The residue was subjected to flash chromatography (SiO2, 15x4.5 
cm, cyclohexane/Et2O 50:1, 20 mL fractions) to afford 381 (1.2 g, 5.5 mmol, 88%) as a colourless oil. 
 
C13H18OSi (MW = 218.37 g/mol): 
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1H-NMR (400 MHz, CDCl3) δ 7.42 (d, J = 7.1 Hz, 1H), 7.20 (t, J = 7.5 Hz, 1H), 7.16 (td, J = 7.4, 1.5 Hz, 
1H), 7.11 (d, J = 6.6 Hz, 1H), 5.20 (t, J = 4.6 Hz, 1H), 2.77 (t, J = 8.0 Hz, 2H), 2.36 – 2.30 (m, 2H), 0.27 (s, 
10H); 13C{1H}-NMR (101 MHz, CDCl3) δ 148.18, 137.20, 133.66, 127.41, 127.08, 126.30, 121.95, 105.4, 
28.30, 22.30, 0.35. 
 
 
2-(tert-butyl)-3,4-dihydronaphthalen-1(2H)-one (382)[93] 
 
A flame-dried 50 mL two-necked round bottom flask was purged with argon three 
times before being charged with 381 (1.18 g, 5.4 mmol, 1.0 eq.) and 2-chloro-2-
methylpropane (521 mg, 5.63 mmol, 1.04 eq.). The reactants were dissolved in dry 
CH2Cl2 (10 mL) and the reaction mixture cooled to -40 °C. In another flask was placed TiCl4 (1.025 g, 5.4 
mmol, 1.0 eq.) and dissolved in dry CH2Cl2 (15 mL) and cooled to -40 °C. It was then transferred to the 
reaction mixture via cannula over the course of 5 minutes. Stirring was continued at -40 °C for 2 hours. TLC 
analysis (SiO2, pentane/Et2O 10:1) indicated complete consumption of starting material. The cold solution 
was then poured on ice/water (80 mL) and extracted with CH2Cl2 (3x50 mL). The organic layer was washed 
with NaHCO3 (10% w/w, 50 mL). The combined aequeous layers were re-extracted with CH2Cl2 (15 mL) 
and the combined organic layers then dried over anhydrous MgSO4, filtered and solvents removed under 
reduced pressure. The residue was purified by distillation (150 °C, 0.08 torr), where small amounts of 
tetralone were observed. The product was further purified by flash chromatography (SiO2, pentane/Et2O 
20:1, 10x3 cm, 20 mL fractions) to afford 382 (369 mg, 1.82 mmol, 34 %) as a clear oil. 
 
C14H18O (MW = 202.29 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 7.95 (dd, J = 7.8, 1.1 Hz, 1H), 7.43 (td, J = 7.5, 1.4 Hz, 1H), 7.29 (d, J = 7.5 
Hz, 1H), 7.20 (d, J = 7.6 Hz, 1H), 3.06 – 2.90 (m, 2H), 2.36 – 2.25 (m, 2H), 1.94 (dddd, J = 14.3, 12.9, 10.4, 
5.5 Hz, 1H), 1.11 (s, 9H); 13C{1H}-NMR (400 MHz, CDCl3) δ 200.31, 143.55, 134.72, 132.78, 128.42, 
127.30, 126.59, 56.87, 33.34, 29.64, 28.50, 25.48. 
 
 
2-(2-(diphenylphosphino)phenyl)-4,4-dimethyl-4,5-dihydrooxazole[98] 
 
A 250 mL three-necked round-bottom flask was equipped with a magnetic stirrer and 
evacuated before being flame-dried with a bunsen burner. After cooling to room 
temperature it was purged with argon three times, charged with 4,4-dimethyl-2-
phenyl-4,5-dihydrooxazole (1.0 g, 5.7 mmol, 1.0 eq.) and dissolved in dry pentane 
(45 mL). TMEDA (730 mg, 6.27 mmol, 1.1 eq.) was added and the solution was degassed by three freeze-
pump-thaw cycles. It was then cooled to -78 °C and n-butyllithium (1.4 M, 6.27 mmol, 1.1 eq.) was added 
dropwise and the reaction stirred at -78 °C for 10 minutes. It was then warmed up to 0 °C and stirred for 10 
minutes before chlorodiphenylphosphine (1.63 g, 7.41 mmol, 1.3 eq.) was added, the solution stirred for 
another 10 minutes at 0 °C before being allowed to warm to room temperature while stirring overnight. The 
volatiles were removed under reduced pressure and the residual semi-solid subjected to flash 
chromatography (SiO2, Et2O/pentane 9:1, 16x5.5 cm, 20 mL fractions) to afford as a sticky oil/solid. It was 
further purified by dissolving in a minimal amount of ethanol and heated to reflux to effect crystallisation 
which afforded 2-(2-(diphenylphosphino)phenyl)-4,4-dimethyl-4,5-dihydrooxazole (1.0 g, 2.8 mmol, 49 %) 
as white crystals. 
 
C23H22NOP (MW = 359.40 g/mol): 
m.p.: 103 °C; 1H-NMR (400 MHz, CDCl3) δ 7.85 (ddd, J = 7.5, 3.5, 1.5 Hz, 1H), 7.38 – 7.30 (m, 10H), 7.30 
– 7.24 (m, 2H), 6.81 (ddd, J = 7.7, 4.5, 1.0 Hz, 1H), 3.73 (s, 2H), 1.05 (s, 6H); 31P{1H}-NMR (162 MHz, 
CDCl3) δ -7.54. 
 
 
2-(2-(diphenylphosphino)phenyl)-4,5-dihydrooxazole[98] 
 
A 250 mL three-necked round-bottom flask was equipped with a magnetic stirrer and 
evacuated before being flame-dried with a bunsen burner. After cooling to room 
temperature it was purged with argon three times, charged with 2-phenyl-4,5-
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dihydrooxazole (1.0 g, 6.8 mmol, 1.0 eq.) and dissolved in dry pentane (50 mL). TMEDA (864 mg, 7.48 
mmol, 1.1 eq.) was added and the solution was degassed by three freeze-pump-thaw cycles. It was then 
cooled to -78 °C and n-butyllithium (1.4 M, 7.48 mmol, 1.1 eq.) was added dropwise and the reaction stirred 
at -78 °C for 10 minutes. It was then warmed up to 0 °C and stirred for 10 minutes before 
chlorodiphenylphosphine (1.94 g, 8.84 mmol, 1.3 eq.) was added, the solution stirred for another 10 minutes 
at 0 °C before being allowed to warm to room temperature while stirring overnight. The volatiles were 
removed under reduced pressure and the residual semi-solid subjected to flash chromatography (SiO2, 
Et2O/pentane 9:1, 16x5.5 cm, 20 mL fractions) to afford as a sticky oil/solid. It was further purified by 
dissolving in a minimal amount of ethanol and heated to reflux to effect crystallisation which afforded 2-(2-
(diphenylphosphino)phenyl)-4,5-dihydrooxazole (1.4 g, 4.4 mmol, 65 %) as white crystals. 
 
C21H18NOP (MW = 331.35 g/mol): 
 
m.p.: 107 °C; 1H-NMR (400 MHz, CDCl3) δ 7.85 (ddd, J = 7.5, 3.5, 1.3 Hz, 1H), 7.39 – 7.28 (m, 12H), 6.89 
(ddd, J = 7.8, 4.3, 1.0 Hz, 1H), 4.08 (t, J = 9.4 Hz, 2H), 3.78 (t, J = 9.4 Hz, 2H); 31P{1H}-NMR (162 MHz, 
CDCl3) δ -4.46. 
 
 
(S)-Valinol[189] 
 
A 500 mL three-neck round bottom flask was equipped with a magnetic stirrer, a reflux 
condenser, a thermometer and a dropping funnel. It was then evacuated and flame-dried 
with a bunsen burner before being purged with Argon three times. It was then charged 
with (S)-valine (10 g, 85.4 mmol, 1.0 eq.) and dissolved in dry THF (200 mL). The reaction mixture was 
cooled to 4 °C in a water/ice bath and NaBH4 (7.75 g, 205 mmol, 2.4 eq.) were added in one portion. To the 
dropping funnel was added iodine (21.67 g, 85.4 mmol, 1.0 eq.) and dissolved in dry THF (50 mL) before 
being added dropwise to the reaction mixture. The cooling bath was removed and the reaction mixture heated 
to reflux for 18 hours. After cooling to 0 °C with an ice bath it was quenched by adding methanol (100 mL) 
dropwise and stirred for one hour while warming to room temperature. The solvents were then removed 
under reduced pressure and the residual semisolid was dissolved in KOH (20% w/w, 150 mL). The mixture 
was stirred for 5 hours before the organic components were extracted with CH2Cl2 (6x150 mL), dried over 
Na2SO4, filtered and solvents removed under reduced pressure. Purification by distillation (60 °C, 0.1 mbar) 
afforded (S)-valinol (7.35 g, 71.25 mmol, 83 %) as a clear oil.  
 
C5H13NO (MW = 103.16 g/mol): 
1H-NMR (500 MHz, CDCl3) δ 4.39 – 4.30 (m, 1H), 4.09 (t, J = 8.0 Hz, 1H), 3.94 (ddd, J = 9.6, 7.6, 6.1 Hz, 
1H), 3.21 (s, 1H), 1.76 (dq, J = 13.3, 6.7 Hz, 1H), 0.95 (d, J = 6.8 Hz, 3H), 0.88 (d, J = 6.8 Hz, 3H); Optical 
rotation: [] = -17 (c = 1.0 in CHCl3 with 0.75% EtOH); lit. [] = -23.2 (c = 3.7 in CHCl3)[190] 
 
 
(S)-2-(4-isopropyl-4,5-dihydrooxazol-2-yl)propan-2-ol[191] 
 
A 50 mL two-necked round bottom flask was equipped with a reflux condenser and a 
septum and purged with Argon three times. It was then charged with (S)-valinol (3 g, 
29 mmol, 1.05 eq.) and 2-hydroxy-2-methylpropanoic acid (2.88 g, 27.7 mmol, 1.0 
eq.) and dissolved in mesitylene (25 mL). The reaction mixture was heated to reflux 
for 2.5 days before being cooled to room temperature. The crude reaction mixture was 
subjected to elution chromatography (SiO2, cyclohexane) to remove the solvent before the crude product was 
washed down with EtOAc. After removal of solvents under reduced pressure, the residue was subjected to 
flash chromatography  (SiO2, cyclohexane/EtOAc 1:1, 13x4 cm, 20 mL fractions) to afford (S)-2-(4-
isopropyl-4,5-dihydrooxazol-2-yl)propan-2-ol (411 mg, 2.4 mmol, 9 %) as a clear oil. 
 
C9H17NO2 (MW = 171.24 g/mol): 
1H-NMR (500 MHz, CDCl3) δ 4.35 (t, J = 9.1 Hz, 1H), 4.09 (t, J = 8.0 Hz, 1H), 3.98 – 3.89 (m, 1H), 3.24 (s, 
1H), 1.81 – 1.69 (m, 1H), 1.44 (s, 6H), 0.95 (d, J = 6.8 Hz, 3H), 0.88 (d, J = 6.8 Hz, 3H); Optical rotation: [] = -78 (c = 1.0 in CHCl3 with 0.75% EtOH); lit. -78.5 (c = 1.07 in CHCl3)[191]  
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N-(triphenylphosphoranylidene)aniline[192] 
 
Aniline (6 mL, 6.3 mmol, 1.0 eq.) was suspended in water (50 mL) in a 250 mL 
round-bottomed flask and cooled to 0 °C. NaNO2 (5.45 g, 7.9 mmol, 1.25 eq.) was 
added and HCl (37% w/w, 20 mL) was added via dropping funnel. The reaction 
mixture was stirred for one hour until a dark blue colour was observed. NaN3 (5.5 g, 
8.46 mmol, 1.34 eq.) was added in one portion and the reaction stirred for another 
two hours. PPh3 (18 g, 6.86 mmol, 1.09 eq.) was added portionwise at 0 °C and then 
the reaction mixture was allowed to warm up to 23 °C while stirring overnight. After dilution with Et2O (50 
mL), the heterogeneous mixture was rinsed through a silica plug (4 cm, 6 cm ø) and rinsed with Et2O (100 
mL) to give an orange clear solution. The organic phase was decanted, dried over Na2SO4 and solvents 
removed under reduced pressure. The residue was resuspended in n-hexane to remove any soluble 
components before the residual solids were purified by recrystallisation from MeOH. Upon trituration of the 
saturated MeOH solution, N-(triphenylphosphoranylidene)aniline (8.16 g, 2.5 mmol, 40%) was obtained as 
an amorphous orange solid, which was dried in vacuo and stored under an atmosphere of argon in the 
freezer. 
 
C24H20NP (MW = 353.40 g/mol): 
1H-NMR (400 MHz, CDCl3) δ 7.82 – 7.73 (m, 6H), 7.56 – 7.49 (m, 3H), 7.49 – 7.41 (m, 6H), 7.03 (t, J = 7.6 
Hz, 2H), 6.87 – 6.80 (m, 2H), 6.68 (dd, J = 10.6, 3.8 Hz, 1H); 13C{1H}-NMR (101 MHz, CDCl3) δ 151.22 
(d, J = 3 Hz), 132.73 (d, J = 10 Hz), 131.73 (d, J = 2 Hz), 128.74, 128.70 (d, J = 1 Hz), 128.62, 123.64 (d, J 
= 18 Hz), 117.41; 31P{1H}-NMR (162 MHz, CDCl3) δ 3.53. 
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α  alpha 
Å  Ångstrom 
Ac  Acetyl 
Alk  Alkyl 
aq.  Aequeous 
ATR  attenuated total reflection (IR) 
Ar  Aryl 
BArF  Tetrakis[3,5-bis(trifluoromethyl)phenyl]borate 
BINAP  2,2’-Bis(diphenylphosphino)-1,1’-binaphtyl 
Bn  Benzyl 
br  broad 
b.p.  boiling point 
Bu  Butyl 
°C  Degrees Centigrade 
c  concentration 
calc.  calculated 
cat.  Catalyzed 
COD  Cyclooctadiene 
conv.  conversion 
Cp  Cyclopentadienyl 
Cp*  Pentamethylcyclopentadienyl 
Cy  Cyclohexyl 
d  days 
DCM  Dichloromethane 
dec.  decomposed 
DIOP  O-Isopropylidene-2,3-dihyroxy-1,4-bis(diphenylphosphino)butane 
DMF  Dimethylformamide 
DMSO  Dimethylsulfoxide 
DtBPF  Di-tert-butyl-phosphinoferrocene 
EA  Elemental Analysis 
ee  enantiomeric excess 
EI (MS) Electronic ionisation 
eq.  equivalents 
ESI (MS) Electronic Spray Ionisation 
Et  Ethyl 
EtOAc  Ethyl Acetate 
FAB (MS) Fast Atom Bombardement 
FTIR  Fourier Transformation Infrared Spectroscopy 
GC  Gas Chromatography 
h  hour 
HMBC  Heteronuclear Multiple Bond Coherence 
HMQC  Heteronuclear Multiple Quantum Coherence 
HPLC  High Performance Liquid Chromatography 
Hz  Hertz 
IR  Infrared Spectroscopy 
iPr  isopropyl 
J  Coupling constant 
K  Kelvin 
L  Ligand 
LDA  Lithium diisopropyl amine 
List of Abbreviations 
267 
L-DOPA L-3,4-Dihydroxyphenylalanine 
M  Molarity in solution 
m  meta 
MALDI Matrix Assisted Laser Desorption Ionization 
Me  Methyl 
MeOH  Methanol 
min  minutes 
mL  milliliters 
m.p.  melting point 
MS  Mass Spectroscopy 
MTBE  Methyl tert-butyl ether 
m/z  mass to charge ratio 
n.d.  not determined 
n-BuLi  1-butyl lithium 
NMR  Nuclear Magnetic Resonance 
NOE  Nuclear Overhause Effect 
n-Pr  1-propyl 
o  ortho 
o-Tol  ortho-Tolyl 
p  para 
Pd/C  Palladium on charcoal 
Ph  Phenyl 
PHOX  Phosphineoxazoline 
ppm  parts per million 
rac.  racemic 
RT  Room Temperature 
sat.  saturated 
tBu  tert-butyl 
T  Temperature 
TBAF  tetrabutylammonium fluoride 
t-BuLi  tert-butyl lithium 
TBDMS tert-butyl dimethylsilyl 
TFAA  Trifluoroacetic anhydride 
THF  Tetrahydrofuran 
TLC  Thin Layer Chromatography 
TMS  Trimethylsilyl 
tR  retention time 
Ts  Tosyl 
υ  wave number in cm-1 
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The mechanistic studies on iridium catalysed imine hydrogenation commenced by Dr. Fabiola Barrios were 
continued towards the development of an efficient hydrogenation protocol for purely aliphatic imines. 
Chapter 2 summarizes the previous results where new iridium(III) complexes, formed under the reaction 
conditions, were observed and characterized.  
 
 
 
These iridacycles bear a cyclometalated imine and were used as catalysts, showing virtually identical 
enantioselectivity and similar conversion as the iridium(I) complexes initially used as catalysts for imine and 
olefin hydrogenation. Furthermore, these in situ formed iridacycles demonstrated superior reactivity in the 
hydrogenation of dialkyl imines compared to their corresponding iridium(I) complexes. 
 
 
 
In-depth understanding of the reaction course was obtained with extended mechanistic investigations 
outlined in chapter 3. Cyclometalation of a chiral imine to an achiral iridium complex generated a chiral 
catalyst was formed. The structure of the cyclometalated imine was demonstrated to influence the 
enantioselectivity of the catalyst as well as to be involved in the enantiodiscriminating step of the 
hydrogenation. Furthermore, the iridacycle remained stable throughout the reaction as no dissociation of the 
cyclometalated imine was observed. 
 
P N
O
Ir
N
H
Ph
Ph
S
BArFN R
R
P N
O
Ph
Ph
BArF
Ir
Ph
N
Ph
Ph
HN
Ph
CH2Cl2, H2 [1 bar], 23 °C  
 
While acyclic chiral imines as cyclometalating ligands gave only low ee’s, cyclic ligand structures with a  
C-N double bond such as benzoxazines gave consistently higher ee’s.  
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The iridacycles were investigated in further detail by two-dimensional NMR studies and their preparation 
was improved by counterion metathesis. Deuterium labelling experiments depicted addition of hydrogen 
along the C-N double bond. Nevertheless, multiple isomerisation and scrambling processes were detected as 
well. Imine-enamine tautomerism occurs under hydrogenation conditions but hydrogenation proceeding via 
the enamine tautomer was excluded with imine substrates preventing tautomerism. Chiral phosphoric acids 
were evaluated as additives but resulted in low reactivity as well as imine hydrolysis. 
 
 
 
Chapter 4 summarizes the synthetic efforts for the synthesis of the different ligands with a C-N double bond 
employed in cyclometalation. Three different ligand scaffolds were prepared.  
 
 
 
Chapter 5 presents the optimisation studies for an efficient asymmetric hydrogenation protocol for purely 
aliphatic imines. Identification of the optimal imine additive used as a cyclometalating ligand led to the 
sterically demanding 2,6-dimethyl aniline derived imine. Furthermore, hydrogenations could be conducted at 
‒5 °C achieving full conversion and improving enantioselectivity up to 92%. Cyclic aliphatic imines could 
also be hydrogenated with these iridacycles, but required elevated reaction temperatures as well as hydrogen 
pressures to achieve turnover and displayed low conversions and enantioselectivities. 
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These studies concluded that iridium-catalysed imine hydrogenation is commenced by cyclometalation of the 
imine substrate to form an active iridium(III) catalyst prior to hydrogenation. If the imine substrate subjected 
to hydrogenation cannot undergo cyclometalation, low conversions and enantioselectivities as well as 
competitive hydrolysis are observed, as other catalytically active complexes are formed in solution. 
Therefore, acetophenone-derived imines can be used as additives to improve both reactivity and 
enantioselectivity of iridium catalysts for the hydrogenation of dialkyl imines generating a superior catalyst 
in situ. A postulated catalytic cycle is presented and includes both the possibility of an IrIII/IrV cycle as well 
as a constant oxidation state of IrIII. 
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